US20040193090A1 - Ambulatory medical apparatus with handheld communication device - Google Patents

Ambulatory medical apparatus with handheld communication device Download PDF

Info

Publication number
US20040193090A1
US20040193090A1 US10/824,083 US82408304A US2004193090A1 US 20040193090 A1 US20040193090 A1 US 20040193090A1 US 82408304 A US82408304 A US 82408304A US 2004193090 A1 US2004193090 A1 US 2004193090A1
Authority
US
United States
Prior art keywords
communication device
telemetry
processor
external communication
telemetry system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/824,083
Inventor
Ronald Lebel
Varaz Shahmirian
Timothy Starkweather
Daniel Villegas
David Choy
Philip Weiss
Colin Chong
Peter Lord
Wayne Morgan
Paul Meadows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Minimed Inc
Medical Res Group Inc
Original Assignee
Medtronic Minimed Inc
Medical Res Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Minimed Inc, Medical Res Group Inc filed Critical Medtronic Minimed Inc
Priority to US10/824,083 priority Critical patent/US20040193090A1/en
Publication of US20040193090A1 publication Critical patent/US20040193090A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14276Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37235Aspects of the external programmer
    • A61N1/37247User interfaces, e.g. input or presentation means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37258Alerting the patient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37264Changing the program; Upgrading firmware
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/3727Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data characterised by the modulation technique
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37276Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data characterised by means for reducing power consumption during telemetry
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F3/00Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
    • G06F3/06Digital input from, or digital output to, record carriers, e.g. RAID, emulated record carriers or networked record carriers
    • G06F3/0601Interfaces specially adapted for storage systems
    • G06F3/0602Interfaces specially adapted for storage systems specifically adapted to achieve a particular effect
    • G06F3/0614Improving the reliability of storage systems
    • G06F3/0619Improving the reliability of storage systems in relation to data integrity, e.g. data losses, bit errors
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F3/00Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
    • G06F3/06Digital input from, or digital output to, record carriers, e.g. RAID, emulated record carriers or networked record carriers
    • G06F3/0601Interfaces specially adapted for storage systems
    • G06F3/0628Interfaces specially adapted for storage systems making use of a particular technique
    • G06F3/0646Horizontal data movement in storage systems, i.e. moving data in between storage devices or systems
    • G06F3/065Replication mechanisms
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F3/00Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
    • G06F3/06Digital input from, or digital output to, record carriers, e.g. RAID, emulated record carriers or networked record carriers
    • G06F3/0601Interfaces specially adapted for storage systems
    • G06F3/0668Interfaces specially adapted for storage systems adopting a particular infrastructure
    • G06F3/0671In-line storage system
    • G06F3/0673Single storage device
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F8/00Arrangements for software engineering
    • G06F8/60Software deployment
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F8/00Arrangements for software engineering
    • G06F8/60Software deployment
    • G06F8/65Updates
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/40ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0204Operational features of power management
    • A61B2560/0209Operational features of power management adapted for power saving
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3507Communication with implanted devices, e.g. external control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3507Communication with implanted devices, e.g. external control
    • A61M2205/3523Communication with implanted devices, e.g. external control using telemetric means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/582Means for facilitating use, e.g. by people with impaired vision by tactile feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/60General characteristics of the apparatus with identification means
    • A61M2205/6018General characteristics of the apparatus with identification means providing set-up signals for the apparatus configuration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8206Internal energy supply devices battery-operated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00Methods of manufacture, assembly or production
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37252Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
    • A61N1/37254Pacemaker or defibrillator security, e.g. to prevent or inhibit programming alterations by hackers or unauthorised individuals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/37512Pacemakers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02DCLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
    • Y02D10/00Energy efficient computing, e.g. low power processors, power management or thermal management
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/13Infusion monitoring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/903Radio telemetry
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49002Electrical device making
    • Y10T29/49117Conductor or circuit manufacturing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49826Assembling or joining

Definitions

  • This invention relates generally to electronically controlled ambulatory medical systems that include an ambulatory medical device and a hand held microprocessor controlled communication device with enhanced user friendliness including enhanced display/patient notification features, safety features, and/or medical device programming/communication features.
  • Preferred embodiments relate to implantable infusion pumps and external devices for communicating therewith.
  • Implantable infusion pumps for dispensing controlled volumes of a drug have been proposed and even attempts at implementation and commercialization made.
  • One such pump is the MMT2001 Implantable Pump System as sold by Minimed Inc. of Northridge, Calif.
  • This device presented the user with the ability to perform basic infusion actions such as the delivery of a basal rate, delivery of a temporary basal rate, or the delivery of a meal bolus. The user was, however, not presented with the ability to perform more sophisticated delivery related operations that may be desirable for optimum control of blood glucose level.
  • the system also suffered from an external controller that was large, hard to carry and awkward to use.
  • the controller dimensions are 6.0 inches by 3.5 inches by 1.3 inches with a display that is a small fraction of the size of the face of the controller.
  • the controller included a cover plate that would close over the display area when not in use and would be opened during use. More particularly, during programming the cover plate is opened at a ninety-degree angle relative to the front of the display to allow viewing of the display and to allow positioning of the cover plate immediately over the site of the infusion pump so that successful telemetry communication may occur. As such the system does not supply delivery or system status related information to the user accept at the times that the user elects to open and turn on his/her controller.
  • the system further suffers from the inability of the implantable device to send out unsolicited telemetry messages to the controller concerning operational conditions within the implantable device.
  • system conditions within the implantable device are primarily conveyed to the user via an auditory alarm that is internal to the implantable device.
  • a first aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device weighs no more than about 10 oz and includes a CD housing having a volumetric size smaller than 20 cubic inches.
  • MD ambulatory medical device
  • CD communication device
  • a second aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical-device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD readable display which includes a bit map region for displaying selected information.
  • MD ambulatory medical device
  • CD communication device
  • a third aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a readable display which includes at least one icon.
  • MD ambulatory medical device
  • CD communication device
  • a fourth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a readable CD display which further includes a backlight.
  • MD ambulatory medical device
  • CD communication device
  • the communication device additionally includes a touch sensitive CD input device and wherein the backlight is automatically activated when one or more selected locations on the CD input device are touched.
  • the backlight is activated automatically when a light level falling on a sensor on the communication device is less than a predetermined amount and a touch sensitive region of the communication device is touched.
  • a fifth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device further includes an automatically activated CD alarm that is capable of providing a signal to the patient of the existence of a particular condition in at least one of the medical device or the communication device, and wherein the CD alarm includes at least one of a CD vibration mechanism or a CD audio
  • the communication device is configured to enable a patient to select between the CD alarm using the audio and vibration mechanism.
  • an alarm condition in the medical device is transmitted to the communication device via an unsolicited telemetry message.
  • the communication device is configured to automatically switch from one of the audio alarm or the vibration alarm to the other of the vibration alarm or the audio alarm under selected circumstances associated with at least one error condition.
  • one of the medical device or the communication device includes an audio alarm that produces a plurality of tones emitted in a predetermined sequence.
  • a sixth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a CD touch sensitive input device, and wherein the communication device additionally includes a readable CD display which further includes a capability of displaying different colors.
  • MD ambulatory medical device
  • CD communication device
  • the CD display is configured to display a single color at any one time.
  • the CD display is configured to display a plurality of colors at a single time.
  • a seventh aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a readable display that is also touch sensitive for allowing user inputs to be entered into the communication device.
  • MD ambulatory medical device
  • CD communication device
  • a eighth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD touch sensitive input device and a CD speaker that is controlled to supply speech based output to the patient.
  • MD ambulatory medical device
  • CD communication device
  • a ninth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD input device which further includes a CD microphone and a CD voice recognition system that are controlled to allow speech based input to the communication device.
  • MD ambulatory medical device
  • CD CD electronic control circuitry
  • CD processor that controls, at least in part, operation
  • a tenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a CD touch sensitive input device, and wherein the communication device is configured to perform a plurality of functions, and wherein the performance of at least a first function requires that the communication device be placed in an operational state dictated by a first or a second
  • the communication device can perform all functions with the second password that can be performed with the first password.
  • a eleventh aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device includes a touch sensitive CD input device, and wherein at least one of the communication device or the medical device may be reset, or placed in a state to allow reset to occur, by contacting a plurality of selected locations on the touch sensitive CD input device in a prescribed
  • password must be entered into the communication device prior to touching the plurality of selected locations on the touch sensitive CD input device in order for reset to occur.
  • a password must be entered into the communication device after touching the plurality of selected locations on the touch sensitive CD input device in order for reset to occur.
  • the plurality of touch sensitive locations are touched sequentially in order for reset to occur.
  • resetting may occur to different extents depending on variations in the plurality of touch sensitive locations touched, variations in the sequence of touching, or variations in the sequence of untouching.
  • a twelfth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is configured to receive status information on an MD battery via telemetry from the medical device.
  • MD ambulatory medical device
  • CD communication device
  • the medical device provides a periodic indication of the MD battery voltage when the MD battery is experiencing a current load that is closer to the minimum load during normal operation of the medical device than a maximum load during normal operation.
  • the medical device provides a periodic indication of the MD battery voltage when the MD battery is experiencing a current load which is closer to the maximum load during normal operation than a minimum load during normal operation.
  • MD battery status is provided using both a lower current load and a higher current load at least once a week.
  • the communication device provides an auditory, visual, or tactile warning when the MD battery is estimated to be capable of powering the medical device for less than a predetermined additional amount of time.
  • a thirteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes at least one battery and the medical device includes at least one battery, and wherein the communication device is configured to display log data of MD battery status information or CD battery status information.
  • MD ambulatory medical device
  • CD communication device
  • the log information includes a plurality of voltage readings taken from a predefined battery when the predefined battery is powering a first load and when the predefined battery is powering a second load which is different from the first load.
  • the log data is accumulated at least once per week.
  • a fourteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a socket for a removable memory module.
  • MD ambulatory medical device
  • CD communication device
  • the communication device includes the removable memory module.
  • the removal memory module contains replacement software for the communication device, replacement software for the medical device, or calibration data for a sensor that forms part of the medical device.
  • a fifteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device includes an implantable device, and wherein the communication device includes a memory for simultaneously storing a plurality of parameters that are each used during a different time period to, at least in part, control the treatment provided to the body or the monitoring of the body that is provided by
  • MD
  • the implantable device includes an infusion pump that is capable of dispensing a selected quantity of a drug according to a programmed parameter, and wherein each of the plurality of parameters includes a basal rate parameter that is programmed for use in controlling the dispensing of the drug during a selected time period during the day.
  • the plurality of parameters comprise a plurality of sets of parameters, wherein each set includes a plurality of parameters, wherein the medical device is capable of storing only one set at a time, and wherein the communication device transmits a selected on of the sets to the communication device when it is desired for the parameters of the transmitted set to control, at least in part, the dispensing of the drug.
  • a sixteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical system additionally includes a second device (SD) that includes an SD communication system, wherein the communication device further includes a second CD communication system, and wherein the communication device is programmable so as to echo all CD telemetry system messages, sent or received from the medical device,
  • MD
  • a seventeenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical system additionally includes a second device (SD) that includes an SD communication system, wherein the communication device further includes a second CD communication system, and wherein the communication device is programmable to pass messages received from the second device on to the medical device via transfer from the SD communication system
  • MD
  • a eighteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical system additionally includes a second device (SD) that includes an SD communication system, wherein the communication device further includes a second CD communication system that is capable of sending messages to or receiving messages from the SD communication system, and wherein the communication device additionally includes a CD keypad
  • a nineteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is programmed to accept input parameters that specify the delivery of a predefined quantity of treatment to the body of the patient over a prescribed time period wherein the average rate of delivery per minute of portions of the predefined quantity varies as a function of time according to a preprogramm
  • the preprogrammed delivery profile results in a bell shaped curve of average delivery per minute versus time.
  • the communication device allows the patient to select a most suitable of a plurality of bell shaped delivery profiles.
  • at least one of the curves is symmetric.
  • at least one of the curves is non-symmetric with a generally steeper upward slope than downward slope.
  • a twentieth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is powered by a replaceable battery and wherein sufficient power is stored in one or more capacitors within the communication device that a controlled power down can occur when the replaceable battery is removed such that upon replacement of the battery the communication device need not be reprogrammed to resume operation
  • MD
  • the communication device monitors the voltage on the replaceable batter so as to detect a removal of the battery and initiate and complete a controlled shut down prior to the capacitors losing a required minimum voltage.
  • a twenty-first aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device is configured to provide a drug to the body of a patient in amounts that are integer multiples of a quantized amount, wherein the communication device is programmed to allow entry of delivery quantities that are not integral multiples of the quantized amount.
  • MD ambulatory medical device
  • a twenty-second aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD display device for providing visual communication signals to the patient which further includes a zoomable display so that the size of displayed images may be adjusted to a desired size.
  • MD ambulatory medical device
  • CD communication device
  • CD includes CD electronic control circuitry that
  • the CD display device includes a LCD bit map display.
  • a twenty-third aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device includes an infusion pump, and wherein the CD display device is controlled to show a plurality of infusion parameters simultaneously.
  • MD ambulatory medical device
  • CD communication device
  • a twenty-fourth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the CD display device includes a moving image that graphically depicts a status of the system.
  • MD ambulatory medical device
  • CD communication device
  • the medical device includes an infusion pump and the status being depicted includes an indication of a delivery status.
  • the moving image rotates.
  • the image includes a number of elements that may be active or inactive and differing numbers of active elements indicates different delivery states.
  • a twenty-fifth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device includes a CD display controlled by the at least one CD processor for providing visual feedback to the patient, and wherein the feedback includes a display of the quantity of a consumable estimated to be remaining in the system.
  • MD ambulatory medical device
  • CD communication device
  • the consumable is a quantity of a drug estimated to be remaining in a reservoir.
  • the consumable is either (1) battery power remaining in a replaceable CD battery in the communication device and a voltage level on the CD battery is graphically depicted with a desired resolution, or (2) battery power remaining in an MD battery in the medical device and a voltage level on the battery is graphically depicted with a desired resolution.
  • a twenty-sixth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the CD display is controlled to depict a plurality of patient programmable options and wherein at least one of the patient programmable options may be enabled or disabled such that when disabled the at least one patient programmable option is no longer displayed as an option.
  • MD ambulatory medical
  • a twenty-seventh aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device or the communication device monitors battery voltage and generates a voltage log, wherein the medical device monitors a CD voltage of a CD battery in the communication device and generates a CD voltage log.
  • MD ambulatory medical device
  • CD computer electronic control circuit
  • the log includes a plurality of CD voltage values for each of a plurality of different current drain states.
  • a twenty-eighth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein both the medical device and the communication device have memories for storing selected data about system operation, wherein at least a portion of the selected data is duplicated in the medical device and the communication device.
  • MD ambulatory medical device
  • CD communication device
  • the communication device is programmed to periodically synchronize the duplicated data.
  • At least a portion of the selected data is synchronized automatically or is synchronized in response to a synchronization command.
  • a twenty-ninth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is programmed to allow a user to set a plurality of parameters to predefined default values by issuing a command that does require specification of any of the default values.
  • MD ambulatory medical device
  • CD communication device
  • a thirtieth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is capable of performing a test of battery voltage with a load on the battery.
  • MD ambulatory medical device
  • CD communication device
  • the test of battery voltage is performed automatically and periodically. In a further variation at least one of the following will occur, (1) the battery voltage is also automatically and periodically checked with the battery under a minimal load, (2) at least one selected electrical component is forced on to produce the load for testing, or (3) the test is made to occur at least in part when at least one selected electrical component is powered on in the performance of its normal operation, wherein the electrical component provides a load for the testing.
  • a thirty-first aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein at least one of the medical device or communication device has a memory for storing at least one calibration factor needed for proper operation of the system.
  • MD ambulatory medical device
  • CD communication device
  • the medical device includes an infusion pump mechanism for dispensing a drug held in a reservoir within the medical device and the at least one calibration factor includes at least one of (1) information about the concentration of the drug, (2) delivery volume per discrete operation of an infusion pump mechanism, (3) the amount of drug placed in the reservoir when filled, (4) a voltage value necessary to cause the pump mechanism to operate properly, (5) a value to be used by a pulse stealer circuit, (6) a calibration factor to be used by an analog to digital converter, or (7) a specific telemetry ID of the device.
  • a thirty-second aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein at least one of the medical device or communication device includes a first component or module that may be powered directly by a battery when the battery's output voltage is above a predetermined level, and wherein the at least on of the medical device or communication device includes a voltage up converter that
  • a thirty-third aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein at least one watchdog circuit is capable of causing the CD processor to undergo a predefined process in the event that the watchdog circuit does not receive a first signal and a second signal, which is different from the first signal, within a predefined time period.
  • MD ambulatory medical
  • the predefined process causes the CD processor to be reset.
  • one of the first or second signals is a signal generated by mainline software.
  • the other of the first or second signals is a signal generated by interrupt hardware.
  • a thirty-fourth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein an antenna for the MD telemetry system is mounted on a hybrid circuit board in the medical device and wherein the antenna for the CD telemetry system is mounted on a hybrid circuit board in the communication device.
  • MD ambulatory medical device
  • CD communication device
  • a thirty-fifth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device monitors electrical activity of at least one electronic module or component located within the communication device and compares the electrical activity to at least one predetermined value.
  • MD ambulatory medical device
  • CD communication device
  • the at least one electronic module is located within an application specific integrated circuit that includes the CD processor, (2) the at least one electronic module includes a crystal oscillator circuit, (3) the at least one electronic module includes a driver for the treatment or monitoring device, (4) the predetermined value includes an upper and lower limit of a range of values, or (5) the electrical activity includes a current flow.
  • implantable devices such as implantable infusion pumps, implantable physiological sensors, implantable stimulators, and the like, or external devices such subcutaneous delivery infusion pumps or sensors that ascertain a physiological parameter or parameters from subcutaneous tissue or from the skin of the patient.
  • implantable devices such as implantable infusion pumps, implantable physiological sensors, implantable stimulators, and the like, or external devices such subcutaneous delivery infusion pumps or sensors that ascertain a physiological parameter or parameters from subcutaneous tissue or from the skin of the patient.
  • infusion pumps may dispense insulin, analgesics, neurological drugs, drugs for treating aids, drugs for treating chronic ailments or acute ailments.
  • Sensors may be used to detect various physiological parameters such as hormone levels, insulin, pH, oxygen, other blood chemical constituent levels, and the like.
  • the sensor may be of the electrochemical type, optical type, and may or may not be enzymatic in operation.
  • a first portion of the MD telemetry system is incorporated into the MD processor and a second portion of the MD telemetry system is external to the MD processor
  • a first portion of the CD telemetry system is incorporated into the CD processor and a second portion of the CD telemetry system is external to the CD processor
  • the MD processor includes an MD central processing unit and at least one other MD functional module
  • the CD processor includes a CD central processing unit and at least one other CD functional module
  • the MD electronic control circuitry includes at least one external MD functional module, other than a portion of the MD telemetry system, that is external to the MD processor
  • the CD electronic control circuitry includes at least one external CD functional module, other than a portion of the CD telemetry system, that is external to the CD processor.
  • FIG. 1 a depicts a perspective view of the main body of the implantable device of the first preferred embodiment
  • FIG. 1 b depicts a perspective view of the support and catheter assembly that attaches to the main body of the implantable device of the first preferred embodiment
  • FIG. 2 depicts a perspective view of the external communication device of the first preferred embodiment
  • FIG. 3 depicts a block diagram of the main components/modules of both the implantable device and the external communication device of the first preferred embodiment.
  • FIGS. 4 a and 4 b depict a block diagram of the main components/modules and their inter-connections as used in the external communication device of the first preferred embodiment
  • FIG. 5 depicts the display screen of the external communication device of the first preferred embodiment
  • FIG. 6 depicts a block diagram of the various modules of the processor IC used in both the implantable device and the external communication device of the first preferred embodiment
  • FIGS. 7 a and 7 b depicts the main menu structure for the user interface of the external communication device of the first preferred embodiment
  • FIGS. 8 a and 8 b depicts the setup menu structure for the user interface of the external communication device of the first preferred embodiment
  • FIGS. 9 a and 9 b depicts the setup ii menu structure for the user interface of the external communication device of the first preferred embodiment
  • FIGS. 10 a and 10 b depicts the supervisor menu structure for the user interface of the external communication device of the first preferred embodiment
  • FIG. 11 depicts the bolus delivery sequence or menu structure for the user interface of the external communication device of the first preferred embodiment.
  • FIG. 12 depicts the communication sequence associated with the user interface of the external communication device of the first preferred embodiment.
  • the implantable device is capable of operating under control of different software programs, wherein a first program operates after resetting the implantable device and is not capable of allowing significant medical functionality but is capable of selected telemetry operations including telemetry operations that allow replacement software to be downloaded, and wherein a second program may be caused to take control of the device and enables medical functionality and selected telemetry operations but is incapable of receiving replacement software.
  • a software image may be received in multiple messages where each message is provided with its own validation code and wherein a validation code for the whole image is provided and wherein each provided validation code must compared to a derived validation code prior to accepting the validity of the replacement software.
  • Messages are transmitted using a multipart format that includes a preamble, a frame sync, a telemetry ID, data, and a validation code.
  • the data portion of the message includes an op-code that dictates various other elements that form part of the message.
  • the data portion may also include additional elements such as sequence numbers, bolus numbers, and duplicate data elements.
  • a telemetry ID for the transmitting device may be implicitly embedded in the message as part of the validation code that is sent with the message and that must be pre-known by the receiver to confirm the integrity of the received message.
  • the window may be forced to an open state, by use of an attention signal, in anticipation of an incoming message.
  • an attention signal In anticipation of an incoming message.
  • the estimate is updated as a result of information obtained with the reception of each message from the medical device.
  • bit transitions for portions of messages may be enhanced by applying a pseudo-randomization scheme to those portions of messages that are transmitted in a way that allows the receiver to extract the original data from the received randomized data.
  • Preferred randomization techniques modify (i.e. randomize) the data using a CRC value that is being accumulated while simultaneously causing the modified data to modify subsequent accumulation of the CRC itself.
  • the reversal of data randomization is then made to occur so that the intended message is appropriately received.
  • Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur.
  • Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur.
  • the accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions.
  • the first embodiment of the present invention provides a long term implantable medical delivery system that controllably supplies insulin to the body of a patient afflicted with diabetes mellitus.
  • This embodiment includes an implantable medical device and an external communication device.
  • the communication device is a hand held device that is used directly by the patient to interact with the medical device as opposed to being limited to use by a physician, nurse, or technician. It is preferred that the communication device provide (1) the ability to send commands to the medical device, (2) receive information from the medical device, and (3) be able to present to the patient at least a portion of the information it receives from the medical device.
  • the patient interacts with the medical device via the communication device at least once per week, on average, more preferably at least once every other day, on average, and most preferably at least once per day, on average.
  • the implantable medical device includes a biocompatible housing; a reservoir within the housing for holding a quantity of insulin; a side port that attaches to the side of the housing, a catheter, that connects to the side port; a pumping mechanism, within the housing for moving the insulin from the reservoir through the sideport and through the catheter to the body of the patient; and control, monitoring, and communication electronics located within the housing.
  • various portions of implantable medical device hardware may be located outside the housing.
  • the pumping mechanism or a telemetry antenna may be located within the sideport or other side mounted housing; or a telemetry antenna may mounted on the outside surface of the housing, or extend along the catheter
  • the external communication device communicates commands to the medical device, receives information from the medical device, and communicates system status and system history to the patient.
  • the external communication device includes a housing; a keypad mounted on the housing; a display forming part of the housing; and control, monitoring, and communication electronics located within the housing.
  • the keypad may be replaced in whole or in part by a touch sensitive display or a voice recognition system.
  • the display may be replaced in whole or in part by a speech generation system or other audio communication system.
  • FIGS. 1 a and 1 b The outer appearance of the implantable device 2 is depicted in two pieces in FIGS. 1 a and 1 b and includes housing 6 having a drug outlet port 8 , and a refill port 12 , a removable sideport 14 that mounts against the side of the housing 6 over outlet port 8 , and a catheter 16 having a distal end 18 and a proximal end that attaches to sideport 14 .
  • the implantable device may take on a different shape and/or the sideport may be removed in favor of a permanently mounted catheter assembly.
  • FIG. 2 The outer appearance of the external communication device 32 is depicted in FIG. 2.
  • Housing 34 is divided into a front portion 34 a and a back portion 34 b.
  • the front portion 34 a is provided with an opening in which an LCD panel 36 is positioned.
  • the panel 36 has a lower portion that is a bit map display and an upper portion that provides icons and fixed element displays.
  • the front portion 34 a of the external communication device is also provided with a five-element keypad 38 .
  • a first key 38 a is not located under a raised pad and does not provide tactile feedback when it is touched and may be used for special functions.
  • the remaining four keys 38 b, 38 c, 38 d, and 38 e have raised pads that provide tactile feedback when they are depressed. These remaining keys may be used in normal device operation and are known as the select key, the up arrow key, down arrow key, and the activate key, respectively.
  • the back portion 34 b of the housing is fitted with a door under which a compartment is located for holding a replaceable battery.
  • the implantable device includes a memory for storing program code and data.
  • a portion of the memory in the implantable device is preferably used to store configuration information for the external communication device and for the implantable device itself. This allows the configuration data to be reloaded into a replacement external communication device if the original should be lost or damaged.
  • This memory is also used to store system operation information in the form of activity logs and counters, such an insulin delivery log.
  • Various portions of the contents of implantable device memory are downloaded to the external communication device periodically. The downloads to the external communication device may occur manually, automatically, or semi-automatically.
  • the implantable device control electronics include various self-checking mechanisms to ensure that reliable operation of the system occurs. For example, as the pumping mechanism in this first embodiment requires a firing voltage that is significantly greater than the supply voltage, a pre-fire voltage on the pump firing circuit is checked to ensure it is large enough to cause the pump to execute a full stroke. After firing, the voltage is checked again, to ensure that discharging of the circuit occurred.
  • Each processor is monitored by a watchdog circuit that must be serviced, periodically. As implemented in the software, servicing must occur at both the interrupt level and at the mainline code level to ensure that the processor has not malfunctioned at either level. Insulin delivery calculations are performed by both processors in such a manner that both processors must agree on the quantity and timing of insulin delivery.
  • the implantable device may be placed in a protective mode (i.e. suspend mode or stop mode) where insulin delivery is cut back to a medically insignificant rate (e.g. about 1 pump stroke per hour) or stopped completely. It is preferred to have a small amount of insulin be delivered periodically to help prevent the occurrence of catheter blockage. In any event, if system failure does occur the system effectively stops delivery and attempts to warn the patient.
  • a protective mode i.e. suspend mode or stop mode
  • a medically insignificant rate e.g. about 1 pump stroke per hour
  • the identity of the sender is preferably embedded implicitly in the message. This implicit embedding occurs by using the identification information of the sender in calculating a cyclical redunancy code (CRC) that is sent with the message. As such, the implantable device must know the identity of the sender in order to successfully check the content of the message against the transmitted CRC.
  • CRC cyclical redunancy code
  • the values of the data in the message are compared to an operation code (Op Code) sent with the message to ensure that the code and data are compatible.
  • This Op Code is also used to set the size of the most messages, thereby providing a mechanism to increase electrical efficiency of the system by providing a way to limit reception time to only that amount necessary to receive a particular message.
  • the device may attempt to inform the patient of the event by sending a telemetry message to the external communication device or alternatively by activating an audio alarm mechanism within the implantable device itself.
  • the implantable device is preferably configured so that the software running in it can be replaced or upgraded if the need should arise.
  • the software may be downloaded into the implantable device through telemetry.
  • the implantable device may be operated under two types of software: (1) bootloader code, or (2) application code.
  • the bootloader code may be broken down into first stage boot loader code which is stored in the ROM that is internal to the ASIC and second stage bootloader code that is stored in a SEEPROM or other non-volatile memory associated with each ASIC.
  • the bootloader code and application code are different for each ASIC.
  • the bootloader code does not care about the application in which the implantable device may be used.
  • the bootloader code is not concerned with whether, the implantable device is an infusion device, a sensor, a stimulator, or the like, or a combination thereof.
  • the application code is concerned with the medical functionality of the device and thus is designed specifically for a given type of application. As such, if an implantable device includes a pump and was initially configured (i.e. loaded with specific application software) to work with one drug (e.g. insulin) in one manner (e.g.
  • the implantable device When operating under control of the bootloader code, the implantable device allows certain telemetry operations to occur and also allows downloading of new application code, but does not allow any drug delivery.
  • the application code when controlling the system, on the other hand, knows how to handle drug delivery but is not capable of downloading new code, or otherwise modifying itself (other than to accept changes in parameter values).
  • the bootloader code is also designed and operated in such a way that new bootloader code can be downloaded to the SEEPROM if an upgrade is felt to be appropriate.
  • the implantable device assembly includes a detachable catheter and sideport that provides a pathway for the insulin to a desired infusion location in the patient's body (e.g. into the patient's peritoneal cavity).
  • the sideport allows for non-surgical diagnosis of a catheter blockage by using pressure.
  • the sideport allows introduction of a refill needle and small syringe to clear an obstructed catheter (e.g. using up to 110 psi of pressure).
  • the sideport also allows the introduction of a refill needle and a pipet to verify pump stroking.
  • the catheter includes a check valve that seals (e.g.
  • the sideport in conjunction with the check valve facilitates rinsing the fluid path within the implanted device with sodium hydroxide, or other functionally similar material, by allowing effluent to be drawn out the sideport rather than pumped out the catheter tip.
  • a sideport may not be used.
  • the external communication device has both an audio alarm and a vibrator for alerting the patient or user of warnings and alarm conditions.
  • the user has some control over the selection of audio alarm or vibration while the system can automatically switch from vibration to audio if the vibrational alarm is not responded to in a timely manner.
  • the audio alarm is programmable to emit at different frequencies, at different volume levels, for different durations, and with different repetition patterns. These various alternatives are used to signal different conditions.
  • the vibratory alarm is also programmable to go off for different durations and with differing repetition patterns. In alternative embodiments, only one type of alarm may be used and it may be used with or without different frequencies, volumes, durations, or loudnesses.
  • the software controlling the external communication device is permanently stored within the external communication device using a non-volatile memory such as a serial electrically erasable programmable read only memory (SEEPROM) and is transferred to random access memroy (RAM) for execution.
  • SEEPROM serial electrically erasable programmable read only memory
  • RAM random access memroy
  • the code being executed in RAM can be reloaded from that SEEPROM as needed.
  • Software located within the SEEPROM can be replaced with new software under controlled conditions.
  • the external communication device is provided with sufficient memory capability to store a duplicate, or upgrade, version of application software for the implantable device as well as to store about 120 days of operational data. Under controlled conditions the external communication device may be reset to its default configuration automatically (i.e. upon command without the user having to specifically identify specific parameter values).
  • the software may be stored in a different device (e.g. a physical ROM, volatile RAM, non-volatile RAM, or in a replaceable plug in module).
  • the software may be divided into boot
  • the implantable device and external communication device communicate with each other through radio frequency telemetry where reception and transmission within the implantable device uses an antenna that is located within the metalic device housing based on a carrier frequency that allows an acceptable amount of signal to penetrate through the housing and through the human body.
  • an antenna for the implantable device may be placed on the housing or be otherwise located external to the housing so that outgoing and/or incoming signals need not penetrate the housing material.
  • the preferred frequency is either about 131 kHz or about 262 kHz.
  • the preferred data transfer rate is at about 8200 bits/second.
  • different carrier frequencies may be used, e.g. from tens of kilohertz to thousands of megahertz.
  • the external communication device and implantable device are configured and operate together to provide rapid feedback to the operator.
  • a response to a basal rate or bolus programming telemetry interaction is preferably provided to the patient within no more than 20 seconds and more preferably within less than about 10 seconds, and most preferably within less than about 5 seconds.
  • Each implantable device and external communication device are preferably assigned unique telemetry identifiers and a particular implantable device and particular external communication device are made to undergo a linking process (alternatively known as a marrying process) so substantive communication (e.g. communications that allow the external communication device to control the medical operation of the implantable device) is limited to a joined pair.
  • the communication link between the external communication device and implantable device provides various levels of checking and confirmation to minimize the possibility of the implantable device receiving and then acting on an erroneous delivery command message.
  • unique identifiers may be supplied to only one of the implantable or external communication devices, or even non-unique identifiers may be utilized.
  • the linking or marrying process is completed prior to a external communication device being allowed to send drug delivery commands or updated software to a particular implantable device.
  • the marrying feature provides the mechanism to configure an implantable device to communicate with a particular external communication device. This is carried out when the implantable device and the external communication device are initially configured.
  • the linking process requires positive assertion from the user indicating that external communication device is linking to the correct implantable device.
  • the linking process starts with the external communication device sending an interrogate message to all implantable devices within range by using a universal identifier.
  • Each implantable device that is within range responds to the external communication device's interrogate message by sending a response that includes patient identity information as stored in that particular implantable device. If the desired implantable device is the first to respond to the interrogate signal, the user can acknowledge his/her desire to link the external communication device and the implantable device. Otherwise, if the first responding implantable device is not the one to be linked to, the patient may indicate so and that particular implantable device identifier is added to a temporary exclusion list and the interrogate message is resent (including the exclusion list). When the interrogate message is received by each implantable device, only those whose identifiers are not in the exclusion list will attempt a response, thereby allowing other implantable devices within range to respond and be heard.
  • the user can elect to start the linking process. Once the link is established, the implantable device is made to enter suspend mode and then the user must reprogram all basal rates including temporary basal rates that were in progress, profile basal rates, and delivery patterns. In alternative embodiments, all or a portion of this information may be retrieved from the implantable device, assuming it was programmed previously, but in this particular embodiment as an added measure of safety, it was preferred that these parameters should be reprogrammed so that the user is made to provide a positive assertion that he/she knows the delivery parameters that the implantable device is using.
  • the external communication device obtains other data from the implantable device that it requires in performing its operations, e.g. the external communication device obtains stroke volume information for the pulsatile pump and obtains insulin concentration data that is stored in the implantable device.
  • the sending and receiving of IR signals by the external communication device is based on basic IrDA standards.
  • the transfer rate for the IR link is about 115 kbits/second. Of course in other embodiments other baud rates may be used or even automatically selected between.
  • the IR link may be used to (1) upload new software to the external communication device from a second external device, (2) download system operation information to the second external device for further analysis as desired, and/or (3) pass commands/responses to or from a second external device from or to the implantable device.
  • the second external device may be personal computer running appropriate software or a more specialized system.
  • the communications sent over the IR link are based on protocol details that ensure that only intended messages, and correctly received messages, are received and acted upon.
  • a second or third external communication device may be used in conjunction with the first external communication device or as a temporary or partial replacement therefor.
  • a chest strap, wrist watch, mattress pad, or the like containing appropriate telecommunication capabilities might be used as a relay device to pick up warning signals or other communication signals coming from the implantable device and then to transmit them to the first external communication device or a third external communication device so that a warning may be sounded to wake up the patient, to directly notify emergency personnel of a problem, or to notify other monitoring personnel in a timely manner of medical device operation or patient condition.
  • Such notification may occur using any appropriate telecommunication systems, such as telephonic or internet connections.
  • the second communication device may implement the warning signal directly.
  • the second or third external communication devices may communicate with the first external communication device via RF telemetry, IR communication link, optical link, galvanic connection, inductive communication, or the like.
  • the implantable device of the present embodiment has various delivery modes.
  • One of these modes is the suspend mode wherein the system is caused to reduce insulin delivery to a clinically insignificant amount (e.g. 1 pump stroke (approximately 0.2 units of insulin assuming a stroke volume of 0.5 microliters and a U-400 insulin concentration) per hour. It is intended that this minimal rate of delivery keep the catheter open.
  • the “suspend mode” mode may be used to interrupt delivery of a bolus, priming bolus, profile basal rate, diagnostic rate, and/or temporary basal rate.
  • the system is programmed to alarm periodically to indicate to the user that the system is delivering insulin at a clinically insignificant rate. The user may exit suspend mode and resume basal delivery.
  • any bolus that is in progress when suspend mode is asserted is canceled such that any undelivered portion will not be delivered even when suspend mode is cleared.
  • the implantable device is delivering a temporary basal rate when suspend mode is entered, the temporary basal rate duration continues while the pump is in suspend mode, and the temporary basal rate is reasserted when suspend mode is cleared for any portion of the duration that has not already lapsed.
  • other control options may be implemented with regard to going into or coming out of a mode analogous to suspend mode.
  • the external communication device is programmable using an audio bolus mode.
  • This mode allows a user to program the delivery of a bolus without looking at the external communication device display.
  • This mode provides an audio feedback to the user to indicate the amount of the bolus that is being programmed.
  • the audio bolus feature allows programming of immediate boluses. Immediate boluses are those that specify a quantity of insulin to be delivered in as short a time as possible, e.g. a short as time as necessitated and allowed by any required repeated operation of the pumping mechanism. Under selected conditions a parameter selection may be made that dictates the incremental increase in bolus amount with each successive key entry (e.g. press of the Up-Arrow Key) when in audio bolus mode.
  • the external communication device provides another parameter that enables or disables the audio bolus feature.
  • the user may confirm the accuracy of the selected amount by pressing a different key (e.g. the ACT key).
  • a different key e.g. the ACT key
  • the external communication device plays a sequence of audio tones so as to indicate the amount programmed. If the amount is correct the user may press the ACT key again to initiate delivery. If the amount is incorrect the user may simply wait a predetermined, but short, period of time for the external communication device to time out or alternatively, the user may press any key other than the confirmation key. A distinct sound is emitted to indicate that delivery was not initiated, a which point the user may simply start over with the audio or visual programming.
  • key press sequences may be used in the performance of programming an audio bolus.
  • audio programming could be performed without any keystrokes or with a single keystroke to activate the external communication device's listening mode.
  • the external communication device were configured with a sound transducer and appropriate speech enabling hardware and/or software, then instead of sounding a series of beeps to indicate program status, it could communicate to the user, in a predefined language, to indicate the status.
  • speech recognition and/or speech generation hardware could be used to replace or supplement keypad or touch screen input capabilities.
  • basal rate delivery and bolus delivery may be programmed to occur in conjunction with each other as opposed to one replacing the other.
  • the system does not replace basal rate delivery with bolus deliver but instead combines the amount to be delivered under basal programming with the amount to be delivered under bolus programming to cause a net amount to be delivered that is equal to the sum of both amounts.
  • the user may program a bolus amount on the external communication device and the implantable device will respond by delivering that amount. The amount of the bolus is subjected to a bolus maximum as described below.
  • the system allows the user to program an amount to deliver that the implantable device will deliver as quickly as possible using a required number of pump strokes with typically no more than 6 seconds between successive pump strokes (e.g. 1-3 seconds per stroke).
  • This type of bolus is sometimes referred to as an immediate bolus or phase I bolus.
  • the system allows a bolus to be delivered where the user programs an amount and a duration.
  • the implantable device delivers the amount as a rate (i.e. number of pump strokes per unit time) for the duration specified such that the amount programmed by the user is delivered within the duration.
  • a rate i.e. number of pump strokes per unit time
  • This is analogous to a basal rate or temporary basal rate delivery in some manner but is not identical as the total amount to be delivered is the sum of this amount and any basal rate that is currently in effect.
  • the user does not program the delivery amount as a rate.
  • This type of bolus is sometimes referred to a square wave or phase II bolus.
  • the system supports a “dual wave bolus” where the user programs an amount for immediate delivery (immediate bolus) and a second amount for delivery during a specified duration (square wave bolus).
  • the implantable device delivers the immediate amount as described above, followed by delivery of the second amount over the duration as a square wave amount also as described above.
  • the system also supports delivery of an immediate bolus while delivery of a square wave bolus is in progress or while delivery of the square wave portion of the dual wave bolus is in progress so long as the immediate portion of the dual wave bolus has been completed.
  • variable bolus option The programming of boluses in the external communication device is further controlled by a variable bolus option. If the variable bolus option is set to “no”, only immediate bolus programming is allowed and the square wave and dual bolus options are removed from the menu choices available on the external communication device. If the variable bolus option is set to “yes”, immediate, square wave, and dual wave bolus programming are allowed and all menu options are presented to the user.
  • the implantable device holds a number of logs.
  • One of these logs is a bolus history log.
  • the implantable device maintains the time and amount of boluses that have been delivered.
  • This log contains the most recent boluses that were delivered.
  • This log is set to contain up to a predefined number of boluses after which the log wraps around and deletes older entries in favor of recording new entries.
  • the external communication device receives these records from the implantable device. These records may be viewed on the external communication device or alternatively they may be downloaded to a second external device where they can be viewed in numerical form or be plotted for viewing in graphical form.
  • the storage of this log information in the implantable device ensures that historical information remains available even in the event that the external communication device is lost, damaged, or otherwise fails.
  • Each time a new bolus is programmed from the external communication device and confirmed by the implantable device the details of the previously delivered bolus are provided back to the external communication device so a log maintained in the external communication device is almost as up to date as the log maintained by the implantable device.
  • the log maintained in the external communication device can be scrolled through for review by the patient or healthcare provider.
  • Each bolus history record includes the amount, time, and date of the bolus delivery.
  • the implantable device maintains another log that provides the total amount of insulin delivered by date.
  • the implantable device maintains a history of the most recent 120 days of insulin delivery totals with the daily total separated by basal delivery and bolus delivery.
  • the daily totals are downloaded automatically or semi-automatically from the implantable device to the external communication device each day. As with the bolus log, this information is protected from loss or failure of the external communication device by its retention in the implantable device.
  • the system maintains multiple sets of basal rates where each set dictates basal rate delivery for a selected interval of time and each element in each set dictates the basal rate delivery for a subset of that selected interval of time.
  • the number of sets is three
  • the selected interval of time is 24 hours beginning at midnight
  • the subset of the selected interval of time is 30 minutes which starts at the beginning of each half hour mark during the day.
  • each set consists of up to 48 rates that can start on any half-hour of the day.
  • the delivery rates need not be entered for each subset but instead only for those subsets that represent a change in delivery rate compared to the previous subset.
  • basal rate values are only entered for the subset half hours in which transitions occur and are entered by specifying the start times and rates.
  • Up to three 24-hour profiles may be entered with only one of the profiles selected as active at any given time. When a profile is made active, information about that profile is communicated to the implantable device to replace any other basal rate information retained there.
  • only one profile set is stored in the implantable device at any given time. The active profile is repeatedly used day after day to control basal rate delivery in the implantable device until it is replaced by a different or revised profile.
  • Such basal profile sets may be used for different types of days, e.g. work days, non-work days, exercise days, non-exercise days, sick days, high stress days, and the like.
  • the system allows a temporary basal rate to replace any profile based basal rates during a specified period. This feature allows the user to program a basal rate without changing the basal profile. When the temporary basal rate duration lapses, the implantable device resumes delivery of the basal profile rate that is then in effect based on the selected profile and the then current time of day.
  • the temporary basal rate for example, may be utilized to program lower basal rates during periods of exercise, or used to program higher rates during periods of high stress.
  • Selected “personal events” are recordable by the user in a personal event log.
  • the personal event log is accessed through the external communication device and stored in the external communication device. In alternative embodiments these events may be communicated to the implantable device for safekeeping.
  • the user may record the time that certain events occurred, such as exercising, meals, or illness.
  • a parameter may be set so as to disable personal event logging. When disabled, the option does not present itself on the user menu in the external communication device. In the present embodiment, the system provides sufficient memory and control for retention and review of up to 100 such events.
  • “Automatic Off” is another feature of this embodiment.
  • the insulin delivery system turns itself off if the user does not interact with the implantable device through telemetry for a programmed amount of time.
  • This feature may be enabled or disabled.
  • the turning off of the implantable device refers to the implantable device going into suspend mode.
  • the implantable device alarms if it goes into minimum delivery mode as a result of the automatic off interval lapsing.
  • the automatic off interval is reset each time the implantable device receives a valid telemetry message from the external communication device intended specifically for it.
  • the external communication device is programmed to track the time that elapses between communications and to alarm 5 minutes before the automatic off interval lapses. This enables the user to clear the alarm and interact with the implantable device before the implantable device itself alarms and thus results in reduced power consumption by the implantable device.
  • An additional parameter of the present embodiment is bolus maximum which specifies the size of the largest single bolus that can be delivered.
  • a pumping operation used in setting up the implantable device, called priming bolus is not subject to this maximum.
  • the external communication device is programmed so that a user can not program an immediate bolus amount greater than the bolus maximum.
  • the external communication device is also programmed so that the sum of the immediate amount and the extended amount of a bolus (regardless of the duration) may not exceed the Bolus Maximum.
  • the implantable device uses the bolus maximum as a safety check of each bolus request that is received from the external communication device.
  • the external communication device is programmed to sound a maximum alarm if the user attempts to deliver an amount of insulin during a predefined period that exceeds a predefined limit.
  • the predefined period of time is one hour and the maximum alarm is termed the hourly maximum alarm and the predefined limit is 2.5 times the Bolus Maximum.
  • This alarm is intended as a safety alert to the user and not as an absolute limit on the amount that can be dispensed in any one hour period.
  • the external communication device is programmed to compute the total amount of bolus delivery during the previous one hour period each time a bolus is programmed. If the amount already delivered summed with the programmed amount exceeds 2.5 times the programmed bolus maximum, the external communication device alarms and the bolus is not allowed.
  • the short window is set at ten minutes.
  • both amounts programmed for an immediate and square wave boluses are considered in triggering the hourly maximum exceeded alarm regardless of when the extended bolus amount was or is to be delivered.
  • the external communication device may be programmed to take into account quantities that have or will be delivered within a one hour period based on the programmed amounts and time intervals.
  • the maximum amount in the predefined period may be determined based on something other than the maximum bolus amount.
  • the maximum bolus amount may be implemented as a hard limit. In still further embodiments, a second or subsequent bolus programmed in the same short window would not be subject to the warning. In other embodiments, the external communication device could not only warn the patient that the maximum amount has been exceeded but would also indicate the amount that was delivered in the period being considered.
  • External communication device programming and implantable device delivery are also limited by a basal rate maximum which is the highest rate that may be delivered using a profile basal rate or a temporary basal rate.
  • a delivery rate used for diagnostic purposes known as the diagnostic rate is not subject to this maximum.
  • the external communication device is programmed to inhibit the user from entering a basal rate greater than the basal rate maximum.
  • the implantable device uses the basal rate maximum as a safety check of each basal rate that is programmed.
  • the implantable device ignores delivery requests that include basal rate amounts greater than the basal rate maximum.
  • the external communication device is configured to inhibit the user and physician from setting a maximum basal rate that is less than any of the basal rates already programmed including those in the profiles that are not currently active.
  • the external communication device is capable of displaying an estimate of the amount of medication remaining in the insulin reservoir.
  • the external communication device is programmed to alarm when the medication remaining becomes less than a predefined low-reservoir threshold.
  • low-reservoir threshold alarms are reasserted after clearing if appropriate actions have not been taken to resolve the condition that gave rise to the error or event (e.g. refilling of the reservoir has not been completed).
  • the alarm will be reasserted so as to provide the user with a reminder to have the reservoir refilled.
  • the implantable device and external communication device retain clinical history information as records of various events that the system tracks. For example, events that stop the delivery of insulin such as alarms are recorded in the clinical history. User-initiated events such as suspend mode that stop the delivery of insulin are also recorded. Refills are also recorded.
  • the system also contains logs for system diagnostics such as implantable device battery levels. Through menu options the user may view these various history logs.
  • the system is programmed to allow a user to initiate a self test in both the external communication device and the implantable device. If there are any error conditions detected, they are reported to the user.
  • the system self test includes a number of different checks: (1) implantable device memory, (2) external communication device memory, (3) implantable device piezo operation, (4) external communication device piezo operation, (5) external communication device vibrator operation, and (6) external communication device display. If an error is detected, the system reports the error to the user using visual, vibrational or audio alarms.
  • the external communication device is configured to emit audio alarms, or to vibrate, in the event an alarm condition exists.
  • the implantable device always emits an audio alarm if an error condition persists beyond a predefined amount of time based on the particular alarm condition that exists.
  • the external communication device is configured to allow the user to selected audio or vibration notification when alarm conditions exist.
  • the implantable device is programmed to contact the external communication device by telemetry prior to sounding an alarm on its own. In the event that the external communication device receives the message and successfully notifies the user of the condition and the user clears the alarm prior to a predefined time period passing, the implantable device does not sound the alarm directly on its own. In the event that the alarm condition is cleared but not resolved, the implantable device may directly reassert and sound the alarm later or may reassert and recontact the external communication device through telemetry.
  • the system supports an audio feedback mode where the implantable device may be programmed to beep on a first predefined number (e.g. 3-10 pump strokes after a rate change, and for a first predefined number (e.g. 3-10) pump strokes of a bolus.
  • a first predefined number e.g. 3-10 pump strokes after a rate change
  • a first predefined number e.g. 3-10 pump strokes of a bolus.
  • other feedback techniques may be implemented.
  • the system supports a storage mode for the implantable device and for the external communication device.
  • Storage mode in the implantable device is a state where there is no drug delivery and no alarms and the frequency of waking up to listen for incoming telemetry messages is reduced.
  • Storage mode in the external communication device is a state where the screen is blank and no user functions are available.
  • the implantable device is programmed to enter storage mode upon receipt of a particular telemetry command.
  • the implantable device is programmed to exit storage mode by receipt of a particular telemetry command. There is no implantable device alarm that indicates that the implantable device is entering storage mode.
  • the external communication device is programmed to enter storage mode if there is no user interaction with the external communication device for an extended period of time (e.g. 5-10 days).
  • the external communication device is programmed to exit storage mode in the event of user interaction with external communication device such as button presses.
  • external communication device such as button presses.
  • the system allows refilling of the pump and reporting on delivery accuracy.
  • the system is programmed to allow entry of an extracted volume and a fill volume during the refill process.
  • the external communication device may be made to display delivery accuracy based on a difference between the expected amount remaining in the insulin reservoir and the actual amount of insulin removed during the refill process.
  • the system is configured to support user and physician programming of the delivery options using insulin units based on a desired resolution value not based on a predetermined pump stroke volume.
  • the external communication device When the external communication device is programmed to deliver a certain amount of insulin, the external communication device calculates the number of pump strokes necessary to deliver that quantity and passes the pump stroke information onto the implantable device.
  • the pump stroke information is passed in fixed point format including both an integer portion and a fractional portion.
  • the determination of pump strokes is based on the implantable device pump stroke volume and the insulin concentration.
  • the system of this embodiment is configured to allow a programming option to be set that allows the physician to prime the catheter quickly. As will be discussed further hereafter, this option is only available as a supervisor function.
  • the priming function/option triggers the implantable device to deliver an amount of insulin large enough to fill the catheter. In this mode, pump strokes are delivered as fast as possible. The physician is notified when the priming bolus is completed.
  • the system supports a special rate called diagnostic rate that is only programmable as a “supervisor only” function. This special rate is used in determining delivery accuracy.
  • the diagnostic rate function triggers the implantable device to deliver at a programmed rate that is not subject to the basal rate maximum.
  • the setting of system maximum basal rate and maximum bolus amounts may be programmed to be inaccessible to the patient and only accessible through a supervisor menu.
  • the patient's ability to access these maximum values is controlled by a maximum lock parameter that is a supervisor function.
  • the maximum lock feature When the maximum lock feature is enabled, the user may view, but not change, the bolus maximum and the basal rate maximum.
  • the maximum lock feature When the maximum lock feature is disabled, the user may change the bolus maximum and the basal rate maximum.
  • the system includes memory space and program capability to personalize the external communication device and implantable device so that information such as the patient name and physician name can be stored for later retrieval and review.
  • the personal ID may be as little as 10 characters and as much as 200 characters or more.
  • this information it is preferred that at least a portion of this information be used in determining that the external communication device has contacted the desired implantable device (assuming the implantable device has already been previously programmed with identity information.
  • identification information is updated in the external communication device it is passed on to and stored in the implantable device.
  • the system retains factory default information and may be reset to those values when operating under supervisor control so that the system may be configured rapidly to a known state.
  • the system may also be placed in a stop mode or controlled to replace or reload implantable device software when operating under supervisor control.
  • supervisor menu is password protected.
  • the password may be set by the physician while in supervisor mode.
  • the supervisor menu system may also be entered by using a factory password.
  • the factory password may be derived from the system characteristics.
  • the factory password may be a fixed number or character pattern. It may be based on a variable parameter, such as the date reflected by the external communication device, and/or the time reflected by the external communication device, and/or the serial number of the external communication device.
  • Supervisor options/functions include the following: (1) refill, (2) priming bolus, (3) diagnostic rate, (4) maximum lock, (5) personal ID setting, (6) initialize to factory defaults, (7) download implantable device software, (8) stop pump, and (9) set supervisor password.
  • the user interface uses four keys, e.g. a SEL, ACT, UP and DOWN key, to navigate through menus, display options and features, and to program values.
  • the external communication device changes the display to the idle display which shuts off the bit map display if the external communication device keypad is idle for a predefined period of time, preferably between 2 seconds and 30 seconds, more preferably between 4 seconds and 15 seconds and more preferably between 5 seconds and 10 seconds e.g. 7 seconds, while the user is viewing options.
  • the external communication device may change the display to the idle display using a different predetermined time, e.g. a longer time such as 15 seconds, if the external communication device is idle while the user is in a programming or data entry screen.
  • the system is programmed to display the current time and date.
  • the time may be displayed in either a 12-hour or 24-hour format depending on user preference though in either event internal calculations that require time are based on a 24 hour clock.
  • All time displays by the external communication device are shown in the same format including time stamps on historical data and profile start times.
  • This format in the present embodiment is based on a relative time measured in minutes since the factory initialization of the implantable device.
  • Acceptable parameter ranges for selected variables used in this first embodiment are depicted in the following table. Of course, in other embodiments other ranges are possible, other programming units may be used, some parameters may be converted to constants while other parameters may be added as variables.
  • Acceptable Parameter Ranges Parameter Name Values Automatic Off Duration Off, 1-16 hours Audio Bolus Increment 0.4 units or 0.8 units Bolus Amount 0.2 U to Bolus Maximum by 0.2 U Bolus Duration 30 min to 4 hours Maximum Bolus 0.2 U to 35.0 U by 0.2 U Hourly Maximum Bolus 21 ⁇ 2 times the programmed Maximum Bolus Basal Rate 0.2 U/hr to Basal Rate Maximum by 0.1 U/hr Temporary Basal Rate 0.2 U/hr to Basal Rate Maximum by 0.1 U/hr Temporary Basal Rate Duration 30 min to 24 hrs by 30 min Basal Rate Maximum 0.2 U/hr to 35 U/hr by 0.1 U/hr Diagnostic Rate 10 to 150 u/hr by 10 u/hr in U-400 10 to
  • both the implantable device and the external communication device detect and report alarm conditions.
  • the following table depicts examples of different types of alarms and examples of associated delivery states that are entered in response to the condition that gave rise to the alarm.
  • Alarm Conditions ALARM Alarm Condition Alarm State Action Low Battery Alarm when there is Alarm Only/Icon ON battery energy remaining of about 8 weeks or less Depleted Battery None guaranteed No Delivery Low Reservoir Alarm when 2 mL of Alarm Only/Icon ON drug remaining Empty Reservoir Alarm when 1 mL of Alarm Only/Icon ON drug remaining Any implantable Alarm No Delivery device Hardware Failure Detect Over Delivery Alarm when disagreement No Delivery from various delivery calculations produces a discrepancy of a first type. Under Delivery Alarm when disagreement No Delivery from various delivery calculations produces a discrepancy of a second type.
  • Self Test Failure Alarm when the periodic No Delivery self test including the memory test fails
  • the implantable device and external communication device preferably meet certain physical targets: (1) The implantable device is preferably packaged in disk shaped housing that is thinner than about 1 inch, and preferably thinner than 0.9 inches, and more preferably thinner than about 0.8 inches or less, with a diameter of less than about 4 inches and more preferably about 3.2 inches or less, and having an empty weight of less than about 180 grams and more preferably less than about 165 grams, and (2) The external communication device has been packaged in a somewhat rounded but nominally rectangular shaped package having dimensions of less than about 1.0 inch by 3.5 inches by 4.0 inches, but more preferably having dimensions about 0.8 inch or less by about 2.8 inches or less by about 3.5 inches or less, and weighing less than about 6 oz. In other embodiments, various other device shapes and sizes may be used.
  • the implantable device and external communication device are preferably also designed and are controlled to meet certain longevity requirements in combination with the desired functional requirements. It is desired that the implantable device remain operational within the body of a patient for a period of about five years or longer, more preferably a period of about seven years or longer, and most preferably a period of about 9 years or longer.
  • the longevity of the implantable device is primarily dictated by the power consumption of the electronic modules and the capacity of the battery. The determination of longevity is complicated by the fact that the power consumption of the electronic modules is not constant over time but varies depending on the actions that are required by the user.
  • Two elements of the preferred embodiment that lead to an acceptable level of longevity are the use of low power electronic circuit elements and the controlled application of power and/or clocking signals to various modules.
  • the power and/or clocking signals are supplied to the modules on an as needed basis and operational protocols have been put into place to minimize the amount of time that the various modules need to operate.
  • operational protocols include the implantable device's attempt to communicate with the external communication device by telemetry prior to using a more power consumptive internal alarming process.
  • Another example involves the implantable device having a storage mode that uses less power than a normal operational mode.
  • a further example includes the implantable device's process of turning on its receive telemetry for short periods of time (about four milliseconds) on a periodic basis (once every two seconds) to listen for incoming messages and then shutting off the telemetry system if no messages are incoming.
  • An additional example includes the processor's ability to turn itself off when it is not needed and to be awakened by interrupt signals when needed.
  • FIG. 3 depicts a simplified block diagram of various functional components or modules (i.e. single components or groups of components) included in the implantable medical device 2 and external communication device 32 .
  • the external communication device 32 includes (1) a housing or cover 34 preferably formed from a durable plastic material, (2) processing electronics 42 including a CPU and memory elements for storing control programs and operation data, (3) an LCD display 36 for providing operation for information to the user, (4) a keypad 38 for taking input from the user, (5) an audio alarm 44 for providing information to the user, (6) a vibrator 46 for providing information to the user, (7) a main battery 52 for supplying power to the device, (8) a backup battery 54 to provide memory maintenance for the device, (9) a radio frequency (RF) telemetry system 56 for sending signals to the implantable medical device and for receiving signals from the implantable medical device, and (10) an infrared (IR) input/output system 58 for communicating with a second external device.
  • RF radio frequency
  • the second external device may include input, display and programming capabilities.
  • the second device may include a personal computer operating specialized software.
  • the computer may be used to manipulate the data retrieved from the communication device or the medical device or it may be used to program new parameters into the communication device or directly into the medical device, or even used to download new software to the communication device or to the medical device.
  • the manipulation of the data may be used in generating graphical displays of the data to help aid in the interpretation of the data.
  • Such data interpretation might be particularly useful if the medical device provides data concerning a physiological parameter of the body of the patient, such as a glucose level versus time. More particularly the computing power and display attributes of the second device might be even more useful when the medical device includes both an implanted sensor (e.g.
  • the second external device may be used to enhance the ability to ascertain the effectiveness of the two devices working together. Successful control periods and problem control periods could be more readily identified. In fact, if the two devices work on a closed loop basis or semi-closed loop basis, the analysis performable by the second external device may be useful in deriving new closed loop control parameters and/or in programming those parameters directly into the communication device or the medical device or devices.
  • the implantable device 2 includes (1) a housing or cover 6 preferably made of titanium that may or may not be coated to enhance biocompatibility, (2) processing electronics 72 including two CPUs and memory elements for storing control programs and operation data, (3) battery 74 for providing power to the system, (4) RF telemetry system 76 for sending communication signals (i.e. messages) to the external device and for receiving communication signals (i.e.
  • alarm or buzzer 82 for providing feedback to the user
  • refill port 12 for accepting a new supply of drug as needed
  • reservoir 84 for storing a drug for future infusion
  • pumping mechanism 86 for forcing selected quantities of drug from the reservoir through the catheter to the body of the patient
  • sideport 14 for providing a replaceable connection between the (10) catheter and the pump housing and for allowing diagnostic testing of the fluid handling system to occur
  • catheter 16 for carrying medication from the implant location to the desired infusion location.
  • the pump mechanism is preferably a low power, electromagnetically driven piston pump.
  • a low power, electromagnetically driven piston pump such as for example Model Nos. P650005 or P650009 as sold by Wilson Greatbatch Ltd. of Clarence, N.Y. which have stroke volumes of 0.5 microliters and draw under 7 mJ (e.g. about 6 mJ) per pump stroke and under 4 mJ (e.g. about 3 mJ) per pump stroke, respectively.
  • the pump mechanism dispenses a sufficiently small volume of insulin per stroke so that a desired level of infusion resolution is achieved. For example if an infusion resolution of 0.2 units of insulin were desired when using U400 insulin, then a stroke volume of about 0.5 microliters would be appropriate.
  • other types of infusion pumps may be used, e.g. peristaltic pumps, screw driven pumps, and the like.
  • the implantable device includes a reservoir 84 for holding a desired quantity of insulin.
  • the drug held in the reservoir is preferably maintained at a slight negative differential pressure (with respect to the pressure on the outside of the housing) so that in the event of a leakage in the reservoir 84 or housing 6 , the drug will not be forced from the housing into the body of the patient.
  • the drug is added to the reservoir 84 by means of a transcutaneous needle that is passed from a position exterior to the body into self sealing refill port 12 . Due to the slight negative pressure that the reservoir experiences, insulin in a syringe connected to the needled is drawn into the reservoir without need of external force.
  • the drug is extracted from the reservoir 84 and forced through catheter 16 by an electronically controlled pump mechanism 86 .
  • positive pressure reservoirs may be used in combination with pumping mechanisms that force the medication or drug from the implantable device and/or used with flow restrictors that dispensed the drug at a fixed rate or at a variable rate with the aid of valves or flow diverters.
  • the size of the reservoir is preferably large enough to hold sufficient insulin so that refilling does not have to occur too often. For example, it is preferred that time between refills be within the range of 1.5-4 months or longer, more preferably at least 2 months, and most preferably at least 3 months. Opposing the containment of a large volume of insulin, is the desire to keep the implantable device as small as possible. In the present embodiment the implantable device and reservoir has been designed to hold about 13 ml of insulin.
  • a preferred insulin has a concentration of 400 units per milliliter and is available from Aventis HOE 21 Ph U-400 from Aventis Pharma (formerly Hoechst Marion Roussel AG, of Frankfurt am Main, Germany).
  • This insulin is a highly purified, semi-synthetic human insulin with 0.2% phenol as a preserving agent, glycerol as an isotonic component, TRIS as a buffer, plus zinc and Genopal® as stabilizing agents.
  • This quantity and insulin concentration allows about 2-4 months between refills. In other embodiments higher insulin concentrations may be used (e.g. U-500 or U-1000) to increase time between refills or to allow reduction in reservoir size. In some embodiments, when higher concentrations are used, any quantized minimum delivery amounts may be reduced by modifying the pumping mechanism, control circuitry, or software control algorithm so that infusion resolution is not adversely impacted.
  • the external communication device contains appropriate software to provide proper control of the device including appropriate functionality to allow communication with the medical device, to allow adequate control of the operation of the medical device, and to give appropriate feedback to the user regarding overall system operation.
  • the medical device is provided with appropriate software to allow communication with the external communication device, to allow safe and appropriate operation of the medical functionality of the device, and to allow direct feedback to the user concerning device status via the internal alarm.
  • control electronics of both the implantable device and external communication device are centered around microprocessor based integrated circuits, i.e. processor ICs, that are implemented in the present embodiment in the form of application specific integrated circuits (ASICs).
  • ASICs application specific integrated circuits
  • Two such ASICs are used in the implantable device to increase operational safety of the device by configuring the device to require that the two ASICs act in conjunction with each other in order for medication infusion to occur.
  • control electronics may be implemented within one or more processor ICs while any remaining portions may be implemented external to the processor IC(s).
  • the processor IC may be referred to as an MD processor if used in the medical device portion of the system or a CD processor if used in the communication device portion of the system.
  • the process IC used in the communication device may be different, e.g. have a different CPU or different peripheral modules, from a processor IC used in the medical device.
  • each of the processors may be different. They may be specifically designed for their intended roles when they perform at least partially different functions.
  • portions of the electronics not embodied in the processor ICs may form part of one or more hybrid circuit boards or be otherwise mounted within, on, or even in some cases external to a device housing.
  • FIG. 6 A functional block diagram of the Processor IC for the present embodiment is depicted in FIG. 6.
  • Each processor IC of the present embodiment includes a CPU 912 and various peripheral modules that are used for system control, data acquisition, and interfacing with electrical components external to the processor IC.
  • the peripheral modules of the processor IC of the present embodiment include (1) a non-volatile memory interface module, e.g. a SEEPROM interface module 914 , (2) a boot ROM module 916 ; (3) an SRAM module 918 ; (4) a memory decoder module 920 ; (5) a crystal oscillator module 922 ; (6) a timer module 924 ; (7) a pump interface module 926 ; (8) a watchdog module 928 ; (9) an RF telemetry module 930 ; (10) an interrupt handler module 932 ; (12) an analog-to-digital converter module 934 ; (13) an LCD clock driver module 936 ; (14) an alarm interface module 938 ; and (15) first and second synchronous serial interface modules 942 and 944 .
  • a non-volatile memory interface module e.g. a SEEPROM interface module 914 , (2) a boot ROM module 916 ; (3) an SRAM module 918 ; (4) a memory decoder
  • the memory decoder module interfaces with the core processor, boot ROM, and internal SRAM using a 16 bit address bus which also is available off chip for addressing external memory. With the exception of the crystal oscillator module all other internal module communicate over an 8-bit data bus or 16-bit data bus.
  • FIG. 6 further illustrates that the A/D module may take input from sources internal to the processor IC and similarly the interrupt handler can take up to 9 interrupts from sources internal to the processor IC. Additionally, most of the modules communicate with outside components or modules over one or more input/output lines.
  • peripheral modules may be incorporated into the processor ICs.
  • the processor IC may simply incorporate a CPU with all other modules being external thereto.
  • almost all, if not all, electronic components may be incorporated into a single processor IC.
  • Intermediate alternatives might incorporate a single additional module into the processor IC (in addition to the CPU), others might incorporate more than one, e.g. 4 or more, 8 or more, or the like.
  • the number of peripheral modules or components in an entire device may be considered and more than a certain percentage of them incorporated into one or more processor ICs, e.g. more than 50%, more than 75%, or even more than 90%.
  • the processor ICs are responsible for basic system management and communication of information between the implantable device and the external communication device through the RF telemetry link.
  • the telemetry systems of the present embodiment are implemented in part through electrical hardware and in part through software controlled by a processor IC.
  • the required electrical modules for the implantable device are integrated within the processor ICs. However, several are not. These additional modules include two independent crystal oscillators (one for each ASIC); two non-volatile memory modules (one for each ASIC), e.g. SEEPROM chips; a volatile memory module (used only by one of the ASICs), e.g. an SRAM chip; pump driver circuitry (partially controlled by the each ASIC); front end telemetry system circuitry; and voltage measurement circuitry associated with the pump driver circuit; a buzzer; and a battery.
  • ASIC application-specific integrated circuit
  • monitor processor controls the buzzer and is thus responsible for audio communications coming from the implantable device.
  • the medical functionality of the implantable device i.e. the administration of insulin in the present embodiment
  • both processors To maintain the implantable device in a fail-safe operational mode, these two processors must maintain an appropriate level of agreement concerning infusion instructions or a system reset is forced to occur.
  • the main and monitor processors communicate with each other through the use of hardwired-serial input and output ports.
  • the control electronics of the external communication device are centered around an ASIC that controls and interacts with a number of peripheral modules.
  • peripheral modules include an LCD display and driver, an IR port and driver, a crystal oscillator, a keypad and keypad interface, power management modules and reset circuitry, external volatile memory (e.g. SRAM) and non-volatile memory (e.g. SEEPROM), a buzzer, and front end telemetry hardware.
  • the external communication device is a hand-held device that allows a user to program and communicate with the implantable device.
  • the external communication device of the present embodiment preferably has a weight of less than about ounces, a thickness of less than about 0.8 inches, a width of less than about 2.8 inches, and a length of less than about 4.0 inches.
  • the external communication device is enclosed by housing 34 as depicted in FIG. 2 and includes within housing 34 a number of different electronic modules or components. These modules and a high level outline of their interconnections are depicted in FIGS. 4 a and 4 b.
  • FIGS. 4 a and 4 b form the left and right halves of a single block diagram.
  • the electronic configuration of the external communication device is centered on an ASIC 502 which has been divided for presentation purposes into left and right halves 502 a and 502 b.
  • the ASIC 502 includes a microprocessor, internal ROM, internal RAM and a number of additional modules.
  • a number of the ASIC modules used by the external communication device are depicted in FIGS. 4 a and 4 b. These modules include (1) a watchdog 522 , (2) an external reset 534 , (3) an A/D converter 542 , (4) a serial ROM port 572 , (5) a first serial synchronous interface port 592 , (6) an RF module 612 , (7) an oscillator module ( 650 ), (7) a tone alarm driver 682 , and (8) LCD port 692 , (9) three interrupt inputs, and (10) a number of I/O buses.
  • the preferred ASIC for use in the external communication device is identical to the ASICs used in the implantable device. Further details about the ASIC are provided hereafter.
  • the ASIC includes a first interrupt input 512 that receives interrupt signals 514 generated by a key interrupt generator circuit 516 .
  • the ASIC includes a watchdog 522 and watchdog output 524 that is fed into “OR” logic circuitry 526 that effectively performs an “OR” operation on three different signals.
  • An output signal 528 of the OR logic circuitry 526 is fed into an input 532 of the ASIC which in turn is connected to reset circuitry 534 that triggers the Processor IC to be reset.
  • the Processor IC can be reset by making any of the three signals high which in turn will drive the output of the “OR” logic circuitry high and thus the input 532 high.
  • the watchdog output signal 524 is made to go high when the processor does not reset the watchdog in a timely manner.
  • the ASIC includes analog-to-digital converter electronics 542 that uses two external inputs 544 and 546 which are used, respectively, for measuring a voltage (VAA) of a main battery and a voltage (VCOIN) of a backup battery.
  • VAA voltage
  • VCOIN voltage
  • the ASIC includes a second external interrupt input 552 that is connected to battery failure detection circuitry 554 by line 556 that carries a high reset signal.
  • the ASIC includes an I/O bus 562 for carrying address, data and control signals to and from 1 megabyte of external SRAM 564 located on two external chips.
  • Each chip is a four megabit, low power SRAM, organized as 256 k by 16 bits, operating between 2.7 and 3.6 volts, with a maximum standby current of 15 ⁇ A.
  • This memory may be accessed either byte-wide or word-wide, as controlled by two external ram signals from the ASIC.
  • an additional two signals from the ASIC are used for chip selection and a third additional signal is sued for bank selection.
  • the third additional signal uses the same output as did the pump fire signal on the monitor processor in the Implantable Device.
  • I/O bus further provides 17 address lines and 16 data lines.
  • a power management module 722 produces a back up battery power signal 762 that goes high when the main battery 732 fails and power is being supplied by the back up battery 752 .
  • the signal 762 is high, access to the SRAM chips is disabled and thus memory access is denied. This is implemented to prevent memory access during unstable periods and to t ti-state the memory chip outputs so they are not driving low impedance inputs when boosted voltage 736 (VCC), coming from up-converter 734 that is powered by the main battery 732 , fails.
  • VCC boosted voltage 736
  • the 762 signal and one of chip selection signals are provided to the inputs of an OR gate and the signal from the OR gate (not shown) is the control signal that is passed to the SRAM. As such, for the particular SRAM chip to be accessible both these signals must be in their low states.
  • VPOS power signal 756
  • the ASIC includes a SEEPROM port 572 that is used to connect to two external SEEPROMs 574 using a power output signal 576 , a clock output signal 578 , and a bidirectional data communication line 582 .
  • the SEEPROMs may be identical chips, for example. They preferably have a two wire interface, are internally organized as 64 k by 8 bits, support bidirectional data transfer, and use an operating voltage between 1.8 and 3.6 volts. These chips are used to provide memory space for program code and program data. The addresses of these two SEEPROM chips are set by hard wiring. Each chip has a capacity of 64K bytes, organized as 512 pages of 128-bytes each. Each SEEPROM is configured so that it can be written to as well as read from during run time by the system processor.
  • one of the SEEPROMs is used for storing external communication device software which is loaded into internal RAM or external RAM during system boot up, while the other SEEPROM is capable of holding software for download to the implantable device.
  • the ASIC includes a first synchronous serial interface port 592 that is functionally connected to an external UART 594 using several lines 596 , including a single clock line for both incoming and outgoing data, a data-in line for data coming from the UART to the Processor, and a data-out line for data going to UART.
  • a third external interrupt input 602 for the ASIC is connected to UART 594 by line 604 .
  • a high signal is generated on line 604 by the UART chip whenever serial data is received through the IrDA port.
  • the ASIC also provides an RF telemetry module 612 which provides TXI and TXQ signals, on lines 614 and 616 , to RF transmitter circuitry 618 .
  • the RF telemetry module also provides a power signal 622 to RF receiver circuitry 624 .
  • the RF receiver circuitry provides a first and second mixer input signals, 626 and 628 , respectively, back to a mixer 632 in the RF telemetry module 612 .
  • the RF module also provides a control signal 634 to switching circuitry 636 that effectively connects either the RF transmitter circuitry to an antenna 638 or RF Receiver circuitry to the antenna 638 .
  • the control signal 634 is also provided to a NAND gate 642 .
  • the RF telemetry system in the external communication device is similar to that of the implantable device in overall configuration and in control though some differences in circuit detail do exist.
  • the RF system uses a carrier frequency of about 250 kHz (e.g. 262,144 Hz ⁇ 125 Hz).
  • the RF telemetry subsystem is composed of analog and digital modules.
  • the digital module includes a QFAST® modulator/demodulator, a control and timing logic circuit that are integrated in the Processor IC.
  • the analog module consists of an RF front-end circuit and a mixer.
  • the mixer is also integrated in the processor IC.
  • the RF front-end circuit consists of RF transmitter circuitry and RF receiver circuitry, which is in-turn composed of a band-pass filter and a 3-stage amplifier.
  • the RF receive circuitry and transmit circuitry share the same antenna 638 .
  • the antenna 638 is a faraday-shielded, air-coil, housed within the housing of the external communication device.
  • the antenna and the faraday shield are connected to the printed circuit board.
  • the antenna is switched between transmit and receive functions in a similar manner to that described above with regard to the implantable device.
  • Switch 636 is similar to switch 234 of the implantable device and includes a tristate driver and an analog switch. The switch is also controlled in an analogous manner.
  • the transmitter 618 is substantially the same as that described above for the implantable device.
  • the RF Receiver 624 is similar to that used in the implantable device. As with the implantable device, the RF Receiver module 624 includes three amplifier stages that are tuned to pass and amplify desired signals. In contradiction to the implementation in the implantable device, all three stages of in the external communication device are tuned.
  • the first stage has its frequency response set by a tank circuit with tuning adjustable by a variable capacitor. The signal from the tank circuit is passed through a direct current voltage blocking capacitor and then on to a pair of transistors in a push-pull configuration.
  • the transistors may be identical to those used in the implantable device.
  • the second and third stages use tuned push-pull transistor configurations.
  • the signal resulting from these three stages has preferably been amplified by 70 to 90 dB with an RF passband of about 16 kHz (e.g. about 2 14 Hz) centered around a 262,144 kHz carrier at the 2 dB ripple peak-to-peak maximum.
  • An RF stopband of about ⁇ 65 dB is provided at below about 150 kHz and at above about 550 kHz.
  • the line carrying the output signal from these three stages is taken to ground through a 100 k ⁇ resistor and then a 390 ⁇ F capacitor.
  • a first signal, RFI is taken from the output signal prior to the output signal passing through the resistor.
  • a second signal, RFQ is taken from the output signal from between the resistor and the capacitor.
  • the RFI and RFQ signals are then passed onto the main processor IC.
  • the RFI signal is the filtered and amplified RF signal that was received by the telemetry system, while the RFQ signal is a direct current signal having a voltage value equal to the average voltage value of the RFI signal.
  • the ASIC is also connected in parallel to a crystal oscillator 652 and associated resistor 654 by lines 656 and 658 .
  • the ASIC is additionally connected to a first output port 662 by an I/O bus 664 and a second output port 668 by an I/O bus 672 .
  • Each of these two output ports may be formed from an octel tristate non-inverting D flip-flop. These output ports are latching so that inputs from the CPU need not be maintained constantly.
  • Address decoding and port enablement are provided by a single external port and address decoder chip.
  • This decoder is preferably a 1-of-8 Decoder/Demultiplexer.
  • This address decoder chip is used by both the output ports as well as the keyboard input port 702 .
  • the output ports are enabled/disabled by the RESET signal 726 . Such that when RESET is asserted (low) due to the main battery voltage VAA falling below a programmed threshold, the output ports are tri-stated. When this happens, pull-up resistors set the outputs to appropriate states so that all high current devices are shutdown. This is done to preserve the energy stored in the VCC storage capacitors so it is only used for powering the appropriate portions of the circuit for an orderly shut-down.
  • the ASIC further provides tone driver circuitry 682 to an audio alarm 44 (e.g. a piezo alarm) by lines 686 and 688 that carry first and second buzzer signals that are produced by the Processor IC.
  • an audio alarm 44 e.g. a piezo alarm
  • the ASIC further includes a second synchronous serial interface port 692 that functions as an LCD port for communicating with an LCD module 694 that includes LCD driver and display 36 (FIGS. 2 and 3).
  • Three communication lines 696 are used between the serial interface port and the LCD module.
  • One of the lines provides a selectable clock, for driving the LCD, of either about 64 kHz or 32 kHz (i.e. about 2 16 Hz or 2 15 Hz).
  • An additional three control signals 782 are provided by output port 662 . These control signals include a chip select signal, a reset signal, and a clock loop back signal.
  • the LCD of the present embodiment is powered by an LCD driver chip, such as Part No. MC141800A from Motorola. Communication to the LCD module is performed using I 2 C serial communication protocol. The communication lines are supplied directly from the second serial synchronous interface communication port of the Processor IC.
  • the external communication device visually communicates to the patient using an LCD display 36 .
  • This display includes a dot-matrix graphics LCD for displaying a portion of the information to be conveyed and an icon/fixed segment display for displaying the remaining information to be conveyed.
  • the dot-matrix display allows various languages to be displayed with only a software change or change of a parameter (variable) within the software.
  • the dot-matrix portion has a display region of about 100 ⁇ 55 pixels.
  • FIG. 5 depicts the display 36 of external communication device 32 including the icon/fixed display region 852 and the bitmap display area 854 .
  • the icon/fixed element display bar includes a time-of-day indicator 856 which is made up of 4 seven segment display elements, a “:” symbol, an “AM” symbol, and a “PM” symbol.
  • the icon bar also includes a battery symbol 858 that turns on when the main battery of External Communication Device is getting low.
  • the icon display also includes an alarm icon 860 in the shape of a bell that is turned on when an alarm condition is in effect.
  • the icon display further includes a 4 segment reservoir level indicator 862 . When the reservoir is estimated to be full all four segments are powered and as the estimated reservoir level drops individual segments are successively turned off.
  • the icon display further includes a circular display 864 comprised of 4 pie shaped wedge elements.
  • the number of pie-shaped wedges being displayed and their motion are indicative of the delivery condition that is currently active.
  • a month indicator 866 is formed from three 16-segment displays while a date display 868 is formed from two additional 7-segment displays.
  • the ASIC is further connected to an input port 702 by an I/O bus 704 .
  • This input port preferably is an octal 3-state non-inverting/buffer/line driver/line receiver. This is a non-latching port.
  • Address decoding and port enablement is provided by a single external port and address decoder chip whose use is shared by output ports 668 and 662 .
  • the keypad 38 is linked to an integrated key interface device 712 .
  • the integrated key interface device includes key interfacing, key debouncing, and ESD suppression functions. This device is preferably an octel CMOS switch debouncer with ESD protection for input pins up to 15 kV.
  • the keypad 38 includes four keys with raised buttons and tactile responsiveness and one key without a raised button or tactile responsiveness (i.e. a hidden key).
  • the integrated key interface device 712 outputs five signals 714 that are provided to input port 702 , the key interrupt generator 516 , and to a key reset generator 716 .
  • Signals 714 include a separate signal for each of the five keys. The signal for each key is low when that key is depressed.
  • the de-bounce duration provided by device 712 is at least 20 ms and is 40 ms typically.
  • the ESD suppression is rated at 15 kV using the human body model.
  • the key interrupt generator 516 includes an 8 input NAND gate that takes the signal from each of the five keys and performs a NAND operation on them, such that if any one of the keys is depressed (i.e. at least one low input) a high signal will be output by the NAND gate and if no key is depressed (i.e. no low input) a low signal will be output by the NAND gate.
  • the output of the NAND gate is then passed to one input of a two input AND gate along with the reset signal 726 as the other input. As a result if reset signal 726 is high (i.e. not asserted and at least one key is depressed then a high asserted signal is received on line 514 by the first interrupt input 512 . If reset signal 726 is low (i.e. asserted) then any keyboard activity is blocked from asserting the interrupt signal.
  • the key reset generator 716 provides an output signal 718 to an input of the OR logic circuitry 526 .
  • the key reset generator 716 receives low signals from the keys that are pressed and high signals from the keys that are not being pressed.
  • a series of OR gates are used to determine if all five keys are depressed (i.e. the four keys with raised buttons and one key without a raised push button).
  • the output of the OR gates is passed through a 100 K ⁇ resistor and is linked to ground using a 0.1 ⁇ F capacitor. This capacitor and resistor are used to suppress short glitches that might be caused by static discharge from the external world via the keypad. Glitches shorter than about 10 milliseconds are suppressed.
  • the output signal is then fed to an inverter and then passed to one input of a two input AND gate.
  • the other input of the AND gate is reset signal 726 .
  • the output of the AND gate is the key reset signal 718 . Which is passed on to the OR logic circuitry 526 .
  • the input port 702 In addition to the input port 702 receiving key press signals 714 from the integrated keyboard interface 712 , it also receives main battery low input signal 724 from power management circuitry 722 and a reset signal 726 from battery fail detector 554 .
  • the signal 724 is asserted low and when asserted indicates that the main battery voltage is low.
  • the reset signal 726 is asserted low and when asserted indicates that the main battery is dead.
  • the state of keypad is monitored by input port 702 and the processor is expected to read the input-port to determine which key was pressed after receiving a keyboard interrupt.
  • the main source of power for the external device is a replaceable, M cell main battery 732 of either the alkaline type or lithium type.
  • a main battery voltage signal 738 (VAA) is supplied to various components and modules as needed.
  • Signal 738 is supplied to an input pin 544 of the analog-to-digital converter that is included in the Processor IC.
  • the VAA signal 738 is also supplied to a switching type pulse width modulated DC-DC up-converter 734 that produces a boosted voltage signal 736 (VCC) of a definable amount.
  • VCC voltage signal 736
  • the definable amount is 3.45 volts ⁇ 0.1 volt when powering a minimum load of 30 ohms and when supplied with an input voltage of between about 1.1 volts and 1.8 volts.
  • the maximum ripple is 80 mV peak-to-peak.
  • the start-up voltage of the up-converter is no greater than 1.00 V when the starting load is less than 100 ohm at the output.
  • the switching frequency is between 550 kHz and 750 kHz, nominally 600 kHz.
  • the up-converter utilizes burst mode, resulting in a wider noise spectrum.
  • the up-converter is preferably shielded from other components so as to minimize negative effects that might otherwise result, such as, for example, on telemetry reception.
  • about 440 ⁇ F of capacitance is supplied to the VCC lines so as to provide some energy storage for the VCC signal.
  • the output signal 736 of the converter 734 is the main operating power for the external communication device though FIGS. 4 a and 4 b, explicitly depict only two of the modules to which voltage signal 736 (VCC) is routed: (1) the external power on reset generator module 742 , and (2) power management module 722 .
  • a backup battery 752 is shown as supplying a voltage signal 754 VCOIN, to power management module 722 and is also passed to analog-to-digital converter input 546 for voltage monitoring.
  • a preferred backup battery is a 3.0 volt lithium battery having a 48 mAHr capacity.
  • the power management module outputs a signal 756 that supplies power to the any circuits that are to remain powered by the backup battery when the main battery voltage signal 738 , and thus boosted voltage signal 736 , falls below a usable level.
  • the external SRAM 564 is powered by signal 756 .
  • the voltage supplied must be at least 2.3 volts.
  • signal 756 supplies a voltage of about 2.7 to about 3.6 volts depending on whether or not the power is being supplied by the main battery or backup battery.
  • the maximum operating current for signal 756 is about 1 mA.
  • Power management in the present embodiment is based on the power management module 722 , battery fail detector module 554 , and external power on reset generator module 742 . These modules are implemented using three primary integrated circuits along with other peripheral elements.
  • the functions of the power management system include providing back-up power for the on-board SRAM, providing proper power-up reset, and providing adequate time for orderly system shut-down when the main battery is dead or removed.
  • the first chip is a 3 volt adjustable microprocessor supervisory IC which handles the functions performed by the power management module 722 .
  • This chip monitors signal 736 , VCC, and provides signal 736 as the source for output signal 756 so long as VCC is about 2.7 volts or greater and otherwise provides signal 754 , VCOIN, as the source for output signal 756 .
  • VCC rises above, about 2.90 volts
  • signal 736 is switched back in as the source for output signal 756 .
  • the chip also monitors main battery voltage (VAA) and provides low power signal 724 when VAA falls below a desired threshold that is settable by selection of peripheral voltage dividing resistors. In the present embodiment the selected amount is about 1.1 volts.
  • VAA main battery voltage
  • the low power output signal 724 is connected to input port 702 where it can be monitored by the system processor.
  • the low power signal 724 is used by the Processor IC to provide a low battery indication to the patient.
  • the battery management IC also asserts an output signal 762 when the backup battery is switched in as the source of VPOS.
  • This signal is used to gate the chip select of the SRAM chips 564 so that when the back up battery is maintaining the data in the SRAM chips, the SRAM chips cannot be accessed so as to protect the integrity of the data.
  • This asserted state also cuts the backup battery voltage to the processor using a PFET switch that opens line 754 so that it is not connected to A/D input 546 . This is done so that the backup battery is protected from a potentially low impedance path to ground (e.g. the A/D input of the ASIC) that may occur when VCC is absent.
  • the second chip is a micro-power voltage monitor IC that is used as a programmable voltage detector and handles the functions performed by the battery fail detector module 554 .
  • the programmability is determined by the two voltage divider resistors. A hysterisis effect is used to ensure a good pulse and is obtained by use of a 500 k ⁇ resistor that bridges the input and output lines of the chip.
  • This comparator monitors the voltage signal 738 of the main battery.
  • the output line of the chip provides low reset signal 726 .
  • a second output signal for the battery fail detect module is provided by passing signal 726 through an inverter to obtain a high reset signal 556 .
  • the threshold is set at about 1.0 V in the present embodiment.
  • the low reset output signal 726 is connected to one of the inputs of input port 702 .
  • the high reset signal 556 is used as a power-fail interrupt signal to the processor. This interrupt signal is fed directly to the second external processor interrupt input 552 .
  • the Processor When the low reset signal 726 is asserted, the Processor disables the output ports, which in turn shut down all high power devices. This is to ensure that the energy stored in the VCC storage capacitance is used only to support the orderly shutdown activities of the system in the case when the AA battery is dead or removed.
  • shutdown mode a number of conditions are set: (1) key presses no longer generate key board interrupts to the processor, (2) UART activity no longer generates a UART interrupt to the processor, (3) the output ports, 668 and 662 are tri-stated, (4) the LCD is held in unselected and reset state, (5) the backlight is disabled, (6) the vibrator is disabled, (7) the IrDA module is put in shutdown state, (8) the UART is put in shutdown state, and (9) a 150-ohm dummy load is disabled.
  • the high reset signal 556 is asserted by VAA falling below a threshold value (i.e. failure value for VAA) and since the failure of VAA will cause voltage up conversion by module 734 to cease and since all high powered circuits have been shut down and since the back up battery on signal is triggered by VCC failing and since VCC will be maintained for some period of time by storage capacitance, there is a time lag between assertion of the high reset 556 and then assertion of the back up battery on signal 762 .
  • the circuitry and storage capacitance have been configured to provide a lag of at least about 100 ms. This amount of time has been selected as it is sufficient to enable all shut down activities by the processor to be completed prior to assertion of the back up battery on signal 762 .
  • the third chip is an open drain reset IC and handles the functions performed by the external power-on reset generator 742 . It monitors the voltage signal 736 , VCC.
  • the chip produces an output pulse, or reset pulse, when the VCC voltage level transitions through a programmed threshold voltage level. This reset pulse occurs when transitions are from low to high or from high to low. This reset pulse is routed through an inverter and then to an input of an AND gate.
  • the input to the inverter is normally retained in a high state by a pull up resistor. However, the input to the inverter is brought low when the low level reset pulse output by the chip occurs.
  • a second input to the AND gate is provided by the low reset signal 726 . This is done so as to only pass the pulse on VCC rising but not the pulse on VCC falling. From the AND gate the signal is routed to OR gate 526 .
  • Output port 668 provides UART control signals 758 to the UART circuitry and provides a signal IrDA power down signal 760 to an IrDA module.
  • the UART control signals include a chip selector signal and a shutdown signal.
  • a preferred UART has an SPITM/MicrowireTM interface and is capable of supporting RS-232 and IrDA links.
  • the UART supplies data on line 764 to an inverter 772 and from the inverter 772 to an IrDA transceiver module 780 on line 764 ′.
  • the IrDA transceiver module then transmits that data through an infrared carrier to a receiver in a second external device (not shown).
  • Data that the IrDA device receives from the second external device through an infrared carrier is in turn passed to an inverter 774 on line 766 ′ and the inverter then sends the data on line 766 to the UART.
  • the data transfer rate through this port is fixed at 115.2 Kbit/s.
  • This port complies with the IrDA 1.2 Low Power standard.
  • a UART interrupt is generated by the UART IC. This interrupt, after passing through an inverter, is fed directly to the third external interrupt input of the processor.
  • the UART may be placed in a shutdown state to save power. When the UART is in shutdown state, its oscillator is stopped. When the UART is set to be taken out of shutdown state, it takes some time to start up the oscillator, and as such, application software is configured to provide a minimum of 100 ms for the UART to come out of shutdown state before real data is transported using this port.
  • Output port 662 also provides an enable quiet mode signal 784 to NAND gate 642 the enable quiet mode signal 784 is used for quiet RF mode control. This signal is asserted high and is used when asserted to disable the EL backlight 806 and the vibrator 46 . This signal is asserted during RF reception so that noise from these devices will not interfere with RF reception.
  • the NAND gate 642 takes signals 784 (enable quiet mode) and 634 (RF receive power) and produces an RF quiet signal 786 and provides it as input to AND gates 792 and 794 .
  • the enable quiet signal 784 and RF receive power signals are both asserted high, the output of the NAND gate is low when both are asserted.
  • the low RF quiet signal 786 disables the high noise devices stated above. It is also connected to VCC using a 150 ohm dummy load. The purpose of this load is to force the up-converter to operate at the 600 kHz nominal switching frequency, instead of any other frequency or burst mode. This helps in reducing noise during RF reception.
  • Output port 662 provides an output signal (not shown) to a 150 ohm dummy load that may be used to place a load on the AA battery during battery voltage measurement. This load is turned on by providing a high signal to it from the processor IC.
  • Output port 662 provides an enable LED signal 788 to AND gate 794 .
  • the enable signal 788 is the backlight “on” signal and is asserted high. When asserted, this signal causes the backlight to be turned on unless the RF quiet signal is being asserted (i.e. low).
  • AND gate 794 supplies its output 802 as an input to a backlight driver 804 which in turn powers an Electroluminescent (EL) backlight 806 which lights up the LCD device.
  • EL Electroluminescent
  • a high RF quiet signal 786 enables the selection of the backlight while a low RF quiet signal disables the selection of the backlight, while the enable LED signal turns on and off the backlight when enabled.
  • the backlight is controlled in this way because it is high current/high noise device, and it is desirable to disable it during RF reception.
  • the backlight is enabled regardless of the setting of enable quiet signal 784 because RF receive power signal 634 is low.
  • the Electroluminescent (EL) backlight panel is used to illuminate the LCD in low light level conditions with a green light having about 0.15 ft Lm brightness at 0.75 inches from the output of the LCD display.
  • the EL panel is driven by a DC-AC converter IC that boosts the voltage level.
  • the DC-AC converter with the aid of an inductor to help generate the boosted voltage level and a capacitor for setting the oscillator frequency boosts the voltage from VCC to a signal of about 140 VAC peak-to-peak at about 300 Hz.
  • Output port 662 provides and an enable vibrator signal 790 to AND gate 792 .
  • the enable vibrator signal 790 is asserted high. When asserted this signal turns the vibrator on unless the RF quiet signal 786 is being asserted (i.e. low).
  • AND gate 792 provides its output 812 as an input to the vibrator device 46 .
  • the RF quiet signal 786 enables (logic high) and disables (logic low) the selection of the vibrator, while the enable vibrator signal 790 turns on and off the vibrator when enabled.
  • the vibrator is controlled in this way because it is a high current/high noise device, and it is desirable to disable it during RF reception. When the system is not in RF reception state, the vibrator is enabled regardless of the setting of the enable quiet signal 784 because the RF receive power signal 634 is low.
  • the vibrator 46 is a DC vibration motor which is used as a secondary alarm device.
  • the preferred motor draws a current of about 60 mA and has a nominal rpm of about 8100 .
  • the signal from AND gate 792 is used to control an N-MOSFET transistor switch to supply the VCC signal to the motor.
  • processor IC As discussed above, a single processor IC is used in the external communication device while two processor ICs are used in the Implantable Device. In this first preferred embodiment all three of these processors are identical.
  • the implantable device have a long implanted life, and as the implantable device of the present embodiment does not use rechargeable batteries, a low-power constraint is imposed on the processor IC.
  • This low power constraint is three-fold: (1) use of low power circuit elements and design, (2) use of electronic modules that are capable of being put into low-power consuming states or non-power consuming states when not needed to perform specific functions, and (3) use of control hardware or software to put the modules in their reduced power states and to pull them out of those states.
  • the processor IC is designed and controlled to operate at an average power of less than about 30 ⁇ W. At a supply voltage of 2.9 Volts, this power consumption turns into an average current of less than about 11 ⁇ A.
  • the entire implanted electronic system preferably draws an average of less than about 32 ⁇ A.
  • the processor IC operates with a voltage of between about 2.3 V and 3.6 V.
  • the processor IC is a custom designed CMOS device using 0.8 micron technology with the physical construction of cell design utilizing small gates, drains, and diffusion regions.
  • the core processor 912 design preferred in the present embodiment is a CMOS low power version of the INTEL 8086 processor with a minimized number of logic gates and enhanced timing so as to consume less power.
  • the Core Processor includes ten additional instructions so that it is software compatible with the 80186 processor. It is a multiplexed bus device having the 16 low order address bits, out of a total of 20 address bits, multiplexed with the 16 data lines. De-multiplexing is achieved with on-chip latches so that the low order 16 address lines are available as outputs to the device. The four high order address lines and the bus high enable signal are not multiplexed.
  • the processor IC also integrates a number of modules and functions so as to reduce the power consumption as compared to using discrete components for achieving the same functionality.
  • a SEEPROM interface 914 is provided within the processor IC for exchanging information with an off chip SEEPROM device.
  • a two line interface is used to exchange data with the SEEPROM device and a power line is also supplied from the processor IC to the SEEPROM so that it may be selectively powered so as to reduce power consumption when access to the SEEPROM is not needed.
  • the SEEPROM associated with each of the two processor ICs in the implantable device has a capacity of 32 kbytes while the two SEEPROMs used in the external communication device have a capacity of 64 kbytes each.
  • the SEEPROM provides periodic acknowledgments when the SEEPROM is interacted with.
  • a SEEPROM control register and a SEEPROM data register are also provided these two registers provide a bit that supplies power to the SEEPROM, a bit that provides an oscillating signal to the SEEPROM, a bit that provides data to be written to the SEEPROM, and a bit that can be read to pickup data that is being supplied by the SEEPROM.
  • the Boot ROM 916 is an on-chip read only memory that provides the initial boot code for the CPU.
  • the Boot ROM is 1 kbyte metal mask programmable ROM.
  • a 16 kbyte section of static RAM (SRAM) 918 is provided within the ASIC. This space is used for stack, general variables, and core program space such that most of the operational implantable device code and external communication device code reside in this space.
  • SRAM static RAM
  • the processor IC includes a memory decoder module 920 that is capable of decoding the 16 kbytes of internal SRAM and is also directly capable of decoding 512 Kbytes of external memory.
  • the memory decoder contains Boolean logic gates to decode the 8086 address space for each individual bus transaction.
  • the amount of externally addressable SRAM may be increased by adding one or more additional bank select triggers such as by using the a processor IC output that is not being used for some other function. For example, in the external device the output signal that is used to fire the pump mechanism may instead be used as a bank select signal as it is otherwise not being used. This provides the ability for the external communication device to be able to decode 1 Mbyte, or more, of external SRAM.
  • the memory decoder is further capable of decoding the 1 Kbyte of internal ROM.
  • a low power crystal oscillator module 922 internal to the Processor IC is used in conjunction with the an external oscillator crystal and a shunting resistance to provide a stable 1.049100 MHz ⁇ 500 Hz clock source while drawing less than about 2 ⁇ A from a 2.2 V to 3.5 V supply.
  • the circuit is intended to operate with a minimum frequency of 1.048576 MHz crystal using a shunt resistance of about 20 M ⁇ in the implantable device and about 2 M ⁇ in the external communication device.
  • the shunt capacitance of the crystal is preferably no greater than 1.5 pF.
  • An external shunt resistor is provided in parallel to the clock crystal across two external connectors of the ASIC to provide DC feedback to the circuit. The amount of resistance is selected as a balance between oscillation start up and current consumption.
  • the timer module 924 is composed of the system clock generator and circuits responsible for generating various timing signals.
  • the processor IC uses the (1.048576 MHz ⁇ 500 Hz) external crystal to generate the system clocks. Tolerance of the crystal oscillator is be better than ⁇ 500 parts per million (ppm) including the drift due to aging, and temperature induced variances within a range of ⁇ 10° to 50° C.
  • the Timer Module 924 consists of a (A) system clock generator; (B) a CPU clock module; (C) a pulse stealer; (D) a clock enable register; (E) four independent timers (wake up 1 , wake up 2 , sleep, and one minute), and (f) a time-of-day timer that can be made to register time in subsecond intervals.
  • the system clock generator module is a 20 bit ripple counter that has the ability to load a pattern into its lower 14 bits. This counter is used to provide the system clocks necessary for operation of all other modules. In the present embodiment a pulse stealing technique is used to fine tune the oscillation frequency for all clock signals generated by this module that have a frequency of about 8192 Hz or less.
  • the clock frequency of the CPU (i.e. the frequency of the CPU clock) may be selected and the CPU clock made to stop by writing appropriate values to appropriate CPU clock registers.
  • the frequency select circuit consists of two registers and a synchronizing circuit. The synchronizing circuit is used to ensure that narrow clock signals (i.e. glitches) are avoided when the frequency of the CPU Clock is changed.
  • a pulse stealer circuit is provided for precise system timing of selected clock signals.
  • the pulse stealer function is applied to the clock signal that has a frequency that is just slightly more than 8192 Hz target frequency as provided by the system clock generator.
  • the pulse stealer circuit gives the ability to periodically steal pulses from a selected clock signal to produce a clock signal of lower and more desirable average frequency.
  • the pulse stolen signal is used to create all system clocks that of lower frequency.
  • the CPU loads a 16 bit value into two eight bit configuration registers.
  • the timer whose signal is to be modified is used to cause a counter to count up from zero to the value loaded into the registers at each time a comparator recognizes a match.
  • a single pulse is removed from the output signal (stolen from the output signal) to provide the modified output signal. Then the counting begins again from zero and the process is repeated over and over so that a modified output signal, or pulse train, having a desired average frequency is generated.
  • a clock enable control register is provided so as to allow the CPU to selectively enable or disable the clock signals used by other modules.
  • these other modules include the first and second synchronous serial ports, the analog-to-digital converter, and the insulin pump charging circuitry. Enablement/disablement for a given module is “bit mapped” to the control register so that the control register may be used to “gate” these clocks on or off.
  • timers Four system timers are provided. These timers provide interrupts to the CPU at selected intervals. The internal logic of the first three of these timers is identical with the exception of the input clock frequency and the number of bits to count to before causing an interrupt.
  • the interrupt interval for each timer is programmable by the CPU by writing an appropriate value to an appropriately sized control register associated with each timer. Once an interrupt interval is written into the timer by the CPU, interrupts will be continuously generated by the timer without further intervention of the CPU.
  • the timers continue to “run” independent of when or if the CPU services the interrupts that they create. Thus, interrupts will continue to be “issued” at the same programmed interval, and will stay asserted if not serviced.
  • the act of servicing the interrupt clears the interrupt condition. The CPU clears any pending interrupts by writing to the associated control register.
  • the first of these timers is the first wake-up timer and it generates a first wakeup signal that based on a 1 Hz input clock frequency and a programmed count value that is to be reached before generating its interrupt signal.
  • Examples of the use of this timer in the present embodiment include Watchdog monitoring and nominal RF reception and transmission start times.
  • the second of these timers is the second wake-up timer and operates off an 8 Hz input clock frequency and is also programmable to count to a specified value before generating its interrupt signal.
  • Examples of the use of this timer in the present embodiment include various uses within the external communication device, including spinning the pumping status indicator on the display panel, IrDA timing for missing bytes and closing the channel, beeping, and keyboard blink timing.
  • the third timer is the sleep timer which operates off a 1,024 Hz input clock frequency and is programmable to count to a specified value before generating its interrupt signal.
  • An example of the use of this timer in the present embodiment includes pump stroke charging and recharging.
  • the fourth timer is a one minute wake up timer and provides an interrupt every 60 seconds based on a 1 Hz input clock frequency.
  • This counter provides two functions: (1) it provides the seconds portion for the time of day, and (2) it interrupts the CPU every 60 seconds.
  • the principal purpose for the CPU writing into this timer is to adjust the software perception of the second number within a minute.
  • the register for this timer does not hold the number to be counted to but instead holds the present count of the counter that continues to increment each second until a count of 60 is reached and then it starts over. Examples of the use of this timer in the present embodiment include counting elapsed minutes, performance of delivery calculations for pump strokes, determination of the present half hour, and one minute RF listening by the external communication device.
  • one register bit is controllable to indicate whether RF reception is given priority over the charging of the pump circuit for noise considerations even though there may be some negative impact on power drain resulting from a need to partially recharge the pumping circuitry after a. telemetry interruption.
  • the pump clock itself is disabled whenever an RF receive power signal is asserted and the priority bit is set to give priority to RF reception.
  • this bit is oppositely set, by software, then the pump clock is allowed to remain on regardless of telemetry activity. As both telemetry operations and pumping operations are current intensive, it may be desirable to avoid both systems operating simultaneous so as to reduce maximum current drain on the battery at any given instant in time.
  • a watchdog monitor circuit 928 is provided to ensure that detection and system reset will occur if the CPU ceases to properly execute instructions.
  • the watchdog monitor is configured to assert a system reset signal if an interrupt signal from the first wake-up timer occurs twice without the CPU properly servicing the watchdog monitor.
  • the CPU resets the watchdog monitor by two writes into the watchdog monitor. Data for the first write has first pattern and data for the second write has a second pattern that is different from the first pattern. To ensure that the system is operating properly at both the interrupt level and the mainline code level, one of the two values is written by an interrupt routine while the other is written by the mainline code. Writes of values other than the first pattern followed by the second pattern will reset the sequence that the Watchdog is expecting. The reset signal generated by the watchdog is brought out of the ASIC and back to the external reset input of the ASIC.
  • the watchdog monitor is not active. This allows the CPU time to perform initial configuration and housekeeping.
  • the watchdog is activated, or enabled, as soon as the CPU writes any data pattern to a watchdog monitor register. Once enabled, the watchdog cannot be disabled until another CPU reset occurs.
  • the ROM boot code activates the watchdog early on in its execution but sets the first wake up interval to a time sufficient for system configuration to occur.
  • a piezo signal is put out so that an audio alarm will sound. This piezo signal remains on until the CPU re-activates the Watchdog.
  • the RF Module 930 in the processor IC consists of an (A.) RF timer circuit, (B.) a digital RF transmitter section that includes a QFAST® RF modulation transmitter, (C.) an analog receive module, (D.) a digital receive section that includes a QFAST® RF modulation receiver, and (E) a time synchronization section.
  • the RF timer circuit provides clock signals used by the other portions of the telemetry circuitry to provide a carrier signal for transmission, provide a signal for modulating ⁇ the carrier, provide signals for demodulating received signals, and the like.
  • the primary signal timer signal is pulled from the system clock generator module.
  • the generation and shut of the primary RF timer signal is controllable by hardware or software based on values that are written into various registers which enable signal generation when needed and power savings when not needed.
  • the time synchronization module ensures that the concept of time as held by the communication device and as held by the medical device are sufficiently close so as to enable RF communication to occur while maintaining transmission time and listening time of the RF hardware to a minimum. Further details on RF timing synchronization, autonomous and software activation and deactivation of telemetry hardware components are provided in the above referenced U.S. patent application corresponding to Docket No. USP-1077-A.
  • the telemetry system provides a half-duplex link between the implantable device and the external communication device using a carrier frequency of about 250 kHz and a data signal having a frequency of about 8 kHz.
  • the transmitter hardware uses the 8 kHz data signal to modulate the carrier signal to generate signals that will be transmitted by the antenna.
  • the receive hardware receives the modulated signal and demodulates it to extract the 8 kHz data signal.
  • Both the implantable device and the external communication device have transmit and receive capabilities to allow two-way communication.
  • RF telemetry circuits necessary for communication between the external communication device and the implantable device are implemented in the processor IC.
  • a high-gain RF amplifier is implemented off-chip.
  • an RF antenna, that is used for both transmission and reception, and circuitry to select between reception and transmission are implemented off chip.
  • the remaining analog sections and all the digital demodulation circuits are implemented in the processor IC.
  • the RF module of the Processor IC outputs transmission signals for transmission by the external antenna. It also provides a power signal to the external amplifier and an RF receive power control signal that is used to switch between a transmission configuration and a reception configuration. Both these signals are controllable by bit values placed into registers so that power consumption may be minimized when component operation is not required.
  • the RF module also receives input signals from the external receiver hardware.
  • Quadrature Fast Acquisition Spread Spectrum Technique (QFAST®) is used as the modulation technique.
  • QFAST® modulation is based on an Offset Quadrature Phase Shift Keying (QPSK) modulation technique.
  • QPSK Quadrature Phase Shift Keying
  • data generated by the CPU modulates clock signals at the carrier frequency.
  • quadrature modulation in-phase and quadrature-phase components of the given data stream are generated. These two components are then applied to opposite ends of the external antenna so that a combined signal is transmitted.
  • QFAST® data rate adaptability is accomplished through a spread-spectrum “coding gain” concept, with the spreading code being a simple clock.
  • the modulation produced by the QFAST® modulator can be demodulated in a manner which delivers both clock and data. All of the QFAST® modulation and demodulation circuits are digital and are incorporated into the processor IC.
  • the QFAST® technique provides a communication system with the following attributes: (1) it extracts the clock from the received signal without a clock recovery loop; (2) it provides demodulation of data without phase ambiguity and without the requirement for synchronous demodulation; (3) it makes effective use of the available transmission bandwidth, (4) it results in fast acquisition of the message signal; (5) it is relatively immune to the effects of highly dispersive and distorting propagation media; (6) it does not require regeneration of a phase-coherent local replica at the receiver of the transmitted carrier; (7) it does not require resolution of ambiguity between the in-phase and quadrature-phase channels in the receiver; and (8) it does not exhibit data phase ambiguity.
  • the transmitter section of the telemetry system receives byte wide parallel data packets from the CPU and then loads the data into a parallel-to-serial shift register.
  • the serial data is then sent to the QFAST® RF modulation transmitter section to modulate two quadrature clock signal components each operating with a carrier frequency of about 2 18 Hz) and shifted in phase relative to each other by 90 degrees.
  • the two components are then delivered to opposite ends of the antenna.
  • the RF transmitter remains activated. If the transmitter doesn't have data available when the next byte is to be transmitted the message is considered to have been completely transmitted and the CPU shuts off the transmitter circuitry so as to minimize continued power drain.
  • the received RF signal is amplified by a high gain receive amplifier.
  • a bandpass filter is used to attenuate out-of-band components such as those due to AM radio stations.
  • the amplified RF signal then enters a mixer in the RF module of the processor IC and is converted to baseband using a two mixers, one in-phase mixer and one quadrature mixer both at the carrier frequency.
  • the mixer outputs are the quadrature components of the baseband signals.
  • An integrator & dump function in the RF module then removes the sum frequency (2 fc) and high frequency noise (i.e. acting as a low pass filter) from each of the two signal components.
  • the processed signals are then digitized using a comparator and passed to the demodulator where the data and clock are recovered.
  • QFAST® Quadrature Fast Acquisition Spread Spectrum Technique
  • the ASIC also includes an interrupt handler 932 .
  • the interrupt handler module consists of a capture module for capturing interrupt conditions, a handling module, and a priority encoder module. Three of the nine interrupts may be used for external as well as internal interrupt sources, as for example by the external communication device.
  • the capture module is used to capture the occurrence of an interruptible event.
  • This module contains two sets of registers: an enable control register (under CPU control), and (2) the capture register.
  • the enable control register is bit mapped to each of the possible interrupt inputs. If the bit corresponding to an interrupt in this register is high the interrupt is enabled and can cause the interrupt signal to the CPU to be asserted.
  • an interrupt condition signal sets a bit in the capture register and a corresponding interrupt signal is asserted.
  • the bits in the Capture Register are de-asserted only by a system reset or individually when a corresponding signal is asserted.
  • the interrupt signals are passed to the interrupt processor module and combined with respect to priority to provide a single interrupt to the 8086 CPU delivered on the CPU's interrupt input line.
  • the handling module provides the necessary logic to accommodate the 8086 double interrupt acknowledge cycle as well as daisy chaining the interrupt signals to provide a priority for the highest level of interrupt in cases where multiple interrupts are pending simultaneously.
  • the highest is serviced first. This is accomplished by asserting the output signal corresponding to the highest pending interrupt during the second CPU interrupt acknowledge cycle. This signal serves two purposes. First it is fed back to the capture module to clear the pending interrupt and second it is sent to the priority encoder module for encoding the interrupt vector.
  • An analog-to-digital converter 934 (A/D) and associated signal multiplexer system are provided to sample analog signals.
  • the analog signals for the implantable device include (1) battery voltage, and (2) the charge pump voltage.
  • the analog multiplexer is used to select the analog input signal that is to be provided to the A/D.
  • An amplifier is used following the MUX to provide signal conditioning for the input signals. Bits are provided in a control register for selecting the MUX channels, for enabling the MUX, for enabling the amplifier, enabling the analog to digital converter, providing a conversion status indication, providing a begin conversion signal, and for supplying a clock signal to the A/D converter.
  • the LCD Clock Driver consists of two input clocks (e.g. about 64 kHz (e.g. 216 Hz) and about 32 kHz (e.g. 215 Hz)), a MUX to select between them and a bit and an AND gate to gate the clock on and off.
  • two input clocks e.g. about 64 kHz (e.g. 216 Hz) and about 32 kHz (e.g. 215 Hz)
  • a MUX to select between them and a bit
  • an AND gate to gate the clock on and off.
  • the Processor IC has an alarm driver and interface 938 that offers direct control of a piezo buzzer alarm.
  • the processor IC drives the alarm through a 2-wire interface.
  • Software may be used to select one out of 128 frequencies ranging from about 64 Hz to about 8192 Hz.
  • the tone duration and volume are also under software control.
  • the monitor processor controls the buzzer.
  • the piezo buzzer logic consists of a register, a counter, and compare functionality to provide a variable frequency to the piezo buzzer. The value in the register is compared to the value in the counter. Each time the values are equal the driving signal toggles to the next programmed signal. Additional logic circuitry is provided to allow volume control for the piezo buzzer. The outputs of each line are used externally as differential signals to the piezo buzzer.
  • the piezo can sound different frequencies and the volume of the piezo buzzer can be controlled.
  • the piezo is driven at about 1024 Hz. This signal is gated with the output of a register bit that is under control of the CPU. The piezo signal is inhibited by this gate when the CPU writes into the watchdog enable register.
  • the Processor IC has two Synchronous Serial Interface (SSI) ports 944 and 942 .
  • SSI Synchronous Serial Interface
  • Each interface provides full duplex serial communication ports that operate at about 500 kHz.
  • One of these ports is used for inter-processor communication in the dual processor implantable device.
  • one port is used for IR based serial communications and the other is used as an interface for the LCD display panel.
  • Each interface port supplies both data and clock.
  • the clock driving the SSI may be enabled or disabled, thus controlling power consumption when the SSI is not needed.
  • a control register is used to turn ON/OFF the SSI.
  • the RF communication between the implantable device and the external communication device occurs in the form of messages (sometimes referred to as communication signals or packets) that are passed back and forth between the two devices.
  • messages sometimes referred to as communication signals or packets
  • these messages have a multi-part format or protocol: (1) preamble, (2) frame sync, (3) telemetry identifier, and (4) data.
  • the preamble is a repeating pattern of “10”, i.e. 10101010. This alternating pattern of ones and zeros is broadcast for 8-bit times. This pattern is considered the standard preamble pattern.
  • the preamble is either of the standard preamble pattern but applied for an extended number of bit times (e.g. 24, 48, or 96) or is of an attention preamble pattern that is applied for, typically, even a longer extended number of bit times.
  • the attention preamble pattern is formed of a repeated pattern of “110110 . . . 110”. In other embodiments, other attention preamble patterns may be used (e.g. repetitions of “011”, “100”, “001, “1011”, and the like).
  • the preamble whether of the standard pattern or the attention pattern, is used so that the RF reception hardware can establish bit synchronization (i.e. bit boundary recognition) of the incoming data.
  • the attention preamble is further used to get and hold the receiver's attention for a defined period of time. As long as the attention preamble is being received, the receiver's hardware will stay on and continue tracking the signal in anticipation of an incoming message.
  • the attention preamble is considered to be lost, or no longer being received, when the receiver receives more than 2 inappropriate bit values during receipt of any 64-bits or when the frame sync pattern is received.
  • the attention preamble may be used when there is some uncertainty in the time synchronization of the two devices.
  • the extra length of the attention preamble allows the receiver's reception window to open a little latter than anticipated and to still have the receiver pick up the entire message.
  • the extra length of the attention preamble allows the receiver's reception window to open earlier than anticipated, so long as a minimum number of bits are heard by the receiver during the time its reception window is normally open, and still have the receiver's attention locked onto the preamble and have the receiver remain on as long as the attention preamble is being received, plus a little more, in anticipation of receiving a frame sync pattern.
  • frame sync may actually be considered byte sync (i.e. frames are bytes) and is a single byte of a selected pattern and is used so the receiver can obtain byte boundaries for the transmitted data.
  • the selected pattern is “10110000
  • This comparison process continues so long as the receiver continues to listen for an incoming message or until a valid frame sync pattern has been received. If the receiver is continuing to listen beyond its normal reception window (i.e. listening period), due to the reception of an attention preamble, the listening will not stop immediately upon the attention preamble being lost.
  • the comparison process for ascertaining the receipt of frame sync continues for a number of bits after attention preamble is lost, even if the listening period has ended, as its loss may be associated with the partial receipt of frame sync. Once frame sync is received a valid frame sync signal is asserted.
  • the telemetry identifier (i.e. telemetry ID) is a 3-byte value that is used to ensure that only the intended receiver receives a message.
  • the value of all “1s” indicates a universal message that is to be received by all receivers, otherwise the telemetry ID must be agreed upon between the receiver and transmitter.
  • a unique ID is provided for each implantable device and each external communication device during manufacturing. Only the external communication device can transmit a message using the universal ID code.
  • the telemetry IDs that the receiver will consider to be valid are the ID of the receiver or the universal ID. All other incoming bit patterns will be rejected with the result that the receiver will be either turned off or will start again looking for a valid frame sync pattern attention preamble.
  • data is provided in an integer number of bytes following the telemetry ID.
  • the first byte of the data indicates the message type.
  • the first seven bits of the first byte is an operation code or op-code while the eighth bit is either ignored or is set and interpreted as a sequence number (to be discussed hereafter) dependent on whether or not the first seven bits call for a sequence number or not.
  • Each op-code based on its nature, is followed by data in a defined number of bytes.
  • the specific op-code itself may dictate the number of bytes that follow or alternatively the specific op-code may dictate that the number of bytes to follow may be extracted from the first byte or several bytes of information that follow it.
  • op-codes may have a different length, or not be used at all, the message length or message end may be dictated in other ways. Based on the op-code and potentially one or more bytes following it, the receiver knows exactly how many more bytes of data to listen for. After receiving those bytes, the receiver may be turned off to conserve power.
  • the data portion of the message may include a bolus number.
  • the bolus number is similar to the sequence number in that it is incremented by both the implantable device and external communication device under controlled conditions so as to reduce the possibility of bolus requests being delivered more than once when duplicate requests may be made as a result of the external communication device failing to receive a confirmation that a previous request was received.
  • the bolus number may be a single bit number in some embodiments but in more preferred embodiments it is a multibit number (e.g. 2-bit, 4-bit, 7-bit, 1-byte, or 2-bytes) so that it can take on more than two values thereby making it less likely that an error will escape detection due to received and expected numbers erroneously matching.
  • the incrementing of the bolus number may occur within the external communication device when it receives confirmation that a message was correctly received and it may be incremented by the implantable device when it correctly receives a bolus request.
  • a duplicate request for a bolus is received by the implantable device it can recognize that the expected and received bolus numbers do not match and that requested bolus is not a new request.
  • the implantable device can respond to the repeated request that the bolus was correctly received and delivered (with out performing a second delivery and without incrementing its expectation of what the next bolus number will be).
  • the data portion of the message ends with a one or 2-byte validation or error checking code (its type is dictated by the op-code included with the message).
  • the preferred error checking code of this embodiment is in the form of a cyclic redundancy code (CRC).
  • the telemetry system may loose bit synchronization if insufficient bit transitions are received per unit time (e.g. if more than about 100 to 120-bit times lapse without receiving a transition.
  • the data portion of the message, with the exception of the op-code is randomized prior to transmission and is de-randomized upon receipt.
  • the external communication device and implantable device attempt to maintain a common time base, transmissions are set to start at specified times, and reception windows are set for specified times and lengths. In this way, the receiver may remain in a powered down mode most of the time and can turn on to listen for a potential incoming message at the specified times for the specified lengths of time. If a message is found to be incoming, the receiver stays on, otherwise it goes back to sleep (i.e. power down mode).
  • time synchronization for telemetry communication is maintained using two techniques.
  • the first technique periodically determines the present difference in the concept of time (e.g. second boundaries) as held by the communication device and medical device and the difference is used to reestablish synchronization of the timers.
  • reestablishment occurs on the part of the communication device each time it receives a valid communication from the medical device.
  • the second technique determines a rate of drift that has occurred between the concept of time held by the communication device and that of the medical device.
  • the determined rate of drift is used in combination with a determined lapse in time to estimate how much drift has occurred. This amount of drift is then used in shifting a listening start time or transmission start time of a first one of the devices to match what is believed to be the potential transmission period or listening period of a second one of the devices.
  • software may be downloaded from the external communication device to the implantable device.
  • the downloading of software may include the downloading of executable software as well as the downloading of data structures that may be used by the executable software.
  • a specific external communication device is configured/programmed to communicate substantively with only one specific implantable device, that is in turn configured/programmed to communicate substantively with only the same specific external communication device.
  • An external communication device is capable of retaining the telemetry ID of exactly one implantable device at a time and an implantable device is capable of retaining the telemetry ID of exactly one external communication device at a time.
  • a small amount of non-substantive communication i.e. communication that does not impact insulin delivery
  • many different types of messages and responses thereto can be written into the programs that control the implantable device and the external communication device according to the guidelines set forth above.
  • These messages may be used for a number of different purposes. For example, (1) they may be system level messages that are used for testing devices, for resetting devices, or for establishing relationships between implantable devices and external communication devices, (2) they may be alarm messages that are used to convey alarm conditions or to clear alarm conditions, (3) they may be miscellaneous messages that set various parameters or perform various read operations, (4) they may be delivery messages that set delivery amounts, read delivery status, or set parameters such as concentration and pump stroke volume that may be required to appropriately control delivery of the drug, (5) they may be data log messages that set data log boundaries, read boundaries, or clear data logs, boundaries or read information from various data logs or supply information to those data logs, (5) they may be refill messages that are related to amounts of material that are added to the reservoir periodically, (7) they may be compound messages that perform more than one function, or (8) they may be error messages that
  • the External Communication Device (CD or ECD) is a hand-held device that is used to program and communicate with an Implantable Device (ID).
  • ID an Implantable Device
  • the External Communication Device includes the hardware features discussed herein above.
  • the CD hardware and CD software work together to provide the desired functionality for the system.
  • the hardware includes a display with an icon region and a dot matrix region, a backlight for the display, a five-button keypad (one button is hidden), an alarm, a vibrator, and an IR device for serial communications with a second external device.
  • the CD software is menu-driven. The device operates from a replaceable 1.5 Volt M battery. There is a backup battery that retains memory while the replaceable battery is removed.
  • the dot matrix region is used to display the majority of the information that is provided to the user. This region, however, consumes more battery power than the icon region, as such when the external communication device is idle, the dot-matrix region is powered down to conserve energy. If the dot-matrix region is powered down, it is powered back on once a key is pressed.
  • FIGS. 7 a and 7 b The various main menu options provided to the user in this embodiment are depicted in the block diagram of FIGS. 7 a and 7 b.
  • Various set up menu options accessible from the pump setup menu display of FIGS. 7 a and 7 b are depicted in the block diagram of FIGS. 8 a and 8 b.
  • Various pump set Up II menu options accessible from the pump setup II display of FIGS. 8 a and 8 b are depicted in the block diagram of FIGS. 9 a and 9 b.
  • FIGS. 10 a and 10 b Various supervisor functions/options that are accessible from the Supervisor display of FIGS. 7 a and 7 b are depicted in the block diagram of FIGS. 10 a and 10 b.
  • FIG. 7 a and 7 b is further detailed in the block diagram of FIG. 11.
  • the communications sequence of FIGS. 7 a and 7 b is further detailed in FIG. 12.
  • the ACT and SEL indications depict the keystroke necessary to change from one display to the next.
  • the up-arrow symbol and down-arrow symbols indicate that parameter values within the menu display may be modified by pressing the UP key or the Down key.
  • One of the icons included in the icon region is the low-battery icon 858 (FIG. 5) which is displayed when there is a low or depleted main or backup battery.
  • Another icon is the bell icon 860 (FIG. 5) which is turned on by the CD software when the external communication device receives a telemetry message from the implantable device indicating that the implantable device has detected one or more for the following: (1) implantable device inter-processor communications failure, (2) under-delivery, (3) over-delivery, (4) charge time too long, (5) post-fire voltage too high, (6) low implantable device battery, and (7) depleted implantable device battery.
  • the bell icon is cleared by CD software when all alarm conditions above have been cleared.
  • the bell icon is displayed when the external communication device is showing the ‘time and alarm’ screen.
  • Another icon is the reservoir level indicator icon 862 (FIG. 5). It is composed of 4 segments that provide a graphical indication as to the level of insulin in the implantable device reservoir.
  • the CD software maintains an estimate of the implantable device reservoir level. The estimate is based on the refill amount indicated at the time of the latest refill which is decremented by an estimate of the insulin that has been delivered each day. The estimate of insulin delivered each day is derived from the daily total log that records the number of pump strokes delivered each day. All segments of the reservoir level icon are set when the pump is refilled. The top-most segment of the reservoir level icon is cleared when the external communication device estimates that the reservoir is less than 75% full.
  • the top two segments of the reservoir level icon are cleared when the external communication device estimates that the reservoir is less than 50% full.
  • the top three segments of the reservoir level icon are cleared when the external communication device estimates that the reservoir is less than 25% full. All segments of the reservoir level icon are cleared when the external communication device estimates that the reservoir is empty.
  • a greater number, or lesser number of indicators may be used to convey the reservoir level.
  • the last icon could be cleared when the reservoir level is not empty but instead has reached a predefined “low level”.
  • one or more of the elements could be controlled to blink when a low or empty reservoir condition exists.
  • FIG. 5 Another icon is the Insulin Delivery Icon 864 (FIG. 5). This icon provides a rotating display when the external communication device estimates that insulin delivery is in progress. The icon includes four elements each forming a quarter of a pie shape. The rotational appearance is provided by the CD software displaying alternating patterns that change every four seconds. When the external communication device is simulating the delivery of a bolus, the pattern includes three delivery segments on, and one off. When the external communication device is simulating the delivery of a basal rate, the pattern includes one delivery segment on, three segments off. When the external communication device is simulating no insulin delivery, all four segments are on and as such, the rotational appearance is removed.
  • SEL SEL
  • ACT ACT
  • UP UP
  • DOWN DOWN
  • the backlight is activated by pressing the DOWN key from the ‘Time and Message’ screen or the ‘time & alarm’ screen.
  • the backlight is programmed to remain on for a selected period of time that may vary (e.g. 4 to 15 seconds) depending on the screen that is being displayed and/or the keys that have been pressed. For example, preprogrammed time is 4 seconds following the display of the ‘time and message’ screen, the ‘self test results’ screen, and the ‘24 hour basal total’ screen.
  • the timer controlling automatic shut off is reset each time a key is pressed or held down so that the timing out of the backlight may be held off.
  • the external communication device includes two SEEPROMs, one is used to hold CD software and data and the other may contain an image of the implantable device software.
  • a third SEEPROM may be loaded into the external communication device for providing updated calibration parameters and the like.
  • the external communication device uses the power management hardware to determine the battery voltage level for the main battery and for the backup battery.
  • the external communication device includes A/D hardware that is used in conjunction with CD software to read the main battery level every hour, and to read the backup battery level every day at noon.
  • the CD software checks the main low battery bit /signal 724 (FIG. 4 b ) in the hardware every hour to detect a dead battery.
  • the external communication device Upon battery removal, the external communication device writes data from internal RAM to external RAM to prepare for the hardware to put the microprocessor in the reset state.
  • the data written from internal to external RAM includes parameters and data that are necessary for the external communication device to recover when the battery is replaced. This data is termed “external communication device recovery data.”
  • the CD software powers down the LCD so that the screen goes blank and power is conserved for completion of the writing operation.
  • the CD software also computes a 16-bit RAM sum of the external communication device recovery data, and stores the RAM sum and its arithmetic inverse in external RAM. When the battery is replaced, external communication device performs boot up operations as described herein later.
  • the external communication device communicates with the implantable device through messages passed by a RF telemetry link.
  • the external communication device attempts to change parameters in the implantable device, the external communication device does not consider the parameter values to have been changed un less it receives the appropriate telemetry response message from the implantable device.
  • the CD software verifies the CRC of all the telemetry messages that are received. If the calculated CRC does not match the CRC in the telemetry message, the external communication device updates a counter and otherwise ignores the receipt of the message. The CD software ignores all messages that were transmitted with the universal ID.
  • sequence numbers are used.
  • the sequence number provides a means to recover when the external communication device does not receive a telemetry response from the implantable device.
  • the external communication device sends a telemetry message and is expecting a response, if the response is not received, the external communication device has no way of knowing if the implantable device received the message and the external communication device missed the response, or if the implantable device simply missed the message.
  • the sequence number provides a means for the implantable device to know whether or not it has already received a message and thus whether or not it should act on a message.
  • the external communication device When the external communication device resends a message (as it did not get a response from the previous message), the external communication device uses the same sequence number it used when it initially sent the message. If the implantable device received the previous message, the implantable device knows not to duplicate its actions because the sequence number in the current message is the same as the sequence number in the previous message. In response to the resent message, the implantable device resends its response packet using the same sequence number. This mechanism allows for the retransmission of a telemetry message without the implantable device acting on the message more than once.
  • the external communication device uses the sequence number parameter in the sync response telemetry message as the sequence number for the next telemetry message.
  • the external communication device uses the sequence number parameter in the interrogate response telemetry message as the sequence number for the next telemetry message after the user has confirmed the patient ID by pressing ACT on the ‘confirm implantable device serial number’ screen.
  • the external communication device When the external communication device receives a valid response to a telemetry message, unless the response is an error message, the external communication device changes the sequence number.
  • the sequence number is a single bit and as such can take on the values of “1” or “0”. When the Sequence Number is 0, it is changed to 1. Similarly, if the Sequence Number is 1, it is changed to 0.
  • the external communication device transmits to the implantable device on inbound time slots.
  • the external communication device enables the RF receiver every minute on the outbound time slot (e.g. on the second boundary after the minute boundary).
  • the CD software in the external communication device may enable the RF receiver on the one-second boundary and may use a listening window size that is proportional to the length of the transmitted preamble. Alternatively, the CD software may simply enable the receiver and force it on for a time that is sufficient to capture an outbound response.
  • the RF timing system on the external communication device is configured to synchronize its concept of seconds and subseconds to those of the implantable device time upon receipt of each telemetry packet if the calculated CRC matches the CRC in the telemetry message, and the telemetry message is a valid response to an external communication device message or a valid unsolicited message.
  • the external communication device computes a value for a one-minute RF drift variable and enters RF drift mode. If the time between receptions is not in this range, the external communication device enters preamble mode.
  • the CD software updates a register, known as register B, by using a running RF drift value.
  • the register B value may also be updated based on a predefined value or based on the length of the preamble so as to start transmission a desired amount of time prior to when the external communication device believes the implantable device will open its reception window. For example, the desired amount of time may be from zero to up to one half the preamble length or more.
  • the running RF drift value is initialized to zero or some other nominal value when drift mode is entered. When the external communication device is in RF drift mode, the running RF drift value is incremented by a one-minute drift value each minute.
  • the one-minute drift value is obtained by consideration of the time between the previous two communications and the amount of drift that was detected upon receipt of the latest transmission.
  • the external communication device uses a preamble of 6 bytes. Further detail about register B and how the information in it is used to set reception times and transmission times is provided in previously referenced U.S. patent application No. (Docket No. USP-1077-A)
  • the external communication device enters attention mode.
  • attention mode the external communication device transmits using a two-second preamble of the attention pattern and initiates transmission using the maximum B Register value. This use of the maximum value in the B register is selected in hope of missing the reception window of the implantable device when the transmission is first initiated and in the hope of catching the attention of the implantable device closer to the end of the transmission, thus minimizing the time that the implantable device's reception system is forced to remain powered up.
  • the CD software maintains a running number of preamble bytes variable.
  • This variable is initially set to a desired minimum value (e.g. 4, 6, or 8 bytes) and is incremented by a desired incremental value (e.g. 1-4 byte) each minute since the last communication occurred and is transmitted using the attention preamble pattern.
  • the external communication device sets the register B value so that the preamble is centered on the telemetry second boundary as determined by the external communication device.
  • a predefined maximum value e.g. 256-512 bytes
  • preamble mode RF drift mode or attention mode.
  • other modes may be defined such as a combined preamble and drift mode that widens the preamble length as time passes since the previous communication and also uses a drift rate to reposition the transmission window to keep it targeted to what the external communication device believes is the most likely position of the reception window on the implantable device.
  • the external communication device initiates communication with the implantable device by sending a telemetry message. If there is no response from the implantable device within a predefined time that is set by the CD software, or if the CRC of the received message does not match the CRC as calculated by the CD software, the CD software causes the packet to be resent. The CD software sets the preamble of this second packet to be twice as long as that used by the former packet but no longer than two seconds. The second message may be termed a retry packet. If the retry packet fails, the CD software initiates another retry but this time using a two-second preamble. If the external communication device does not receive a response to the second retry message, or if the response CRC does not match the calculated CRC, the CD software reports a no response error.
  • the CD software sets aside the original message and a sync message is prepared and sent using an attention preamble that spans the gap that is believed to exist between successive reception windows (e.g. 2 seconds). If a response is still not received, the CD software may automatically (and without user notification) resend the sync message again up to a predefined number of times (e.g. 0-3 times). If a response has not been received, the no response error is again displayed. This process is repeated each time the error is cleared.
  • the CD software then retransmits the original message using a sequence number as provided in the sync response message. If the original message was for an insulin request, the user may check the delivery logs that were updated in conjunction with the last sync response message to determine whether or not the previous delivery was acted upon and thus whether or not it is appropriate to prepare a new delivery request.
  • the external communication device is locked out from performing any other operations other than continued attempts to reestablish communication.
  • the user may elect to reset the external communication device and program it to send an interrogate message which will initially be sent with a preamble that spans the entire period between successive reception windows that exist when the implantable device is in normal mode. If this fails to achieve communication, the CD software automatically, and without user notification, resends the interrogate message using a preamble that spans the entire period between successive reception windows when the implantable device is in storage mode.
  • the CD software controls the external communication device to display the “transmitting to implantable device” screen so as to present the user with a positive visual feedback that the external communication device is attempting to communicate the required telemetry commands.
  • the external communication device recognizes a number of different types of alarms and conditions.
  • the various alarms and conditions are defined with an alarm description, siren, alarm origin, and a display definition for three message areas on the dot matrix portion of the display.
  • the siren indicates whether a yellow (Y) or blue (B) siren will be used when the alarm is active.
  • the alarm origin indicates if the alarm is generated from a condition associated with the external communication device or with the implantable device.
  • An alarm code is specified for a number of the potential alarm conditions. This is a unique number for each alarm condition and is used to identify the alarm in the error log and on the display.
  • the CD software When the CD software recognizes an alarm condition originating from the implantable device (received through telemetry), the CD software activates a siren and displays a message on the dot matrix display. The message is displayed on the ‘time & alarm’ screen and the siren is initiated immediately. The CD software cancels any active user interactions.
  • the alarm is acknowledged by the user, (e.g. by pressing the SEL key followed by the ACT key)
  • the CD software prepares a telemetry message to clear the active implantable device alarm and to request an update of the error log. If multiple alarms are present, they are presented one at a time in prioritized order and each one may be acknowledged, cleared, and the log updated according to the above noted process. After clearing the alarms, the processing that was in progress when the alarm conditions are asserted is allowed to continue in most cases. In alternative embodiments, multiple alarm conditions may be displayed simultaneously and cleared simultaneously, or they may reviewed in turn and then cleared simultaneously.
  • alarm conditions The purpose of alarm conditions is to get the user's attention as soon as possible under most conditions. Exceptions are stop pump, suspend pump, and implantable device auto off as these conditions are system states that are cleared when the user presses SEL and ACT. As the system generally attempts to initiate alarm conditions on the external communication device first to save power in the implantable device, since telemetry transmissions are less power consumptive than buzzer activations, minimizing the duration of the alarm condition on the external communication device result in reducing the possibility of the Implantable Device alarming internally.
  • Reassertion of implantable device alarms are dependent on the alarm condition not being removed (i.e. the condition has not been cleared though its existence was previously acknowledged) by the time reassertion is to occur and on the implantable device communicating the error to the external communication device. Reassertion results in the alarm condition again being displayed on the LCD and the siren being activated and requiring that the use acknowledge the alarm.
  • the CD software handles external communication device alarms in much the same manner that it handles implantable device alarm conditions with the exception that telemetry packets need not be prepared and sent to acknowledge the alarm conditions.
  • Reassertion of external communication device alarm conditions is similar to that for reassertion of Implantable Device alarm conditions in that they also result in a new alarm condition on the external communication device which the user must acknowledge.
  • the exceptions to this rule are temporary basal rate, delivering diagnostic rate, and delivering priming bolus which are system states that require the external communication device to beep periodically.
  • the following Table depicts the various alarm conditions that are recognized in the present embodiment in order of priority.
  • an Alarm Code is additionally displayed as a numeral that indicates the specific cause of the alarm condition.
  • the CD software records all external communication device alarms in the external communication device system events log.
  • the CD software initiates a CD battery low alarm.
  • a low battery message will persist on the “Time and Message’ screen until the battery has been replaced.
  • the existence of this condition may only be displayed for limited times. For example, it may be displayed when the user first interacts with the device after a time out period, or it may also be displayed after various commands are given. If the external communication device is not recognizing a dead battery condition, the CD software initiates a low battery condition check every hour. When the low battery condition is detected, the CD software logs the event.
  • the CD software initiates a CD Main Battery Depleted alarm.
  • the CD software causes a depleted battery message to persist on the “Time and Message’ screen until the battery is replaced.
  • the CD software logs the event.
  • the CD software causes the voltage of the backup battery to be checked every day. If the battery voltage is too low, then the external communication device needs to be refurbished.
  • the CD software also checks for the depleted backup battery condition every day. When the depleted backup battery condition is detected, the CD software causes the depleted backup battery message to be displayed on the ‘time and message’ screen and logs the event. Though the user may clear the alarm, the depleted backup battery message continues to be displayed on the ‘Time and Message’ screen until refurbishing occurs.
  • the external communication device ‘Time and Alarm’ screen is active, and the user must clear the display. In the present embodiment, this is accomplished by pressing the SEL key and then the ACT key for alarms generated by the external communication device. This is initiated by pressing the SEL key and then the ACT key for alarms generated by the Implantable Device.
  • the CD software When an implantable device alarm is cleared by the user, the CD software prepares a clear alarm telemetry message that is transmitted to the implantable device. Upon receipt of the response, the CD software clears the active alarm condition that is displayed to the user. The CD software also re-prioritizes its alarm conditions. If there are any outstanding errors, the CD software causes the one with the highest priority to be displayed and the external communication device remains in an error state. The process of displaying, clearing, and reprioritizing continues until there are no more outstanding errors. If the alarm was detected during a telemetry transaction, the CD software resumes the telemetry transaction.
  • the initialization process is not resumed but must be restarted beginning with the Interrogate Message.
  • the CD software is configured to periodically write to the watchdog hardware registers. If the system watchdog requirements are not met, a watchdog alarm is triggered and the watchdog tone is enabled by the hardware. An infinite loop at mainline or an infinite loop at interrupt level will cause the watchdog to reset the processor IC as the CD software must write one of a 0 ⁇ 5 B or a 0A5 to the watchdog register in mainline code and the other at interrupt level.
  • Sirens are activated by the CD software when the external communication device detects an alarm condition. Sirens are deactivated by CD software when the alarm condition is cleared by the user.
  • yellow sirens when the alarm type is set to ‘vibrator,’ the CD software activates the vibrator for 3 seconds every minute while the yellow siren is active.
  • the alarm type is not set to ‘vibrator,’ the CD software initiates a high beep tone 6 times with 250 ms between each beep, every minute while the yellow siren is active.
  • the CD software sets the alarm type to high and initiates an alert tone every minute until the yellow siren is deactivated. If the alarm type was set to vibrator prior to crossing the 30-minute threshold, the alarm type is converted to high (i.e. loud audio) at the 30-minute threshold.
  • the CD software will activate the vibrator for 3 seconds every 30 minutes while the blue siren is active.
  • the CD software initiates a high beep tone 3 times with 250 ms between each beep, every 30 minutes while the blue siren is active.
  • Tone Frequencies Tone Duration Frequency Repeat Number ACT Tone 125 ms 516 Hz 1 High Beep Tone 250 ms 941 Hz 1 Audio Bolus Tone 1 250 ms 516 Hz 1 Audio Bolus Tone 2 250 ms 592 Hz 1 Audio Bolus Tone 3 250 ms 667 Hz 1 Audio Bolus Tone 4 250 ms 696 Hz 1 Double Audio Bolus 250 ms 516 Hz 2 with 125 ms Tone 1 delay between Double Audio Bolus 250 ms 592 Hz 2 with 125 ms Tone 2 delay between Double Audio Bolus 250 ms 667 Hz 2 with 125 ms Tone 3 delay between Double Audio Bolus 250 ms 696 Hz 2 with 125 ms Tone 4 delay between No Action Tone 500 ms 380 Hz 1 Alert Tone 250 ms each 941 Hz followed 6 by 516 Hz
  • ROM boot code within the processor IC loads the external communication device bootloader code from the SEEPROM and factory defined parameters.
  • CD software When the external communication device boots, CD software reads the power down recovery data from external RAM and calculates the power down recovery data checksum by performing a 16 -bit sum with the carry of the data.
  • the CD software calculates the power down recovery data checksum inverse by performing an arithmetic inverse of the power down recovery data checksum.
  • the bootloader code copies the CD software (i.e. application code) from external RAM into internal RAM.
  • the external communication device loads the application code into external RAM from the SEEPROM. Once application code is resident in external memory, the internal portion of the code is copied from external memory to internal memory.
  • the external communication device loads the application code into external RAM from the SEEPROM. Once the application code is resident in memory, the internal code portion is copied from external memory to internal memory.
  • the external communication device application code is started by an inter-segment jump to the main external RAM initialization address location.
  • the CD software Before performing conversions between insulin units and pump strokes, the CD software compares the stroke volume variable to its compliment form. If they do not agree, the CD software causes the external communication device to be reset.
  • the CD software Before performing conversions, the CD software compares the insulin concentration variable to its compliment form. If they do not agree, the CD software causes the external communication device to reset.
  • the CD software causes the external communication device to display insulin quantities to the user based on one more selected predefined units of resolution (e.g. 0.2 units for bolus quantities and 0.1 units for basal quantities).
  • predefined units of resolution e.g. 0.2 units for bolus quantities and 0.1 units for basal quantities.
  • the pump stroke volume is nominally 0.5 ⁇ L actually pump stroke volume may vary from this amount.
  • a dispensing resolution of nominally 0.2 units of insulin results.
  • the stroke volume may vary, the actual dispensing resolution may also vary. As such programming and interfacing between the user and device occur in increments that are not necessarily integer values of the pump stroke volume.
  • Suspend mode is a mode where the implantable device is programmed to deliver at a rate of one pump stroke an hour. The rate is clinically insignificant and serves to prevent catheter blockage.
  • Suspend mode is enabled by the CD software from the 'suspend pump’ screen.
  • suspend mode is entered, the CD software prepares a telemetry message for transmission to the implantable device to set its delivery mode to “suspend”.
  • the CD software causes the display the alarm screen to display the “pump suspended” alarm as active.
  • the CD software When the “pump suspended” alarm condition is cleared, the CD software prepares a message for transmission to the implantable device to set the implantable device delivery mode to “normal”. When the “pump_suspended” alarm condition is cleared, the CD software determines if a bolus was interrupted when suspend mode was entered. If so, it updates the bolus history log to indicate the amount of the bolus that was delivered. The CD software only provides access to the Supervisor Menu Screens while the pump is in suspend mode. A block diagram of the supervisor menu screens and options is provided in FIG. 10.
  • An audio bolus option is provided that enables the user to safely and reliably deliver a bolus without looking at the display.
  • the CD software enables and disables this option from the Audio Bolus Screen in the setup menu.
  • a block diagram of the set up menu screens and options is provided in FIG. 8.
  • the CD software When audio bolus status is ON, the CD software enables the user to initiate delivery of a bolus by pressing the up arrow key from the ‘time and message’ screen as well as the ‘time’ screen.
  • the CD software causes the external communication device to beep and the bolus increment to be displayed as when the up key is first depressed.
  • the CD software provides no scrolling effect when a key is held down.
  • the CD software increases the amount displayed by the bolus increment amount and beeps with each subsequent press of the up key.
  • the CD software provides a single tone beep when the increment amount is set to 0.4 U, and a double tone beep when the increment value is set to 0.8 U.
  • the CD software could control an appropriately configured external communication device to speak to the user.
  • the CD software could provide voice recognition features to an appropriately configured the external communication device so that commands could be spoken instead of keyed in.
  • the CD software facilitates counting the audio bolus increments by varying the audio tones for the beeps that accompany the Up arrow key presses.
  • the CD software provides four frequencies that are used in a repeating sequence as the UP arrow key is repeatedly pressed until the desired bolus amount is selected.
  • the CD software interprets a pressing of the down key and sel keys to cancel the bolus.
  • the desired bolus amount has been programmed (and is displayed)
  • the user may activate it by pressing the act key.
  • the act key is pressed and the amount is not zero, the CD software causes the external communication device to play back the beep sequence generated during bolus amount selection.
  • the CD software interprets a subsequent pressing of the ACT key, as confirmation that the user wants to have the programmed amount delivered and as such displays the ‘immediate bolus confirmation’ screen.
  • the CD software prepares a bolus delivery message for transmission to the implantable device after the user confirms the bolus amount selection by pressing the ACT key again.
  • the user may either allow the CD software to time-out and return to the ‘time and message’ screen or the user may press any key other than the act key.
  • the CD software When the delivery of an audio bolus is canceled, the CD software causes the ‘time and message’ screen to be displayed and causes a no action tone to be emitted.
  • the CD software stores the audio bolus status and audio bolus increment parameters in the external communication device data block.
  • the CD software enables the external communication device to request delivery of three types of boluses. These are the normal bolus, the square wave bolus and the dual-phase bolus.
  • the normal bolus (immediate bolus or phase 1 bolus) gives the user the option to program a bolus amount in units of insulin.
  • the insulin units requested for delivery are translated by the external communication device to an integer number of pump strokes, a telemetry message is prepared and transmitted to the implantable device which then delivers the amount.
  • the square wave bolus (phase 2 bolus) is programmed as an amount in units and a duration.
  • the CD software translates the amount into a rate, a telemetry message is prepared and transmitted to the Implantable Device which then delivers insulin the computed rate for the given duration.
  • the dual phase bolus (two-phase bolus) is a combination of the normal bolus and the square wave bolus.
  • the user programs a phase-one amount, a phase-two amount, and a phase-two duration into the CD software.
  • the phase one amount is treated like-a normal bolus.
  • the phase-two amount and duration are treated like a square wave.
  • a telemetry message is prepared and transmitted to the implantable device which is then programmed to deliver the two components of the bolus.
  • variable bolus status When a parameter called variable bolus status is set to OFF, the only type of bolus delivery that can be programmed is the normal bolus.
  • the CD software presents the user with a ‘set bolus amount’ screen that the user may interact with to program a normal bolus.
  • the CD software allows the user to increment up and down through allowable bolus amounts by using the up and down keys.
  • the maximum amount that can be scrolled to is equal to programmable maximum bolus quantity.
  • the CD software displays the ‘immediate bolus confirmation’ screen when the user depresses the act key (so long as the bolus amount indicated is not zero).
  • the act key When the act key is pressed again, the CD software prepares a bolus delivery request message for transmission to the implantable device.
  • the CD software allows a Square Wave bolus to be programmed when the variable bolus status is set ON. From the set bolus display, the CD software enables the user to select, intra alia, a square wave bolus. Once selected, the CD software shows the user a ‘set bolus amount’ screen with portion of the display blinking indicating that an amount may be entered. A desired bolus amount may be entered by the user using the up and down keys. The CD software limits the amount that may be entered to the predefined maximum bolus amount. After entering the amount and pressing the act key, the CD software displays a blinking region for setting bolus duration.
  • the CD software After entering the desired duration and depressing the act key, the CD software displays a blinking screen that shows the details of the extended bolus that has been programmed (i.e. ‘Extended Bolus Confirmation’ screen). If the user agrees that a delivery having the indicated details should be made, the CD software initiates a telemetry delivery request message when the act key is pressed again
  • the CD software also allows a dual bolus to be programmed when the variable bolus status is set on and the bolus delivery type is set to dual.
  • three screens are presented to the user one after the other: (1) the ‘set bolus amount’ screen is displayed for entry of the immediate portion of the bolus, (2) the ‘set phase 2 amount’ is displayed for entry of the square wave portion of the bolus, and (3) the ‘set phase 2 duration’ screen is displayed for entry of the square wave duration.
  • the user progresses through these screens by entering the desired amount as each screen is displayed and then hitting the act key. After the act key is depressed while the ‘set phase 2 duration’ screen is displayed, a flashing the ‘Extended Bolus Confirmation’ screen is shown.
  • the CD software initiates a telemetry delivery request message when the act key is pressed again.
  • the CD software limits the total bolus amount programmed for the combination of the Immediate and the phase-2 boluses to be no more than the predefined maximum bolus amount.
  • bolus delivery is initiated by the CD software preparing and initiating a deliver bolus, read totals telemetry packet.
  • the CD software calculates the number of pumps to be delivered in the immediate bolus based on the amount programmed with the result rounded to the nearest integral number of pump strokes.
  • the CD software also uses the phase-2 amount and duration to calculate a phase-2 delivery rate in pump strokes per minute. The calculated amount, rate and duration are passed to the implantable device for delivery in the above noted delivery request message.
  • the rotating delivery status icon indicates that a delivery is in progress and ‘time and message’ screen provides a delivering bolus message and an estimate of the amount delivered.
  • the CD software estimates the amount delivered in the immediate phase of a bolus to be one pump stroke during each predefined interval of time (e.g. 2-4 seconds). Incrementing starts on the minute following completion of bolus programming.
  • the CD software disables the ‘set maximums’ screen during delivery of a bolus. Also when the estimate of the immediate amount delivered is less than the programmed amount, the ‘set bolus amount’ screen is also disabled. When the estimate of the immediate amount delivered equals the programmed amount, the ‘set bolus amount’ screen is enabled. When the estimated delivery of the combined amounts (immediate and extended) is complete the CD software causes the external communication device to emit an end of bolus tone. The CD software inhibits entry of an additional extended bolus delivery when an extended bolus is already in progress. The CD software locks out all bolus delivery screens during the delivery of an immediate bolus, diagnostic rate, or primary bolus.
  • variable bolus rate option in provided.
  • a variable bolus status parameter is also provided that is indicative of whether the user has the capability of entering delivery instructions for all three bolus types or only the immediate type.
  • bolus delivery includes a screen to choose the bolus type.
  • the option is off, the user can only program normal boluses. In either event, the CD software provides the user with access to those screens and options that are available to him/her and removes access/display of those screens that provide programming capability for the unavailable options.
  • the CD software provides a ‘variable bolus’ screen that may be used to set the variable bolus status parameter to on and off for enabling the programming of square wave boluses and dual wave boluses.
  • the CD software causes the variable bolus status parameter to be stored in the external communication device data block.
  • the CD software provides the user with the capability of displaying the time of delivery and the amount for each of the most recent 512 boluses. Priming boluses are displayed along with variable and audio boluses.
  • the CD software provides a ‘bolus history’ screen that display the most recently delivered or programmed bolus. The older entries in the bolus history log are displayed when the down arrow is pressed. Newer entries in the bolus history log are displayed when the up arrow is pressed. The up arrow is ignored when the external communication device is displaying the most recent bolus. The CD software ignores any down key presses when the external communication device is displaying the oldest log entry.
  • the CD software sets the bolus status parameter to ‘programmed’ .
  • the CD software updates the bolus history log when the response to the deliver bolus read totals &telemetry packet is received.
  • the CD software blanks a bolus status parameter when a response to a deliver bolus read totals telemetry packet indicates that the amount displayed for the most recently programmed bolus was delivered.
  • the CD software provides the user with the ability to display the total amount of insulin delivered during each of the most recent 120 days on a ‘daily totals’ screen.
  • the amount for the current day is only accurate up through the delivery of the previous bolus, not the current bolus, or the last bolus.
  • the CD software retains the total basal delivery and the total bolus delivery as separate amounts for each day in the daily totals log.
  • the CD software displays older entries in the daily total log when the down arrow is pressed.
  • the CD software displays newer entries in the daily total log when the up arrow is pressed.
  • the CD software ignores Up key presses when the most recent entry in the daily total log is displayed and ignores the down key presses when the oldest daily total log entry is displayed.
  • the CD software updates the Daily Totals log using the current day's total and yesterday's total from the TM message, when a response to the Deliver Bolus, Read Totals telemetry packet is received.
  • the CD software maintains a pointer that indicates “today” in the daily total log.
  • the CD software increments this pointer at midnight.
  • the CD software increments the pointer indicating “today”, the daily total for the new day is set to dashes.
  • the CD software provides the user with the ability to display the contents of the external communication device event log on a ‘external communication device ‘clinical history’ screen.
  • the most recent event code for the most recently logged external communication device event is displayed on the screen.
  • the CD software displays older entries in the external communication device event log when the down arrow is pressed and newer entries in the external communication device event log when the up arrow is pressed.
  • the CD software ignores up arrow key presses when the external communication device is displaying the most recent entry in the external communication device event log and ignores down key presses when the external communication device is displaying the oldest entry in the external communication device event log.
  • the CD software maintains a pointer to the most recent entry in the external communication device event log.
  • the CD software provides memory space for storing the contents of the implantable device event log and the ability to display those events on an ‘implantable device clinical history’ screen.
  • the event code for the most recently logged implantable device event is initially displayed on the screen.
  • the CD software displays older entries in the implantable device event log when the down arrow is pressed and newer entries in the implantable device event log when the up arrow is pressed.
  • the CD software ignores up key presses when the external communication device is displaying the most recent entry in the implantable device event log and down key presses when the external communication device is displaying the oldest entry in the implantable device event log.
  • the CD software maintains a pointer to the most recent entry in the implantable device Event Log.
  • the CD software updates its implantable device event log to match the event log in the implantable device during a link and when executing the read implantable device data functionality.
  • the CD software provides memory space for storing entries to the implantable device battery voltage log and the ability to display those entries on an implantable device voltage history screen.
  • the CD software initially displays the most recently logged loaded and unloaded implantable device battery voltages on this screen.
  • the CD software displays the older entries in this log when the down arrow is pressed and newer entries in this log when the up arrow is pressed.
  • the CD software ignores the pressing of the up key when the most recent entry in the log is being displayed and the down key when the oldest entry in the log is displayed.
  • the external communication device maintains a pointer to the most recent entry in the implantable device battery voltage log.
  • the CD software updates this log to match the battery voltage log in the implantable device during a link and when executing the read implantable device data feature.
  • the CD software provides for a predefined number (e.g. 3 in the present embodiment) of separately programmable sets of basal rates.
  • Each set, or profile consists of a predefined number (e.g. up to 48 in the present embodiment) of basal rates, one for each of a predefined set of time slots (e.g. each half-hour of the day in the present embodiment).
  • the profile rates are programmed by setting a start time and a rate.
  • the CD software provides a basal rate screen that allows the user to view the basal rate that is currently being delivered. When there is no temporary basal rate active (the temporary basal duration is zero) the CD software displays the currently active basal profile along with its number. When a temporary basal rate is active, the active profile number is replaced with “OFF”.
  • the CD software displays the set profile rate screen showing profile 1 when act is pressed when the ‘basal rate’ screen is displayed when the act key is pressed from the set profile rate screen, the CD software displays the set profile start time screen.
  • the minimum value for scrolling the start time is one half-hour after the start time of the previous profile.
  • Basal profile setting is complete when the rate for a profile starting at 11:30 pm is set. Alternatively, basal profile setting is completed when the user presses the act key for a profile start time that is dashes.
  • the CD software prepares and sends a set profile basal rates message to the implantable device.
  • the CD ⁇ software allows up to 3 delivery patterns to be separately programmed with up to 48 rates each and the patterns to be stored in the external communication device. Any one of the patterns may be set active at any time.
  • the CD software allows the Selection of the active basal delivery pattern from the set basal delivery pattern screen. When the basal delivery pattern is set (i.e. made active) that pattern becomes accessible on the ‘profile basal rate’ screen and a set profile basal rates message is prepared and transmitted to the implantable device.
  • the temporary basal rate is a basal rate that when programmed, will run in lieu of the basal profile rate.
  • the temporary basal rate runs for the amount of time specified by the temporary basal duration.
  • the CD software enables setting of the temporary basal rate using the set temporary basal rate screen.
  • the CD software prepares and sends a set temporary basal rate message to-the implantable device.
  • the CD software causes the remaining temporary basal rate duration to be displayed on the temporary basal rate screen.
  • the CD software causes dashes to be displayed as the amount and duration of the temporary basal rate.
  • any temporary basal rate in progress is canceled.
  • the CD software sets the default duration to the time remaining on the rate that is in progress rounded down to the nearest half-hour.
  • the CD software increases the duration by one half-hour when the up key is pressed and decreases the amount by one half-hour when down key is pressed.
  • the CD software locks out the set temporary basal rate screen during a diagnostic rate delivery and priming bolus delivery.
  • the CD software maintains a log of personal events.
  • the CD software allows personal events to be set from a personal events screen.
  • the CD software updates the log with a time and event type after the user completes the personal event data entry sequence.
  • the personal events screen is not displayed when a personal events enable parameter is set to OFF.
  • the personal events screen is displayed, the most recent personal event is displayed.
  • the CD software displays the previous personal event in the log and when the Up key is pressed, the CD software displays the next personal event in the log.
  • the CD software ignores presses of the Down key when the oldest personal event is being displayed and ignores the Up key when the newest personal event is being displayed.
  • Automatic Off is set from the ‘set automatic off’ screen.
  • the CD software prepares and sends a set automatic off telemetry message to the implantable device.
  • the automatic off interval is programmed to dashes, the CD software disables the feature.
  • the CD software maintains a timer that indicates the amount of time remaining in the automatic off interval.
  • the CD software resets the timer to the automatic off interval.
  • the CD software decrements the time in the automatic off interval timer every minute. When the amount of time in the automatic off interval is five minutes (indicating that the Implantable Device will alarm in 5 minutes), the CD software reports an “automatic off alarm” alarm.
  • the CD software maintains the time and the date.
  • the CD software enables the time and the date to be set from the ‘time and date’ screen.
  • ACT is pressed
  • the ‘set time’ screen is displayed.
  • the CD software allows the user to change the hours and the minutes.
  • act is pressed and the minutes are displayed
  • the CD software displays the set date screen.
  • the CD software prepares and sends out a set current time telemetry message to the implantable device.
  • the external communication device has direct knowledge of date and changes in date that may occur, this direct knowledge is not used in determining, among other thing, how to set daily totals.
  • this direct knowledge may be used for this purpose; however, in the present embodiment the following analysis is performed by the CD software and associated conclusions made: (1) If the new hour is less than the current hour (measured on a 24 hour clock), and the new hour subtracted from the current hour is greater than or equal to 12, new day processing takes place, (2) If the new hour is greater than the current hour and the current hour subtracted from the new hour is greater than or equal to 12, previous day processing takes place, and (3) If the new hour and current hour are not separated by more than 12 hours the day is considered to remain unchanged.
  • the CD software updates the daily totals as is normally carried out at midnight. When previous day processing occurs, the CD software moves the daily total data log pointer to the previous day and adds current daily total values to those of the previous day.
  • An hourly maximum amount is provided for by the CD software.
  • the hourly maximum is the amount of insulin that may be delivered with boluses in one hour. If a higher amount is programmed, the CD software reports an error.
  • the hourly maximum amount is not a hard limit but one that may be bypassed if desired by the patient. In effect, the hourly maximum amount provides a warning to the patient so that the patient will not unintentionally deliver a large amount of insulin within a single 60-minute period.
  • a window of predefined length e.g. 10 minutes
  • an additional bolus of up to the single bolus maximum amount i.e.
  • the bolus maximum may be delivered without triggering the hourly maximum amount error.
  • the hourly maximum amount is set to a predetermined multiple of the single bolus maximum amount (e.g. 2.5 times).
  • the time period of the maximum may be specified to a larger or shorter amount and/or the amount of the maximum may be set in a different way.
  • the CD software computes the amount of bolus delivery that occurred during the previous 60 minutes. If the amount delivered summed with the programmed amount is greater than 21 ⁇ 2 times the bolus maximum, the CD software reports an “hourly maximum exceeded” alarm and the CD software does not transmit a telemetry message to the implantable device to initiate the bolus. When the “hourly maximum exceeded” alarm is cleared the CD software sets a ten-minute time period in which CD software will not test for the “hourly maximum exceeded” alarm. The CD software resumes testing for the “hourly maximum exceeded” alarm after the ten-minute time period elapses.
  • the testing may be based on amounts programmed during the last 60 minutes. Also in alternative embodiments, an estimated timing of delivery for the amount(s) programmed may be factored into the calculations before concluding that the hourly maximum will actually be exceeded, especially when the amount programmed for delivery includes an extended bolus.
  • the CD software allows a basal rate maximum to be defined and then uses this maximum value in limiting the basal rates that can be programmed for delivery during any one period of time.
  • the CD software inhibits the user from programming basal profiles or temporary basal rates that are greater than the value of the basal rate maximum.
  • the CD software prepares and sends the implantable device a set maximums Message.
  • the CD software inhibits a maximum basal rate from being programmed that is set to a value lower than a programmed basal rate, including profile basal rates, both active and inactive, and the temporary basal rate.
  • the CD software sets the medication remaining parameter to the refill amount when a response to a “set refill amount and alarm thresholds” message is received.
  • the CD software subtracts the daily total values (not taken from the amounts displayed but instead derived from the number of pump strokes executed) from the “remaining medication” parameter once per day at midnight.
  • the CD software performs a self-test and initiates the implantable device self-test through telemetry.
  • the external communication device self-test is initiated from the external communication device self-test screen.
  • the CD software sends an Initiate Self-Test telemetry message to the implantable device so that it may be tested as well.
  • the CD software receives a valid response to the initiate self-test telemetry message, the CD software indicates to the user that the Implantable Device has passed the self-test. If the external communication device does not receive a response to the initiate self-test telemetry message, the CD software indicates that the implantable device has failed the self-test.
  • the external communication device sends the implantable device a read self-test status message when the external communication device wants to know the results of the test.
  • the CD software displays the ‘screen operation verification’ screen, an alert tone is emitted, the vibrator is enabled for a predefined period of time (e.g. 3 seconds), the CD software computes a CRC of the code area in internal RAM and compares the computed value to the CRC stored in the SEEPROM, the CD software computes a CRC of the code area in external RAM and compares the computed value to the CRC stored in the SEEPROM, and the CD software illuminates the Backlight for a predefined period of time (e.g. four seconds). If either of these CRC comparisons do not produce a match, the CD software causes the external communication device to reset. When the CD software has completed the self-test sequence, the.
  • a predefined period of time e.g. 3 seconds
  • CD software indicates that the external communication device has passed the self-test (assuming it has). It is up to the user to confirm whether the vibrator operated and whether the display was illuminated. In other embodiments, appropriate transducers and circuitry may be used to automatically ascertain the functionality of various components such as those noted above.
  • the external communication device alarm type is set from the alarms screen, in conjunction with the audio feedback mode audio and vibration alarms are set by the ‘alarms’ screen.
  • the CD software displays the external communication device alarm type screen.
  • the CD software displays the ‘audio feedback mode’ screen.
  • the CD software stores the alarm type parameter in the external communication device memory but when the parameter is changed, it also transmits a set external communication device data block message (containing the updated alarm type parameter) to the implantable device for storage in the external communication device data block.
  • the CD software allows the audio feedback mode to be set from the alarms screen, in conjunction with the external communication device alarm type audio feedback mode is enabled and disabled from the set audio feedback mode screen.
  • the audio feedback status parameter is set to ON the CD software sends the implantable device the set audio feedback mode message enabling audio feedback mode.
  • the audio feedback status parameter is set to OFF the CD software sends the implantable device the set audio feedback mode telemetry message disabling audio feedback mode.
  • the CD software causes the external communication device to storage mode if there is no keyboard activity and there have been no telemetry packets received for seven days.
  • the external communication device exits storage mode if a key is pressed or the batteries are removed and replaced.
  • the screen is disabled and the telemetry hardware is disabled, time is maintained (but not displayed) and memory is retained but all other functions become unavailable.
  • the pump refill process is initiated from the ‘pump refill’ screen pressing act on the pump refill screen causes the ‘set extracted amount’ screen to be displayed. Pressing ACT on the ‘set extracted amount’ screen causes the ‘set refill amount’ screen to be displayed. Pressing act on the ‘set refill amount’ screen causes the ‘Set Concentration’ screen to be displayed. Pressing ACT on the ‘set concentration’ screen initiates the CD software to calculate the delivery accuracy. When the CD software computes the delivery accuracy to be a negative number, it displays the value as positive number along with the words “Under-Delivery”. When the cd software computes the delivery accuracy to be a positive number, the value is displayed along with the words “over-delivery”.
  • the extracted amount is dashes
  • the extracted amount is logged as zero and this event is logged in the system event log.
  • the accuracy is displayed as dashes.
  • the CD software determines that the extracted amount is more than the previous refill amount, the CD software logs a system event and displays the accuracy as dashes.
  • the CD software determines that the extracted amount equals the previous refill amount, the CD software logs a system event and displays the accuracy as dashes.
  • Changing the insulin concentration is part of the refill screen sequence.
  • the CD software resets all profile basal rates and the temporary basal rate to factory default values.
  • the CD software sends the implantable device a set basal rates message and a set insulin concentration message.
  • the CD software recomputes the current basal rate maximum and bolus maximum and sends the implantable device a set maximums message.
  • the priming bolus screen is found on the supervisor menu.
  • the CD software locks out the priming bolus screen unless the pump is in stop mode. Priming the pump is initiated from the priming bolus screen.
  • the CD software displays the confirm priming bolus screen.
  • the CD software displays the reconfirm priming bolus screen.
  • the cd software sends a set delivery mode message to the implantable device with the mode set to indicate priming bolus, and the priming bolus amount set to a predefined value (such as 650 pump strokes).
  • the diagnostic rate screen is on the supervisor menu. It is used to perform diagnostic procedures on the pumping mechanism by setting very high rates. Normally, the reservoir is not filled with insulin when this feature is used. The diagnostic rate screen is locked out unless the pump is in stop mode diagnostic rate is initiated on the ‘diagnostic rate’ screen.
  • the CD software displays the set diagnostic rate Screen.
  • the cd software displays the confirm diagnostic rate screen.
  • the CD software displays the reconfirm diagnostic rate screen.
  • the CD software When the user presses the act key on the reconfirm diagnostic rate screen, the CD software prepares and sends a set delivery mode message to the implantable device with the mode set to indicate diagnostic rate, and the diagnostic rate amount equal to the amount set on the ‘set diagnostic rate’ screen. While the diagnostic rate is in progress, the CD software displays a message on the ‘time and message’ screen to indicate that the diagnostic rate is in progress.
  • the maximum lock feature is a safety feature accessible from the supervisor menu. This feature enables and disables the patient's ability to change the delivery maximums.
  • the maximum lock feature is accessible on the ‘lock bolus and basal maximums’ screen.
  • the set lock screen is displayed.
  • the CD software sends a set maximums message to the implantable device.
  • the locked maximum status parameter is on
  • the CD software ignores the act key when it is pressed while the max bolus screen is displayed.
  • the locked maximum status parameter is on, the CD software ignores the act key when it is pressed while the max basal rate screen is displayed.
  • the read implantable device data feature synchronizes the external communication device and the implantable device.
  • the read implantable device data feature is accessible from the read implantable device data screen. When the user presses act on this screen, the CD software initiates the read implantable device data process.
  • the read implantable device data process includes reading the Implantable device data log pointers and reading all of the data necessary to make the data logs in the external communication device mirror the data logs in the implantable device.
  • the external communication device contains an image of the implantable device software in one of its SEEPROMs.
  • the image includes-instructions to perform all of the telemetry transactions necessary to download the software, including for example, an interrogate message, a link message, a reset message, an interrogate message, a link message, download start message & data, one or more download continue messages and data, and a bootstrap message the SEEPROM includes code and data for both the main and the monitor processors on the implantable device.
  • Downloading implantable device software is initiated on the “download implantable device software” screen. When the user presses the act key on the “download implantable device software” screen, the CD software displays the “confirm download implantable device software” screen.
  • the CD software When the user selects ‘yes’ and presses the act key on this screen, the CD software displays the re-confirm download implantable device software screen. When the user presses the ACT key on this screen, the CD software initiates the software download. The CD software reads the SEEPROM and uses the size and the data, in formulating telemetry packets to send to the implantable device. If appropriate message responses are received by the CD software, it continues sending packets until the data read from the SEEPROM indicates that there is no more data. If errors are detected during the download process, the CD software displays the download error screen.
  • Stop mode is a mode where the implantable device is programmed to stop all insulin delivery.
  • the CD software limits accessibility to only supervisor menu screens when the pump is in stop mode stop mode is enabled from the “stop pump” screen.
  • stop mode the CD software prepares and transmits a telemetry message to the implantable device to set the delivery mode to stop mode.
  • stop mode the CD software displays the alarm screen with “pump stopped” alarm active.
  • the CD software sets prepares and sends a telemetry message to the implantable device to set the delivery mode to normal mode and also updates the bolus history log to indicate the amount of the latest bolus that was delivered.
  • the CD software provides single command ability to set parameter values in the implantable device to their factory default values. This capability is produced from the “initialize to factory defaults” screen. Several telemetry commands are used to initialize the implantable device to factory defaults successfully. When the choice is confirmed to reset the parameters, the CD software sends the telemetry messages indicated in the following table to the implantable device to set the parameters to their factory default values: Telemetry Messages to Initialize to Factory Defaults Set Current Time Set Automatic Off Set External Communication Device Data Block Set Maximums Set Audio Feedback Mode Set Personal ID Set Temp Basal Rate Set Basal Profile Rates Set Delivery Mode
  • the CD software provides a one command process for initializing the external communication device to implantable device. After completing this sequence, the external communication device is configured to match the implantable device settings with the exception of the basal profiles which are set to factory defaults in the implantable device and the external communication device.
  • the Initialize external communication device to implantable device process is initiated from the initialize external communication device to implantable device screen.
  • the CD software sends the implantable device an interrogate message.
  • the CD software displays the ‘confirm implantable device serial number’ Screen. This screen contains a message that gives the user the choice to confirm or reject the displayed personal ID.
  • the user may choose “yes” or “no” to confirm or reject and abort the initialization process.
  • the CD software sets the “no” choice as the default.
  • the external communication device attempts to add the telemetry ID from the interrogate response message to the exclusion list. If the exclusion list is full, the CD software reports an “exclusion list full” alarm. If the exclusion list is not full, the CD software sends out another interrogate message, in hopes of getting the correct implantable device to respond. The rejection process may be repeated multiple times if a large number of implantable devices are in the vicinity.
  • the CD software sends the telemetry messages to the implantable device as indicated in the table below.
  • the stroke volume received in the read stroke volume response is range-checked by the CD software to ensure that it is a valid value. If the stroke volume is not within range, and “invalid stroke volume” alarm is reported, and the CD software will not initialize the external communication device to the implantable device. If valid, the CD software stores the stroke volume as received and once more in its complimented form.
  • the insulin concentration received in the read concentration response is also range checked by the CD software to ensure that it is a valid value. If the insulin concentration is not within the range, the CD software reports an “invalid stroke volume” alarm and the CD software will not initialize the external communication device to the implantable device. If valid, the CD software stores the insulin concentration as received and once more in its complimented form.
  • the CD software sets the delivery mode to suspend.
  • the CD software sets the implantable device basal rates, including the profiles and temp basal rates to the factory default values.
  • the external communication device During programming of the external communication device, if there is no active alarm and no buttons are pressed, the external communication device will return to the ‘time and message’ screen after a predefined period of inactivity. When an alarm is in the‘process of being cleared, the CD software returns the external communication device to the “time and alarm” screen.
  • the time-out i.e. predefined period of inactivity is dependent upon the last key that was pressed, if telemetry occurred, and if an alarm was beeping.
  • time-out is 4 seconds after telemetry occurs; (2) 15 seconds after an interrogate; (3) 15 seconds after audio bolus beeping; (4) 7 seconds after a sel key is pressed; (5) 15 seconds after all other keys are pressed, except for when the down key is pressed to activate the backlight; and (6) 4 seconds after the activation of the backlight.
  • the CD software provides a set of functions that are only accessible with a supervisor password.
  • the user In order for the user to access the supervisor menu, the user must enter a supervisor password on the password screen.
  • a predefined group of keys are pressed simultaneously (e.g. the two arrow keys), for a predefined number of seconds (e.g. 3-5 seconds), from one or more selected screens (e.g. the time alarm & sel screen, or the pump setup screen) the password screen is displayed.
  • the password screen When the user is presented with the password screen, the user enters a selected number of parameters (e.g. four parameters defined as password entry 1, password entry 2, password entry 3, and password entry 4).
  • the CD software presents one parameter at a time for entry.
  • subsequent password entry parameters may be entered when “act” is pressed after specifying password entry 4, the CD software compares password entry 1-4 parameters to password 1-4 parameters. If the four values match, the CD software displays the ‘supervisor menu’ screen. If the values do not match, the CD software compares password entry 1-4 parameters to the factory password parameters 1-4. If the four values are within a predefined amount of each other (e.g. less than or equal to 24 apart), the CD software displays the supervisor menu screen. If the values do not match, the CD software displays the time and message screen.
  • the following tables present a listing of the various screen names along with a brief description of them.
  • the Main Menu contains the following screens Screen Description Main Menu Screens Time This is the screen that displays the current time and the icons.
  • Time and Message This screen will be displayed when there are messages such as bolus delivery in progress and temporary basal rate in progress.
  • Bolus History This is the screen that shows the boluses that have been delivered. A new bolus may be started from this screen.
  • Suspend Pump This is the screen where the user can stop (clinically speaking) insulin delivery.
  • Basal Bate This is the screen where the basal profiles may be reviewed and programmed.
  • Temporary Basal This is the screen where a temporary Rate basal rate may be programmed or canceled.
  • Personal Events This screen is where the user can (when enabled) record the incidence of events such as exercise and meals for later review. Note that this screen will not be in the Main Menu unless it is enabled in the Setup II menu.
  • History Menu This is a menu (described below) that shows historical insulin delivery information.
  • Pump Setup This is the menu where the pump setup options are located.
  • the History Menu contains the following screens: History Menu Screens Read Implantable This screen is where the user can Device Data Synchronize the Implantable Device data and the external communication device data. Medication This screen shows how much medication Remaining is remaining in the pump reservoir. Daily Totals This screen shows the total amount of insulin delivered for the most recent 90 days. Exit History This screen exits the History Menu and returns to the Main Menu. External This screen shows the external Communication communication device Event Log entries.
  • Device Clinical History Implantable Device This screen shows the Implantable Device Clinical History Event Log entries.
  • Implantable Device This screen shows the Implantable Device Voltage History Battery Voltage Log entries.
  • the Pump Setup Menu contains the following screens: Pump Setup Menu Screens Time and Date This is the screen where the user sets the time and the date. Automatic Off This is the screen where the user sets and clears the automatic off duration. Alarms This is the screen where the user sets the alarm type (audio high, audio low, or vibrator) and where the user sets audio feed back mode. Self-Test This is the screen where the user initiates a self-test for the external communication device and the Implantable Device. Basal Delivery This is the screen where one of the Pattern three basal profile delivery patterns is selected. Initialize External This is where the external communication Communication device and the Implantable Device are Device to Implant “married”. This must be carried out before an external communication device and an Implantable Device can communicate. Pump Setup II This is where the Pump II menu can be entered.
  • the Pump Setup II Menu contains the following screens: Pump Setup II Menu Screens Audio Bolus This is where the audio bolus feature is enabled and disabled. Variable Bolus This is where the ability to choose a bolus type on the bolus setting screen is enabled and disabled. Maximum Bolus This is where the maximum bolus amount is set. Maximum Basal This is where the maximum basal rate Rate is set. Time display format This is where the time display can be set to either 12-hour or 24-hour clock. Personal Events This is where the personal events feature is enabled and disabled. Exit to Pump Setup This screen exits Pump Setup II and enters Pump Setup I menu.
  • Supervisor Menu Screens Refill This is where the user enters the amount of medication put into the pump. This is used for the low and empty reservoir alarms. Priming Bolus This is where a priming bolus that is designed to remove air from the catheter is programmed. Diagnostic Rate This where the diagnostic rate is programmed. Bolus and Basal This is where the ability for the user to Maximum Lock change maximums in the Pump Setup II Menu is enabled and disabled. Personal ID This is where the 32 character personal ID is set. Initialize to Factory This feature programs pump parameters to Defaults the factory defaults. Download Pump This is where the pump software can be Software. downloaded. Stop Pump This feature stops and resumes all pumping. Set Supervisor This is where the password for the Password Supervisor Menu is set. Exit Supervisor This screen exits the Supervisor Menu and Menu returns to the Main Menu.
  • numeric parameter will generally be a number.
  • the definition for numeric parameters includes a minimum value and a maximum value and a unit of how the parameter is measured. For all parameters, the defaults values are shown. Numeric parameters also include a step value that indicates how scrolling will increment and decrement when the parameter can be changed by the user. Numeric parameters may show dashes when they are disabled. This is indicated by the term ‘dashes’.
  • Option parameters will generally be a set of options that the user scrolls through when the parameter is set. Option Parameters are shown with all the available choices and the default.
  • the factory default is the value or option that the parameter will be set to when the external communication device is shipped from the factory as a new product.
  • the operating default is the value or option that the parameter will be set to when the external communication device has been initialized properly to an Implantable Device, and the user has interacted with the parameter.
  • PART 1 - External Communication Device Parameter Summary Factory Parameter Default Operating Default Units Delta Value Accuracy Status “%” will be displayed. “Under Delivery” will be displayed if Delivery Accuracy is negative; otherwise “Over Delivery” will be displayed.
  • Audio Bolus Increment 0.4 Previously programmed value. Units 0.4 Audio Bolus Status OFF Previously programmed value. Audio Feedback Status OFF Previously programmed value. Auto-Off Duration DISABLED Previously programmed value.
  • the external communication device may use its IrDA port to communicate with other secondary external devices, such as a desktop personal computers.
  • the external communication device may communicate with two classes of secondary devices: (1) devices for extracting information from the communication device for providing primarily health care related analysis for use by the patient or physician, i.e. a clinician station, and (2) devices for extracting information from and writing information to the communication device for system related diagnostics and problem solving, i.e. diagnostic station.
  • the clinician station may be a desktop computer running a program designed to monitor and display diagnostic information provided by the external communication device and an implantable device for a health care professional.
  • the clinician station type external device cannot write data to the external communication device or the implantable device.
  • the diagnostic station may be a desktop computer running a program designed to aid in the diagnosis of system problems through communication with the implantable device and the external communication device.
  • the diagnostic station has the capability to write data to the implantable device and to the external communication device.
  • a full-duplex link between, the external communication device and an second external device such as the clinician station is provided through the serial communication port.
  • This port provides transmit and receive lines that support infrared LEDs for establishing functional connections to external devices.
  • the transmit and receive lines also support RS232 connections to external devices.
  • Messages are initiated by the second external device.
  • the receiving device allows a predefined time before concluding the transmission has ended. If this time is exceeded before a complete message is received, the receiving device responds with a “no acknowledge” message. The receiver expects the next byte to be the first byte of a message.
  • the external communication device maintains a low power state by disabling some of the UART circuitry.
  • the second external device transmits a “wake-up” message in order to enable the external communication device receiver.
  • the external communication device When the external communication device is in the UART low power state and a byte is received, the external communication device enables all UART capabilities appropriate for communication with an external device.
  • the external communication device UART When the external communication device UART is idle for 10 seconds it enters the low-power state. All messages except for a wake-up and listen message follow a format similar to that noted above for an RF telemetry message.
  • the external communication device recognizes two distinct communication channels using the IR port: the clinician channel and the diagnostic channel.
  • the clinician station software uses a clinician channel to communicate to the external communication device.
  • the messages that are available for each channel type are different.
  • the clinician channel messages do not modify external communication device or implantable device memory but diagnostic channel messages can.
  • a specific channel closes when the “channel close” message is received or when the interval between messages exceeds a predefined channel time out interval. Each channel is closed upon system start-up and remains closed a “channel open” message is received for that specific channel.
  • the electronic control features disclosed herein may be used in other ambulatory devices such as implantable pacemakers, defibrillators, other implantable tissue stimulators, implantable physiologic sensors such as electrochemical oxygen sensors, peroxide sensors, or enzymatic sensors such as glucose sensors, externally carried infusion pumps, implantable infusion pumps that use other pumping mechanisms or simply used excess pressure and controlled flow elements to infuse various medications and drugs such as analgesics, drugs for treating AIDS, drugs for treating psychological disorders and the like.
  • implantable pacemakers defibrillators, other implantable tissue stimulators
  • implantable physiologic sensors such as electrochemical oxygen sensors, peroxide sensors, or enzymatic sensors such as glucose sensors
  • implantable infusion pumps that use other pumping mechanisms or simply used excess pressure and controlled flow elements to infuse various medications and drugs such as analgesics, drugs for treating AIDS, drugs for treating psychological disorders and the like.
  • the features presented above may be used with an external infusion pump that may or may not have a built in display and keypad but is equipped with a telemetry system that can communicate with a physically separated communication device so that the pump need not be accessed in order to provide commands to it and receive data from it.
  • the physical, electronic, and programmed features of the communication device and implantable device may have different components and features than presented above for the implantable pump system so that their desired medical functionality and safety requirements are achieved and such that appropriate control and feedback is provided between the medical device and its communication device.
  • the medical device may include two medical devices such as an implantable pump and an implantable sensor.
  • the pump may dispense a drug whose physiological impact on the body (e.g. analgesic impact) is ascertained by the sensor or alternatively the sensor may supply a physiological reading that indicates a need for infusion of the drug.
  • the pump may operate in a closed loop manner with the sensor or it may operate in an open loop manner where the patient is required to interpret sensor output information and is required to issue appropriate infusion commands to the pump.
  • the drug may be insulin and the sensor may detect glucose level.
  • two medical devices may be implanted adjacent one another or at an extended distance from one another. If not placed in physical contact with one another, a lead may be used to provide power conduction from one device to the other and also be used to conduct communication signals between the devices.
  • each device may include at least one telemetry system that allows direct communication between each or allows indirect communication to occur via the external communication device or other external device.
  • Each device may be supplied with its own power supply. Depending on the communication requirements each device may use two way communication (i.e. both outbound and inbound communication) or allow only one way communication (i.e. outbound communication or possibly inbound communication).
  • both the medical device and the communication device may be external devices (e.g. an external pump and an external RF telemetry based communication device).
  • a first type of medical device may be implanted (e.g. an infusion pump or a sensor) while a second medical device may be external (e.g. the opposite of a sensor or an infusion pump).
  • a second medical device may be external (e.g. the opposite of a sensor or an infusion pump).
  • the medical devices may also function as the communication device for the other medical device in which case it may possess a display for providing information to the patient and a keypad for allowing entry of commands for issuance to the implantable device as well as for direct use by itself.
  • an external, non-medical communication device may be supplied that has information output (e.g. display) capabilities and input (e.g. keypad) capabilities. If a separate communication device is provided, the external medical device may or may not have display and input capabilities.
  • the telemetry features presented above may be used with various forms of distant communication (e.g. between the implantable device and other external devices or between the external communication device and other external devices). For example communication may occur via various electromagnetic links like IR, optical links, longer or shorter wavelength RF, audio links, ultrasonic links, acoustic links, inductive links, and the like.
  • Various telemetry systems may be used. Telemetry systems may be of the analog type, digital type, or mixed.
  • two independent processors may be used that operate from a single timing chain.
  • at least one of the timing signals e.g. one of the lower frequency timers
  • an independently timed watchdog circuit to reduce the risk of timing problems going undetected.
  • an implantable glucose sensor may be used in conjunction with an implantable insulin pump to provide feedback to the patient or physician on the effectiveness of the insulin delivery system.
  • the patient could use the feedback to assist in making insulin delivery decisions in an open loop manner.
  • the operation of the pump could be tied to the sensor output in a more or less closed loop manner to give a more automated character to system operation.
  • Insulin may be infused without any user intervention, without pre-delivery information, and even without direct post delivery feedback.
  • drug infusion recommendations could be derived by the system and presented to the user before delivery or the system could require user acknowledgment prior to proceeding with delivery for amounts or rates exceed a predefined limit.
  • the implantable sensor may have its own power supply or may receive power from the control circuitry provided within the pump housing through a physical lead that connects them. Power may be supplied through one or more independent leads or alternatively may be transferred over one or more data lines through the communication signals themselves. Communication may be exchanged in various ways including, for example, via galvanic leads, RF telemetry, fiber optics, and the like, and may be of digital, analog, or combined form.
  • the sensor system may include a plurality of sensor elements which might allow continued glucose data to be supplied even though some portion of the sensors stop operating, lose calibration or produce questionable readings.
  • the most preferred sensors would include electronic processing capability in the form of an integrated circuit mounted in or forming a part of a housing for the sensor. This configuration has the advantage of allowing digital communications between the physical sensor and any separated electronic control module.
  • the control of an implantable sensor could be provided through the functionality of one or both Processor ICs.
  • One Processor IC could supply power and/or control signals to the sensor(s) and receive data back from the sensor, while the other processor could monitor the activity to ensure that sensor activity meets certain predefined guidelines.
  • the External Communication Device of the first embodiment could be functionally linked to an external glucose sensor system such as the continuous glucose monitoring system (CGMS) offered by Minimed Inc. of Northridge, Calif.
  • CGMS continuous glucose monitoring system
  • the link may be established, for example, through a physical lead or by RF telemetry.
  • implantable, or external, sensor systems that measure something other than glucose could also be functionally coupled to the implantable device either to receive power and/or to provide data.
  • Other such sensors might include oxygen sensors, peroxide sensors, pulse rate sensors, temperature sensors, accelerometers, and the like.
  • the electronic control system of the first embodiment could be configured to control one or more implantable sensors or electrical stimulators with or without infusion functionality incorporated into the implantable device.

Abstract

A communication device (CD) exchanges messages with an implantable infusion pump via telemetry such that commands are supplied thereto and operational information is obtained therefrom. The CD is controlled, at least in part, by a processor IC according to a software program operating therein and provides feedback to a user via a visual display, an audio alarm, and a vibrational alarm, and allows input from the user via a touch sensitive keypad. Certain input functions are restricted by password. The visual display includes an icon and fixed element display region and a bitmap display region. The fixed element display region includes time and date displays, battery and drug level displays that decrement, and a moving delivery state display. Various screens allow operational or log information to be displayed and/or user entry of commands. Program features when disabled are removed from a series of screen options that can be scrolled through.

Description

    RELATED APPLICATIONS
  • This application claims the benefit of prior filed U.S. Provisional Patent Application No. 60/177,414; filed Jan. 21, 2000, by Ronald J. Lebel, et al., and entitled “Medical Apparatus and Method Including an Implantable Device and an External Communication Device” The entirety of this provisional application is hereby incorporated herein by this reference, including appendices filed therewith and any references incorporated therein by reference, as if set forth in full herein.[0001]
  • FIELD OF THE DISCLOSURE
  • This invention relates generally to electronically controlled ambulatory medical systems that include an ambulatory medical device and a hand held microprocessor controlled communication device with enhanced user friendliness including enhanced display/patient notification features, safety features, and/or medical device programming/communication features. Preferred embodiments relate to implantable infusion pumps and external devices for communicating therewith. [0002]
  • BACKGROUND
  • Implantable infusion pumps for dispensing controlled volumes of a drug (e.g. insulin) have been proposed and even attempts at implementation and commercialization made. [0003]
  • One such pump is the MMT2001 Implantable Pump System as sold by Minimed Inc. of Northridge, Calif. This device presented the user with the ability to perform basic infusion actions such as the delivery of a basal rate, delivery of a temporary basal rate, or the delivery of a meal bolus. The user was, however, not presented with the ability to perform more sophisticated delivery related operations that may be desirable for optimum control of blood glucose level. When using this system three delivery options exist: (1) delivery of a standard but programmable basal rate, (2) delivery of a standard basal rate and a meal bolus simultaneously, or (3) delivery of a temporary basal rate either immediately or at a programmable start time within a specifiable start time. In this system not only could a meal bolus and a temporary basal rate not occur at the same time, they could not be programmed into the system when the other was already programmed but delivery not yet completed even though no overlap in delivery between the two amounts might exist. As such the user could only program one variable rate into the system at a time, even in the event that several variable rates may be desired to follow one another. As such, this system is less than optimal with regard to user convenience in programming his/her insulin treatment. [0004]
  • The system also suffered from an external controller that was large, hard to carry and awkward to use. The controller dimensions are 6.0 inches by 3.5 inches by 1.3 inches with a display that is a small fraction of the size of the face of the controller. The controller included a cover plate that would close over the display area when not in use and would be opened during use. More particularly, during programming the cover plate is opened at a ninety-degree angle relative to the front of the display to allow viewing of the display and to allow positioning of the cover plate immediately over the site of the infusion pump so that successful telemetry communication may occur. As such the system does not supply delivery or system status related information to the user accept at the times that the user elects to open and turn on his/her controller. [0005]
  • The system further suffers from the inability of the implantable device to send out unsolicited telemetry messages to the controller concerning operational conditions within the implantable device. As such, system conditions within the implantable device (other than communication related failures) are primarily conveyed to the user via an auditory alarm that is internal to the implantable device. [0006]
  • The system further suffers from the entire operational history of the pump being subject to loss as this historical data is only held in the controller. [0007]
  • The system further suffered from a relatively short life for the implantable device of approximately 2.5 years. [0008]
  • Based on the above noted shortcomings, and other shortcomings of systems in the field, a need exists for improved systems that offer enhanced programming capabilities, enhanced user interface capabilities, reduced controller size, enhanced operational performance, enhanced security of system/patient historical data, enhanced safety features, and/or enhanced implantable device life. [0009]
  • It is believed that related shortcoming may exist in other ambulatory medical devices as well, such as in externally carried infusion pumps, implantable pacemakers, implantable defibrillators, implantable neural stimulators, implantable physiological sensors, externally carried physiologic sensors, and the like. [0010]
  • SUMMARY OF THE INVENTION
  • It is a first object of certain aspects of the invention to enhance programming capabilities for ambulatory medical systems and in particular for implantable infusion pump systems. [0011]
  • It is a second object of certain aspects of the invention to enhance user interface capabilities in ambulatory medical systems and in particular for implantable infusion pump systems. [0012]
  • It is a third object of certain aspects of the invention to reduce system size for patient convenience in ambulatory medical systems and in particular for implantable infusion pump systems. [0013]
  • It is a fourth object of certain aspects of the invention to enhance operational performance of ambulatory medical systems and in particular for implantable infusion pump systems. [0014]
  • It is a fifth object of certain aspects of the invention to enhance security of system/patient historical data. [0015]
  • It is a sixth object of certain aspects of the invention to enhance the operational safety of ambulatory medical systems and in particular of implantable infusion pump systems. [0016]
  • It is a seventh object of certain aspects of the invention to enhance longevity of ambulatory medical systems and in particular of implantable infusion pump systems. [0017]
  • Other objects and advantages of various aspects of the invention will be apparent to those of skill in the art upon review of the teachings herein. The various aspects of the invention set forth below as well as other aspects of the invention not specifically set forth below but ascertained from the teachings found herein, may address the above noted objects or other objects ascertained from the teachings herein individually or in various combinations. As such, it is intended that each aspect of the invention address at least one of the above noted objects or address some other object that will be apparent to one of skill in the art from a review of the teachings herein. It is not intended that all, or even a portion of these objects, necessarily be addressed by any single aspect of the invention even though that may be the case with regard to some aspects. [0018]
  • A first aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device weighs no more than about 10 oz and includes a CD housing having a volumetric size smaller than 20 cubic inches. [0019]
  • A second aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical-device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD readable display which includes a bit map region for displaying selected information. [0020]
  • A third aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a readable display which includes at least one icon. [0021]
  • A fourth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a readable CD display which further includes a backlight. [0022]
  • In a specific variation of the fourth aspect of the invention the communication device additionally includes a touch sensitive CD input device and wherein the backlight is automatically activated when one or more selected locations on the CD input device are touched. [0023]
  • In a specific variation of the fourth aspect of the invention the backlight is activated automatically when a light level falling on a sensor on the communication device is less than a predetermined amount and a touch sensitive region of the communication device is touched. [0024]
  • A fifth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device further includes an automatically activated CD alarm that is capable of providing a signal to the patient of the existence of a particular condition in at least one of the medical device or the communication device, and wherein the CD alarm includes at least one of a CD vibration mechanism or a CD audio alarm mechanism. [0025]
  • In a specific variation of the fifth aspect of the invention the communication device is configured to enable a patient to select between the CD alarm using the audio and vibration mechanism. [0026]
  • In a specific variation of the fifth aspect of the invention an alarm condition in the medical device is transmitted to the communication device via an unsolicited telemetry message. [0027]
  • In a specific variation of the fifth aspect of the invention the communication device is configured to automatically switch from one of the audio alarm or the vibration alarm to the other of the vibration alarm or the audio alarm under selected circumstances associated with at least one error condition. [0028]
  • In a specific variation of the fifth aspect of the invention one of the medical device or the communication device includes an audio alarm that produces a plurality of tones emitted in a predetermined sequence. [0029]
  • A sixth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a CD touch sensitive input device, and wherein the communication device additionally includes a readable CD display which further includes a capability of displaying different colors. [0030]
  • In a specific variation of the sixth aspect of the invention the CD display is configured to display a single color at any one time. [0031]
  • In a specific variation of the sixth aspect of the invention the CD display is configured to display a plurality of colors at a single time. [0032]
  • A seventh aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a readable display that is also touch sensitive for allowing user inputs to be entered into the communication device. [0033]
  • A eighth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD touch sensitive input device and a CD speaker that is controlled to supply speech based output to the patient. [0034]
  • A ninth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD input device which further includes a CD microphone and a CD voice recognition system that are controlled to allow speech based input to the communication device. [0035]
  • A tenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system wherein the communication device additionally includes a CD touch sensitive input device, and wherein the communication device is configured to perform a plurality of functions, and wherein the performance of at least a first function requires that the communication device be placed in an operational state dictated by a first or a second password and the performance of at least a second function requires that the communication device be placed in an operational state dictated the second password. [0036]
  • In a specific variation of the tenth aspect of the invention the communication device can perform all functions with the second password that can be performed with the first password. [0037]
  • A eleventh aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device includes a touch sensitive CD input device, and wherein at least one of the communication device or the medical device may be reset, or placed in a state to allow reset to occur, by contacting a plurality of selected locations on the touch sensitive CD input device in a prescribed order. [0038]
  • In a specific variation of the eleventh aspect of the invention password must be entered into the communication device prior to touching the plurality of selected locations on the touch sensitive CD input device in order for reset to occur. [0039]
  • In a specific variation of the eleventh aspect of the invention a password must be entered into the communication device after touching the plurality of selected locations on the touch sensitive CD input device in order for reset to occur. [0040]
  • In a specific variation of the eleventh aspect of the invention the plurality of touch sensitive locations are touched sequentially in order for reset to occur. [0041]
  • In a specific variation of the eleventh aspect of the invention at least a portion of the plurality of touch sensitive locations must be touched simultaneously for reset to occur. [0042]
  • In a specific variation of the eleventh aspect of the invention at least a portion of the plurality of touch sensitive locations must be touched and then untouched in a particular order for reset to occur. [0043]
  • In a specific variation of the eleventh aspect of the invention resetting may occur to different extents depending on variations in the plurality of touch sensitive locations touched, variations in the sequence of touching, or variations in the sequence of untouching. [0044]
  • A twelfth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is configured to receive status information on an MD battery via telemetry from the medical device. [0045]
  • In a specific variation of the twelfth aspect of the invention the medical device provides a periodic indication of the MD battery voltage when the MD battery is experiencing a current load that is closer to the minimum load during normal operation of the medical device than a maximum load during normal operation. [0046]
  • In a specific variation of the twelfth aspect of the invention the medical device provides a periodic indication of the MD battery voltage when the MD battery is experiencing a current load which is closer to the maximum load during normal operation than a minimum load during normal operation. [0047]
  • In a specific variation of the twelfth aspect of the invention MD battery status is provided using both a lower current load and a higher current load at least once a week. [0048]
  • In a specific variation of the twelfth aspect of the invention the communication device provides an auditory, visual, or tactile warning when the MD battery is estimated to be capable of powering the medical device for less than a predetermined additional amount of time. [0049]
  • A thirteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes at least one battery and the medical device includes at least one battery, and wherein the communication device is configured to display log data of MD battery status information or CD battery status information. [0050]
  • In a specific variation of the thirteenth aspect of the invention the log information includes a plurality of voltage readings taken from a predefined battery when the predefined battery is powering a first load and when the predefined battery is powering a second load which is different from the first load. [0051]
  • In a specific variation of the thirteenth aspect of the invention the log data is accumulated at least once per week. [0052]
  • A fourteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a socket for a removable memory module. [0053]
  • In a specific variation of the fourteenth aspect of the invention the communication device includes the removable memory module. [0054]
  • In a specific variation of the fourteenth aspect of the invention the removal memory module contains replacement software for the communication device, replacement software for the medical device, or calibration data for a sensor that forms part of the medical device. [0055]
  • A fifteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device includes an implantable device, and wherein the communication device includes a memory for simultaneously storing a plurality of parameters that are each used during a different time period to, at least in part, control the treatment provided to the body or the monitoring of the body that is provided by the medical device. [0056]
  • In a specific variation of the fifteenth aspect of the invention the implantable device includes an infusion pump that is capable of dispensing a selected quantity of a drug according to a programmed parameter, and wherein each of the plurality of parameters includes a basal rate parameter that is programmed for use in controlling the dispensing of the drug during a selected time period during the day. In a further variation the plurality of parameters comprise a plurality of sets of parameters, wherein each set includes a plurality of parameters, wherein the medical device is capable of storing only one set at a time, and wherein the communication device transmits a selected on of the sets to the communication device when it is desired for the parameters of the transmitted set to control, at least in part, the dispensing of the drug. [0057]
  • A sixteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical system additionally includes a second device (SD) that includes an SD communication system, wherein the communication device further includes a second CD communication system, and wherein the communication device is programmable so as to echo all CD telemetry system messages, sent or received from the medical device, through the second CD communication system to the SD communication system. [0058]
  • A seventeenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical system additionally includes a second device (SD) that includes an SD communication system, wherein the communication device further includes a second CD communication system, and wherein the communication device is programmable to pass messages received from the second device on to the medical device via transfer from the SD communication system to the second CD communication system to the CD telemetry system and on to MD telemetry system of the medical device, and/or to pass messages received from the medical device to the second device via transfer from MD telemetry system to the CD telemetry system to the second CD communication system and then onto the SD telemetry system of the second device, and wherein the content of the messages is passed without modification. [0059]
  • A eighteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical system additionally includes a second device (SD) that includes an SD communication system, wherein the communication device further includes a second CD communication system that is capable of sending messages to or receiving messages from the SD communication system, and wherein the communication device additionally includes a CD keypad, and wherein the communication device is capable of receiving messages from the second device that emulate keystrokes on the keypad. [0060]
  • A nineteenth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is programmed to accept input parameters that specify the delivery of a predefined quantity of treatment to the body of the patient over a prescribed time period wherein the average rate of delivery per minute of portions of the predefined quantity varies as a function of time according to a preprogrammed delivery profile. [0061]
  • In a specific variation of the nineteenth aspect of the invention the preprogrammed delivery profile results in a bell shaped curve of average delivery per minute versus time. In a further variation the communication device allows the patient to select a most suitable of a plurality of bell shaped delivery profiles. In a further variation at least one of the curves is symmetric. In still a further variation at least one of the curves is non-symmetric with a generally steeper upward slope than downward slope. [0062]
  • A twentieth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is powered by a replaceable battery and wherein sufficient power is stored in one or more capacitors within the communication device that a controlled power down can occur when the replaceable battery is removed such that upon replacement of the battery the communication device need not be reprogrammed to resume operation. [0063]
  • In a specific variation of the twentieth aspect of the invention the communication device monitors the voltage on the replaceable batter so as to detect a removal of the battery and initiate and complete a controlled shut down prior to the capacitors losing a required minimum voltage. [0064]
  • A twenty-first aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device is configured to provide a drug to the body of a patient in amounts that are integer multiples of a quantized amount, wherein the communication device is programmed to allow entry of delivery quantities that are not integral multiples of the quantized amount. [0065]
  • A twenty-second aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device additionally includes a CD display device for providing visual communication signals to the patient which further includes a zoomable display so that the size of displayed images may be adjusted to a desired size. [0066]
  • In a specific variation of the twenty-second aspect of the invention the CD display device includes a LCD bit map display. [0067]
  • A twenty-third aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device includes an infusion pump, and wherein the CD display device is controlled to show a plurality of infusion parameters simultaneously. [0068]
  • A twenty-fourth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the CD display device includes a moving image that graphically depicts a status of the system. [0069]
  • In a specific variation of the twenty-fourth aspect of the invention the medical device includes an infusion pump and the status being depicted includes an indication of a delivery status. In a further variation the moving image rotates. In a further variation the image includes a number of elements that may be active or inactive and differing numbers of active elements indicates different delivery states. [0070]
  • A twenty-fifth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device includes a CD display controlled by the at least one CD processor for providing visual feedback to the patient, and wherein the feedback includes a display of the quantity of a consumable estimated to be remaining in the system. [0071]
  • In a specific variation of the twenty-fifth aspect of the invention the consumable is a quantity of a drug estimated to be remaining in a reservoir. [0072]
  • In a specific variation of the twenty-fifth aspect of the invention the consumable is either (1) battery power remaining in a replaceable CD battery in the communication device and a voltage level on the CD battery is graphically depicted with a desired resolution, or (2) battery power remaining in an MD battery in the medical device and a voltage level on the battery is graphically depicted with a desired resolution. [0073]
  • A twenty-sixth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the CD display is controlled to depict a plurality of patient programmable options and wherein at least one of the patient programmable options may be enabled or disabled such that when disabled the at least one patient programmable option is no longer displayed as an option. [0074]
  • A twenty-seventh aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the medical device or the communication device monitors battery voltage and generates a voltage log, wherein the medical device monitors a CD voltage of a CD battery in the communication device and generates a CD voltage log. [0075]
  • In a specific variation of the twenty-seventh aspect of the invention the log includes a plurality of CD voltage values for each of a plurality of different current drain states. [0076]
  • A twenty-eighth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein both the medical device and the communication device have memories for storing selected data about system operation, wherein at least a portion of the selected data is duplicated in the medical device and the communication device. [0077]
  • In a specific variation of the twenty-eighth aspect of the invention the communication device is programmed to periodically synchronize the duplicated data. [0078]
  • In a specific variation of the twenty-eighth aspect of the invention at least a portion of the selected data is synchronized automatically or is synchronized in response to a synchronization command. [0079]
  • A twenty-ninth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is programmed to allow a user to set a plurality of parameters to predefined default values by issuing a command that does require specification of any of the default values. [0080]
  • A thirtieth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device is capable of performing a test of battery voltage with a load on the battery. [0081]
  • In a specific variation of the thirtieth aspect of the invention the test of battery voltage is performed automatically and periodically. In a further variation at least one of the following will occur, (1) the battery voltage is also automatically and periodically checked with the battery under a minimal load, (2) at least one selected electrical component is forced on to produce the load for testing, or (3) the test is made to occur at least in part when at least one selected electrical component is powered on in the performance of its normal operation, wherein the electrical component provides a load for the testing. [0082]
  • A thirty-first aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein at least one of the medical device or communication device has a memory for storing at least one calibration factor needed for proper operation of the system. [0083]
  • In a specific variation of the thirty-first aspect of the invention the medical device includes an infusion pump mechanism for dispensing a drug held in a reservoir within the medical device and the at least one calibration factor includes at least one of (1) information about the concentration of the drug, (2) delivery volume per discrete operation of an infusion pump mechanism, (3) the amount of drug placed in the reservoir when filled, (4) a voltage value necessary to cause the pump mechanism to operate properly, (5) a value to be used by a pulse stealer circuit, (6) a calibration factor to be used by an analog to digital converter, or (7) a specific telemetry ID of the device. [0084]
  • A thirty-second aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein at least one of the medical device or communication device includes a first component or module that may be powered directly by a battery when the battery's output voltage is above a predetermined level, and wherein the at least on of the medical device or communication device includes a voltage up converter that is used to supply electrical potential to the first component or module when the battery voltage is below the predetermined level. [0085]
  • A thirty-third aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein at least one watchdog circuit is capable of causing the CD processor to undergo a predefined process in the event that the watchdog circuit does not receive a first signal and a second signal, which is different from the first signal, within a predefined time period. [0086]
  • In a specific variation of the thirty-third aspect of the invention the predefined process causes the CD processor to be reset. In a further variation one of the first or second signals is a signal generated by mainline software. In a further variation the other of the first or second signals is a signal generated by interrupt hardware. [0087]
  • A thirty-fourth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein an antenna for the MD telemetry system is mounted on a hybrid circuit board in the medical device and wherein the antenna for the CD telemetry system is mounted on a hybrid circuit board in the communication device. [0088]
  • A thirty-fifth aspect of the invention provides a medical system that includes (a) an ambulatory medical device (MD) that includes MD electronic control circuitry that further includes at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and (b) a communication device (CD) that includes CD electronic control circuitry that further includes at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system, wherein the communication device monitors electrical activity of at least one electronic module or component located within the communication device and compares the electrical activity to at least one predetermined value. [0089]
  • In a specific variation of the thirty-fifth aspect of the invention, there will be one of the following, (1) the at least one electronic module is located within an application specific integrated circuit that includes the CD processor, (2) the at least one electronic module includes a crystal oscillator circuit, (3) the at least one electronic module includes a driver for the treatment or monitoring device, (4) the predetermined value includes an upper and lower limit of a range of values, or (5) the electrical activity includes a current flow. [0090]
  • Additional specific variations, provide the medical devices of each of the above aspects and above noted variations as implantable devices such as implantable infusion pumps, implantable physiological sensors, implantable stimulators, and the like, or external devices such subcutaneous delivery infusion pumps or sensors that ascertain a physiological parameter or parameters from subcutaneous tissue or from the skin of the patient. Such infusion pumps may dispense insulin, analgesics, neurological drugs, drugs for treating aids, drugs for treating chronic ailments or acute ailments. Sensors may be used to detect various physiological parameters such as hormone levels, insulin, pH, oxygen, other blood chemical constituent levels, and the like. The sensor may be of the electrochemical type, optical type, and may or may not be enzymatic in operation. [0091]
  • In even further variations of the above noted aspects, and above noted variations, one or more of the following is provided: (1) a first portion of the MD telemetry system is incorporated into the MD processor and a second portion of the MD telemetry system is external to the MD processor, (2) a first portion of the CD telemetry system is incorporated into the CD processor and a second portion of the CD telemetry system is external to the CD processor, (3) the MD processor includes an MD central processing unit and at least one other MD functional module, (4) the CD processor includes a CD central processing unit and at least one other CD functional module, (5) the MD electronic control circuitry includes at least one external MD functional module, other than a portion of the MD telemetry system, that is external to the MD processor, or (6) the CD electronic control circuitry includes at least one external CD functional module, other than a portion of the CD telemetry system, that is external to the CD processor. [0092]
  • Still additional aspects of the invention set forth method counterparts to the above system aspects as well as to other functional associations and relationships, and processes that have not been specifically set forth above but will be understood by those of skill in the art from a review of the teachings provided herein. [0093]
  • Further aspects of the invention will be understood by those of skill in the art upon reviewing the teachings herein. These other aspects of the invention may provide various combinations of the aspects presented above as well as provide other configurations, structures, functional relationships, and processes that have not been specifically set forth above.[0094]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The above referred to objects and aspects of the present invention will be further understood from a review of the description to follow, the drawings, and the claims set forth hereafter, wherein: [0095]
  • FIG. 1 a depicts a perspective view of the main body of the implantable device of the first preferred embodiment; [0096]
  • FIG. 1[0097] b depicts a perspective view of the support and catheter assembly that attaches to the main body of the implantable device of the first preferred embodiment;
  • FIG. 2 depicts a perspective view of the external communication device of the first preferred embodiment; and [0098]
  • FIG. 3 depicts a block diagram of the main components/modules of both the implantable device and the external communication device of the first preferred embodiment. [0099]
  • FIGS. 4[0100] a and 4 b depict a block diagram of the main components/modules and their inter-connections as used in the external communication device of the first preferred embodiment;
  • FIG. 5 depicts the display screen of the external communication device of the first preferred embodiment; [0101]
  • FIG. 6 depicts a block diagram of the various modules of the processor IC used in both the implantable device and the external communication device of the first preferred embodiment; [0102]
  • FIGS. 7[0103] a and 7 b depicts the main menu structure for the user interface of the external communication device of the first preferred embodiment;
  • FIGS. 8[0104] a and 8 b depicts the setup menu structure for the user interface of the external communication device of the first preferred embodiment;
  • FIGS. 9[0105] a and 9 b depicts the setup ii menu structure for the user interface of the external communication device of the first preferred embodiment;
  • FIGS. 10[0106] a and 10 b depicts the supervisor menu structure for the user interface of the external communication device of the first preferred embodiment;
  • FIG. 11 depicts the bolus delivery sequence or menu structure for the user interface of the external communication device of the first preferred embodiment; and [0107]
  • FIG. 12 depicts the communication sequence associated with the user interface of the external communication device of the first preferred embodiment.[0108]
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • Various details about the structural and functional configuration and operation of preferred ambulatory medical devices and preferred communication devices are found in several U.S. patent applications filed concurrently herewith and incorporated herein by reference in their entireties: (1) Docket No. USP-1075-A, (2) Docket No. USP-1076-A, (3) Docket No. USP-1077-A, (4) Docket No. USP-1079-A, and (5) Docket No. USP-1080-A. [0109]
  • U.S. patent application Ser. No. To Be Determined, filed on Jan. 22, 2001 (concurrently herewith), by Starkweather, et al., entitled “Ambulatory Medical Apparatus and Method Having Telemetry Modifiable Control Software”, corresponding to Medical Research Group, Inc. Docket No. USP-1075-A, is hereby incorporated herein by this reference as if set forth in full herein. This application provides teachings concerning an implantable medical device (e.g. infusion pump) and handheld communication device wherein the implantable device is capable of operating under control of different software programs, wherein a first program operates after resetting the implantable device and is not capable of allowing significant medical functionality but is capable of selected telemetry operations including telemetry operations that allow replacement software to be downloaded, and wherein a second program may be caused to take control of the device and enables medical functionality and selected telemetry operations but is incapable of receiving replacement software. It is also taught that a software image may be received in multiple messages where each message is provided with its own validation code and wherein a validation code for the whole image is provided and wherein each provided validation code must compared to a derived validation code prior to accepting the validity of the replacement software. [0110]
  • U.S. patent application Ser. No. To Be Determined, filed on Jan. 22, 2001 (concurrently herewith), by Lebel, et al., entitled “Ambulatory Medical Apparatus and Method Using a Robust Communication Protocol”, corresponding to Medical Research Group, Inc. Docket No. USP-1076-A, is hereby incorporated herein by the references as if set forth in full herein. An implanted medical device (e.g. infusion pump) and external device communicate with one another via telemetry wherein messages are transmitted under a robust communication protocol. The communication protocol gives enhanced assurance concerning the integrity of messages that impact medical operations of the implantable device. Messages are transmitted using a multipart format that includes a preamble, a frame sync, a telemetry ID, data, and a validation code. The data portion of the message includes an op-code that dictates various other elements that form part of the message. The data portion may also include additional elements such as sequence numbers, bolus numbers, and duplicate data elements. A telemetry ID for the transmitting device may be implicitly embedded in the message as part of the validation code that is sent with the message and that must be pre-known by the receiver to confirm the integrity of the received message. [0111]
  • U.S. patent application Ser. No. To Be Determined, filed on Jan. 22, 2001 (concurrently herewith), by Bowman, et al., entitled “Ambulatory Medical Apparatus and Method using a Telemetry System with Predefined Reception Listening Periods”, corresponding to Medical Research Group, Inc. Docket No. USP-1077-A, is hereby incorporated herein by the reference as if set forth in full herein. This application provides teachings concerning an implantable medical device (e.g. infusion pump) and an external device that communicate with one another via telemetry messages that are receivable only during listening windows. Each listening window is open for a prescribed listening period and is spaced from other listening windows by an interval. The listening period is typically kept small to minimize power consumption. To increase likelihood of successful communication, the window may be forced to an open state, by use of an attention signal, in anticipation of an incoming message. To further minimize power consumption, it is desirable to minimize use of extended attention signals, and this is accomplished by the transmitter maintaining an estimate of prescribed listening start times and attempting to send messages only during listening periods. In the communication device, the estimate is updated as a result of information obtained with the reception of each message from the medical device. [0112]
  • U.S. patent application Ser. No. To Be Determined, filed on Jan. 22, 2001 (concurrently herewith), by Starkweather, et al., entitled “Method and Apparatus for Communicating Between an Ambulatory Medical Device and Control Device Via Telemetry Using Randomized Data”, corresponding to Medical Research Group, Inc. Docket No. USP-1079-A, is hereby incorporated herein by this reference as if set forth in full herein. This application provides teachings concerning an implantable medical device (e.g. infusion pump) and handheld communication device that communicate with one another via telemetry wherein transmitted messages have enhanced numbers of and/or regularity of bit transitions to minimize the risk of synchronization loss between transmitted bits of data and received bits of data. It is taught that bit transitions for portions of messages may be enhanced by applying a pseudo-randomization scheme to those portions of messages that are transmitted in a way that allows the receiver to extract the original data from the received randomized data. Preferred randomization techniques modify (i.e. randomize) the data using a CRC value that is being accumulated while simultaneously causing the modified data to modify subsequent accumulation of the CRC itself. Upon reception, the reversal of data randomization is then made to occur so that the intended message is appropriately received. [0113]
  • U.S. patent application Ser. No. To Be Determined, filed on Jan. 22, 2001 (concurrently herewith), by Lebel, et al., entitled “Microprocessor Controlled Ambulatory Medical Apparatus with Hand Held Communication Device”, corresponding to Medical Research Group, Inc. Docket No. USP-1080-A, is hereby incorporated herein by this reference as if set forth in full herein. This application provides teachings concerning an implantable medical device (e.g. infusion pump) and handheld communication device wherein an implantable infusion pump possesses operational functionality that is, at least in part, controlled by software operating in two processor ICs which are configured to perform some different and some duplicate functions. The pump exchanges messages with the external communication device via telemetry. Each processor controls a different part of the drug infusion mechanism such that both processors must agree on the appropriateness of drug delivery for infusion to occur. Delivery accumulators are incremented and decremented with delivery requests and with deliveries made. When accumulated amounts reach or exceed, quantized deliverable amounts, infusion is made to occur. The accumulators are capable of being incremented by two or more independent types of delivery requests. Operational modes of the infusion device are changed automatically in view of various system errors that are trapped, various system alarm conditions that are detected, and when excess periods of time lapse between pump and external device interactions. [0114]
  • The first embodiment of the present invention provides a long term implantable medical delivery system that controllably supplies insulin to the body of a patient afflicted with diabetes mellitus. This embodiment includes an implantable medical device and an external communication device. In the most preferred embodiments, the communication device is a hand held device that is used directly by the patient to interact with the medical device as opposed to being limited to use by a physician, nurse, or technician. It is preferred that the communication device provide (1) the ability to send commands to the medical device, (2) receive information from the medical device, and (3) be able to present to the patient at least a portion of the information it receives from the medical device. In preferred embodiments, the patient interacts with the medical device via the communication device at least once per week, on average, more preferably at least once every other day, on average, and most preferably at least once per day, on average. [0115]
  • The implantable medical device (MD) includes a biocompatible housing; a reservoir within the housing for holding a quantity of insulin; a side port that attaches to the side of the housing, a catheter, that connects to the side port; a pumping mechanism, within the housing for moving the insulin from the reservoir through the sideport and through the catheter to the body of the patient; and control, monitoring, and communication electronics located within the housing. In alternative embodiments various portions of implantable medical device hardware may be located outside the housing. For example, the pumping mechanism or a telemetry antenna may be located within the sideport or other side mounted housing; or a telemetry antenna may mounted on the outside surface of the housing, or extend along the catheter [0116]
  • The external communication device (CD) communicates commands to the medical device, receives information from the medical device, and communicates system status and system history to the patient. The external communication device includes a housing; a keypad mounted on the housing; a display forming part of the housing; and control, monitoring, and communication electronics located within the housing. In alternative embodiments, the keypad may be replaced in whole or in part by a touch sensitive display or a voice recognition system. In addition, or alternatively, the display may be replaced in whole or in part by a speech generation system or other audio communication system. [0117]
  • The outer appearance of the [0118] implantable device 2 is depicted in two pieces in FIGS. 1a and 1 b and includes housing 6 having a drug outlet port 8, and a refill port 12, a removable sideport 14 that mounts against the side of the housing 6 over outlet port 8, and a catheter 16 having a distal end 18 and a proximal end that attaches to sideport 14. In alternative embodiments, the implantable device may take on a different shape and/or the sideport may be removed in favor of a permanently mounted catheter assembly.
  • The outer appearance of the [0119] external communication device 32 is depicted in FIG. 2. The various components of the external communication device are fitted in or on housing 34. Housing 34 is divided into a front portion 34 a and a back portion 34 b. The front portion 34 a is provided with an opening in which an LCD panel 36 is positioned. The panel 36 has a lower portion that is a bit map display and an upper portion that provides icons and fixed element displays. The front portion 34 a of the external communication device is also provided with a five-element keypad 38. A first key 38 a is not located under a raised pad and does not provide tactile feedback when it is touched and may be used for special functions. The remaining four keys 38 b, 38 c, 38 d, and 38 e have raised pads that provide tactile feedback when they are depressed. These remaining keys may be used in normal device operation and are known as the select key, the up arrow key, down arrow key, and the activate key, respectively. The back portion 34 b of the housing is fitted with a door under which a compartment is located for holding a replaceable battery.
  • The implantable device includes a memory for storing program code and data. A portion of the memory in the implantable device is preferably used to store configuration information for the external communication device and for the implantable device itself. This allows the configuration data to be reloaded into a replacement external communication device if the original should be lost or damaged. This memory is also used to store system operation information in the form of activity logs and counters, such an insulin delivery log. Various portions of the contents of implantable device memory are downloaded to the external communication device periodically. The downloads to the external communication device may occur manually, automatically, or semi-automatically. [0120]
  • The implantable device control electronics include various self-checking mechanisms to ensure that reliable operation of the system occurs. For example, as the pumping mechanism in this first embodiment requires a firing voltage that is significantly greater than the supply voltage, a pre-fire voltage on the pump firing circuit is checked to ensure it is large enough to cause the pump to execute a full stroke. After firing, the voltage is checked again, to ensure that discharging of the circuit occurred. Each processor is monitored by a watchdog circuit that must be serviced, periodically. As implemented in the software, servicing must occur at both the interrupt level and at the mainline code level to ensure that the processor has not malfunctioned at either level. Insulin delivery calculations are performed by both processors in such a manner that both processors must agree on the quantity and timing of insulin delivery. If an error of a significant nature is found in the system, the implantable device may be placed in a protective mode (i.e. suspend mode or stop mode) where insulin delivery is cut back to a medically insignificant rate (e.g. about 1 pump stroke per hour) or stopped completely. It is preferred to have a small amount of insulin be delivered periodically to help prevent the occurrence of catheter blockage. In any event, if system failure does occur the system effectively stops delivery and attempts to warn the patient. [0121]
  • As the implantable device is controlled by messages that it receives from the external communication device, messages sent to the implantable device have their accuracy and appropriateness checked with varying degrees of scrutiny depending on the critically of the message. [0122]
  • First, for example, all most all messages are sent from a particular external communication device to a particular implantable device using explicit identification information of the receiver to identify itself as the intended recipient. It is considered desirable to use identification information with messages that relate to medical treatment (e.g. the changing of insulin infusion rates). More particularly it is desirable to use identification information with messages that relate to changing medical treatment in a way that could have acute ramifications (e.g. to over supplying a drug such as insulin as opposed to under supplying the drug). [0123]
  • Second, the identity of the sender is preferably embedded implicitly in the message. This implicit embedding occurs by using the identification information of the sender in calculating a cyclical redunancy code (CRC) that is sent with the message. As such, the implantable device must know the identity of the sender in order to successfully check the content of the message against the transmitted CRC. [0124]
  • Third, the values of the data in the message are compared to an operation code (Op Code) sent with the message to ensure that the code and data are compatible. This Op Code is also used to set the size of the most messages, thereby providing a mechanism to increase electrical efficiency of the system by providing a way to limit reception time to only that amount necessary to receive a particular message. [0125]
  • Fourth, if the message pertains to drug delivery, the message is sent with redundant data that must match for the message to be interpreted as valid. If for any reason the message is interpreted as invalid, the message is ignored. [0126]
  • To avoid problems associated with long transmissions that may otherwise contain long strings of non-transitioning data (i.e. long strings of 1 s or 0s), the data portion of most messages are randomized prior to transmission and de-randomized upon receipt. For energy savings and time savings, randomization and de-randomization preferably occur in a single pass through the data and preferably utilize the semi-random attributes of the CRC tables from which CRC codes are built. [0127]
  • In the event that an error or other significant event occurs in the implantable device, the device may attempt to inform the patient of the event by sending a telemetry message to the external communication device or alternatively by activating an audio alarm mechanism within the implantable device itself. [0128]
  • The implantable device is preferably configured so that the software running in it can be replaced or upgraded if the need should arise. The software may be downloaded into the implantable device through telemetry. The implantable device may be operated under two types of software: (1) bootloader code, or (2) application code. The bootloader code may be broken down into first stage boot loader code which is stored in the ROM that is internal to the ASIC and second stage bootloader code that is stored in a SEEPROM or other non-volatile memory associated with each ASIC. The bootloader code and application code are different for each ASIC. [0129]
  • The bootloader code does not care about the application in which the implantable device may be used. The bootloader code is not concerned with whether, the implantable device is an infusion device, a sensor, a stimulator, or the like, or a combination thereof. On the other hand, the application code is concerned with the medical functionality of the device and thus is designed specifically for a given type of application. As such, if an implantable device includes a pump and was initially configured (i.e. loaded with specific application software) to work with one drug (e.g. insulin) in one manner (e.g. allowing different preprogrammed basal rate changes to occur at the beginning of each half hour of the day and allowing simultaneous use of an immediate bolus and an extended bolus), it could be reconfigured to operate in a completely different manner while using the same drug or a different drug by simply changing its application code. The replacement of application code in this context is different from a mere change in program variables that may allow various control limits to be changed or even to allow the code to execute different algorithms that are preexistant within the code. The replacement of application code in this context involves the replacement of at least portions of the code that set forth program algorithms. [0130]
  • When operating under control of the bootloader code, the implantable device allows certain telemetry operations to occur and also allows downloading of new application code, but does not allow any drug delivery. The application code when controlling the system, on the other hand, knows how to handle drug delivery but is not capable of downloading new code, or otherwise modifying itself (other than to accept changes in parameter values). The bootloader code is also designed and operated in such a way that new bootloader code can be downloaded to the SEEPROM if an upgrade is felt to be appropriate. [0131]
  • In alternative embodiments, it is possible to merge the functionality of the second stage bootloader code and the application code into a single piece of code that can be upgraded as desired. In still further embodiments, it may be possible only to upgrade the application code and not the second stage bootloader code. [0132]
  • As noted above, the implantable device assembly includes a detachable catheter and sideport that provides a pathway for the insulin to a desired infusion location in the patient's body (e.g. into the patient's peritoneal cavity). The sideport allows for non-surgical diagnosis of a catheter blockage by using pressure. The sideport allows introduction of a refill needle and small syringe to clear an obstructed catheter (e.g. using up to 110 psi of pressure). The sideport also allows the introduction of a refill needle and a pipet to verify pump stroking. The catheter includes a check valve that seals (e.g. at between 0.5 to 3 psid) and provides a redundant valve outside the pump to prevent medication or body fluids from back flowing into the implantable device reservoir. The sideport in conjunction with the check valve facilitates rinsing the fluid path within the implanted device with sodium hydroxide, or other functionally similar material, by allowing effluent to be drawn out the sideport rather than pumped out the catheter tip. In alternative embodiments, a sideport may not be used. [0133]
  • As noted above, the external communication device has both an audio alarm and a vibrator for alerting the patient or user of warnings and alarm conditions. The user has some control over the selection of audio alarm or vibration while the system can automatically switch from vibration to audio if the vibrational alarm is not responded to in a timely manner. The audio alarm is programmable to emit at different frequencies, at different volume levels, for different durations, and with different repetition patterns. These various alternatives are used to signal different conditions. The vibratory alarm is also programmable to go off for different durations and with differing repetition patterns. In alternative embodiments, only one type of alarm may be used and it may be used with or without different frequencies, volumes, durations, or loudnesses. [0134]
  • The software controlling the external communication device is permanently stored within the external communication device using a non-volatile memory such as a serial electrically erasable programmable read only memory (SEEPROM) and is transferred to random access memroy (RAM) for execution. The code being executed in RAM can be reloaded from that SEEPROM as needed. Software located within the SEEPROM can be replaced with new software under controlled conditions. The external communication device is provided with sufficient memory capability to store a duplicate, or upgrade, version of application software for the implantable device as well as to store about 120 days of operational data. Under controlled conditions the external communication device may be reset to its default configuration automatically (i.e. upon command without the user having to specifically identify specific parameter values). In alternative embodiments the software may be stored in a different device (e.g. a physical ROM, volatile RAM, non-volatile RAM, or in a replaceable plug in module). The software may be divided into bootloader and application code portions. [0135]
  • As noted above, the implantable device and external communication device communicate with each other through radio frequency telemetry where reception and transmission within the implantable device uses an antenna that is located within the metalic device housing based on a carrier frequency that allows an acceptable amount of signal to penetrate through the housing and through the human body. In alternative embodiments, an antenna for the implantable device may be placed on the housing or be otherwise located external to the housing so that outgoing and/or incoming signals need not penetrate the housing material. For the present embodiment the preferred frequency is either about 131 kHz or about 262 kHz. The preferred data transfer rate is at about 8200 bits/second. In alternative embodiments, different carrier frequencies may be used, e.g. from tens of kilohertz to thousands of megahertz. Also in alternative embodiments other data transfer rates may be used. The external communication device and implantable device are configured and operate together to provide rapid feedback to the operator. For example, a response to a basal rate or bolus programming telemetry interaction is preferably provided to the patient within no more than 20 seconds and more preferably within less than about 10 seconds, and most preferably within less than about 5 seconds. [0136]
  • Each implantable device and external communication device are preferably assigned unique telemetry identifiers and a particular implantable device and particular external communication device are made to undergo a linking process (alternatively known as a marrying process) so substantive communication (e.g. communications that allow the external communication device to control the medical operation of the implantable device) is limited to a joined pair. The communication link between the external communication device and implantable device provides various levels of checking and confirmation to minimize the possibility of the implantable device receiving and then acting on an erroneous delivery command message. In alternative embodiments unique identifiers may be supplied to only one of the implantable or external communication devices, or even non-unique identifiers may be utilized. [0137]
  • The linking or marrying process is completed prior to a external communication device being allowed to send drug delivery commands or updated software to a particular implantable device. In this embodiment, each time an external communication device is replaced or reset, the marrying process must be repeated. The marrying feature provides the mechanism to configure an implantable device to communicate with a particular external communication device. This is carried out when the implantable device and the external communication device are initially configured. The linking process requires positive assertion from the user indicating that external communication device is linking to the correct implantable device. The linking process starts with the external communication device sending an interrogate message to all implantable devices within range by using a universal identifier. Each implantable device that is within range responds to the external communication device's interrogate message by sending a response that includes patient identity information as stored in that particular implantable device. If the desired implantable device is the first to respond to the interrogate signal, the user can acknowledge his/her desire to link the external communication device and the implantable device. Otherwise, if the first responding implantable device is not the one to be linked to, the patient may indicate so and that particular implantable device identifier is added to a temporary exclusion list and the interrogate message is resent (including the exclusion list). When the interrogate message is received by each implantable device, only those whose identifiers are not in the exclusion list will attempt a response, thereby allowing other implantable devices within range to respond and be heard. Once the correct implantable device is the one that has its response displayed by the external communication device, the user can elect to start the linking process. Once the link is established, the implantable device is made to enter suspend mode and then the user must reprogram all basal rates including temporary basal rates that were in progress, profile basal rates, and delivery patterns. In alternative embodiments, all or a portion of this information may be retrieved from the implantable device, assuming it was programmed previously, but in this particular embodiment as an added measure of safety, it was preferred that these parameters should be reprogrammed so that the user is made to provide a positive assertion that he/she knows the delivery parameters that the implantable device is using. During the linking process the external communication device obtains other data from the implantable device that it requires in performing its operations, e.g. the external communication device obtains stroke volume information for the pulsatile pump and obtains insulin concentration data that is stored in the implantable device. [0138]
  • The sending and receiving of IR signals by the external communication device is based on basic IrDA standards. In the present embodiment, the transfer rate for the IR link is about 115 kbits/second. Of course in other embodiments other baud rates may be used or even automatically selected between. The IR link may be used to (1) upload new software to the external communication device from a second external device, (2) download system operation information to the second external device for further analysis as desired, and/or (3) pass commands/responses to or from a second external device from or to the implantable device. The second external device may be personal computer running appropriate software or a more specialized system. The communications sent over the IR link are based on protocol details that ensure that only intended messages, and correctly received messages, are received and acted upon. [0139]
  • In an alternative embodiment a second or third external communication device may be used in conjunction with the first external communication device or as a temporary or partial replacement therefor. For example, at night, a chest strap, wrist watch, mattress pad, or the like containing appropriate telecommunication capabilities might be used as a relay device to pick up warning signals or other communication signals coming from the implantable device and then to transmit them to the first external communication device or a third external communication device so that a warning may be sounded to wake up the patient, to directly notify emergency personnel of a problem, or to notify other monitoring personnel in a timely manner of medical device operation or patient condition. Such notification may occur using any appropriate telecommunication systems, such as telephonic or internet connections. In the case of directly warning the patient, if the second communication device has sufficient power and functionality it may implement the warning signal directly. The second or third external communication devices may communicate with the first external communication device via RF telemetry, IR communication link, optical link, galvanic connection, inductive communication, or the like. [0140]
  • The implantable device of the present embodiment has various delivery modes. One of these modes is the suspend mode wherein the system is caused to reduce insulin delivery to a clinically insignificant amount (e.g. 1 pump stroke (approximately 0.2 units of insulin assuming a stroke volume of 0.5 microliters and a U-400 insulin concentration) per hour. It is intended that this minimal rate of delivery keep the catheter open. The “suspend mode” mode may be used to interrupt delivery of a bolus, priming bolus, profile basal rate, diagnostic rate, and/or temporary basal rate. The system is programmed to alarm periodically to indicate to the user that the system is delivering insulin at a clinically insignificant rate. The user may exit suspend mode and resume basal delivery. In this embodiment, any bolus that is in progress when suspend mode is asserted is canceled such that any undelivered portion will not be delivered even when suspend mode is cleared. Other than when entering suspend mode through the linking process, if the implantable device is delivering a temporary basal rate when suspend mode is entered, the temporary basal rate duration continues while the pump is in suspend mode, and the temporary basal rate is reasserted when suspend mode is cleared for any portion of the duration that has not already lapsed. Of course in other embodiments other control options may be implemented with regard to going into or coming out of a mode analogous to suspend mode. [0141]
  • The external communication device is programmable using an audio bolus mode. This mode allows a user to program the delivery of a bolus without looking at the external communication device display. This mode provides an audio feedback to the user to indicate the amount of the bolus that is being programmed. The audio bolus feature allows programming of immediate boluses. Immediate boluses are those that specify a quantity of insulin to be delivered in as short a time as possible, e.g. a short as time as necessitated and allowed by any required repeated operation of the pumping mechanism. Under selected conditions a parameter selection may be made that dictates the incremental increase in bolus amount with each successive key entry (e.g. press of the Up-Arrow Key) when in audio bolus mode. Under selected conditions, the external communication device provides another parameter that enables or disables the audio bolus feature. In the present embodiment, once the desired bolus amount has been achieved by the repeated pressing of the select key, the user may confirm the accuracy of the selected amount by pressing a different key (e.g. the ACT key). When this confirmation key is pressed for the first time the external communication device plays a sequence of audio tones so as to indicate the amount programmed. If the amount is correct the user may press the ACT key again to initiate delivery. If the amount is incorrect the user may simply wait a predetermined, but short, period of time for the external communication device to time out or alternatively, the user may press any key other than the confirmation key. A distinct sound is emitted to indicate that delivery was not initiated, a which point the user may simply start over with the audio or visual programming. [0142]
  • Of course in other embodiments, other key press sequences may be used in the performance of programming an audio bolus. Alternatively, if the system were configured with a microphone or other sound transducer and appropriate audio command recognition software or hardware, audio programming could be performed without any keystrokes or with a single keystroke to activate the external communication device's listening mode. In a similar vane, if the external communication device were configured with a sound transducer and appropriate speech enabling hardware and/or software, then instead of sounding a series of beeps to indicate program status, it could communicate to the user, in a predefined language, to indicate the status. In still further alternatives, speech recognition and/or speech generation hardware could be used to replace or supplement keypad or touch screen input capabilities. [0143]
  • In the present embodiment, basal rate delivery and bolus delivery may be programmed to occur in conjunction with each other as opposed to one replacing the other. The system does not replace basal rate delivery with bolus deliver but instead combines the amount to be delivered under basal programming with the amount to be delivered under bolus programming to cause a net amount to be delivered that is equal to the sum of both amounts. The user may program a bolus amount on the external communication device and the implantable device will respond by delivering that amount. The amount of the bolus is subjected to a bolus maximum as described below. [0144]
  • The system allows the user to program an amount to deliver that the implantable device will deliver as quickly as possible using a required number of pump strokes with typically no more than 6 seconds between successive pump strokes (e.g. 1-3 seconds per stroke). This type of bolus is sometimes referred to as an immediate bolus or phase I bolus. [0145]
  • The system allows a bolus to be delivered where the user programs an amount and a duration. The implantable device delivers the amount as a rate (i.e. number of pump strokes per unit time) for the duration specified such that the amount programmed by the user is delivered within the duration. This is analogous to a basal rate or temporary basal rate delivery in some manner but is not identical as the total amount to be delivered is the sum of this amount and any basal rate that is currently in effect. Furthermore, in this delivery mode the user does not program the delivery amount as a rate. This type of bolus is sometimes referred to a square wave or phase II bolus. [0146]
  • The system supports a “dual wave bolus” where the user programs an amount for immediate delivery (immediate bolus) and a second amount for delivery during a specified duration (square wave bolus). When programmed in this manner the implantable device delivers the immediate amount as described above, followed by delivery of the second amount over the duration as a square wave amount also as described above. [0147]
  • The system also supports delivery of an immediate bolus while delivery of a square wave bolus is in progress or while delivery of the square wave portion of the dual wave bolus is in progress so long as the immediate portion of the dual wave bolus has been completed. [0148]
  • The programming of boluses in the external communication device is further controlled by a variable bolus option. If the variable bolus option is set to “no”, only immediate bolus programming is allowed and the square wave and dual bolus options are removed from the menu choices available on the external communication device. If the variable bolus option is set to “yes”, immediate, square wave, and dual wave bolus programming are allowed and all menu options are presented to the user. [0149]
  • The implantable device holds a number of logs. One of these logs is a bolus history log. In this log the implantable device maintains the time and amount of boluses that have been delivered. This log contains the most recent boluses that were delivered. This log is set to contain up to a predefined number of boluses after which the log wraps around and deletes older entries in favor of recording new entries. The external communication device receives these records from the implantable device. These records may be viewed on the external communication device or alternatively they may be downloaded to a second external device where they can be viewed in numerical form or be plotted for viewing in graphical form. The storage of this log information in the implantable device ensures that historical information remains available even in the event that the external communication device is lost, damaged, or otherwise fails. Each time a new bolus is programmed from the external communication device and confirmed by the implantable device, the details of the previously delivered bolus are provided back to the external communication device so a log maintained in the external communication device is almost as up to date as the log maintained by the implantable device. The log maintained in the external communication device can be scrolled through for review by the patient or healthcare provider. Each bolus history record includes the amount, time, and date of the bolus delivery. [0150]
  • The implantable device maintains another log that provides the total amount of insulin delivered by date. The implantable device maintains a history of the most recent 120 days of insulin delivery totals with the daily total separated by basal delivery and bolus delivery. The daily totals are downloaded automatically or semi-automatically from the implantable device to the external communication device each day. As with the bolus log, this information is protected from loss or failure of the external communication device by its retention in the implantable device. [0151]
  • The system maintains multiple sets of basal rates where each set dictates basal rate delivery for a selected interval of time and each element in each set dictates the basal rate delivery for a subset of that selected interval of time. In the present embodiment the number of sets is three, the selected interval of time is 24 hours beginning at midnight, and the subset of the selected interval of time is 30 minutes which starts at the beginning of each half hour mark during the day. As such, each set consists of up to 48 rates that can start on any half-hour of the day. [0152]
  • For programming convenience, the delivery rates need not be entered for each subset but instead only for those subsets that represent a change in delivery rate compared to the previous subset. As such, in this embodiment, basal rate values are only entered for the subset half hours in which transitions occur and are entered by specifying the start times and rates. Up to three 24-hour profiles may be entered with only one of the profiles selected as active at any given time. When a profile is made active, information about that profile is communicated to the implantable device to replace any other basal rate information retained there. As an added safety feature, only one profile set is stored in the implantable device at any given time. The active profile is repeatedly used day after day to control basal rate delivery in the implantable device until it is replaced by a different or revised profile. Such basal profile sets may be used for different types of days, e.g. work days, non-work days, exercise days, non-exercise days, sick days, high stress days, and the like. [0153]
  • The system allows a temporary basal rate to replace any profile based basal rates during a specified period. This feature allows the user to program a basal rate without changing the basal profile. When the temporary basal rate duration lapses, the implantable device resumes delivery of the basal profile rate that is then in effect based on the selected profile and the then current time of day. The temporary basal rate, for example, may be utilized to program lower basal rates during periods of exercise, or used to program higher rates during periods of high stress. [0154]
  • Selected “personal events” are recordable by the user in a personal event log. The personal event log is accessed through the external communication device and stored in the external communication device. In alternative embodiments these events may be communicated to the implantable device for safekeeping. The user may record the time that certain events occurred, such as exercising, meals, or illness. A parameter may be set so as to disable personal event logging. When disabled, the option does not present itself on the user menu in the external communication device. In the present embodiment, the system provides sufficient memory and control for retention and review of up to 100 such events. [0155]
  • “Automatic Off” is another feature of this embodiment. When this feature is enabled the insulin delivery system turns itself off if the user does not interact with the implantable device through telemetry for a programmed amount of time. This feature may be enabled or disabled. In this context, the turning off of the implantable device refers to the implantable device going into suspend mode. The implantable device alarms if it goes into minimum delivery mode as a result of the automatic off interval lapsing. The automatic off interval is reset each time the implantable device receives a valid telemetry message from the external communication device intended specifically for it. In order to save battery power in the implantable device, the external communication device is programmed to track the time that elapses between communications and to alarm 5 minutes before the automatic off interval lapses. This enables the user to clear the alarm and interact with the implantable device before the implantable device itself alarms and thus results in reduced power consumption by the implantable device. [0156]
  • An additional parameter of the present embodiment is bolus maximum which specifies the size of the largest single bolus that can be delivered. A pumping operation used in setting up the implantable device, called priming bolus is not subject to this maximum. The external communication device is programmed so that a user can not program an immediate bolus amount greater than the bolus maximum. The external communication device is also programmed so that the sum of the immediate amount and the extended amount of a bolus (regardless of the duration) may not exceed the Bolus Maximum. The implantable device uses the bolus maximum as a safety check of each bolus request that is received from the external communication device. [0157]
  • The external communication device is programmed to sound a maximum alarm if the user attempts to deliver an amount of insulin during a predefined period that exceeds a predefined limit. In this embodiment the predefined period of time is one hour and the maximum alarm is termed the hourly maximum alarm and the predefined limit is 2.5 times the Bolus Maximum. This alarm is intended as a safety alert to the user and not as an absolute limit on the amount that can be dispensed in any one hour period. The external communication device is programmed to compute the total amount of bolus delivery during the previous one hour period each time a bolus is programmed. If the amount already delivered summed with the programmed amount exceeds 2.5 times the programmed bolus maximum, the external communication device alarms and the bolus is not allowed. When an hourly maximum alarm is cleared, there is a short window where the user may program a bolus that normally would trigger an hourly maximum exceeded alarm. Following the short window, bolus programming is subject to the hourly maximum limitation and warning again. In the present embodiment the short window is set at ten minutes. In the present embodiment both amounts programmed for an immediate and square wave boluses are considered in triggering the hourly maximum exceeded alarm regardless of when the extended bolus amount was or is to be delivered. In alternative embodiments, the external communication device may be programmed to take into account quantities that have or will be delivered within a one hour period based on the programmed amounts and time intervals. In other embodiments the maximum amount in the predefined period may be determined based on something other than the maximum bolus amount. In still further embodiments the maximum bolus amount may be implemented as a hard limit. In still further embodiments, a second or subsequent bolus programmed in the same short window would not be subject to the warning. In other embodiments, the external communication device could not only warn the patient that the maximum amount has been exceeded but would also indicate the amount that was delivered in the period being considered. [0158]
  • External communication device programming and implantable device delivery are also limited by a basal rate maximum which is the highest rate that may be delivered using a profile basal rate or a temporary basal rate. A delivery rate used for diagnostic purposes known as the diagnostic rate is not subject to this maximum. The external communication device is programmed to inhibit the user from entering a basal rate greater than the basal rate maximum. The implantable device uses the basal rate maximum as a safety check of each basal rate that is programmed. The implantable device ignores delivery requests that include basal rate amounts greater than the basal rate maximum. The external communication device is configured to inhibit the user and physician from setting a maximum basal rate that is less than any of the basal rates already programmed including those in the profiles that are not currently active. [0159]
  • The external communication device is capable of displaying an estimate of the amount of medication remaining in the insulin reservoir. The external communication device is programmed to alarm when the medication remaining becomes less than a predefined low-reservoir threshold. As with other alarm conditions in the system, low-reservoir threshold alarms are reasserted after clearing if appropriate actions have not been taken to resolve the condition that gave rise to the error or event (e.g. refilling of the reservoir has not been completed). Once the low-reservoir alarm is cleared, and a predetermined period of time has lapsed and the system determines that the reservoir has not yet been refilled, the alarm will be reasserted so as to provide the user with a reminder to have the reservoir refilled. [0160]
  • The implantable device and external communication device retain clinical history information as records of various events that the system tracks. For example, events that stop the delivery of insulin such as alarms are recorded in the clinical history. User-initiated events such as suspend mode that stop the delivery of insulin are also recorded. Refills are also recorded. The system also contains logs for system diagnostics such as implantable device battery levels. Through menu options the user may view these various history logs. [0161]
  • In this embodiment, the system is programmed to allow a user to initiate a self test in both the external communication device and the implantable device. If there are any error conditions detected, they are reported to the user. The system self test includes a number of different checks: (1) implantable device memory, (2) external communication device memory, (3) implantable device piezo operation, (4) external communication device piezo operation, (5) external communication device vibrator operation, and (6) external communication device display. If an error is detected, the system reports the error to the user using visual, vibrational or audio alarms. [0162]
  • The external communication device is configured to emit audio alarms, or to vibrate, in the event an alarm condition exists. The implantable device always emits an audio alarm if an error condition persists beyond a predefined amount of time based on the particular alarm condition that exists. The external communication device is configured to allow the user to selected audio or vibration notification when alarm conditions exist. For many alarm conditions, the implantable device is programmed to contact the external communication device by telemetry prior to sounding an alarm on its own. In the event that the external communication device receives the message and successfully notifies the user of the condition and the user clears the alarm prior to a predefined time period passing, the implantable device does not sound the alarm directly on its own. In the event that the alarm condition is cleared but not resolved, the implantable device may directly reassert and sound the alarm later or may reassert and recontact the external communication device through telemetry. [0163]
  • The system supports an audio feedback mode where the implantable device may be programmed to beep on a first predefined number (e.g. 3-10 pump strokes after a rate change, and for a first predefined number (e.g. 3-10) pump strokes of a bolus. In other alternative embodiments, other feedback techniques may be implemented. [0164]
  • The system supports a storage mode for the implantable device and for the external communication device. Storage mode in the implantable device is a state where there is no drug delivery and no alarms and the frequency of waking up to listen for incoming telemetry messages is reduced. Storage mode in the external communication device is a state where the screen is blank and no user functions are available. The implantable device is programmed to enter storage mode upon receipt of a particular telemetry command. The implantable device is programmed to exit storage mode by receipt of a particular telemetry command. There is no implantable device alarm that indicates that the implantable device is entering storage mode. [0165]
  • The external communication device is programmed to enter storage mode if there is no user interaction with the external communication device for an extended period of time (e.g. 5-10 days). The external communication device is programmed to exit storage mode in the event of user interaction with external communication device such as button presses. When the external communication device is in storage mode the screen is blank and the external communication device hardware is put into a low-power state. [0166]
  • The system allows refilling of the pump and reporting on delivery accuracy. The system is programmed to allow entry of an extracted volume and a fill volume during the refill process. The external communication device may be made to display delivery accuracy based on a difference between the expected amount remaining in the insulin reservoir and the actual amount of insulin removed during the refill process. [0167]
  • In the present embodiment, the system is configured to support user and physician programming of the delivery options using insulin units based on a desired resolution value not based on a predetermined pump stroke volume. When the external communication device is programmed to deliver a certain amount of insulin, the external communication device calculates the number of pump strokes necessary to deliver that quantity and passes the pump stroke information onto the implantable device. The pump stroke information is passed in fixed point format including both an integer portion and a fractional portion. The determination of pump strokes is based on the implantable device pump stroke volume and the insulin concentration. [0168]
  • The system of this embodiment is configured to allow a programming option to be set that allows the physician to prime the catheter quickly. As will be discussed further hereafter, this option is only available as a supervisor function. The priming function/option triggers the implantable device to deliver an amount of insulin large enough to fill the catheter. In this mode, pump strokes are delivered as fast as possible. The physician is notified when the priming bolus is completed. [0169]
  • The system supports a special rate called diagnostic rate that is only programmable as a “supervisor only” function. This special rate is used in determining delivery accuracy. The diagnostic rate function triggers the implantable device to deliver at a programmed rate that is not subject to the basal rate maximum. [0170]
  • In this embodiment, the setting of system maximum basal rate and maximum bolus amounts may be programmed to be inaccessible to the patient and only accessible through a supervisor menu. The patient's ability to access these maximum values is controlled by a maximum lock parameter that is a supervisor function. When the maximum lock feature is enabled, the user may view, but not change, the bolus maximum and the basal rate maximum. When the maximum lock feature is disabled, the user may change the bolus maximum and the basal rate maximum. [0171]
  • The system includes memory space and program capability to personalize the external communication device and implantable device so that information such as the patient name and physician name can be stored for later retrieval and review. For example, the personal ID may be as little as 10 characters and as much as 200 characters or more. In the linking process it is preferred that at least a portion of this information be used in determining that the external communication device has contacted the desired implantable device (assuming the implantable device has already been previously programmed with identity information. When identification information is updated in the external communication device it is passed on to and stored in the implantable device. [0172]
  • The system retains factory default information and may be reset to those values when operating under supervisor control so that the system may be configured rapidly to a known state. The system may also be placed in a stop mode or controlled to replace or reload implantable device software when operating under supervisor control. [0173]
  • As noted above certain system functions require special control and their access is restricted. These features are only accessible via a supervisor menu on the external communication device. The supervisor menu is password protected. The password may be set by the physician while in supervisor mode. The supervisor menu system may also be entered by using a factory password. The factory password may be derived from the system characteristics. For example, the factory password may be a fixed number or character pattern. It may be based on a variable parameter, such as the date reflected by the external communication device, and/or the time reflected by the external communication device, and/or the serial number of the external communication device. Supervisor options/functions include the following: (1) refill, (2) priming bolus, (3) diagnostic rate, (4) maximum lock, (5) personal ID setting, (6) initialize to factory defaults, (7) download implantable device software, (8) stop pump, and (9) set supervisor password. [0174]
  • The user interface uses four keys, e.g. a SEL, ACT, UP and DOWN key, to navigate through menus, display options and features, and to program values. The external communication device changes the display to the idle display which shuts off the bit map display if the external communication device keypad is idle for a predefined period of time, preferably between 2 seconds and 30 seconds, more preferably between 4 seconds and 15 seconds and more preferably between 5 seconds and 10 seconds e.g. 7 seconds, while the user is viewing options. The external communication device may change the display to the idle display using a different predetermined time, e.g. a longer time such as 15 seconds, if the external communication device is idle while the user is in a programming or data entry screen. [0175]
  • As noted previously the system is programmed to display the current time and date. The time may be displayed in either a 12-hour or 24-hour format depending on user preference though in either event internal calculations that require time are based on a 24 hour clock. [0176]
  • All time displays by the external communication device are shown in the same format including time stamps on historical data and profile start times. This format in the present embodiment is based on a relative time measured in minutes since the factory initialization of the implantable device. [0177]
  • Acceptable parameter ranges for selected variables used in this first embodiment are depicted in the following table. Of course, in other embodiments other ranges are possible, other programming units may be used, some parameters may be converted to constants while other parameters may be added as variables. [0178]
    Acceptable Parameter Ranges
    Parameter Name Values
    Automatic Off Duration Off, 1-16 hours
    Audio Bolus Increment 0.4 units or 0.8 units
    Bolus Amount 0.2 U to Bolus Maximum by 0.2 U
    Bolus Duration 30 min to 4 hours
    Maximum Bolus 0.2 U to 35.0 U by 0.2 U
    Hourly Maximum Bolus 2½ times the
    programmed Maximum Bolus
    Basal Rate 0.2 U/hr to Basal Rate Maximum
    by 0.1 U/hr
    Temporary Basal Rate 0.2 U/hr to Basal Rate Maximum
    by 0.1 U/hr
    Temporary Basal Rate Duration 30 min to 24 hrs by 30 min
    Basal Rate Maximum 0.2 U/hr to 35 U/hr by 0.1 U/hr
    Diagnostic Rate 10 to 150 u/hr by 10 u/hr in U-400
    10 to 185 u/hr by 10 u/hr in U-500
    Insulin Concentration U-400 or U-500
  • As noted above, both the implantable device and the external communication device detect and report alarm conditions. The following table depicts examples of different types of alarms and examples of associated delivery states that are entered in response to the condition that gave rise to the alarm. [0179]
    Alarm Conditions
    ALARM Alarm Condition Alarm State Action
    Low Battery Alarm when there is Alarm Only/Icon ON
    battery energy
    remaining of about
    8 weeks or less
    Depleted Battery None guaranteed No Delivery
    Low Reservoir Alarm when 2 mL of Alarm Only/Icon ON
    drug remaining
    Empty Reservoir Alarm when 1 mL of Alarm Only/Icon ON
    drug remaining
    Any implantable Alarm No Delivery
    device Hardware
    Failure Detect
    Over Delivery Alarm when disagreement No Delivery
    from various delivery
    calculations produces
    a discrepancy of a
    first type.
    Under Delivery Alarm when disagreement No Delivery
    from various delivery
    calculations produces
    a discrepancy of a
    second type.
    Self Test Failure Alarm when the periodic No Delivery
    self test including the
    memory test fails
  • As noted above, even when an alarm is initially cleared, it may be reasserted if the condition that gave rise to it continues to persist. When a condition persists, the reassertion of and sounding of the alarm may occur for example as indicated in the following table. [0180]
    TABLE 1
    Alarm Reassertion Intervals
    Menu Persistant
    Internal Options Icon/Message
    Exception Reassertion Beep Disabled Display
    Over Delivery 0 5 min Yes Yes
    Under Delivery 0 5 min Yes Yes
    Low Implantable 7 Days 24 Hrs N/A Yes
    Device Battery
    Low Reservoir
    24 Hrs 24 Hrs N/A Yes
    Empty Reservoir 24 Hrs 24 Hrs N/A Yes
    Depleted N/A N/A N/A N/A
    Implantable
    Device Battery
    Automatic Off N/A 5 min N/A Yes
  • In this embodiment, physical and functional features have been considered as well as implantable longevity. In addition to the various features noted above, the implantable device and external communication device preferably meet certain physical targets: (1) The implantable device is preferably packaged in disk shaped housing that is thinner than about 1 inch, and preferably thinner than 0.9 inches, and more preferably thinner than about 0.8 inches or less, with a diameter of less than about 4 inches and more preferably about 3.2 inches or less, and having an empty weight of less than about 180 grams and more preferably less than about 165 grams, and (2) The external communication device has been packaged in a somewhat rounded but nominally rectangular shaped package having dimensions of less than about 1.0 inch by 3.5 inches by 4.0 inches, but more preferably having dimensions about 0.8 inch or less by about 2.8 inches or less by about 3.5 inches or less, and weighing less than about 6 oz. In other embodiments, various other device shapes and sizes may be used. [0181]
  • The implantable device and external communication device are preferably also designed and are controlled to meet certain longevity requirements in combination with the desired functional requirements. It is desired that the implantable device remain operational within the body of a patient for a period of about five years or longer, more preferably a period of about seven years or longer, and most preferably a period of about 9 years or longer. As the present embodiment uses a non-rechargeable battery, the longevity of the implantable device is primarily dictated by the power consumption of the electronic modules and the capacity of the battery. The determination of longevity is complicated by the fact that the power consumption of the electronic modules is not constant over time but varies depending on the actions that are required by the user. Two elements of the preferred embodiment that lead to an acceptable level of longevity are the use of low power electronic circuit elements and the controlled application of power and/or clocking signals to various modules. The power and/or clocking signals are supplied to the modules on an as needed basis and operational protocols have been put into place to minimize the amount of time that the various modules need to operate. As noted previously, an example of such protocols include the implantable device's attempt to communicate with the external communication device by telemetry prior to using a more power consumptive internal alarming process. Another example involves the implantable device having a storage mode that uses less power than a normal operational mode. A further example includes the implantable device's process of turning on its receive telemetry for short periods of time (about four milliseconds) on a periodic basis (once every two seconds) to listen for incoming messages and then shutting off the telemetry system if no messages are incoming. An additional example, includes the processor's ability to turn itself off when it is not needed and to be awakened by interrupt signals when needed. These and other examples of controlled power consumption are discussed further hereafter. [0182]
  • FIG. 3 depicts a simplified block diagram of various functional components or modules (i.e. single components or groups of components) included in the implantable [0183] medical device 2 and external communication device 32. The external communication device 32 includes (1) a housing or cover 34 preferably formed from a durable plastic material, (2) processing electronics 42 including a CPU and memory elements for storing control programs and operation data, (3) an LCD display 36 for providing operation for information to the user, (4) a keypad 38 for taking input from the user, (5) an audio alarm 44 for providing information to the user, (6) a vibrator 46 for providing information to the user, (7) a main battery 52 for supplying power to the device, (8) a backup battery 54 to provide memory maintenance for the device, (9) a radio frequency (RF) telemetry system 56 for sending signals to the implantable medical device and for receiving signals from the implantable medical device, and (10) an infrared (IR) input/output system 58 for communicating with a second external device.
  • The second external device may include input, display and programming capabilities. The second device may include a personal computer operating specialized software. The computer may be used to manipulate the data retrieved from the communication device or the medical device or it may be used to program new parameters into the communication device or directly into the medical device, or even used to download new software to the communication device or to the medical device. The manipulation of the data may be used in generating graphical displays of the data to help aid in the interpretation of the data. Such data interpretation might be particularly useful if the medical device provides data concerning a physiological parameter of the body of the patient, such as a glucose level versus time. More particularly the computing power and display attributes of the second device might be even more useful when the medical device includes both an implanted sensor (e.g. glucose sensor), or external sensor, and an implanted pump (e.g. insulin pump), or external pump, where the second external device may be used to enhance the ability to ascertain the effectiveness of the two devices working together. Successful control periods and problem control periods could be more readily identified. In fact, if the two devices work on a closed loop basis or semi-closed loop basis, the analysis performable by the second external device may be useful in deriving new closed loop control parameters and/or in programming those parameters directly into the communication device or the medical device or devices. [0184]
  • The [0185] implantable device 2 includes (1) a housing or cover 6 preferably made of titanium that may or may not be coated to enhance biocompatibility, (2) processing electronics 72 including two CPUs and memory elements for storing control programs and operation data, (3) battery 74 for providing power to the system, (4) RF telemetry system 76 for sending communication signals (i.e. messages) to the external device and for receiving communication signals (i.e. messages) from the external device, (5) alarm or buzzer 82 for providing feedback to the user, (6) refill port 12 for accepting a new supply of drug as needed, (7) reservoir 84 for storing a drug for future infusion, (8) pumping mechanism 86 for forcing selected quantities of drug from the reservoir through the catheter to the body of the patient, (9) sideport 14 for providing a replaceable connection between the (10) catheter and the pump housing and for allowing diagnostic testing of the fluid handling system to occur, and catheter 16 for carrying medication from the implant location to the desired infusion location.
  • In this embodiment, the pump mechanism is preferably a low power, electromagnetically driven piston pump. Such as for example Model Nos. P650005 or P650009 as sold by Wilson Greatbatch Ltd. of Clarence, N.Y. which have stroke volumes of 0.5 microliters and draw under 7 mJ (e.g. about 6 mJ) per pump stroke and under 4 mJ (e.g. about 3 mJ) per pump stroke, respectively. The pump mechanism dispenses a sufficiently small volume of insulin per stroke so that a desired level of infusion resolution is achieved. For example if an infusion resolution of 0.2 units of insulin were desired when using U400 insulin, then a stroke volume of about 0.5 microliters would be appropriate. In other embodiments other types of infusion pumps may be used, e.g. peristaltic pumps, screw driven pumps, and the like. [0186]
  • As depicted in FIG. 3, the implantable device includes a [0187] reservoir 84 for holding a desired quantity of insulin. In this embodiment, the drug held in the reservoir is preferably maintained at a slight negative differential pressure (with respect to the pressure on the outside of the housing) so that in the event of a leakage in the reservoir 84 or housing 6, the drug will not be forced from the housing into the body of the patient. The drug is added to the reservoir 84 by means of a transcutaneous needle that is passed from a position exterior to the body into self sealing refill port 12. Due to the slight negative pressure that the reservoir experiences, insulin in a syringe connected to the needled is drawn into the reservoir without need of external force. The drug is extracted from the reservoir 84 and forced through catheter 16 by an electronically controlled pump mechanism 86. In alternative embodiment positive pressure reservoirs may be used in combination with pumping mechanisms that force the medication or drug from the implantable device and/or used with flow restrictors that dispensed the drug at a fixed rate or at a variable rate with the aid of valves or flow diverters.
  • The size of the reservoir is preferably large enough to hold sufficient insulin so that refilling does not have to occur too often. For example, it is preferred that time between refills be within the range of 1.5-4 months or longer, more preferably at least 2 months, and most preferably at least 3 months. Opposing the containment of a large volume of insulin, is the desire to keep the implantable device as small as possible. In the present embodiment the implantable device and reservoir has been designed to hold about 13 ml of insulin. A preferred insulin has a concentration of 400 units per milliliter and is available from Aventis HOE 21 Ph U-400 from Aventis Pharma (formerly Hoechst Marion Roussel AG, of Frankfurt am Main, Germany). This insulin is a highly purified, semi-synthetic human insulin with 0.2% phenol as a preserving agent, glycerol as an isotonic component, TRIS as a buffer, plus zinc and Genopal® as stabilizing agents. This quantity and insulin concentration allows about 2-4 months between refills. In other embodiments higher insulin concentrations may be used (e.g. U-500 or U-1000) to increase time between refills or to allow reduction in reservoir size. In some embodiments, when higher concentrations are used, any quantized minimum delivery amounts may be reduced by modifying the pumping mechanism, control circuitry, or software control algorithm so that infusion resolution is not adversely impacted. [0188]
  • The external communication device contains appropriate software to provide proper control of the device including appropriate functionality to allow communication with the medical device, to allow adequate control of the operation of the medical device, and to give appropriate feedback to the user regarding overall system operation. The medical device is provided with appropriate software to allow communication with the external communication device, to allow safe and appropriate operation of the medical functionality of the device, and to allow direct feedback to the user concerning device status via the internal alarm. [0189]
  • The control electronics of both the implantable device and external communication device are centered around microprocessor based integrated circuits, i.e. processor ICs, that are implemented in the present embodiment in the form of application specific integrated circuits (ASICs). Two such ASICs are used in the implantable device to increase operational safety of the device by configuring the device to require that the two ASICs act in conjunction with each other in order for medication infusion to occur. [0190]
  • In different embodiments, more or less of the control electronics may be implemented within one or more processor ICs while any remaining portions may be implemented external to the processor IC(s). The processor IC may be referred to as an MD processor if used in the medical device portion of the system or a CD processor if used in the communication device portion of the system. In other embodiments the process IC used in the communication device may be different, e.g. have a different CPU or different peripheral modules, from a processor IC used in the medical device. In embodiments where more than one processor IC is used in either the medical device or the communication device each of the processors may be different. They may be specifically designed for their intended roles when they perform at least partially different functions. Depending on particular design constraints portions of the electronics not embodied in the processor ICs may form part of one or more hybrid circuit boards or be otherwise mounted within, on, or even in some cases external to a device housing. [0191]
  • A functional block diagram of the Processor IC for the present embodiment is depicted in FIG. 6. Each processor IC of the present embodiment includes a [0192] CPU 912 and various peripheral modules that are used for system control, data acquisition, and interfacing with electrical components external to the processor IC.
  • The peripheral modules of the processor IC of the present embodiment include (1) a non-volatile memory interface module, e.g. a [0193] SEEPROM interface module 914, (2) a boot ROM module 916; (3) an SRAM module 918; (4) a memory decoder module 920; (5) a crystal oscillator module 922; (6) a timer module 924; (7) a pump interface module 926; (8) a watchdog module 928; (9) an RF telemetry module 930; (10) an interrupt handler module 932; (12) an analog-to-digital converter module 934; (13) an LCD clock driver module 936; (14) an alarm interface module 938; and (15) first and second synchronous serial interface modules 942 and 944. The memory decoder module interfaces with the core processor, boot ROM, and internal SRAM using a 16 bit address bus which also is available off chip for addressing external memory. With the exception of the crystal oscillator module all other internal module communicate over an 8-bit data bus or 16-bit data bus. FIG. 6 further illustrates that the A/D module may take input from sources internal to the processor IC and similarly the interrupt handler can take up to 9 interrupts from sources internal to the processor IC. Additionally, most of the modules communicate with outside components or modules over one or more input/output lines.
  • In alternative embodiments fewer, additional, or different peripheral modules may be incorporated into the processor ICs. In one extreme the processor IC may simply incorporate a CPU with all other modules being external thereto. In the other extreme almost all, if not all, electronic components may be incorporated into a single processor IC. Intermediate alternatives might incorporate a single additional module into the processor IC (in addition to the CPU), others might incorporate more than one, e.g. 4 or more, 8 or more, or the like. In still other alternatives, the number of peripheral modules or components in an entire device may be considered and more than a certain percentage of them incorporated into one or more processor ICs, e.g. more than 50%, more than 75%, or even more than 90%. [0194]
  • The processor ICs are responsible for basic system management and communication of information between the implantable device and the external communication device through the RF telemetry link. The telemetry systems of the present embodiment are implemented in part through electrical hardware and in part through software controlled by a processor IC. [0195]
  • In the present embodiment, most of the required electrical modules for the implantable device are integrated within the processor ICs. However, several are not. These additional modules include two independent crystal oscillators (one for each ASIC); two non-volatile memory modules (one for each ASIC), e.g. SEEPROM chips; a volatile memory module (used only by one of the ASICs), e.g. an SRAM chip; pump driver circuitry (partially controlled by the each ASIC); front end telemetry system circuitry; and voltage measurement circuitry associated with the pump driver circuit; a buzzer; and a battery. [0196]
  • Within the implantable device telemetry operations are controlled by a single ASIC (sometimes known as the main processor). The other processor (sometimes known as the monitor processor) controls the buzzer and is thus responsible for audio communications coming from the implantable device. The medical functionality of the implantable device (i.e. the administration of insulin in the present embodiment) is controlled by both processors. To maintain the implantable device in a fail-safe operational mode, these two processors must maintain an appropriate level of agreement concerning infusion instructions or a system reset is forced to occur. The main and monitor processors communicate with each other through the use of hardwired-serial input and output ports. [0197]
  • As with the implantable device, the control electronics of the external communication device are centered around an ASIC that controls and interacts with a number of peripheral modules. These peripheral modules include an LCD display and driver, an IR port and driver, a crystal oscillator, a keypad and keypad interface, power management modules and reset circuitry, external volatile memory (e.g. SRAM) and non-volatile memory (e.g. SEEPROM), a buzzer, and front end telemetry hardware. [0198]
  • The external communication device (CD) is a hand-held device that allows a user to program and communicate with the implantable device. The external communication device of the present embodiment preferably has a weight of less than about ounces, a thickness of less than about 0.8 inches, a width of less than about 2.8 inches, and a length of less than about 4.0 inches. [0199]
  • The external communication device is enclosed by [0200] housing 34 as depicted in FIG. 2 and includes within housing 34 a number of different electronic modules or components. These modules and a high level outline of their interconnections are depicted in FIGS. 4a and 4 b. FIGS. 4a and 4 b, form the left and right halves of a single block diagram. The electronic configuration of the external communication device is centered on an ASIC 502 which has been divided for presentation purposes into left and right halves 502 a and 502 b.
  • The [0201] ASIC 502 includes a microprocessor, internal ROM, internal RAM and a number of additional modules. A number of the ASIC modules used by the external communication device are depicted in FIGS. 4a and 4 b. These modules include (1) a watchdog 522, (2) an external reset 534, (3) an A/D converter 542, (4) a serial ROM port 572, (5) a first serial synchronous interface port 592, (6) an RF module 612, (7) an oscillator module (650), (7) a tone alarm driver 682, and (8) LCD port 692, (9) three interrupt inputs, and (10) a number of I/O buses. According to this first embodiment, the preferred ASIC for use in the external communication device is identical to the ASICs used in the implantable device. Further details about the ASIC are provided hereafter.
  • The ASIC includes a first interrupt [0202] input 512 that receives interrupt signals 514 generated by a key interrupt generator circuit 516.
  • The ASIC includes a [0203] watchdog 522 and watchdog output 524 that is fed into “OR” logic circuitry 526 that effectively performs an “OR” operation on three different signals. An output signal 528 of the OR logic circuitry 526 is fed into an input 532 of the ASIC which in turn is connected to reset circuitry 534 that triggers the Processor IC to be reset. The Processor IC can be reset by making any of the three signals high which in turn will drive the output of the “OR” logic circuitry high and thus the input 532 high. The watchdog output signal 524 is made to go high when the processor does not reset the watchdog in a timely manner.
  • The ASIC includes analog-to-[0204] digital converter electronics 542 that uses two external inputs 544 and 546 which are used, respectively, for measuring a voltage (VAA) of a main battery and a voltage (VCOIN) of a backup battery.
  • The ASIC includes a second external interrupt [0205] input 552 that is connected to battery failure detection circuitry 554 by line 556 that carries a high reset signal.
  • The ASIC includes an I/[0206] O bus 562 for carrying address, data and control signals to and from 1 megabyte of external SRAM 564 located on two external chips. Each chip is a four megabit, low power SRAM, organized as 256 k by 16 bits, operating between 2.7 and 3.6 volts, with a maximum standby current of 15 μA. This memory may be accessed either byte-wide or word-wide, as controlled by two external ram signals from the ASIC. Furthermore, an additional two signals from the ASIC are used for chip selection and a third additional signal is sued for bank selection. The third additional signal uses the same output as did the pump fire signal on the monitor processor in the Implantable Device. I/O bus further provides 17 address lines and 16 data lines.
  • A [0207] power management module 722, to be further discussed hereafter, produces a back up battery power signal 762 that goes high when the main battery 732 fails and power is being supplied by the back up battery 752. When the signal 762 is high, access to the SRAM chips is disabled and thus memory access is denied. This is implemented to prevent memory access during unstable periods and to t ti-state the memory chip outputs so they are not driving low impedance inputs when boosted voltage 736 (VCC), coming from up-converter 734 that is powered by the main battery 732, fails.
  • The [0208] 762 signal and one of chip selection signals (depending on the SRAM chip being selected), are provided to the inputs of an OR gate and the signal from the OR gate (not shown) is the control signal that is passed to the SRAM. As such, for the particular SRAM chip to be accessible both these signals must be in their low states.
  • These memory chips are powered by power signal [0209] 756 (VPOS) that is derived from VCC when it is available and from the backup battery when VCC is not available.
  • The ASIC includes a [0210] SEEPROM port 572 that is used to connect to two external SEEPROMs 574 using a power output signal 576, a clock output signal 578, and a bidirectional data communication line 582. The SEEPROMs may be identical chips, for example. They preferably have a two wire interface, are internally organized as 64 k by 8 bits, support bidirectional data transfer, and use an operating voltage between 1.8 and 3.6 volts. These chips are used to provide memory space for program code and program data. The addresses of these two SEEPROM chips are set by hard wiring. Each chip has a capacity of 64K bytes, organized as 512 pages of 128-bytes each. Each SEEPROM is configured so that it can be written to as well as read from during run time by the system processor.
  • In the present embodiment one of the SEEPROMs is used for storing external communication device software which is loaded into internal RAM or external RAM during system boot up, while the other SEEPROM is capable of holding software for download to the implantable device. [0211]
  • The ASIC includes a first synchronous [0212] serial interface port 592 that is functionally connected to an external UART 594 using several lines 596, including a single clock line for both incoming and outgoing data, a data-in line for data coming from the UART to the Processor, and a data-out line for data going to UART.
  • A third external interrupt [0213] input 602 for the ASIC is connected to UART 594 by line 604. A high signal is generated on line 604 by the UART chip whenever serial data is received through the IrDA port.
  • The ASIC also provides an [0214] RF telemetry module 612 which provides TXI and TXQ signals, on lines 614 and 616, to RF transmitter circuitry 618. The RF telemetry module also provides a power signal 622 to RF receiver circuitry 624. The RF receiver circuitry provides a first and second mixer input signals, 626 and 628, respectively, back to a mixer 632 in the RF telemetry module 612. The RF module also provides a control signal 634 to switching circuitry 636 that effectively connects either the RF transmitter circuitry to an antenna 638 or RF Receiver circuitry to the antenna 638. The control signal 634 is also provided to a NAND gate 642.
  • The RF telemetry system in the external communication device is similar to that of the implantable device in overall configuration and in control though some differences in circuit detail do exist. The RF system uses a carrier frequency of about 250 kHz (e.g. 262,144 Hz ±125 Hz). The RF telemetry subsystem is composed of analog and digital modules. The digital module includes a QFAST® modulator/demodulator, a control and timing logic circuit that are integrated in the Processor IC. [0215]
  • The analog module consists of an RF front-end circuit and a mixer. The mixer is also integrated in the processor IC. The RF front-end circuit consists of RF transmitter circuitry and RF receiver circuitry, which is in-turn composed of a band-pass filter and a 3-stage amplifier. [0216]
  • The RF receive circuitry and transmit circuitry share the [0217] same antenna 638. The antenna 638 is a faraday-shielded, air-coil, housed within the housing of the external communication device. The antenna and the faraday shield are connected to the printed circuit board.
  • The antenna is switched between transmit and receive functions in a similar manner to that described above with regard to the implantable device. [0218] Switch 636 is similar to switch 234 of the implantable device and includes a tristate driver and an analog switch. The switch is also controlled in an analogous manner. The transmitter 618 is substantially the same as that described above for the implantable device.
  • The [0219] RF Receiver 624 is similar to that used in the implantable device. As with the implantable device, the RF Receiver module 624 includes three amplifier stages that are tuned to pass and amplify desired signals. In contradiction to the implementation in the implantable device, all three stages of in the external communication device are tuned. The first stage has its frequency response set by a tank circuit with tuning adjustable by a variable capacitor. The signal from the tank circuit is passed through a direct current voltage blocking capacitor and then on to a pair of transistors in a push-pull configuration. The transistors may be identical to those used in the implantable device. The second and third stages use tuned push-pull transistor configurations.
  • The signal resulting from these three stages has preferably been amplified by 70 to 90 dB with an RF passband of about 16 kHz (e.g. about 2[0220] 14 Hz) centered around a 262,144 kHz carrier at the 2 dB ripple peak-to-peak maximum. An RF stopband of about −65 dB is provided at below about 150 kHz and at above about 550 kHz.
  • The line carrying the output signal from these three stages is taken to ground through a 100 kΩ resistor and then a 390 ρF capacitor. A first signal, RFI, is taken from the output signal prior to the output signal passing through the resistor. A second signal, RFQ, is taken from the output signal from between the resistor and the capacitor. The RFI and RFQ signals are then passed onto the main processor IC. The RFI signal is the filtered and amplified RF signal that was received by the telemetry system, while the RFQ signal is a direct current signal having a voltage value equal to the average voltage value of the RFI signal. [0221]
  • The ASIC is also connected in parallel to a [0222] crystal oscillator 652 and associated resistor 654 by lines 656 and 658.
  • The ASIC is additionally connected to a [0223] first output port 662 by an I/O bus 664 and a second output port 668 by an I/O bus 672. Each of these two output ports may be formed from an octel tristate non-inverting D flip-flop. These output ports are latching so that inputs from the CPU need not be maintained constantly.
  • Address decoding and port enablement are provided by a single external port and address decoder chip. This decoder is preferably a 1-of-8 Decoder/Demultiplexer. This address decoder chip is used by both the output ports as well as the [0224] keyboard input port 702.
  • The output ports are enabled/disabled by the [0225] RESET signal 726. Such that when RESET is asserted (low) due to the main battery voltage VAA falling below a programmed threshold, the output ports are tri-stated. When this happens, pull-up resistors set the outputs to appropriate states so that all high current devices are shutdown. This is done to preserve the energy stored in the VCC storage capacitors so it is only used for powering the appropriate portions of the circuit for an orderly shut-down.
  • The ASIC further provides [0226] tone driver circuitry 682 to an audio alarm 44 (e.g. a piezo alarm) by lines 686 and 688 that carry first and second buzzer signals that are produced by the Processor IC.
  • The ASIC further includes a second synchronous [0227] serial interface port 692 that functions as an LCD port for communicating with an LCD module 694 that includes LCD driver and display 36 (FIGS. 2 and 3). Three communication lines 696 are used between the serial interface port and the LCD module. One of the lines provides a selectable clock, for driving the LCD, of either about 64 kHz or 32 kHz (i.e. about 216 Hz or 215 Hz). An additional three control signals 782 are provided by output port 662. These control signals include a chip select signal, a reset signal, and a clock loop back signal.
  • The LCD of the present embodiment is powered by an LCD driver chip, such as Part No. MC141800A from Motorola. Communication to the LCD module is performed using I[0228] 2C serial communication protocol. The communication lines are supplied directly from the second serial synchronous interface communication port of the Processor IC.
  • The external communication device visually communicates to the patient using an [0229] LCD display 36. This display includes a dot-matrix graphics LCD for displaying a portion of the information to be conveyed and an icon/fixed segment display for displaying the remaining information to be conveyed. The dot-matrix display allows various languages to be displayed with only a software change or change of a parameter (variable) within the software. In the present embodiment the dot-matrix portion has a display region of about 100×55 pixels.
  • FIG. 5 depicts the [0230] display 36 of external communication device 32 including the icon/fixed display region 852 and the bitmap display area 854. The icon/fixed element display bar includes a time-of-day indicator 856 which is made up of 4 seven segment display elements, a “:” symbol, an “AM” symbol, and a “PM” symbol. The icon bar also includes a battery symbol 858 that turns on when the main battery of External Communication Device is getting low. The icon display also includes an alarm icon 860 in the shape of a bell that is turned on when an alarm condition is in effect. The icon display further includes a 4 segment reservoir level indicator 862. When the reservoir is estimated to be full all four segments are powered and as the estimated reservoir level drops individual segments are successively turned off. The icon display further includes a circular display 864 comprised of 4 pie shaped wedge elements. The number of pie-shaped wedges being displayed and their motion are indicative of the delivery condition that is currently active. A month indicator 866 is formed from three 16-segment displays while a date display 868 is formed from two additional 7-segment displays.
  • Turning back to FIGS. 4[0231] a and 4 b, the ASIC is further connected to an input port 702 by an I/O bus 704. This input port preferably is an octal 3-state non-inverting/buffer/line driver/line receiver. This is a non-latching port. Address decoding and port enablement is provided by a single external port and address decoder chip whose use is shared by output ports 668 and 662.
  • The [0232] keypad 38 is linked to an integrated key interface device 712. The integrated key interface device includes key interfacing, key debouncing, and ESD suppression functions. This device is preferably an octel CMOS switch debouncer with ESD protection for input pins up to 15 kV. The keypad 38 includes four keys with raised buttons and tactile responsiveness and one key without a raised button or tactile responsiveness (i.e. a hidden key).
  • The integrated [0233] key interface device 712 outputs five signals 714 that are provided to input port 702, the key interrupt generator 516, and to a key reset generator 716. Signals 714 include a separate signal for each of the five keys. The signal for each key is low when that key is depressed. The de-bounce duration provided by device 712 is at least 20 ms and is 40 ms typically. The ESD suppression is rated at 15 kV using the human body model.
  • The key interrupt [0234] generator 516 includes an 8 input NAND gate that takes the signal from each of the five keys and performs a NAND operation on them, such that if any one of the keys is depressed (i.e. at least one low input) a high signal will be output by the NAND gate and if no key is depressed (i.e. no low input) a low signal will be output by the NAND gate. The output of the NAND gate is then passed to one input of a two input AND gate along with the reset signal 726 as the other input. As a result if reset signal 726 is high (i.e. not asserted and at least one key is depressed then a high asserted signal is received on line 514 by the first interrupt input 512. If reset signal 726 is low (i.e. asserted) then any keyboard activity is blocked from asserting the interrupt signal.
  • The [0235] key reset generator 716 provides an output signal 718 to an input of the OR logic circuitry 526. The key reset generator 716 receives low signals from the keys that are pressed and high signals from the keys that are not being pressed. A series of OR gates are used to determine if all five keys are depressed (i.e. the four keys with raised buttons and one key without a raised push button). The output of the OR gates is passed through a 100 KΩ resistor and is linked to ground using a 0.1 μF capacitor. This capacitor and resistor are used to suppress short glitches that might be caused by static discharge from the external world via the keypad. Glitches shorter than about 10 milliseconds are suppressed. The output signal is then fed to an inverter and then passed to one input of a two input AND gate. The other input of the AND gate is reset signal 726. The output of the AND gate is the key reset signal 718. Which is passed on to the OR logic circuitry 526.
  • In addition to the [0236] input port 702 receiving key press signals 714 from the integrated keyboard interface 712, it also receives main battery low input signal 724 from power management circuitry 722 and a reset signal 726 from battery fail detector 554. The signal 724 is asserted low and when asserted indicates that the main battery voltage is low. The reset signal 726 is asserted low and when asserted indicates that the main battery is dead. The state of keypad is monitored by input port 702 and the processor is expected to read the input-port to determine which key was pressed after receiving a keyboard interrupt.
  • The main source of power for the external device is a replaceable, M cell [0237] main battery 732 of either the alkaline type or lithium type. A main battery voltage signal 738 (VAA) is supplied to various components and modules as needed. Signal 738 is supplied to an input pin 544 of the analog-to-digital converter that is included in the Processor IC.
  • The [0238] VAA signal 738 is also supplied to a switching type pulse width modulated DC-DC up-converter 734 that produces a boosted voltage signal 736 (VCC) of a definable amount. In the present embodiment the definable amount is 3.45 volts ±0.1 volt when powering a minimum load of 30 ohms and when supplied with an input voltage of between about 1.1 volts and 1.8 volts. The maximum ripple is 80 mV peak-to-peak. The start-up voltage of the up-converter is no greater than 1.00 V when the starting load is less than 100 ohm at the output. The switching frequency is between 550 kHz and 750 kHz, nominally 600 kHz. However, under light load, the up-converter utilizes burst mode, resulting in a wider noise spectrum. As VCC is generated using high frequency switching, the up-converter is preferably shielded from other components so as to minimize negative effects that might otherwise result, such as, for example, on telemetry reception. In the present embodiment about 440 μF of capacitance is supplied to the VCC lines so as to provide some energy storage for the VCC signal.
  • The [0239] output signal 736 of the converter 734, VCC, is the main operating power for the external communication device though FIGS. 4a and 4 b, explicitly depict only two of the modules to which voltage signal 736 (VCC) is routed: (1) the external power on reset generator module 742, and (2) power management module 722.
  • A [0240] backup battery 752 is shown as supplying a voltage signal 754 VCOIN, to power management module 722 and is also passed to analog-to-digital converter input 546 for voltage monitoring. A preferred backup battery is a 3.0 volt lithium battery having a 48 mAHr capacity. As noted above, the power management module outputs a signal 756 that supplies power to the any circuits that are to remain powered by the backup battery when the main battery voltage signal 738, and thus boosted voltage signal 736, falls below a usable level.
  • In the present embodiment the [0241] external SRAM 564 is powered by signal 756. For data retention to occur the voltage supplied must be at least 2.3 volts. In this embodiment signal 756 supplies a voltage of about 2.7 to about 3.6 volts depending on whether or not the power is being supplied by the main battery or backup battery. The maximum operating current for signal 756 is about 1 mA.
  • Power management in the present embodiment is based on the [0242] power management module 722, battery fail detector module 554, and external power on reset generator module 742. These modules are implemented using three primary integrated circuits along with other peripheral elements. The functions of the power management system include providing back-up power for the on-board SRAM, providing proper power-up reset, and providing adequate time for orderly system shut-down when the main battery is dead or removed.
  • The first chip is a 3 volt adjustable microprocessor supervisory IC which handles the functions performed by the [0243] power management module 722. This chip monitors signal 736, VCC, and provides signal 736 as the source for output signal 756 so long as VCC is about 2.7 volts or greater and otherwise provides signal 754, VCOIN, as the source for output signal 756. When VCC rises above, about 2.90 volts, signal 736 is switched back in as the source for output signal 756. The chip also monitors main battery voltage (VAA) and provides low power signal 724 when VAA falls below a desired threshold that is settable by selection of peripheral voltage dividing resistors. In the present embodiment the selected amount is about 1.1 volts. The low power output signal 724 is connected to input port 702 where it can be monitored by the system processor. The low power signal 724 is used by the Processor IC to provide a low battery indication to the patient.
  • As noted above, the battery management IC also asserts an [0244] output signal 762 when the backup battery is switched in as the source of VPOS. This signal is used to gate the chip select of the SRAM chips 564 so that when the back up battery is maintaining the data in the SRAM chips, the SRAM chips cannot be accessed so as to protect the integrity of the data. This asserted state also cuts the backup battery voltage to the processor using a PFET switch that opens line 754 so that it is not connected to A/D input 546. This is done so that the backup battery is protected from a potentially low impedance path to ground (e.g. the A/D input of the ASIC) that may occur when VCC is absent.
  • When the main battery is dead or removed, all memory access must be completed before the back up battery on [0245] signal 762 is asserted. The energy storage capacitance on VCC serves this function by providing time for system shutdown (enough time for completing selected shutdown activities before VCC falls low enough that the back up battery on signal 762 is asserted.
  • The second chip is a micro-power voltage monitor IC that is used as a programmable voltage detector and handles the functions performed by the battery [0246] fail detector module 554. The programmability is determined by the two voltage divider resistors. A hysterisis effect is used to ensure a good pulse and is obtained by use of a 500 kΩ resistor that bridges the input and output lines of the chip. This comparator monitors the voltage signal 738 of the main battery. The output line of the chip provides low reset signal 726. A second output signal for the battery fail detect module is provided by passing signal 726 through an inverter to obtain a high reset signal 556. The threshold is set at about 1.0 V in the present embodiment. The low reset output signal 726 is connected to one of the inputs of input port 702. The high reset signal 556 is used as a power-fail interrupt signal to the processor. This interrupt signal is fed directly to the second external processor interrupt input 552.
  • When the [0247] low reset signal 726 is asserted, the Processor disables the output ports, which in turn shut down all high power devices. This is to ensure that the energy stored in the VCC storage capacitance is used only to support the orderly shutdown activities of the system in the case when the AA battery is dead or removed. During shutdown mode a number of conditions are set: (1) key presses no longer generate key board interrupts to the processor, (2) UART activity no longer generates a UART interrupt to the processor, (3) the output ports, 668 and 662 are tri-stated, (4) the LCD is held in unselected and reset state, (5) the backlight is disabled, (6) the vibrator is disabled, (7) the IrDA module is put in shutdown state, (8) the UART is put in shutdown state, and (9) a 150-ohm dummy load is disabled.
  • Since the high reset signal [0248] 556 is asserted by VAA falling below a threshold value (i.e. failure value for VAA) and since the failure of VAA will cause voltage up conversion by module 734 to cease and since all high powered circuits have been shut down and since the back up battery on signal is triggered by VCC failing and since VCC will be maintained for some period of time by storage capacitance, there is a time lag between assertion of the high reset 556 and then assertion of the back up battery on signal 762. In this embodiment, the circuitry and storage capacitance have been configured to provide a lag of at least about 100 ms. This amount of time has been selected as it is sufficient to enable all shut down activities by the processor to be completed prior to assertion of the back up battery on signal 762.
  • The third chip is an open drain reset IC and handles the functions performed by the external power-on [0249] reset generator 742. It monitors the voltage signal 736, VCC. The chip produces an output pulse, or reset pulse, when the VCC voltage level transitions through a programmed threshold voltage level. This reset pulse occurs when transitions are from low to high or from high to low. This reset pulse is routed through an inverter and then to an input of an AND gate.
  • The input to the inverter is normally retained in a high state by a pull up resistor. However, the input to the inverter is brought low when the low level reset pulse output by the chip occurs. A second input to the AND gate is provided by the [0250] low reset signal 726. This is done so as to only pass the pulse on VCC rising but not the pulse on VCC falling. From the AND gate the signal is routed to OR gate 526.
  • [0251] Output port 668 provides UART control signals 758 to the UART circuitry and provides a signal IrDA power down signal 760 to an IrDA module. The UART control signals include a chip selector signal and a shutdown signal. A preferred UART has an SPI™/Microwire™ interface and is capable of supporting RS-232 and IrDA links.
  • The UART supplies data on [0252] line 764 to an inverter 772 and from the inverter 772 to an IrDA transceiver module 780 on line 764′. The IrDA transceiver module then transmits that data through an infrared carrier to a receiver in a second external device (not shown). Data that the IrDA device receives from the second external device through an infrared carrier, is in turn passed to an inverter 774 on line 766′ and the inverter then sends the data on line 766 to the UART.
  • The data transfer rate through this port is fixed at 115.2 Kbit/s. This port complies with the IrDA 1.2 Low Power standard. Whenever external data is received by the IrDA transceiver, a UART interrupt is generated by the UART IC. This interrupt, after passing through an inverter, is fed directly to the third external interrupt input of the processor. [0253]
  • The UART may be placed in a shutdown state to save power. When the UART is in shutdown state, its oscillator is stopped. When the UART is set to be taken out of shutdown state, it takes some time to start up the oscillator, and as such, application software is configured to provide a minimum of 100 ms for the UART to come out of shutdown state before real data is transported using this port. [0254]
  • [0255] Output port 662 also provides an enable quiet mode signal 784 to NAND gate 642 the enable quiet mode signal 784 is used for quiet RF mode control. This signal is asserted high and is used when asserted to disable the EL backlight 806 and the vibrator 46. This signal is asserted during RF reception so that noise from these devices will not interfere with RF reception.
  • The [0256] NAND gate 642 takes signals 784 (enable quiet mode) and 634 (RF receive power) and produces an RF quiet signal 786 and provides it as input to AND gates 792 and 794. As the enable quiet signal 784 and RF receive power signals are both asserted high, the output of the NAND gate is low when both are asserted. The low RF quiet signal 786 disables the high noise devices stated above. It is also connected to VCC using a 150 ohm dummy load. The purpose of this load is to force the up-converter to operate at the 600 kHz nominal switching frequency, instead of any other frequency or burst mode. This helps in reducing noise during RF reception.
  • [0257] Output port 662 provides an output signal (not shown) to a 150 ohm dummy load that may be used to place a load on the AA battery during battery voltage measurement. This load is turned on by providing a high signal to it from the processor IC.
  • [0258] Output port 662 provides an enable LED signal 788 to AND gate 794. The enable signal 788 is the backlight “on” signal and is asserted high. When asserted, this signal causes the backlight to be turned on unless the RF quiet signal is being asserted (i.e. low). AND gate 794 supplies its output 802 as an input to a backlight driver 804 which in turn powers an Electroluminescent (EL) backlight 806 which lights up the LCD device. A high RF quiet signal 786 enables the selection of the backlight while a low RF quiet signal disables the selection of the backlight, while the enable LED signal turns on and off the backlight when enabled. The backlight is controlled in this way because it is high current/high noise device, and it is desirable to disable it during RF reception. When the system is not in an RF reception state, the backlight is enabled regardless of the setting of enable quiet signal 784 because RF receive power signal 634 is low.
  • The Electroluminescent (EL) backlight panel is used to illuminate the LCD in low light level conditions with a green light having about 0.15 ft Lm brightness at 0.75 inches from the output of the LCD display. The EL panel is driven by a DC-AC converter IC that boosts the voltage level. The DC-AC converter with the aid of an inductor to help generate the boosted voltage level and a capacitor for setting the oscillator frequency boosts the voltage from VCC to a signal of about 140 VAC peak-to-peak at about 300 Hz. [0259]
  • [0260] Output port 662 provides and an enable vibrator signal 790 to AND gate 792. The enable vibrator signal 790 is asserted high. When asserted this signal turns the vibrator on unless the RF quiet signal 786 is being asserted (i.e. low). AND gate 792 provides its output 812 as an input to the vibrator device 46. The RF quiet signal 786 enables (logic high) and disables (logic low) the selection of the vibrator, while the enable vibrator signal 790 turns on and off the vibrator when enabled. The vibrator is controlled in this way because it is a high current/high noise device, and it is desirable to disable it during RF reception. When the system is not in RF reception state, the vibrator is enabled regardless of the setting of the enable quiet signal 784 because the RF receive power signal 634 is low.
  • The [0261] vibrator 46 is a DC vibration motor which is used as a secondary alarm device. The preferred motor draws a current of about 60 mA and has a nominal rpm of about 8100. The signal from AND gate 792 is used to control an N-MOSFET transistor switch to supply the VCC signal to the motor.
  • As discussed above, a single processor IC is used in the external communication device while two processor ICs are used in the Implantable Device. In this first preferred embodiment all three of these processors are identical. [0262]
  • As it is preferred that the implantable device have a long implanted life, and as the implantable device of the present embodiment does not use rechargeable batteries, a low-power constraint is imposed on the processor IC. This low power constraint is three-fold: (1) use of low power circuit elements and design, (2) use of electronic modules that are capable of being put into low-power consuming states or non-power consuming states when not needed to perform specific functions, and (3) use of control hardware or software to put the modules in their reduced power states and to pull them out of those states. The result is that the processor IC is designed and controlled to operate at an average power of less than about 30 μW. At a supply voltage of 2.9 Volts, this power consumption turns into an average current of less than about 11 μA. The entire implanted electronic system preferably draws an average of less than about 32 μA. In this embodiment, the processor IC operates with a voltage of between about 2.3 V and 3.6 V. To achieve desired overall power consumption for the implantable device, the processor IC is a custom designed CMOS device using 0.8 micron technology with the physical construction of cell design utilizing small gates, drains, and diffusion regions. [0263]
  • The [0264] core processor 912 design preferred in the present embodiment is a CMOS low power version of the INTEL 8086 processor with a minimized number of logic gates and enhanced timing so as to consume less power. The Core Processor includes ten additional instructions so that it is software compatible with the 80186 processor. It is a multiplexed bus device having the 16 low order address bits, out of a total of 20 address bits, multiplexed with the 16 data lines. De-multiplexing is achieved with on-chip latches so that the low order 16 address lines are available as outputs to the device. The four high order address lines and the bus high enable signal are not multiplexed. As noted above, the processor IC also integrates a number of modules and functions so as to reduce the power consumption as compared to using discrete components for achieving the same functionality.
  • A [0265] SEEPROM interface 914 is provided within the processor IC for exchanging information with an off chip SEEPROM device. A two line interface is used to exchange data with the SEEPROM device and a power line is also supplied from the processor IC to the SEEPROM so that it may be selectively powered so as to reduce power consumption when access to the SEEPROM is not needed. In the present embodiment, the SEEPROM associated with each of the two processor ICs in the implantable device has a capacity of 32 kbytes while the two SEEPROMs used in the external communication device have a capacity of 64 kbytes each. In the present embodiment, the SEEPROM provides periodic acknowledgments when the SEEPROM is interacted with. A SEEPROM control register and a SEEPROM data register are also provided these two registers provide a bit that supplies power to the SEEPROM, a bit that provides an oscillating signal to the SEEPROM, a bit that provides data to be written to the SEEPROM, and a bit that can be read to pickup data that is being supplied by the SEEPROM.
  • The [0266] Boot ROM 916 is an on-chip read only memory that provides the initial boot code for the CPU. The Boot ROM is 1 kbyte metal mask programmable ROM.
  • The address location of the beginning of the [0267] boot ROM 916 is is consistent with the Intel 8086 specification for reset vectors. When reset occurs, the processor begins execution of the code found in ROM which is a program that loads further code from the SEEPROM located off-chip. Further details on execution of the ROM code may be found in the previously referenced U.S. patent application corresponding to Docket No. USP-1075-A.
  • A 16 kbyte section of static RAM (SRAM) [0268] 918 is provided within the ASIC. This space is used for stack, general variables, and core program space such that most of the operational implantable device code and external communication device code reside in this space.
  • The processor IC includes a [0269] memory decoder module 920 that is capable of decoding the 16 kbytes of internal SRAM and is also directly capable of decoding 512 Kbytes of external memory. The memory decoder contains Boolean logic gates to decode the 8086 address space for each individual bus transaction. The amount of externally addressable SRAM may be increased by adding one or more additional bank select triggers such as by using the a processor IC output that is not being used for some other function. For example, in the external device the output signal that is used to fire the pump mechanism may instead be used as a bank select signal as it is otherwise not being used. This provides the ability for the external communication device to be able to decode 1 Mbyte, or more, of external SRAM. The memory decoder is further capable of decoding the 1 Kbyte of internal ROM.
  • A low power [0270] crystal oscillator module 922 internal to the Processor IC is used in conjunction with the an external oscillator crystal and a shunting resistance to provide a stable 1.049100 MHz ±500 Hz clock source while drawing less than about 2 μA from a 2.2 V to 3.5 V supply. The circuit is intended to operate with a minimum frequency of 1.048576 MHz crystal using a shunt resistance of about 20 MΩ in the implantable device and about 2 MΩ in the external communication device. The shunt capacitance of the crystal is preferably no greater than 1.5 pF. An external shunt resistor is provided in parallel to the clock crystal across two external connectors of the ASIC to provide DC feedback to the circuit. The amount of resistance is selected as a balance between oscillation start up and current consumption.
  • The [0271] timer module 924 is composed of the system clock generator and circuits responsible for generating various timing signals. The processor IC uses the (1.048576 MHz ±500 Hz) external crystal to generate the system clocks. Tolerance of the crystal oscillator is be better than ±500 parts per million (ppm) including the drift due to aging, and temperature induced variances within a range of −10° to 50° C.
  • The [0272] Timer Module 924 consists of a (A) system clock generator; (B) a CPU clock module; (C) a pulse stealer; (D) a clock enable register; (E) four independent timers (wake up 1, wake up 2, sleep, and one minute), and (f) a time-of-day timer that can be made to register time in subsecond intervals.
  • The system clock generator module, is a 20 bit ripple counter that has the ability to load a pattern into its lower 14 bits. This counter is used to provide the system clocks necessary for operation of all other modules. In the present embodiment a pulse stealing technique is used to fine tune the oscillation frequency for all clock signals generated by this module that have a frequency of about 8192 Hz or less. [0273]
  • The clock frequency of the CPU (i.e. the frequency of the CPU clock) may be selected and the CPU clock made to stop by writing appropriate values to appropriate CPU clock registers. The frequency select circuit consists of two registers and a synchronizing circuit. The synchronizing circuit is used to ensure that narrow clock signals (i.e. glitches) are avoided when the frequency of the CPU Clock is changed. [0274]
  • A pulse stealer circuit is provided for precise system timing of selected clock signals. In the present embodiment the pulse stealer function is applied to the clock signal that has a frequency that is just slightly more than 8192 Hz target frequency as provided by the system clock generator. The pulse stealer circuit gives the ability to periodically steal pulses from a selected clock signal to produce a clock signal of lower and more desirable average frequency. In the present embodiment the pulse stolen signal, is used to create all system clocks that of lower frequency. In implementing pulse stealing for the present embodiment, the CPU loads a 16 bit value into two eight bit configuration registers. The timer whose signal is to be modified is used to cause a counter to count up from zero to the value loaded into the registers at each time a comparator recognizes a match. After the counter reaches the value specified in the registers, a single pulse is removed from the output signal (stolen from the output signal) to provide the modified output signal. Then the counting begins again from zero and the process is repeated over and over so that a modified output signal, or pulse train, having a desired average frequency is generated. [0275]
  • A clock enable control register is provided so as to allow the CPU to selectively enable or disable the clock signals used by other modules. In the present embodiment these other modules include the first and second synchronous serial ports, the analog-to-digital converter, and the insulin pump charging circuitry. Enablement/disablement for a given module is “bit mapped” to the control register so that the control register may be used to “gate” these clocks on or off. [0276]
  • Four system timers are provided. These timers provide interrupts to the CPU at selected intervals. The internal logic of the first three of these timers is identical with the exception of the input clock frequency and the number of bits to count to before causing an interrupt. The interrupt interval for each timer is programmable by the CPU by writing an appropriate value to an appropriately sized control register associated with each timer. Once an interrupt interval is written into the timer by the CPU, interrupts will be continuously generated by the timer without further intervention of the CPU. The timers continue to “run” independent of when or if the CPU services the interrupts that they create. Thus, interrupts will continue to be “issued” at the same programmed interval, and will stay asserted if not serviced. The act of servicing the interrupt clears the interrupt condition. The CPU clears any pending interrupts by writing to the associated control register. [0277]
  • The first of these timers is the first wake-up timer and it generates a first wakeup signal that based on a 1 Hz input clock frequency and a programmed count value that is to be reached before generating its interrupt signal. Examples of the use of this timer in the present embodiment include Watchdog monitoring and nominal RF reception and transmission start times. [0278]
  • The second of these timers is the second wake-up timer and operates off an 8 Hz input clock frequency and is also programmable to count to a specified value before generating its interrupt signal. Examples of the use of this timer in the present embodiment include various uses within the external communication device, including spinning the pumping status indicator on the display panel, IrDA timing for missing bytes and closing the channel, beeping, and keyboard blink timing. [0279]
  • The third timer is the sleep timer which operates off a 1,024 Hz input clock frequency and is programmable to count to a specified value before generating its interrupt signal. An example of the use of this timer in the present embodiment includes pump stroke charging and recharging. [0280]
  • The fourth timer is a one minute wake up timer and provides an interrupt every 60 seconds based on a 1 Hz input clock frequency. This counter provides two functions: (1) it provides the seconds portion for the time of day, and (2) it interrupts the CPU every 60 seconds. The principal purpose for the CPU writing into this timer is to adjust the software perception of the second number within a minute. The register for this timer does not hold the number to be counted to but instead holds the present count of the counter that continues to increment each second until a count of 60 is reached and then it starts over. Examples of the use of this timer in the present embodiment include counting elapsed minutes, performance of delivery calculations for pump strokes, determination of the present half hour, and one minute RF listening by the external communication device. [0281]
  • In the present embodiment one register bit is controllable to indicate whether RF reception is given priority over the charging of the pump circuit for noise considerations even though there may be some negative impact on power drain resulting from a need to partially recharge the pumping circuitry after a. telemetry interruption. Toward this end, the pump clock itself is disabled whenever an RF receive power signal is asserted and the priority bit is set to give priority to RF reception. On the other hand, when this bit is oppositely set, by software, then the pump clock is allowed to remain on regardless of telemetry activity. As both telemetry operations and pumping operations are current intensive, it may be desirable to avoid both systems operating simultaneous so as to reduce maximum current drain on the battery at any given instant in time. [0282]
  • A [0283] watchdog monitor circuit 928 is provided to ensure that detection and system reset will occur if the CPU ceases to properly execute instructions. To achieve this, the watchdog monitor is configured to assert a system reset signal if an interrupt signal from the first wake-up timer occurs twice without the CPU properly servicing the watchdog monitor. In the present embodiment, the CPU resets the watchdog monitor by two writes into the watchdog monitor. Data for the first write has first pattern and data for the second write has a second pattern that is different from the first pattern. To ensure that the system is operating properly at both the interrupt level and the mainline code level, one of the two values is written by an interrupt routine while the other is written by the mainline code. Writes of values other than the first pattern followed by the second pattern will reset the sequence that the Watchdog is expecting. The reset signal generated by the watchdog is brought out of the ASIC and back to the external reset input of the ASIC.
  • Following a system reset or power-on reset, the watchdog monitor is not active. This allows the CPU time to perform initial configuration and housekeeping. The watchdog is activated, or enabled, as soon as the CPU writes any data pattern to a watchdog monitor register. Once enabled, the watchdog cannot be disabled until another CPU reset occurs. The ROM boot code activates the watchdog early on in its execution but sets the first wake up interval to a time sufficient for system configuration to occur. When the watchdog causes a reset, a piezo signal is put out so that an audio alarm will sound. This piezo signal remains on until the CPU re-activates the Watchdog. [0284]
  • The [0285] RF Module 930 in the processor IC consists of an (A.) RF timer circuit, (B.) a digital RF transmitter section that includes a QFAST® RF modulation transmitter, (C.) an analog receive module, (D.) a digital receive section that includes a QFAST® RF modulation receiver, and (E) a time synchronization section.
  • The RF timer circuit provides clock signals used by the other portions of the telemetry circuitry to provide a carrier signal for transmission, provide a signal for modulating ~the carrier, provide signals for demodulating received signals, and the like. The primary signal timer signal is pulled from the system clock generator module. The generation and shut of the primary RF timer signal is controllable by hardware or software based on values that are written into various registers which enable signal generation when needed and power savings when not needed. The time synchronization module ensures that the concept of time as held by the communication device and as held by the medical device are sufficiently close so as to enable RF communication to occur while maintaining transmission time and listening time of the RF hardware to a minimum. Further details on RF timing synchronization, autonomous and software activation and deactivation of telemetry hardware components are provided in the above referenced U.S. patent application corresponding to Docket No. USP-1077-A. [0286]
  • The telemetry system provides a half-duplex link between the implantable device and the external communication device using a carrier frequency of about 250 kHz and a data signal having a frequency of about 8 kHz. The transmitter hardware uses the 8 kHz data signal to modulate the carrier signal to generate signals that will be transmitted by the antenna. The receive hardware receives the modulated signal and demodulates it to extract the 8 kHz data signal. Both the implantable device and the external communication device have transmit and receive capabilities to allow two-way communication. [0287]
  • Most of the RF telemetry circuits necessary for communication between the external communication device and the implantable device are implemented in the processor IC. In order to minimize the digital noise interference that the processor IC might impart to the weak RF signals that are being received, a high-gain RF amplifier is implemented off-chip. Also as discussed above, an RF antenna, that is used for both transmission and reception, and circuitry to select between reception and transmission are implemented off chip. The remaining analog sections and all the digital demodulation circuits are implemented in the processor IC. [0288]
  • The RF module of the Processor IC outputs transmission signals for transmission by the external antenna. It also provides a power signal to the external amplifier and an RF receive power control signal that is used to switch between a transmission configuration and a reception configuration. Both these signals are controllable by bit values placed into registers so that power consumption may be minimized when component operation is not required. The RF module also receives input signals from the external receiver hardware. [0289]
  • A Quadrature Fast Acquisition Spread Spectrum Technique (QFAST®) is used as the modulation technique. QFAST® modulation is based on an Offset Quadrature Phase Shift Keying (QPSK) modulation technique. In this technique, data generated by the CPU modulates clock signals at the carrier frequency. As a result of quadrature modulation, in-phase and quadrature-phase components of the given data stream are generated. These two components are then applied to opposite ends of the external antenna so that a combined signal is transmitted. [0290]
  • In QFAST®, data rate adaptability is accomplished through a spread-spectrum “coding gain” concept, with the spreading code being a simple clock. The modulation produced by the QFAST® modulator can be demodulated in a manner which delivers both clock and data. All of the QFAST® modulation and demodulation circuits are digital and are incorporated into the processor IC. [0291]
  • The QFAST® technique provides a communication system with the following attributes: (1) it extracts the clock from the received signal without a clock recovery loop; (2) it provides demodulation of data without phase ambiguity and without the requirement for synchronous demodulation; (3) it makes effective use of the available transmission bandwidth, (4) it results in fast acquisition of the message signal; (5) it is relatively immune to the effects of highly dispersive and distorting propagation media; (6) it does not require regeneration of a phase-coherent local replica at the receiver of the transmitted carrier; (7) it does not require resolution of ambiguity between the in-phase and quadrature-phase channels in the receiver; and (8) it does not exhibit data phase ambiguity. [0292]
  • The transmitter section of the telemetry system receives byte wide parallel data packets from the CPU and then loads the data into a parallel-to-serial shift register. The serial data is then sent to the QFAST® RF modulation transmitter section to modulate two quadrature clock signal components each operating with a carrier frequency of about 2[0293] 18 Hz) and shifted in phase relative to each other by 90 degrees. The two components are then delivered to opposite ends of the antenna. As long as there is data in the transmitter parallel-to-serial shift register, the RF transmitter remains activated. If the transmitter doesn't have data available when the next byte is to be transmitted the message is considered to have been completely transmitted and the CPU shuts off the transmitter circuitry so as to minimize continued power drain.
  • External to the processor IC, the received RF signal is amplified by a high gain receive amplifier. A bandpass filter is used to attenuate out-of-band components such as those due to AM radio stations. The amplified RF signal then enters a mixer in the RF module of the processor IC and is converted to baseband using a two mixers, one in-phase mixer and one quadrature mixer both at the carrier frequency. The mixer outputs are the quadrature components of the baseband signals. An integrator & dump function in the RF module then removes the sum frequency (2 fc) and high frequency noise (i.e. acting as a low pass filter) from each of the two signal components. The processed signals are then digitized using a comparator and passed to the demodulator where the data and clock are recovered. [0294]
  • Further detail about QFAST® (Quadrature Fast Acquisition Spread Spectrum Technique) may be found in U.S. Pat. No. 5,559,828, entitled Transmitted Reference Spread Spectrum Communication Using a Single Carrier with Two Mutually Orthogonal Modulated Basis Vectors, by Armstrong, et al. [0295]
  • The ASIC also includes an interrupt [0296] handler 932. There are nine interrupt sources. All interrupts except one are maskable. The only non-maskable interrupt is generated by the memory decoder as a result of an invalid address detection. The interrupt handler module consists of a capture module for capturing interrupt conditions, a handling module, and a priority encoder module. Three of the nine interrupts may be used for external as well as internal interrupt sources, as for example by the external communication device.
  • The capture module is used to capture the occurrence of an interruptible event. This module contains two sets of registers: an enable control register (under CPU control), and (2) the capture register. The enable control register is bit mapped to each of the possible interrupt inputs. If the bit corresponding to an interrupt in this register is high the interrupt is enabled and can cause the interrupt signal to the CPU to be asserted. When enabled, an interrupt condition signal sets a bit in the capture register and a corresponding interrupt signal is asserted. The bits in the Capture Register are de-asserted only by a system reset or individually when a corresponding signal is asserted. The interrupt signals are passed to the interrupt processor module and combined with respect to priority to provide a single interrupt to the 8086 CPU delivered on the CPU's interrupt input line. [0297]
  • The handling module provides the necessary logic to accommodate the [0298] 8086 double interrupt acknowledge cycle as well as daisy chaining the interrupt signals to provide a priority for the highest level of interrupt in cases where multiple interrupts are pending simultaneously. When multiple interrupts are pending, the highest is serviced first. This is accomplished by asserting the output signal corresponding to the highest pending interrupt during the second CPU interrupt acknowledge cycle. This signal serves two purposes. First it is fed back to the capture module to clear the pending interrupt and second it is sent to the priority encoder module for encoding the interrupt vector.
  • Only one of the inputs to the priority encoder module is asserted at a time. This module encodes the interrupt level number of the asserted input and generates the appropriate interrupt vector value. [0299]
  • An analog-to-digital converter [0300] 934 (A/D) and associated signal multiplexer system are provided to sample analog signals. The analog signals for the implantable device include (1) battery voltage, and (2) the charge pump voltage. The analog multiplexer is used to select the analog input signal that is to be provided to the A/D. An amplifier is used following the MUX to provide signal conditioning for the input signals. Bits are provided in a control register for selecting the MUX channels, for enabling the MUX, for enabling the amplifier, enabling the analog to digital converter, providing a conversion status indication, providing a begin conversion signal, and for supplying a clock signal to the A/D converter.
  • The LCD Clock Driver consists of two input clocks (e.g. about 64 kHz (e.g. 216 Hz) and about 32 kHz (e.g. 215 Hz)), a MUX to select between them and a bit and an AND gate to gate the clock on and off. [0301]
  • The Processor IC has an alarm driver and [0302] interface 938 that offers direct control of a piezo buzzer alarm. The processor IC drives the alarm through a 2-wire interface. Software may be used to select one out of 128 frequencies ranging from about 64 Hz to about 8192 Hz. The tone duration and volume are also under software control. In the dual-processor implantable device, the monitor processor controls the buzzer. The piezo buzzer logic consists of a register, a counter, and compare functionality to provide a variable frequency to the piezo buzzer. The value in the register is compared to the value in the counter. Each time the values are equal the driving signal toggles to the next programmed signal. Additional logic circuitry is provided to allow volume control for the piezo buzzer. The outputs of each line are used externally as differential signals to the piezo buzzer. Thus with this scheme, the piezo can sound different frequencies and the volume of the piezo buzzer can be controlled.
  • After a processor IC reset, the piezo is driven at about 1024 Hz. This signal is gated with the output of a register bit that is under control of the CPU. The piezo signal is inhibited by this gate when the CPU writes into the watchdog enable register. [0303]
  • The Processor IC has two Synchronous Serial Interface (SSI) [0304] ports 944 and 942. Each interface provides full duplex serial communication ports that operate at about 500 kHz. One of these ports is used for inter-processor communication in the dual processor implantable device. In the external communication device, one port is used for IR based serial communications and the other is used as an interface for the LCD display panel. Each interface port supplies both data and clock. The clock driving the SSI may be enabled or disabled, thus controlling power consumption when the SSI is not needed. A control register is used to turn ON/OFF the SSI.
  • The RF communication between the implantable device and the external communication device occurs in the form of messages (sometimes referred to as communication signals or packets) that are passed back and forth between the two devices. In this embodiment these messages have a multi-part format or protocol: (1) preamble, (2) frame sync, (3) telemetry identifier, and (4) data. [0305]
  • For communications from the implantable device to the external communication device the preamble is a repeating pattern of “10”, i.e. 10101010. This alternating pattern of ones and zeros is broadcast for 8-bit times. This pattern is considered the standard preamble pattern. [0306]
  • For communications from the external communication device to the implantable device, the preamble is either of the standard preamble pattern but applied for an extended number of bit times (e.g. 24, 48, or 96) or is of an attention preamble pattern that is applied for, typically, even a longer extended number of bit times. The attention preamble pattern is formed of a repeated pattern of “110110 . . . 110”. In other embodiments, other attention preamble patterns may be used (e.g. repetitions of “011”, “100”, “001, “1011”, and the like). [0307]
  • The preamble, whether of the standard pattern or the attention pattern, is used so that the RF reception hardware can establish bit synchronization (i.e. bit boundary recognition) of the incoming data. However, the attention preamble is further used to get and hold the receiver's attention for a defined period of time. As long as the attention preamble is being received, the receiver's hardware will stay on and continue tracking the signal in anticipation of an incoming message. [0308]
  • The attention preamble is considered to be lost, or no longer being received, when the receiver receives more than 2 inappropriate bit values during receipt of any 64-bits or when the frame sync pattern is received. [0309]
  • The attention preamble may be used when there is some uncertainty in the time synchronization of the two devices. The extra length of the attention preamble allows the receiver's reception window to open a little latter than anticipated and to still have the receiver pick up the entire message. The extra length of the attention preamble allows the receiver's reception window to open earlier than anticipated, so long as a minimum number of bits are heard by the receiver during the time its reception window is normally open, and still have the receiver's attention locked onto the preamble and have the receiver remain on as long as the attention preamble is being received, plus a little more, in anticipation of receiving a frame sync pattern. [0310]
  • In the present embodiment, frame sync may actually be considered byte sync (i.e. frames are bytes) and is a single byte of a selected pattern and is used so the receiver can obtain byte boundaries for the transmitted data. In the present embodiment, the selected pattern is “10110000 [0311]
  • This comparison process continues so long as the receiver continues to listen for an incoming message or until a valid frame sync pattern has been received. If the receiver is continuing to listen beyond its normal reception window (i.e. listening period), due to the reception of an attention preamble, the listening will not stop immediately upon the attention preamble being lost. The comparison process for ascertaining the receipt of frame sync continues for a number of bits after attention preamble is lost, even if the listening period has ended, as its loss may be associated with the partial receipt of frame sync. Once frame sync is received a valid frame sync signal is asserted. [0312]
  • In the present embodiment, the telemetry identifier (i.e. telemetry ID) is a 3-byte value that is used to ensure that only the intended receiver receives a message. The value of all “1s” indicates a universal message that is to be received by all receivers, otherwise the telemetry ID must be agreed upon between the receiver and transmitter. A unique ID is provided for each implantable device and each external communication device during manufacturing. Only the external communication device can transmit a message using the universal ID code. The telemetry IDs that the receiver will consider to be valid are the ID of the receiver or the universal ID. All other incoming bit patterns will be rejected with the result that the receiver will be either turned off or will start again looking for a valid frame sync pattern attention preamble. [0313]
  • If a valid telemetry ID is received, the receiver listens to the remaining portion of the message. [0314]
  • In the present embodiment, data is provided in an integer number of bytes following the telemetry ID. In the present embodiment the first byte of the data indicates the message type. The first seven bits of the first byte is an operation code or op-code while the eighth bit is either ignored or is set and interpreted as a sequence number (to be discussed hereafter) dependent on whether or not the first seven bits call for a sequence number or not. Each op-code, based on its nature, is followed by data in a defined number of bytes. The specific op-code itself may dictate the number of bytes that follow or alternatively the specific op-code may dictate that the number of bytes to follow may be extracted from the first byte or several bytes of information that follow it. In alternative embodiments, op-codes may have a different length, or not be used at all, the message length or message end may be dictated in other ways. Based on the op-code and potentially one or more bytes following it, the receiver knows exactly how many more bytes of data to listen for. After receiving those bytes, the receiver may be turned off to conserve power. [0315]
  • For some messages dealing with drug delivery, the data portion of the message may include a bolus number. The bolus number is similar to the sequence number in that it is incremented by both the implantable device and external communication device under controlled conditions so as to reduce the possibility of bolus requests being delivered more than once when duplicate requests may be made as a result of the external communication device failing to receive a confirmation that a previous request was received. The bolus number may be a single bit number in some embodiments but in more preferred embodiments it is a multibit number (e.g. 2-bit, 4-bit, 7-bit, 1-byte, or 2-bytes) so that it can take on more than two values thereby making it less likely that an error will escape detection due to received and expected numbers erroneously matching. The incrementing of the bolus number may occur within the external communication device when it receives confirmation that a message was correctly received and it may be incremented by the implantable device when it correctly receives a bolus request. As such when a duplicate request for a bolus is received by the implantable device it can recognize that the expected and received bolus numbers do not match and that requested bolus is not a new request. As such the implantable device can respond to the repeated request that the bolus was correctly received and delivered (with out performing a second delivery and without incrementing its expectation of what the next bolus number will be). [0316]
  • In the present embodiment, the data portion of the message ends with a one or 2-byte validation or error checking code (its type is dictated by the op-code included with the message). The preferred error checking code of this embodiment is in the form of a cyclic redundancy code (CRC). [0317]
  • In the present embodiment, the telemetry system may loose bit synchronization if insufficient bit transitions are received per unit time (e.g. if more than about 100 to 120-bit times lapse without receiving a transition. In order to ensure that a sufficient number of bit transitions occur, the data portion of the message, with the exception of the op-code is randomized prior to transmission and is de-randomized upon receipt. [0318]
  • In order to keep power requirements low in a preferred implementation, the external communication device and implantable device attempt to maintain a common time base, transmissions are set to start at specified times, and reception windows are set for specified times and lengths. In this way, the receiver may remain in a powered down mode most of the time and can turn on to listen for a potential incoming message at the specified times for the specified lengths of time. If a message is found to be incoming, the receiver stays on, otherwise it goes back to sleep (i.e. power down mode). [0319]
  • In the present embodiment time synchronization for telemetry communication is maintained using two techniques. The first technique periodically determines the present difference in the concept of time (e.g. second boundaries) as held by the communication device and medical device and the difference is used to reestablish synchronization of the timers. In the present embodiment, reestablishment occurs on the part of the communication device each time it receives a valid communication from the medical device. [0320]
  • The second technique determines a rate of drift that has occurred between the concept of time held by the communication device and that of the medical device. The determined rate of drift is used in combination with a determined lapse in time to estimate how much drift has occurred. This amount of drift is then used in shifting a listening start time or transmission start time of a first one of the devices to match what is believed to be the potential transmission period or listening period of a second one of the devices. [0321]
  • In the present embodiment, software may be downloaded from the external communication device to the implantable device. The downloading of software may include the downloading of executable software as well as the downloading of data structures that may be used by the executable software. [0322]
  • In the present embodiment, a specific external communication device is configured/programmed to communicate substantively with only one specific implantable device, that is in turn configured/programmed to communicate substantively with only the same specific external communication device. An external communication device is capable of retaining the telemetry ID of exactly one implantable device at a time and an implantable device is capable of retaining the telemetry ID of exactly one external communication device at a time. A small amount of non-substantive communication (i.e. communication that does not impact insulin delivery) can occur between external communication devices and implantable devices that are not linked (i.e. partnered or married) to one another (i.e. provided with each others telemetry IDs). [0323]
  • In the present embodiment, many different types of messages and responses thereto can be written into the programs that control the implantable device and the external communication device according to the guidelines set forth above. These messages may be used for a number of different purposes. For example, (1) they may be system level messages that are used for testing devices, for resetting devices, or for establishing relationships between implantable devices and external communication devices, (2) they may be alarm messages that are used to convey alarm conditions or to clear alarm conditions, (3) they may be miscellaneous messages that set various parameters or perform various read operations, (4) they may be delivery messages that set delivery amounts, read delivery status, or set parameters such as concentration and pump stroke volume that may be required to appropriately control delivery of the drug, (5) they may be data log messages that set data log boundaries, read boundaries, or clear data logs, boundaries or read information from various data logs or supply information to those data logs, (5) they may be refill messages that are related to amounts of material that are added to the reservoir periodically, (7) they may be compound messages that perform more than one function, or (8) they may be error messages that request error condition status or supply error condition status. [0324]
  • Additional preferred features and aspects of a telemetry system are provided in previously the referenced U.S. patent applications that correspond to Docket Nos. USP-1076-A, USP-1077-A, and USP-1079-A. [0325]
  • The External Communication Device (CD or ECD) is a hand-held device that is used to program and communicate with an Implantable Device (ID). The External Communication Device, of the present embodiment, includes the hardware features discussed herein above. The CD hardware and CD software work together to provide the desired functionality for the system. [0326]
  • The hardware includes a display with an icon region and a dot matrix region, a backlight for the display, a five-button keypad (one button is hidden), an alarm, a vibrator, and an IR device for serial communications with a second external device. The CD software is menu-driven. The device operates from a replaceable 1.5 Volt M battery. There is a backup battery that retains memory while the replaceable battery is removed. [0327]
  • The dot matrix region is used to display the majority of the information that is provided to the user. This region, however, consumes more battery power than the icon region, as such when the external communication device is idle, the dot-matrix region is powered down to conserve energy. If the dot-matrix region is powered down, it is powered back on once a key is pressed. [0328]
  • The various main menu options provided to the user in this embodiment are depicted in the block diagram of FIGS. 7[0329] a and 7 b. Various set up menu options accessible from the pump setup menu display of FIGS. 7a and 7 b are depicted in the block diagram of FIGS. 8a and 8 b. Various pump set Up II menu options accessible from the pump setup II display of FIGS. 8a and 8 b are depicted in the block diagram of FIGS. 9a and 9 b. Various supervisor functions/options that are accessible from the Supervisor display of FIGS. 7a and 7 b are depicted in the block diagram of FIGS. 10a and 10 b. The bolus delivery sequence of FIGS. 7a and 7 b is further detailed in the block diagram of FIG. 11. The communications sequence of FIGS. 7a and 7 b is further detailed in FIG. 12. In these Figures the ACT and SEL indications depict the keystroke necessary to change from one display to the next. The up-arrow symbol and down-arrow symbols indicate that parameter values within the menu display may be modified by pressing the UP key or the Down key.
  • One of the icons included in the icon region is the low-battery icon [0330] 858 (FIG. 5) which is displayed when there is a low or depleted main or backup battery. Another icon is the bell icon 860 (FIG. 5) which is turned on by the CD software when the external communication device receives a telemetry message from the implantable device indicating that the implantable device has detected one or more for the following: (1) implantable device inter-processor communications failure, (2) under-delivery, (3) over-delivery, (4) charge time too long, (5) post-fire voltage too high, (6) low implantable device battery, and (7) depleted implantable device battery. The bell icon is cleared by CD software when all alarm conditions above have been cleared. The bell icon is displayed when the external communication device is showing the ‘time and alarm’ screen.
  • Another icon is the reservoir level indicator icon [0331] 862 (FIG. 5). It is composed of 4 segments that provide a graphical indication as to the level of insulin in the implantable device reservoir. The CD software maintains an estimate of the implantable device reservoir level. The estimate is based on the refill amount indicated at the time of the latest refill which is decremented by an estimate of the insulin that has been delivered each day. The estimate of insulin delivered each day is derived from the daily total log that records the number of pump strokes delivered each day. All segments of the reservoir level icon are set when the pump is refilled. The top-most segment of the reservoir level icon is cleared when the external communication device estimates that the reservoir is less than 75% full. The top two segments of the reservoir level icon are cleared when the external communication device estimates that the reservoir is less than 50% full. The top three segments of the reservoir level icon are cleared when the external communication device estimates that the reservoir is less than 25% full. All segments of the reservoir level icon are cleared when the external communication device estimates that the reservoir is empty. Of course, in alternative embodiments a greater number, or lesser number of indicators may be used to convey the reservoir level. The last icon could be cleared when the reservoir level is not empty but instead has reached a predefined “low level”. Alternatively, one or more of the elements could be controlled to blink when a low or empty reservoir condition exists.
  • Another icon is the Insulin Delivery Icon [0332] 864 (FIG. 5). This icon provides a rotating display when the external communication device estimates that insulin delivery is in progress. The icon includes four elements each forming a quarter of a pie shape. The rotational appearance is provided by the CD software displaying alternating patterns that change every four seconds. When the external communication device is simulating the delivery of a bolus, the pattern includes three delivery segments on, and one off. When the external communication device is simulating the delivery of a basal rate, the pattern includes one delivery segment on, three segments off. When the external communication device is simulating no insulin delivery, all four segments are on and as such, the rotational appearance is removed.
  • Four keys on the external communication device are provided with raised pads and provide tactile responsiveness when depressed. These four keys are labeled SEL, ACT, UP, and DOWN. Some general rules apply to the use of these keys: (1) A SEL key press moves the current screen option to the next screen option and does not change any parameter value, (2) Parameters that blink on the screen change by depressing the UP or DOWN key one or more times or by holding down one of these keys, thereby causing accelerated scrolling to occur, (3) Once parameters are set to the desired value, they are accepted by depressing the ACT key. A valid ACT keystroke is accompanied by a predefined ACT tone that is sounded by the alarm buzzer. When the ACT key triggers a telemetry message to be sent to the implantable device, upon completion of all telemetry transactions, the external communication device emits a second ACT tone to indicate that telemetry is complete. [0333]
  • The backlight is activated by pressing the DOWN key from the ‘Time and Message’ screen or the ‘time & alarm’ screen. The backlight is programmed to remain on for a selected period of time that may vary (e.g. [0334] 4 to 15 seconds) depending on the screen that is being displayed and/or the keys that have been pressed. For example, preprogrammed time is 4 seconds following the display of the ‘time and message’ screen, the ‘self test results’ screen, and the ‘24 hour basal total’ screen. The timer controlling automatic shut off is reset each time a key is pressed or held down so that the timing out of the backlight may be held off.
  • The external communication device includes two SEEPROMs, one is used to hold CD software and data and the other may contain an image of the implantable device software. A third SEEPROM may be loaded into the external communication device for providing updated calibration parameters and the like. [0335]
  • The external communication device uses the power management hardware to determine the battery voltage level for the main battery and for the backup battery. [0336]
  • The external communication device includes A/D hardware that is used in conjunction with CD software to read the main battery level every hour, and to read the backup battery level every day at noon. The CD software checks the main low battery bit /signal [0337] 724 (FIG. 4b) in the hardware every hour to detect a dead battery.
  • Upon battery removal, the external communication device writes data from internal RAM to external RAM to prepare for the hardware to put the microprocessor in the reset state. The data written from internal to external RAM includes parameters and data that are necessary for the external communication device to recover when the battery is replaced. This data is termed “external communication device recovery data.” When the batteries are removed, the CD software powers down the LCD so that the screen goes blank and power is conserved for completion of the writing operation. The CD software also computes a 16-bit RAM sum of the external communication device recovery data, and stores the RAM sum and its arithmetic inverse in external RAM. When the battery is replaced, external communication device performs boot up operations as described herein later. [0338]
  • The external communication device communicates with the implantable device through messages passed by a RF telemetry link. When the external communication device attempts to change parameters in the implantable device, the external communication device does not consider the parameter values to have been changed un less it receives the appropriate telemetry response message from the implantable device. The CD software verifies the CRC of all the telemetry messages that are received. If the calculated CRC does not match the CRC in the telemetry message, the external communication device updates a counter and otherwise ignores the receipt of the message. The CD software ignores all messages that were transmitted with the universal ID. [0339]
  • When transmitting most messages, sequence numbers are used. The sequence number provides a means to recover when the external communication device does not receive a telemetry response from the implantable device. When the external communication device sends a telemetry message and is expecting a response, if the response is not received, the external communication device has no way of knowing if the implantable device received the message and the external communication device missed the response, or if the implantable device simply missed the message. The sequence number provides a means for the implantable device to know whether or not it has already received a message and thus whether or not it should act on a message. When the external communication device resends a message (as it did not get a response from the previous message), the external communication device uses the same sequence number it used when it initially sent the message. If the implantable device received the previous message, the implantable device knows not to duplicate its actions because the sequence number in the current message is the same as the sequence number in the previous message. In response to the resent message, the implantable device resends its response packet using the same sequence number. This mechanism allows for the retransmission of a telemetry message without the implantable device acting on the message more than once. [0340]
  • The external communication device uses the sequence number parameter in the sync response telemetry message as the sequence number for the next telemetry message. The external communication device uses the sequence number parameter in the interrogate response telemetry message as the sequence number for the next telemetry message after the user has confirmed the patient ID by pressing ACT on the ‘confirm implantable device serial number’ screen. [0341]
  • When the external communication device receives a valid response to a telemetry message, unless the response is an error message, the external communication device changes the sequence number. In the present embodiment the sequence number is a single bit and as such can take on the values of “1” or “0”. When the Sequence Number is 0, it is changed to 1. Similarly, if the Sequence Number is 1, it is changed to 0. [0342]
  • The external communication device transmits to the implantable device on inbound time slots. The external communication device enables the RF receiver every minute on the outbound time slot (e.g. on the second boundary after the minute boundary). Following the transmission of a telemetry packet, the CD software in the external communication device may enable the RF receiver on the one-second boundary and may use a listening window size that is proportional to the length of the transmitted preamble. Alternatively, the CD software may simply enable the receiver and force it on for a time that is sufficient to capture an outbound response. The RF timing system on the external communication device is configured to synchronize its concept of seconds and subseconds to those of the implantable device time upon receipt of each telemetry packet if the calculated CRC matches the CRC in the telemetry message, and the telemetry message is a valid response to an external communication device message or a valid unsolicited message. [0343]
  • When the time between receptions is greater than 4 minutes and less than 240 minutes, the external communication device computes a value for a one-minute RF drift variable and enters RF drift mode. If the time between receptions is not in this range, the external communication device enters preamble mode. [0344]
  • When the external communication device is in RF drift mode, the CD software updates a register, known as register B, by using a running RF drift value. The register B value may also be updated based on a predefined value or based on the length of the preamble so as to start transmission a desired amount of time prior to when the external communication device believes the implantable device will open its reception window. For example, the desired amount of time may be from zero to up to one half the preamble length or more. The running RF drift value is initialized to zero or some other nominal value when drift mode is entered. When the external communication device is in RF drift mode, the running RF drift value is incremented by a one-minute drift value each minute. The one-minute drift value is obtained by consideration of the time between the previous two communications and the amount of drift that was detected upon receipt of the latest transmission. When operating in RF drift mode, the external communication device uses a preamble of [0345] 6 bytes. Further detail about register B and how the information in it is used to set reception times and transmission times is provided in previously referenced U.S. patent application No. (Docket No. USP-1077-A)
  • If after the increment, the running RF drift value is out of range, the external communication device enters attention mode. When in attention mode, the external communication device transmits using a two-second preamble of the attention pattern and initiates transmission using the maximum B Register value. This use of the maximum value in the B register is selected in hope of missing the reception window of the implantable device when the transmission is first initiated and in the hope of catching the attention of the implantable device closer to the end of the transmission, thus minimizing the time that the implantable device's reception system is forced to remain powered up. [0346]
  • When the external communication device is in preamble mode, the CD software maintains a running number of preamble bytes variable. This variable is initially set to a desired minimum value (e.g. 4, 6, or 8 bytes) and is incremented by a desired incremental value (e.g. 1-4 byte) each minute since the last communication occurred and is transmitted using the attention preamble pattern. When the external communication device is in preamble mode, the external communication device sets the register B value so that the preamble is centered on the telemetry second boundary as determined by the external communication device. When in the preamble mode, and when the running number of preamble bytes exceeds a predefined maximum value (e.g. 256-512 bytes), the external communication device enters attention mode. [0347]
  • In alternative embodiments, other decision-making processes may be used to select between the use of preamble mode, RF drift mode or attention mode. In fact, other modes may be defined such as a combined preamble and drift mode that widens the preamble length as time passes since the previous communication and also uses a drift rate to reposition the transmission window to keep it targeted to what the external communication device believes is the most likely position of the reception window on the implantable device. [0348]
  • The external communication device initiates communication with the implantable device by sending a telemetry message. If there is no response from the implantable device within a predefined time that is set by the CD software, or if the CRC of the received message does not match the CRC as calculated by the CD software, the CD software causes the packet to be resent. The CD software sets the preamble of this second packet to be twice as long as that used by the former packet but no longer than two seconds. The second message may be termed a retry packet. If the retry packet fails, the CD software initiates another retry but this time using a two-second preamble. If the external communication device does not receive a response to the second retry message, or if the response CRC does not match the calculated CRC, the CD software reports a no response error. [0349]
  • When the no response error is acknowledged by the user, the CD software sets aside the original message and a sync message is prepared and sent using an attention preamble that spans the gap that is believed to exist between successive reception windows (e.g. 2 seconds). If a response is still not received, the CD software may automatically (and without user notification) resend the sync message again up to a predefined number of times (e.g. 0-3 times). If a response has not been received, the no response error is again displayed. This process is repeated each time the error is cleared. [0350]
  • If a valid response is eventually received, and if the message was not an insulin delivery request, the CD software then retransmits the original message using a sequence number as provided in the sync response message. If the original message was for an insulin request, the user may check the delivery logs that were updated in conjunction with the last sync response message to determine whether or not the previous delivery was acted upon and thus whether or not it is appropriate to prepare a new delivery request. [0351]
  • If no valid response is received, the external communication device is locked out from performing any other operations other than continued attempts to reestablish communication. After taking appropriate steps to increase the likelihood of a successful communication without success, the user may elect to reset the external communication device and program it to send an interrogate message which will initially be sent with a preamble that spans the entire period between successive reception windows that exist when the implantable device is in normal mode. If this fails to achieve communication, the CD software automatically, and without user notification, resends the interrogate message using a preamble that spans the entire period between successive reception windows when the implantable device is in storage mode. [0352]
  • When telemetry is initiated by the external communication device, the CD software controls the external communication device to display the “transmitting to implantable device” screen so as to present the user with a positive visual feedback that the external communication device is attempting to communicate the required telemetry commands. [0353]
  • If a response is received from the implantable device, the acceptability of the response is verified by CD software. If the response is incorrect, or the response is not detected, the above noted no response error is asserted after making the multiple initial attempts to establish communication. [0354]
  • The external communication device recognizes a number of different types of alarms and conditions. The various alarms and conditions are defined with an alarm description, siren, alarm origin, and a display definition for three message areas on the dot matrix portion of the display. The siren indicates whether a yellow (Y) or blue (B) siren will be used when the alarm is active. The alarm origin indicates if the alarm is generated from a condition associated with the external communication device or with the implantable device. An alarm code is specified for a number of the potential alarm conditions. This is a unique number for each alarm condition and is used to identify the alarm in the error log and on the display. [0355]
  • When the CD software recognizes an alarm condition originating from the implantable device (received through telemetry), the CD software activates a siren and displays a message on the dot matrix display. The message is displayed on the ‘time & alarm’ screen and the siren is initiated immediately. The CD software cancels any active user interactions. When the alarm is acknowledged by the user, (e.g. by pressing the SEL key followed by the ACT key), the CD software prepares a telemetry message to clear the active implantable device alarm and to request an update of the error log. If multiple alarms are present, they are presented one at a time in prioritized order and each one may be acknowledged, cleared, and the log updated according to the above noted process. After clearing the alarms, the processing that was in progress when the alarm conditions are asserted is allowed to continue in most cases. In alternative embodiments, multiple alarm conditions may be displayed simultaneously and cleared simultaneously, or they may reviewed in turn and then cleared simultaneously. [0356]
  • The purpose of alarm conditions is to get the user's attention as soon as possible under most conditions. Exceptions are stop pump, suspend pump, and implantable device auto off as these conditions are system states that are cleared when the user presses SEL and ACT. As the system generally attempts to initiate alarm conditions on the external communication device first to save power in the implantable device, since telemetry transmissions are less power consumptive than buzzer activations, minimizing the duration of the alarm condition on the external communication device result in reducing the possibility of the Implantable Device alarming internally. [0357]
  • Reassertion of implantable device alarms are dependent on the alarm condition not being removed (i.e. the condition has not been cleared though its existence was previously acknowledged) by the time reassertion is to occur and on the implantable device communicating the error to the external communication device. Reassertion results in the alarm condition again being displayed on the LCD and the siren being activated and requiring that the use acknowledge the alarm. [0358]
  • The CD software handles external communication device alarms in much the same manner that it handles implantable device alarm conditions with the exception that telemetry packets need not be prepared and sent to acknowledge the alarm conditions. Reassertion of external communication device alarm conditions is similar to that for reassertion of Implantable Device alarm conditions in that they also result in a new alarm condition on the external communication device which the user must acknowledge. The exceptions to this rule are temporary basal rate, delivering diagnostic rate, and delivering priming bolus which are system states that require the external communication device to beep periodically. The following Table depicts the various alarm conditions that are recognized in the present embodiment in order of priority. [0359]
    Alarm Conditions
    P Alarm Description O S Messages 0-1 M2AC
    1 MAIN_BATTERY_DEPLETED CD Y CD - DEPLETED BATT
    2 MAIN_BATTERY_LOW CD Y CD - LOW BATTERY
    3 BACK_UP_BATTERY_LOW CD Y CD - NEEDS SERVICE
    4 NO_RESPONSE_EVENT CD Y TELEMETRY - COMM ERROR 3
    5 ID_DEAD_BATTERY ID Y PUMP STOPPED 6
    6 ID_EMPTY_RESERVOIR ID Y EMPTY - RESERVOIR
    7 ID_OVER_DELIVERY_ERROR_BIT ID Y PUMP STOPPED 4
    8 ID_UNDER_DELIVERY_ERROR ID Y PUMP STOPPED 5
    9 ID_IP_COMM_ERROR ID Y PUMP STOPPED 1
    10 ID_CHARGE_TIME_TOO_LONG ID Y PUMP STOPPED 2
    11 ID_POST_FIRE_VOLTAGE_TOO_HIGH ID Y PUMP STOPPED 3
    12 ID_AUTO_OFF_INTERVAL_EXCEEDED ID Y AUTO OFF - PUMP SUSPENDED
    13 ID_LOW_RESERVOIR ID Y LOW - RESERVOIR
    14 ID_LOW_BATTERY ID Y PUMP - LOW BATTERY
    15 APPLICATION_VERSION_ERROR_EVENT CD Y PUMP - ERROR 0
    16 TELEMETRY_VERSION_ERROR EVENT CD Y PUMP - ERROR 1
    17 INVALID CONCENTRATION CD Y PUMP - ERROR 40
    18 INVALID STROKE VOLUME CD Y PUMP - ERROR 41
    19 EXCLUSION_LIST_FULL CD Y TELEMETRY - COMM ERROR 20
    20 STOP_PUMP_ALARM CD B PUMP STOPPED
    21 SUSPEND_ALARM CD B PUMP SUSP ENDED
    22 DOWNLOAD COMPLETE CD Y DOWNLOAD - COMPLETE
    23 DOWNLOAD_FAILURE CD Y TELEMETRY - COMM ERROR 27
    24 UNINITIALIZED_CD_EVENT CD Y CD - NOT INITIALIZED
    25 ID_RESET_TO_DEFAULTS CD Y PUMP - RESET
    26 CHECK_PUMP_STATUS CD Y CHECK - PUMP STATUS
    27 HOURLY_MAXIMUM_EVENT CD Y HOURLY MAX - EXCEEDED
    27 ID_INITIALIZED CD Y PUMP - INITIALIZED
    29 ID_SELF_TEST_ERROR CD Y PUMP - SELF TEST FAIL
    30 AUTO_OFF_ALARM CD Y AUTO OFF - IN 5 MIN
  • When the text in Messages 0-1 do uniquely define an alarm condition, an Alarm Code is additionally displayed as a numeral that indicates the specific cause of the alarm condition. [0360]
  • The CD software records all external communication device alarms in the external communication device system events log. [0361]
  • If the low battery voltage signal is active, the CD software initiates a CD battery low alarm. A low battery message will persist on the “Time and Message’ screen until the battery has been replaced. In alternative embodiments, instead of constantly displaying this condition and thus keeping the dot matrix powered continuously, the existence of this condition may only be displayed for limited times. For example, it may be displayed when the user first interacts with the device after a time out period, or it may also be displayed after various commands are given. If the external communication device is not recognizing a dead battery condition, the CD software initiates a low battery condition check every hour. When the low battery condition is detected, the CD software logs the event. [0362]
  • If the dead battery voltage signal is active, the CD software initiates a CD Main Battery Depleted alarm. The CD software causes a depleted battery message to persist on the “Time and Message’ screen until the battery is replaced. When the depleted main battery condition is detected, the CD software logs the event. [0363]
  • The CD software causes the voltage of the backup battery to be checked every day. If the battery voltage is too low, then the external communication device needs to be refurbished. The CD software also checks for the depleted backup battery condition every day. When the depleted backup battery condition is detected, the CD software causes the depleted backup battery message to be displayed on the ‘time and message’ screen and logs the event. Though the user may clear the alarm, the depleted backup battery message continues to be displayed on the ‘Time and Message’ screen until refurbishing occurs. [0364]
  • When an alarm is displayed, the external communication device ‘Time and Alarm’ screen is active, and the user must clear the display. In the present embodiment, this is accomplished by pressing the SEL key and then the ACT key for alarms generated by the external communication device. This is initiated by pressing the SEL key and then the ACT key for alarms generated by the Implantable Device. [0365]
  • When an implantable device alarm is cleared by the user, the CD software prepares a clear alarm telemetry message that is transmitted to the implantable device. Upon receipt of the response, the CD software clears the active alarm condition that is displayed to the user. The CD software also re-prioritizes its alarm conditions. If there are any outstanding errors, the CD software causes the one with the highest priority to be displayed and the external communication device remains in an error state. The process of displaying, clearing, and reprioritizing continues until there are no more outstanding errors. If the alarm was detected during a telemetry transaction, the CD software resumes the telemetry transaction. However, if the alarm notification from the Implantable Device to the external communication device occurs as a result of one of the messages transmitted as part of the external communication device to Implantable Device initialization process (i.e. marrying process) the initialization process is not resumed but must be restarted beginning with the Interrogate Message. [0366]
  • The CD software is configured to periodically write to the watchdog hardware registers. If the system watchdog requirements are not met, a watchdog alarm is triggered and the watchdog tone is enabled by the hardware. An infinite loop at mainline or an infinite loop at interrupt level will cause the watchdog to reset the processor IC as the CD software must write one of a 0×5 B or a 0A5 to the watchdog register in mainline code and the other at interrupt level. [0367]
  • Sirens (either audio alarm or vibrational alarm) are activated by the CD software when the external communication device detects an alarm condition. Sirens are deactivated by CD software when the alarm condition is cleared by the user. There are two types of sirens, yellow sirens and blue sirens. For yellow sirens, when the alarm type is set to ‘vibrator,’ the CD software activates the vibrator for 3 seconds every minute while the yellow siren is active. When the alarm type is not set to ‘vibrator,’ the CD software initiates a [0368] high beep tone 6 times with 250 ms between each beep, every minute while the yellow siren is active. If the yellow siren is active for more than 30 minutes, (user does not acknowledge the alarm within 30 minutes), the CD software sets the alarm type to high and initiates an alert tone every minute until the yellow siren is deactivated. If the alarm type was set to vibrator prior to crossing the 30-minute threshold, the alarm type is converted to high (i.e. loud audio) at the 30-minute threshold.
  • For the blue sirens, when the external communication device alarm type is set to ‘vibrator,’ the CD software will activate the vibrator for 3 seconds every 30 minutes while the blue siren is active. When the external communication device alarm type is not set to ‘vibrator,’ the CD software initiates a [0369] high beep tone 3 times with 250 ms between each beep, every 30 minutes while the blue siren is active.
  • The frequency and durations for the types of sounds generated by the tone generator are listed in the following table. [0370]
    Tone Frequencies
    Tone Duration Frequency Repeat Number
    ACT Tone 125 ms 516 Hz 1
    High Beep Tone 250 ms 941 Hz 1
    Audio Bolus Tone 1 250 ms 516 Hz 1
    Audio Bolus Tone 2 250 ms 592 Hz 1
    Audio Bolus Tone 3 250 ms 667 Hz 1
    Audio Bolus Tone 4 250 ms 696 Hz 1
    Double Audio Bolus 250 ms 516 Hz 2 with 125 ms
    Tone
    1 delay between
    Double Audio Bolus 250 ms 592 Hz 2 with 125 ms
    Tone
    2 delay between
    Double Audio Bolus 250 ms 667 Hz 2 with 125 ms
    Tone
    3 delay between
    Double Audio Bolus 250 ms 696 Hz 2 with 125 ms
    Tone 4 delay between
    No Action Tone 500 ms 380 Hz 1
    Alert Tone 250 ms each 941 Hz followed 6
    by 516 Hz
    Alarm Tone 250 ms each 941 Hz followed 50
    by 516 Hz
    End Bolus Tone 250 ms 444 Hz 1
  • ROM boot code within the processor IC loads the external communication device bootloader code from the SEEPROM and factory defined parameters. [0371]
  • When the external communication device boots, CD software reads the power down recovery data from external RAM and calculates the power down recovery data checksum by performing a [0372] 16-bit sum with the carry of the data. The CD software calculates the power down recovery data checksum inverse by performing an arithmetic inverse of the power down recovery data checksum.
  • If the calculated power down recovery data checksum matches the value in external RAM, and if the calculated power down recovery data checksum inverse matches the value in external RAM, the bootloader code copies the CD software (i.e. application code) from external RAM into internal RAM. [0373]
  • If the calculated checksum or checksum inverse do not match the values in external RAM, the external communication device loads the application code into external RAM from the SEEPROM. Once application code is resident in external memory, the internal portion of the code is copied from external memory to internal memory. [0374]
  • If the select, up, down, and activate keys are all depressed at power-up, the external communication device loads the application code into external RAM from the SEEPROM. Once the application code is resident in memory, the internal code portion is copied from external memory to internal memory. [0375]
  • When loading of the software is complete, the external communication device application code is started by an inter-segment jump to the main external RAM initialization address location. [0376]
  • Before performing conversions between insulin units and pump strokes, the CD software compares the stroke volume variable to its compliment form. If they do not agree, the CD software causes the external communication device to be reset. [0377]
  • Before performing conversions, the CD software compares the insulin concentration variable to its compliment form. If they do not agree, the CD software causes the external communication device to reset. [0378]
  • The CD software causes the external communication device to display insulin quantities to the user based on one more selected predefined units of resolution (e.g. 0.2 units for bolus quantities and 0.1 units for basal quantities). However, most computations performed by both the implantable device and the external communication device involve pump stroke volumes. In the present embodiment, the pump stroke volume is nominally 0.5 μL actually pump stroke volume may vary from this amount. When using U 400 insulin with a nominal stroke volume of 0.5 μL a dispensing resolution of nominally 0.2 units of insulin results. However, since the stroke volume may vary, the actual dispensing resolution may also vary. As such programming and interfacing between the user and device occur in increments that are not necessarily integer values of the pump stroke volume. [0379]
  • The CD software converts units to pump strokes based on the insulin concentration and the stroke volume: [0380] PumpStrokes = Units ( U ) * 1000 ( uL mL ) Concentration ( U L ) · StrokeVolume ( uL )
    Figure US20040193090A1-20040930-M00001
  • The CD software converts pump strokes to units based on the insulin concentration and the stroke volume: [0381] Units = Concentration ( U mL ) · StrokeVolume ( uL ) 1000 ( uL mL ) × Pump Strokes
    Figure US20040193090A1-20040930-M00002
  • For display, the CD software rounds to units to the nearest 0.2 unit boundary for each Bolus and to 0.1 units for basal rates. All logs however, are maintained in pump stroke units and then converted to appropriate insulin units when displayed Suspend mode is a mode where the implantable device is programmed to deliver at a rate of one pump stroke an hour. The rate is clinically insignificant and serves to prevent catheter blockage. Suspend mode is enabled by the CD software from the 'suspend pump’ screen. When suspend mode is entered, the CD software prepares a telemetry message for transmission to the implantable device to set its delivery mode to “suspend”. When the implantable device is in suspend mode, the CD software causes the display the alarm screen to display the “pump suspended” alarm as active. When the “pump suspended” alarm condition is cleared, the CD software prepares a message for transmission to the implantable device to set the implantable device delivery mode to “normal”. When the “pump_suspended” alarm condition is cleared, the CD software determines if a bolus was interrupted when suspend mode was entered. If so, it updates the bolus history log to indicate the amount of the bolus that was delivered. The CD software only provides access to the Supervisor Menu Screens while the pump is in suspend mode. A block diagram of the supervisor menu screens and options is provided in FIG. 10. [0382]
  • An audio bolus option is provided that enables the user to safely and reliably deliver a bolus without looking at the display. The CD software enables and disables this option from the Audio Bolus Screen in the setup menu. A block diagram of the set up menu screens and options is provided in FIG. 8. When audio bolus status is ON, the CD software enables the user to initiate delivery of a bolus by pressing the up arrow key from the ‘time and message’ screen as well as the ‘time’ screen. The CD software causes the external communication device to beep and the bolus increment to be displayed as when the up key is first depressed. The CD software provides no scrolling effect when a key is held down. The CD software increases the amount displayed by the bolus increment amount and beeps with each subsequent press of the up key. [0383]
  • In order to audibly distinguish bolus increments, when using the audio bolus feature, the CD software provides a single tone beep when the increment amount is set to 0.4 U, and a double tone beep when the increment value is set to 0.8 U. Of course, in alternative embodiments other incremental amounts may be used and different audio signals used to indicate which is active and what increments have been made. In one such alternative, the CD software could control an appropriately configured external communication device to speak to the user. In another such alternative, the CD software could provide voice recognition features to an appropriately configured the external communication device so that commands could be spoken instead of keyed in. [0384]
  • In the present embodiment, the CD software facilitates counting the audio bolus increments by varying the audio tones for the beeps that accompany the Up arrow key presses. The CD software provides four frequencies that are used in a repeating sequence as the UP arrow key is repeatedly pressed until the desired bolus amount is selected. During the programming of the audio bolus amount, the CD software interprets a pressing of the down key and sel keys to cancel the bolus. When the desired bolus amount has been programmed (and is displayed), the user may activate it by pressing the act key. When the act key is pressed and the amount is not zero, the CD software causes the external communication device to play back the beep sequence generated during bolus amount selection. The CD software interprets a subsequent pressing of the ACT key, as confirmation that the user wants to have the programmed amount delivered and as such displays the ‘immediate bolus confirmation’ screen. The CD software prepares a bolus delivery message for transmission to the implantable device after the user confirms the bolus amount selection by pressing the ACT key again. To cancel the delivery of the bolus after an amount has been set or while the confirmation screen is being displayed, the user may either allow the CD software to time-out and return to the ‘time and message’ screen or the user may press any key other than the act key. [0385]
  • When the delivery of an audio bolus is canceled, the CD software causes the ‘time and message’ screen to be displayed and causes a no action tone to be emitted. The CD software stores the audio bolus status and audio bolus increment parameters in the external communication device data block. [0386]
  • The CD software enables the external communication device to request delivery of three types of boluses. These are the normal bolus, the square wave bolus and the dual-phase bolus. [0387]
  • The normal bolus (immediate bolus or [0388] phase 1 bolus) gives the user the option to program a bolus amount in units of insulin. The insulin units requested for delivery are translated by the external communication device to an integer number of pump strokes, a telemetry message is prepared and transmitted to the implantable device which then delivers the amount.
  • The square wave bolus ([0389] phase 2 bolus) is programmed as an amount in units and a duration. The CD software translates the amount into a rate, a telemetry message is prepared and transmitted to the Implantable Device which then delivers insulin the computed rate for the given duration.
  • The dual phase bolus (two-phase bolus) is a combination of the normal bolus and the square wave bolus. The user programs a phase-one amount, a phase-two amount, and a phase-two duration into the CD software. The phase one amount is treated like-a normal bolus. The phase-two amount and duration are treated like a square wave. A telemetry message is prepared and transmitted to the implantable device which is then programmed to deliver the two components of the bolus. [0390]
  • When a parameter called variable bolus status is set to OFF, the only type of bolus delivery that can be programmed is the normal bolus. The CD software presents the user with a ‘set bolus amount’ screen that the user may interact with to program a normal bolus. The CD software allows the user to increment up and down through allowable bolus amounts by using the up and down keys. The maximum amount that can be scrolled to is equal to programmable maximum bolus quantity. The CD software displays the ‘immediate bolus confirmation’ screen when the user depresses the act key (so long as the bolus amount indicated is not zero). When the act key is pressed again, the CD software prepares a bolus delivery request message for transmission to the implantable device. [0391]
  • The CD software allows a Square Wave bolus to be programmed when the variable bolus status is set ON. From the set bolus display, the CD software enables the user to select, intra alia, a square wave bolus. Once selected, the CD software shows the user a ‘set bolus amount’ screen with portion of the display blinking indicating that an amount may be entered. A desired bolus amount may be entered by the user using the up and down keys. The CD software limits the amount that may be entered to the predefined maximum bolus amount. After entering the amount and pressing the act key, the CD software displays a blinking region for setting bolus duration. After entering the desired duration and depressing the act key, the CD software displays a blinking screen that shows the details of the extended bolus that has been programmed (i.e. ‘Extended Bolus Confirmation’ screen). If the user agrees that a delivery having the indicated details should be made, the CD software initiates a telemetry delivery request message when the act key is pressed again [0392]
  • The CD software also allows a dual bolus to be programmed when the variable bolus status is set on and the bolus delivery type is set to dual. In programming the bolus, three screens are presented to the user one after the other: (1) the ‘set bolus amount’ screen is displayed for entry of the immediate portion of the bolus, (2) the ‘set [0393] phase 2 amount’ is displayed for entry of the square wave portion of the bolus, and (3) the ‘set phase 2 duration’ screen is displayed for entry of the square wave duration. The user progresses through these screens by entering the desired amount as each screen is displayed and then hitting the act key. After the act key is depressed while the ‘set phase 2 duration’ screen is displayed, a flashing the ‘Extended Bolus Confirmation’ screen is shown. If the user agrees that a delivery having the indicated details should be made, the CD software initiates a telemetry delivery request message when the act key is pressed again. The CD software limits the total bolus amount programmed for the combination of the Immediate and the phase-2 boluses to be no more than the predefined maximum bolus amount.
  • For each of the above three cases, bolus delivery is initiated by the CD software preparing and initiating a deliver bolus, read totals telemetry packet. The CD software calculates the number of pumps to be delivered in the immediate bolus based on the amount programmed with the result rounded to the nearest integral number of pump strokes. The CD software also uses the phase-2 amount and duration to calculate a phase-2 delivery rate in pump strokes per minute. The calculated amount, rate and duration are passed to the implantable device for delivery in the above noted delivery request message. When the CD software estimates that a bolus delivery is in progress, the rotating delivery status icon indicates that a delivery is in progress and ‘time and message’ screen provides a delivering bolus message and an estimate of the amount delivered. [0394]
  • The CD software, estimates the amount delivered in the immediate phase of a bolus to be one pump stroke during each predefined interval of time (e.g. 2-4 seconds). Incrementing starts on the minute following completion of bolus programming. [0395]
  • The CD software disables the ‘set maximums’ screen during delivery of a bolus. Also when the estimate of the immediate amount delivered is less than the programmed amount, the ‘set bolus amount’ screen is also disabled. When the estimate of the immediate amount delivered equals the programmed amount, the ‘set bolus amount’ screen is enabled. When the estimated delivery of the combined amounts (immediate and extended) is complete the CD software causes the external communication device to emit an end of bolus tone. The CD software inhibits entry of an additional extended bolus delivery when an extended bolus is already in progress. The CD software locks out all bolus delivery screens during the delivery of an immediate bolus, diagnostic rate, or primary bolus. [0396]
  • As noted above, a variable bolus rate option in provided. A variable bolus status parameter is also provided that is indicative of whether the user has the capability of entering delivery instructions for all three bolus types or only the immediate type. When the option is on, bolus delivery includes a screen to choose the bolus type. When the option is off, the user can only program normal boluses. In either event, the CD software provides the user with access to those screens and options that are available to him/her and removes access/display of those screens that provide programming capability for the unavailable options. [0397]
  • The CD software provides a ‘variable bolus’ screen that may be used to set the variable bolus status parameter to on and off for enabling the programming of square wave boluses and dual wave boluses. The CD software causes the variable bolus status parameter to be stored in the external communication device data block. [0398]
  • The CD software provides the user with the capability of displaying the time of delivery and the amount for each of the most recent 512 boluses. Priming boluses are displayed along with variable and audio boluses. The CD software provides a ‘bolus history’ screen that display the most recently delivered or programmed bolus. The older entries in the bolus history log are displayed when the down arrow is pressed. Newer entries in the bolus history log are displayed when the up arrow is pressed. The up arrow is ignored when the external communication device is displaying the most recent bolus. The CD software ignores any down key presses when the external communication device is displaying the oldest log entry. When a bolus is programmed, the CD software sets the bolus status parameter to ‘programmed’ . The CD software updates the bolus history log when the response to the deliver bolus read totals &telemetry packet is received. The CD software blanks a bolus status parameter when a response to a deliver bolus read totals telemetry packet indicates that the amount displayed for the most recently programmed bolus was delivered. [0399]
  • The CD software provides the user with the ability to display the total amount of insulin delivered during each of the most recent 120 days on a ‘daily totals’ screen. The amount for the current day is only accurate up through the delivery of the previous bolus, not the current bolus, or the last bolus. The CD software retains the total basal delivery and the total bolus delivery as separate amounts for each day in the daily totals log. The CD software displays older entries in the daily total log when the down arrow is pressed. The CD software displays newer entries in the daily total log when the up arrow is pressed. The CD software ignores Up key presses when the most recent entry in the daily total log is displayed and ignores the down key presses when the oldest daily total log entry is displayed. The CD software updates the Daily Totals log using the current day's total and yesterday's total from the TM message, when a response to the Deliver Bolus, Read Totals telemetry packet is received. The CD software maintains a pointer that indicates “today” in the daily total log. The CD software increments this pointer at midnight. When the CD software increments the pointer indicating “today”, the daily total for the new day is set to dashes. [0400]
  • The CD software provides the user with the ability to display the contents of the external communication device event log on a ‘external communication device ‘clinical history’ screen. The most recent event code for the most recently logged external communication device event is displayed on the screen. The CD software displays older entries in the external communication device event log when the down arrow is pressed and newer entries in the external communication device event log when the up arrow is pressed. The CD software ignores up arrow key presses when the external communication device is displaying the most recent entry in the external communication device event log and ignores down key presses when the external communication device is displaying the oldest entry in the external communication device event log. The CD software maintains a pointer to the most recent entry in the external communication device event log. [0401]
  • The CD software provides memory space for storing the contents of the implantable device event log and the ability to display those events on an ‘implantable device clinical history’ screen. The event code for the most recently logged implantable device event is initially displayed on the screen. The CD software displays older entries in the implantable device event log when the down arrow is pressed and newer entries in the implantable device event log when the up arrow is pressed. The CD software ignores up key presses when the external communication device is displaying the most recent entry in the implantable device event log and down key presses when the external communication device is displaying the oldest entry in the implantable device event log. The CD software maintains a pointer to the most recent entry in the implantable device Event Log. The CD software updates its implantable device event log to match the event log in the implantable device during a link and when executing the read implantable device data functionality. [0402]
  • The CD software provides memory space for storing entries to the implantable device battery voltage log and the ability to display those entries on an implantable device voltage history screen. The CD software initially displays the most recently logged loaded and unloaded implantable device battery voltages on this screen. The CD software displays the older entries in this log when the down arrow is pressed and newer entries in this log when the up arrow is pressed. The CD software ignores the pressing of the up key when the most recent entry in the log is being displayed and the down key when the oldest entry in the log is displayed. [0403]
  • The external communication device maintains a pointer to the most recent entry in the implantable device battery voltage log. The CD software updates this log to match the battery voltage log in the implantable device during a link and when executing the read implantable device data feature. [0404]
  • The CD software provides for a predefined number (e.g. 3 in the present embodiment) of separately programmable sets of basal rates. Each set, or profile, consists of a predefined number (e.g. up to 48 in the present embodiment) of basal rates, one for each of a predefined set of time slots (e.g. each half-hour of the day in the present embodiment). The profile rates are programmed by setting a start time and a rate. The CD software provides a basal rate screen that allows the user to view the basal rate that is currently being delivered. When there is no temporary basal rate active (the temporary basal duration is zero) the CD software displays the currently active basal profile along with its number. When a temporary basal rate is active, the active profile number is replaced with “OFF”. [0405]
  • The CD software displays the set profile rate [0406] screen showing profile 1 when act is pressed when the ‘basal rate’ screen is displayed when the act key is pressed from the set profile rate screen, the CD software displays the set profile start time screen. The minimum value for scrolling the start time is one half-hour after the start time of the previous profile. When a profile start time is programmed with a start time prior to that of one or more previously defined entries and subsequent start times are cleared (e.g. set to dashes in the present embodiment). Basal profile setting is complete when the rate for a profile starting at 11:30 pm is set. Alternatively, basal profile setting is completed when the user presses the act key for a profile start time that is dashes. When profiles in the active pattern are changed, the CD software prepares and sends a set profile basal rates message to the implantable device.
  • The CD ~ software allows up to 3 delivery patterns to be separately programmed with up to 48 rates each and the patterns to be stored in the external communication device. Any one of the patterns may be set active at any time. The CD software allows the Selection of the active basal delivery pattern from the set basal delivery pattern screen. When the basal delivery pattern is set (i.e. made active) that pattern becomes accessible on the ‘profile basal rate’ screen and a set profile basal rates message is prepared and transmitted to the implantable device. [0407]
  • The temporary basal rate is a basal rate that when programmed, will run in lieu of the basal profile rate. The temporary basal rate runs for the amount of time specified by the temporary basal duration. The CD software enables setting of the temporary basal rate using the set temporary basal rate screen. When the temporary basal rate and duration are set, the CD software prepares and sends a set temporary basal rate message to-the implantable device. When a temporary basal delivery is in progress, the CD software causes the remaining temporary basal rate duration to be displayed on the temporary basal rate screen. When there is no temporary basal rate delivery in progress, the CD software causes dashes to be displayed as the amount and duration of the temporary basal rate. When a temporary basal rate is set with a duration that is zero, any temporary basal rate in progress is canceled. When programming a temporary basal rate when a temporary basal rate is in progress, the CD software sets the default duration to the time remaining on the rate that is in progress rounded down to the nearest half-hour. The CD software increases the duration by one half-hour when the up key is pressed and decreases the amount by one half-hour when down key is pressed. The CD software locks out the set temporary basal rate screen during a diagnostic rate delivery and priming bolus delivery. [0408]
  • The CD software maintains a log of personal events. The CD software allows personal events to be set from a personal events screen. The CD software updates the log with a time and event type after the user completes the personal event data entry sequence. The personal events screen is not displayed when a personal events enable parameter is set to OFF. When the personal events screen is displayed, the most recent personal event is displayed. When the down key is pressed, the CD software displays the previous personal event in the log and when the Up key is pressed, the CD software displays the next personal event in the log. The CD software ignores presses of the Down key when the oldest personal event is being displayed and ignores the Up key when the newest personal event is being displayed. [0409]
  • Automatic Off is set from the ‘set automatic off’ screen. When the automatic off duration is set the CD software prepares and sends a set automatic off telemetry message to the implantable device. When the automatic off interval is programmed to dashes, the CD software disables the feature. The CD software maintains a timer that indicates the amount of time remaining in the automatic off interval. When telemetry responses from the implantable device are received, and the response is not the interrogate response, the CD software resets the timer to the automatic off interval. The CD software decrements the time in the automatic off interval timer every minute. When the amount of time in the automatic off interval is five minutes (indicating that the Implantable Device will alarm in 5 minutes), the CD software reports an “automatic off alarm” alarm. [0410]
  • The CD software maintains the time and the date. The CD software enables the time and the date to be set from the ‘time and date’ screen. When ACT is pressed, the ‘set time’ screen is displayed. When the ‘set time’ screen is displayed, the CD software allows the user to change the hours and the minutes. When act is pressed and the minutes are displayed, the CD software displays the set date screen. When the date and the time are set by the user, the CD software prepares and sends out a set current time telemetry message to the implantable device. In the present embodiment, though the external communication device has direct knowledge of date and changes in date that may occur, this direct knowledge is not used in determining, among other thing, how to set daily totals. In alternative embodiments, this direct knowledge may be used for this purpose; however, in the present embodiment the following analysis is performed by the CD software and associated conclusions made: (1) If the new hour is less than the current hour (measured on a 24 hour clock), and the new hour subtracted from the current hour is greater than or equal to 12, new day processing takes place, (2) If the new hour is greater than the current hour and the current hour subtracted from the new hour is greater than or equal to 12, previous day processing takes place, and (3) If the new hour and current hour are not separated by more than [0411] 12 hours the day is considered to remain unchanged. When new day processing occurs, the CD software updates the daily totals as is normally carried out at midnight. When previous day processing occurs, the CD software moves the daily total data log pointer to the previous day and adds current daily total values to those of the previous day.
  • An hourly maximum amount is provided for by the CD software. The hourly maximum is the amount of insulin that may be delivered with boluses in one hour. If a higher amount is programmed, the CD software reports an error. In the present embodiment, the hourly maximum amount is not a hard limit but one that may be bypassed if desired by the patient. In effect, the hourly maximum amount provides a warning to the patient so that the patient will not unintentionally deliver a large amount of insulin within a single 60-minute period. In the present embodiment, after clearing the warning, a window of predefined length (e.g. 10 minutes) is opened so that an additional bolus of up to the single bolus maximum amount (i.e. bolus maximum) may be delivered without triggering the hourly maximum amount error. In the present embodiment the hourly maximum amount is set to a predetermined multiple of the single bolus maximum amount (e.g. 2.5 times). In alternative embodiments, the time period of the maximum may be specified to a larger or shorter amount and/or the amount of the maximum may be set in a different way. [0412]
  • Each time a bolus is programmed, the CD software computes the amount of bolus delivery that occurred during the previous 60 minutes. If the amount delivered summed with the programmed amount is greater than 2½ times the bolus maximum, the CD software reports an “hourly maximum exceeded” alarm and the CD software does not transmit a telemetry message to the implantable device to initiate the bolus. When the “hourly maximum exceeded” alarm is cleared the CD software sets a ten-minute time period in which CD software will not test for the “hourly maximum exceeded” alarm. The CD software resumes testing for the “hourly maximum exceeded” alarm after the ten-minute time period elapses. [0413]
  • In other alternative embodiments, instead of basing the Hourly Maximum testing on amounts actually delivered in the last 60 minutes, the testing may be based on amounts programmed during the last 60 minutes. Also in alternative embodiments, an estimated timing of delivery for the amount(s) programmed may be factored into the calculations before concluding that the hourly maximum will actually be exceeded, especially when the amount programmed for delivery includes an extended bolus. [0414]
  • The CD software allows a basal rate maximum to be defined and then uses this maximum value in limiting the basal rates that can be programmed for delivery during any one period of time. In the present embodiment, the CD software inhibits the user from programming basal profiles or temporary basal rates that are greater than the value of the basal rate maximum. When the basal rate maximum is changed, the CD software prepares and sends the implantable device a set maximums Message. The CD software inhibits a maximum basal rate from being programmed that is set to a value lower than a programmed basal rate, including profile basal rates, both active and inactive, and the temporary basal rate. [0415]
  • The CD software sets the medication remaining parameter to the refill amount when a response to a “set refill amount and alarm thresholds” message is received. The CD software subtracts the daily total values (not taken from the amounts displayed but instead derived from the number of pump strokes executed) from the “remaining medication” parameter once per day at midnight. [0416]
  • The CD software performs a self-test and initiates the implantable device self-test through telemetry. The external communication device self-test is initiated from the external communication device self-test screen. When the external communication device self-test is initiated, the CD software sends an Initiate Self-Test telemetry message to the implantable device so that it may be tested as well. When the CD software receives a valid response to the initiate self-test telemetry message, the CD software indicates to the user that the Implantable Device has passed the self-test. If the external communication device does not receive a response to the initiate self-test telemetry message, the CD software indicates that the implantable device has failed the self-test. The external communication device sends the implantable device a read self-test status message when the external communication device wants to know the results of the test. [0417]
  • When the external communication device self-test is initiated, the CD software displays the ‘screen operation verification’ screen, an alert tone is emitted, the vibrator is enabled for a predefined period of time (e.g. 3 seconds), the CD software computes a CRC of the code area in internal RAM and compares the computed value to the CRC stored in the SEEPROM, the CD software computes a CRC of the code area in external RAM and compares the computed value to the CRC stored in the SEEPROM, and the CD software illuminates the Backlight for a predefined period of time (e.g. four seconds). If either of these CRC comparisons do not produce a match, the CD software causes the external communication device to reset. When the CD software has completed the self-test sequence, the. CD software indicates that the external communication device has passed the self-test (assuming it has). It is up to the user to confirm whether the vibrator operated and whether the display was illuminated. In other embodiments, appropriate transducers and circuitry may be used to automatically ascertain the functionality of various components such as those noted above. [0418]
  • The external communication device alarm type is set from the alarms screen, in conjunction with the audio feedback mode audio and vibration alarms are set by the ‘alarms’ screen. When the ‘alarms’ screen is displayed and the act key is pressed, the CD software displays the external communication device alarm type screen. When the alarm type screen is displayed and the act key is pressed, the CD software displays the ‘audio feedback mode’ screen. [0419]
  • The CD software stores the alarm type parameter in the external communication device memory but when the parameter is changed, it also transmits a set external communication device data block message (containing the updated alarm type parameter) to the implantable device for storage in the external communication device data block. [0420]
  • The CD software allows the audio feedback mode to be set from the alarms screen, in conjunction with the external communication device alarm type audio feedback mode is enabled and disabled from the set audio feedback mode screen. When the audio feedback status parameter is set to ON the CD software sends the implantable device the set audio feedback mode message enabling audio feedback mode. When the audio feedback status parameter is set to OFF the CD software sends the implantable device the set audio feedback mode telemetry message disabling audio feedback mode. [0421]
  • The CD software causes the external communication device to storage mode if there is no keyboard activity and there have been no telemetry packets received for seven days. The external communication device exits storage mode if a key is pressed or the batteries are removed and replaced. When the external communication device is in storage mode, the screen is disabled and the telemetry hardware is disabled, time is maintained (but not displayed) and memory is retained but all other functions become unavailable. [0422]
  • The pump refill process is initiated from the ‘pump refill’ screen pressing act on the pump refill screen causes the ‘set extracted amount’ screen to be displayed. Pressing ACT on the ‘set extracted amount’ screen causes the ‘set refill amount’ screen to be displayed. Pressing act on the ‘set refill amount’ screen causes the ‘Set Concentration’ screen to be displayed. Pressing ACT on the ‘set concentration’ screen initiates the CD software to calculate the delivery accuracy. When the CD software computes the delivery accuracy to be a negative number, it displays the value as positive number along with the words “Under-Delivery”. When the cd software computes the delivery accuracy to be a positive number, the value is displayed along with the words “over-delivery”. When the extracted amount is dashes, the extracted amount is logged as zero and this event is logged in the system event log. The accuracy is displayed as dashes. When the CD software determines that the extracted amount is more than the previous refill amount, the CD software logs a system event and displays the accuracy as dashes. When the CD software determines that the extracted amount equals the previous refill amount, the CD software logs a system event and displays the accuracy as dashes. [0423]
  • Changing the insulin concentration is part of the refill screen sequence. When insulin concentration is changed on the ‘set concentration’ screen, the CD software resets all profile basal rates and the temporary basal rate to factory default values. When the basal profiles are cleared, the CD software sends the implantable device a set basal rates message and a set insulin concentration message. When the insulin concentration is changed, the CD software recomputes the current basal rate maximum and bolus maximum and sends the implantable device a set maximums message. [0424]
  • The priming bolus screen is found on the supervisor menu. The CD software locks out the priming bolus screen unless the pump is in stop mode. Priming the pump is initiated from the priming bolus screen. When the user presses the act key on the ‘priming bolus’ screen, the CD software displays the confirm priming bolus screen. When the user selects ‘yes’ and presses the act key on the ‘confirm priming bolus’ screen, the CD software displays the reconfirm priming bolus screen. When the user presses the ACT key on the ‘reconfirm priming bolus’ screen, the cd software sends a set delivery mode message to the implantable device with the mode set to indicate priming bolus, and the priming bolus amount set to a predefined value (such as 650 pump strokes). [0425]
  • The diagnostic rate screen is on the supervisor menu. It is used to perform diagnostic procedures on the pumping mechanism by setting very high rates. Normally, the reservoir is not filled with insulin when this feature is used. The diagnostic rate screen is locked out unless the pump is in stop mode diagnostic rate is initiated on the ‘diagnostic rate’ screen. When the user presses the act key on the ‘diagnostic rate’ screen, the CD software displays the set diagnostic rate Screen. When the user presses the act key on the set diagnostic rate screen, the cd software displays the confirm diagnostic rate screen. When the user selects ‘yes’ and presses the act key on the confirm diagnostic rate screen, the CD software displays the reconfirm diagnostic rate screen. When the user presses the act key on the reconfirm diagnostic rate screen, the CD software prepares and sends a set delivery mode message to the implantable device with the mode set to indicate diagnostic rate, and the diagnostic rate amount equal to the amount set on the ‘set diagnostic rate’ screen. While the diagnostic rate is in progress, the CD software displays a message on the ‘time and message’ screen to indicate that the diagnostic rate is in progress. [0426]
  • The maximum lock feature is a safety feature accessible from the supervisor menu. This feature enables and disables the patient's ability to change the delivery maximums. The maximum lock feature is accessible on the ‘lock bolus and basal maximums’ screen. When the user presses act from this screen, the set lock screen is displayed. When the user presses act on the set lock screen, the CD software sends a set maximums message to the implantable device. When the locked maximum status parameter is on, the CD software ignores the act key when it is pressed while the max bolus screen is displayed. When the locked maximum status parameter is on, the CD software ignores the act key when it is pressed while the max basal rate screen is displayed. [0427]
  • The read implantable device data feature synchronizes the external communication device and the implantable device. The read implantable device data feature is accessible from the read implantable device data screen. When the user presses act on this screen, the CD software initiates the read implantable device data process. The read implantable device data process includes reading the Implantable device data log pointers and reading all of the data necessary to make the data logs in the external communication device mirror the data logs in the implantable device. [0428]
  • Setting the personal ID is initiated on the personal ID screen. When act is pressed on the personal ID screen, the CD software displays the “set [0429] personal id character 1” screen. As there are 32 characters available for use as the personal ID in this embodiment, 32 screens are supplied for entry of the personal ID. When, ACT is pressed on the final character of the personal ID, the CD software sends a “set personal id message” to the implantable device.
  • The external communication device contains an image of the implantable device software in one of its SEEPROMs. The image includes-instructions to perform all of the telemetry transactions necessary to download the software, including for example, an interrogate message, a link message, a reset message, an interrogate message, a link message, download start message & data, one or more download continue messages and data, and a bootstrap message the SEEPROM includes code and data for both the main and the monitor processors on the implantable device. Downloading implantable device software is initiated on the “download implantable device software” screen. When the user presses the act key on the “download implantable device software” screen, the CD software displays the “confirm download implantable device software” screen. When the user selects ‘yes’ and presses the act key on this screen, the CD software displays the re-confirm download implantable device software screen. When the user presses the ACT key on this screen, the CD software initiates the software download. The CD software reads the SEEPROM and uses the size and the data, in formulating telemetry packets to send to the implantable device. If appropriate message responses are received by the CD software, it continues sending packets until the data read from the SEEPROM indicates that there is no more data. If errors are detected during the download process, the CD software displays the download error screen. [0430]
  • Stop mode is a mode where the implantable device is programmed to stop all insulin delivery. The CD software limits accessibility to only supervisor menu screens when the pump is in stop mode stop mode is enabled from the “stop pump” screen. When stop mode is entered, the CD software prepares and transmits a telemetry message to the implantable device to set the delivery mode to stop mode. When stop mode is entered, the CD software displays the alarm screen with “pump stopped” alarm active. When the “pump stopped” alarm condition is cleared, the CD software sets prepares and sends a telemetry message to the implantable device to set the delivery mode to normal mode and also updates the bolus history log to indicate the amount of the latest bolus that was delivered. [0431]
  • The CD software provides single command ability to set parameter values in the implantable device to their factory default values. This capability is produced from the “initialize to factory defaults” screen. Several telemetry commands are used to initialize the implantable device to factory defaults successfully. When the choice is confirmed to reset the parameters, the CD software sends the telemetry messages indicated in the following table to the implantable device to set the parameters to their factory default values: [0432]
    Telemetry Messages to Initialize to Factory Defaults
    Set Current Time
    Set Automatic Off
    Set External Communication Device Data Block
    Set Maximums
    Set Audio Feedback Mode
    Set Personal ID
    Set Temp Basal Rate
    Set Basal Profile Rates
    Set Delivery Mode
  • The CD software provides a one command process for initializing the external communication device to implantable device. After completing this sequence, the external communication device is configured to match the implantable device settings with the exception of the basal profiles which are set to factory defaults in the implantable device and the external communication device. The Initialize external communication device to implantable device process is initiated from the initialize external communication device to implantable device screen. When the ACT key is pressed and the ‘initialize external communication device to implantable device’ screen is being displayed, the CD software sends the implantable device an interrogate message. When the response to the interrogate telemetry message is received, the CD software displays the ‘confirm implantable device serial number’ Screen. This screen contains a message that gives the user the choice to confirm or reject the displayed personal ID. The user may choose “yes” or “no” to confirm or reject and abort the initialization process. The CD software sets the “no” choice as the default. When the ‘no’ choice is confirmed, the external communication device attempts to add the telemetry ID from the interrogate response message to the exclusion list. If the exclusion list is full, the CD software reports an “exclusion list full” alarm. If the exclusion list is not full, the CD software sends out another interrogate message, in hopes of getting the correct implantable device to respond. The rejection process may be repeated multiple times if a large number of implantable devices are in the vicinity. When the ‘yes’ choice is confirmed, the CD software sends the telemetry messages to the implantable device as indicated in the table below. [0433]
    Telemetry Messages to Initialize the External
    Communication Device to Implantable Device
    Interrogate
    Link External Communication Device to Implantable Device
    Read Stroke Volume
    Read Lifetime Total Delivered
    Read Audio Feedback Mode
    Read Insulin Concentration
    Read Automatic Off
    Read Implantable Device Data Log Pointers
    Read Refill Counter
    Read Maximums
    Read External Communication Device Data Block
    Read Memory
    Set Temp Basal Rate
    Set Basal Profile Rates
    Set Delivery Mode
  • The stroke volume received in the read stroke volume response is range-checked by the CD software to ensure that it is a valid value. If the stroke volume is not within range, and “invalid stroke volume” alarm is reported, and the CD software will not initialize the external communication device to the implantable device. If valid, the CD software stores the stroke volume as received and once more in its complimented form. [0434]
  • The insulin concentration received in the read concentration response is also range checked by the CD software to ensure that it is a valid value. If the insulin concentration is not within the range, the CD software reports an “invalid stroke volume” alarm and the CD software will not initialize the external communication device to the implantable device. If valid, the CD software stores the insulin concentration as received and once more in its complimented form. [0435]
  • With the set delivery mode message, the CD software sets the delivery mode to suspend. With the set temporary basal rate and the set basal profile rates messages, the CD software sets the implantable device basal rates, including the profiles and temp basal rates to the factory default values. [0436]
  • During programming of the external communication device, if there is no active alarm and no buttons are pressed, the external communication device will return to the ‘time and message’ screen after a predefined period of inactivity. When an alarm is in the‘process of being cleared, the CD software returns the external communication device to the “time and alarm” screen. The time-out (i.e. predefined period of inactivity) is dependent upon the last key that was pressed, if telemetry occurred, and if an alarm was beeping. In the present embodiment, several different time out periods are used: (1) The time-out is 4 seconds after telemetry occurs; (2) 15 seconds after an interrogate; (3) 15 seconds after audio bolus beeping; (4) 7 seconds after a sel key is pressed; (5) 15 seconds after all other keys are pressed, except for when the down key is pressed to activate the backlight; and (6) 4 seconds after the activation of the backlight. [0437]
  • The CD software provides a set of functions that are only accessible with a supervisor password. In order for the user to access the supervisor menu, the user must enter a supervisor password on the password screen. When a predefined group of keys are pressed simultaneously (e.g. the two arrow keys), for a predefined number of seconds (e.g. 3-5 seconds), from one or more selected screens (e.g. the time alarm & sel screen, or the pump setup screen) the password screen is displayed. When the user is presented with the password screen, the user enters a selected number of parameters (e.g. four parameters defined as [0438] password entry 1, password entry 2, password entry 3, and password entry 4). The CD software presents one parameter at a time for entry. When the act key is pressed, subsequent password entry parameters may be entered when “act” is pressed after specifying password entry 4, the CD software compares password entry 1-4 parameters to password 1-4 parameters. If the four values match, the CD software displays the ‘supervisor menu’ screen. If the values do not match, the CD software compares password entry 1-4 parameters to the factory password parameters 1-4. If the four values are within a predefined amount of each other (e.g. less than or equal to 24 apart), the CD software displays the supervisor menu screen. If the values do not match, the CD software displays the time and message screen. The following tables present a listing of the various screen names along with a brief description of them.
    The Main Menu contains the following screens
    Screen Description
    Main Menu Screens
    Time This is the screen that displays
    the current time and the icons.
    Time and Message This screen will be displayed when
    there are messages such as bolus
    delivery in progress and temporary
    basal rate in progress.
    Bolus History This is the screen that shows the
    boluses that have been delivered.
    A new bolus may be started from
    this screen.
    Suspend Pump This is the screen where the user
    can stop (clinically speaking)
    insulin delivery.
    Basal Bate This is the screen where the basal
    profiles may be reviewed and
    programmed.
    Temporary Basal This is the screen where a temporary
    Rate basal rate may be programmed or
    canceled.
    Personal Events This screen is where the user can
    (when enabled) record the incidence of events such
    as exercise and meals for later review.
    Note that this screen will not be in
    the Main Menu unless it is enabled in
    the Setup II menu.
    History Menu This is a menu (described below) that
    shows historical insulin delivery
    information.
    Pump Setup This is the menu where the pump setup
    options are located.
    The History Menu contains the following screens:
    History Menu Screens
    Read Implantable This screen is where the user can
    Device Data Synchronize the Implantable Device
    data and the external communication
    device data.
    Medication This screen shows how much medication
    Remaining is remaining in the pump reservoir.
    Daily Totals This screen shows the total amount of
    insulin delivered for the most recent
    90 days.
    Exit History This screen exits the History Menu and
    returns to the Main Menu.
    External This screen shows the external
    Communication communication device Event Log entries.
    Device Clinical
    History
    Implantable Device This screen shows the Implantable Device
    Clinical History Event Log entries.
    Implantable Device This screen shows the Implantable Device
    Voltage History Battery Voltage Log entries.
    The Pump Setup Menu contains the following screens:
    Pump Setup Menu Screens
    Time and Date This is the screen where the user sets
    the time and the date.
    Automatic Off This is the screen where the user sets
    and clears the automatic off duration.
    Alarms This is the screen where the user sets
    the alarm type (audio high, audio low,
    or vibrator) and where the user sets
    audio feed back mode.
    Self-Test This is the screen where the user
    initiates a self-test for the external
    communication device and the Implantable
    Device.
    Basal Delivery This is the screen where one of the
    Pattern three basal profile delivery patterns
    is selected.
    Initialize External This is where the external communication
    Communication device and the Implantable Device are
    Device to Implant “married”. This must be carried out
    before an external communication device
    and an Implantable Device can communicate.
    Pump Setup II This is where the Pump II menu can be
    entered.
    Exit Setup This screen exits the Pump Setup Menu and
    returns to the Main Menu.
    The Pump Setup II Menu contains the following screens:
    Pump Setup II Menu Screens
    Audio Bolus This is where the audio bolus feature is
    enabled and disabled.
    Variable Bolus This is where the ability to choose a
    bolus type on the bolus setting screen is
    enabled and disabled.
    Maximum Bolus This is where the maximum bolus amount
    is set.
    Maximum Basal This is where the maximum basal rate
    Rate is set.
    Time display format This is where the time display can be set
    to either 12-hour or 24-hour clock.
    Personal Events This is where the personal events feature
    is enabled and disabled.
    Exit to Pump Setup This screen exits Pump Setup II and enters
    Pump Setup I menu.
    Exit Setup This screen exits the Pump Setup II menu
    and returns to the Main Menu.
    The Supervisor Menu contains the following screens:
    Supervisor Menu Screens
    Refill This is where the user enters the amount
    of medication put into the pump. This is
    used for the low and empty reservoir alarms.
    Priming Bolus This is where a priming bolus that is
    designed to remove air from the catheter is
    programmed.
    Diagnostic Rate This where the diagnostic rate is programmed.
    Bolus and Basal This is where the ability for the user to
    Maximum Lock change maximums in the Pump Setup II
    Menu is enabled and disabled.
    Personal ID This is where the 32 character personal
    ID is set.
    Initialize to Factory This feature programs pump parameters to
    Defaults the factory defaults.
    Download Pump This is where the pump software can be
    Software. downloaded.
    Stop Pump This feature stops and resumes all pumping.
    Set Supervisor This is where the password for the
    Password Supervisor Menu is set.
    Exit Supervisor This screen exits the Supervisor Menu and
    Menu returns to the Main Menu.
  • Any field that is displayed and that may be changed over the product lifetime is identified as a parameter field. To clarify parameter definition, parameters can be thought of as being subdivided into numeric parameters and option parameters. The numeric parameter will generally be a number. The definition for numeric parameters includes a minimum value and a maximum value and a unit of how the parameter is measured. For all parameters, the defaults values are shown. Numeric parameters also include a step value that indicates how scrolling will increment and decrement when the parameter can be changed by the user. Numeric parameters may show dashes when they are disabled. This is indicated by the term ‘dashes’. Option parameters will generally be a set of options that the user scrolls through when the parameter is set. Option Parameters are shown with all the available choices and the default. [0439]
  • The factory default is the value or option that the parameter will be set to when the external communication device is shipped from the factory as a new product. The operating default is the value or option that the parameter will be set to when the external communication device has been initialized properly to an Implantable Device, and the user has interacted with the parameter. [0440]
    PART 1 - External Communication Device Parameter Summary
    Factory
    Parameter Default Operating Default Units Delta Value
    Accuracy Status “%” will be displayed.
    “Under Delivery” will
    be displayed if Delivery
    Accuracy is negative;
    otherwise “Over
    Delivery” will
    be displayed.
    Audio Bolus Increment 0.4 Previously programmed value. Units 0.4
    Audio Bolus Status OFF Previously programmed value.
    Audio Feedback Status OFF Previously programmed value.
    Auto-Off Duration DISABLED Previously programmed value. Hours 1
    Basal Rate Total Units
    Bolus Amount Dashes Last Bolus Amount Units
    Bolus Delivery Type NORMAL NORMAL
    Bolus Status Blank. Dependent upon pump status.
    The text PROGRAMMED will be
    displayed at any time the
    bolus on the screen has not
    been confirmed as being
    delivered. If the bolus has
    been delivered this section
    of screen will be blank.
    Bolus Time & Date Dashes Time & Date of last bolus dependent on
    Time Format and
    Date Format
    parameter
    settings.
    Daily Total Basal Amount Dashes Previously programmed value. Units
    Daily Total Bolus Amount Dashes Previously programmed value. Units
    Daily Total Date Dashes Previously programmed value. Month and Day
    Day
    1 Previously programmed value. 1 day
    Delivery Accuracy [100 × (Estimated Percent
    Delivery - Amount Delivered)/
    Amount Delivered],
    where Amount Delivered is
    [Previous Refill Amount -
    Extracted Amount]
    and Estimated Delivery is
    ((1.04 g/mL) × Units
    Delivered/Insulin
    Concentration)
    Delivery Pattern A Previously programmed value.
    Diagnostic Rate 10 10 Units/hour 5
    Event Time & Date Current Current Time & Date Dependent on
    Time & Time Format
    Date
    Event Type MEAL MEAL
    Extended Bolus Amount Dashes Dashes Units 0.2
    Extended Bolus Duration 30 minutes 30 minutes Hours:minutes 30 minutes
    Extracted Amount 0.1 0.1 Grams 0.1
    Factory Operating (24*Month*32 + 24*
    Password 1-4 Default Day + Hour)(Note that
    January is 0, February
    is 1, etc)
    Hour 0 Previously programmed value. Dependent on 1 hour
    Time Format
    parameter setting.
    Immediate Bolus Amount Dashes Dashes Units 0.2
    Insulin Concentration U-400 Previously programmed value.
    Implantable 2-byte from 2-byte from Telemetry
    Device SW Telemetry
    version
    Locked Maximums Status OFF Previously programmed value.
    Maximum Basal Rate 0.2 Previously programmed value. Units/hour 0.1
    Maximum Bolus 10 Previously programmed value. Units 0.2
    Medication Remaining 0 Previously programmed value. Units
    Minutes 0 minutes Previously programmed value. Dependent on 1 minute
    Time Format
    parameter setting.
    Month JAN Previously programmed value.
    Password Character 1 Y Previously programmed value.
    Password Character 2 I Previously programmed value.
    Password Character 3 Q Previously programmed value.
    Password Character 4 8 Previously programmed value.
    Password Entry 0 0
    Character 1-4
    Personal Event Status OFF Previously programmed value
    Personal ID Character 1-32 0 Previously programmed value.
    ECD Alarm Type HIGH Previously programmed value.
    CD software Version 2-byte 2-byte stored value.
    stored
    value.
    Priming Bolus [((Pump [((Pump Volume) + Units
    Volume) + (Catheter Volume)) ×
    (Catheter (Insulin Concentration)]
    Volume)) ×
    (Insulin
    Concentrati-
    on)]
    Profile Basal Rate Amount Dashes Previously programmed value. u/h 0.1
    Profile Basal Previous Previously programmed value. Dependent on 30 minutes
    Rate Start Time start time Time Format
    plus 30 parameter setting.
    minutes
    Refill Amount 0.1 0.1 Grams 0.1
    Temporary Basal Rate Dashes Dashes units/hour 0.1
    Amount
    Temporary Basal Rate Dashes Dashes Hours:minutes 30 minutes
    Duration
    Time Format
    12 HOUR Previously programmed value.
    VariableBolus Status OFF Previously programmed value.
    Year 2000 Previously programmed value. 1 year
  • [0441]
    PART 2 - External Communication Device Parameter, Summary
    Interface Interface Number of
    Parameter Minimum Maximum Options Records
    Accuracy Status
    Audio Bolus Increment 0.4 0.8
    Audio Bolus Status ON or OFF
    Audio Feedback Status ON or OFF
    Auto-Off Duration DISABLED 16
    and then 1
    Basal Rate Total
    Bolus Amount 512
    Bolus Delivery Type NORMAL, DUAL,
    OR SQUARE
    Bolus Status
    Bolus Time &Date 512
    Daily Total Basal Amount 120
    Daily Total Bolus Amount 120
    Daily Total Date 120
    Day 1 31
    Delivery Accuracy 0 100
    Delivery Pattern A, B, or C
    Diagnostic Rate 10 240 for U-400,
    300 for U-500
    Event Time & Date 512
    Event Type MEAL, SNACK, SICK, 512
    EXERCISE, A, B, C.
    Extended Bolus Amount Dashes and Dependent on
    then 0.2 U Maximum Bolus
    parameter
    Extended Bolus Duration 30 minutes 4 hours
    Extracted Amount Dashes and 25
    then 0.1 U
    Factory Password
    1-4
    Hour 0 11:00 PM
    Immediate Bolus Amount Dashes and Dependent on
    then 0.2 U Maximum Bolus
    parameter
    Insulin Concentration U-400, or
    U-500
    Implantable Device
    SW version
    Locked Maximums ON or OFF
    Status
    Maximum Basal Rate 0.2 35
    Maximum Bolus 0 25
    Medication Remaining
    Minutes 0 minutes 59 minutes
    Month JAN, FEB, MAR,
    APR, MAY, JUN,
    JUL, AUG, SEP,
    OCT, NOV, DEC
    Password Character 1 number 0 letter Z
    Password Character 2 number 0 letter Z
    Password Character 3 number 0 letter Z
    Password Character 4 number 0 letter Z
    Password Entry Character number 0 letter Z
    1-4
    Personal Event Status ON or OFF
    Personal ID Character number 0 letter Z
    1-32
    External Communication HIGH, LOW, or
    Device Alarm Type VIBRATE
    CD software Version
    Priming Bolus
    Profile Basal Rate Dashes and dependent on 48 per
    Amount then 0.1 Maximum Basal Delivery
    Rate parameter Pattern
    Profile Basal previous start 11:30 PM 48 per
    Rate Start Time time plus 30 Delivery
    minutes Pattern
    (except if it is
    Profile 1,
    which always
    starts at
    12:00 am)
    Refill Amount 0.1 25
    Temporary Basal Dashes and Dependent on
    Rate Amount then 0.1 Maximum Basal
    Rate parameter
    Temporary Basal Dashes and 24 hours
    Rate Duration then 30
    minutes
    Time Format 12 HOUR
    or 24
    HOUR
    Variable Bolus Status ON or OFF
    Year 1999 2050
  • The external communication device may use its IrDA port to communicate with other secondary external devices, such as a desktop personal computers. The external communication device may communicate with two classes of secondary devices: (1) devices for extracting information from the communication device for providing primarily health care related analysis for use by the patient or physician, i.e. a clinician station, and (2) devices for extracting information from and writing information to the communication device for system related diagnostics and problem solving, i.e. diagnostic station. [0442]
  • The clinician station may be a desktop computer running a program designed to monitor and display diagnostic information provided by the external communication device and an implantable device for a health care professional. The clinician station type external device cannot write data to the external communication device or the implantable device. [0443]
  • The diagnostic station may be a desktop computer running a program designed to aid in the diagnosis of system problems through communication with the implantable device and the external communication device. The diagnostic station has the capability to write data to the implantable device and to the external communication device. [0444]
  • A full-duplex link between, the external communication device and an second external device such as the clinician station is provided through the serial communication port. This port provides transmit and receive lines that support infrared LEDs for establishing functional connections to external devices. The transmit and receive lines also support RS232 connections to external devices. [0445]
  • Messages are initiated by the second external device. The receiving device allows a predefined time before concluding the transmission has ended. If this time is exceeded before a complete message is received, the receiving device responds with a “no acknowledge” message. The receiver expects the next byte to be the first byte of a message. [0446]
  • The external communication device maintains a low power state by disabling some of the UART circuitry. The second external device transmits a “wake-up” message in order to enable the external communication device receiver. When the external communication device is in the UART low power state and a byte is received, the external communication device enables all UART capabilities appropriate for communication with an external device. When the external communication device UART is idle for 10 seconds it enters the low-power state. All messages except for a wake-up and listen message follow a format similar to that noted above for an RF telemetry message. [0447]
  • For safety reasons the external communication device recognizes two distinct communication channels using the IR port: the clinician channel and the diagnostic channel. The clinician station software uses a clinician channel to communicate to the external communication device. The messages that are available for each channel type are different. The clinician channel messages do not modify external communication device or implantable device memory but diagnostic channel messages can. A specific channel closes when the “channel close” message is received or when the interval between messages exceeds a predefined channel time out interval. Each channel is closed upon system start-up and remains closed a “channel open” message is received for that specific channel. [0448]
  • While the above description has provided various teachings concerning how the communication device may handle various RF telemetry operations, IR communication operations, alarm notifications, and other functional activities, many other such operations are definable. These other operations may be defined in manners that are analogous to the teachings presented above or in ways that are consistent with those teachings and do not lead to communication ambiguity or other potential mishandling of medical device operation. [0449]
  • The above embodiment and its alternatives provide numerous enhancements in the electronic control of the medical device. These improvements provide more functional, reliable, safe, user friendly, convenience operation of an implantable medical device and more generically of an ambulatory medical device. [0450]
  • While the above embodiment has primarily been concerned with an implantable infusion pump that dispenses insulin using a piston type (i.e. pulsatile) pump mechanism, the electronic control features disclosed herein may be used in other ambulatory devices such as implantable pacemakers, defibrillators, other implantable tissue stimulators, implantable physiologic sensors such as electrochemical oxygen sensors, peroxide sensors, or enzymatic sensors such as glucose sensors, externally carried infusion pumps, implantable infusion pumps that use other pumping mechanisms or simply used excess pressure and controlled flow elements to infuse various medications and drugs such as analgesics, drugs for treating AIDS, drugs for treating psychological disorders and the like. For example, the features presented above may be used with an external infusion pump that may or may not have a built in display and keypad but is equipped with a telemetry system that can communicate with a physically separated communication device so that the pump need not be accessed in order to provide commands to it and receive data from it. [0451]
  • In these various alternatives, the physical, electronic, and programmed features of the communication device and implantable device may have different components and features than presented above for the implantable pump system so that their desired medical functionality and safety requirements are achieved and such that appropriate control and feedback is provided between the medical device and its communication device. [0452]
  • In other alternative embodiments the medical device may include two medical devices such as an implantable pump and an implantable sensor. The pump may dispense a drug whose physiological impact on the body (e.g. analgesic impact) is ascertained by the sensor or alternatively the sensor may supply a physiological reading that indicates a need for infusion of the drug. The pump may operate in a closed loop manner with the sensor or it may operate in an open loop manner where the patient is required to interpret sensor output information and is required to issue appropriate infusion commands to the pump. For example, in the case of a diabetic patient, the drug may be insulin and the sensor may detect glucose level. [0453]
  • In other alternative embodiments two medical devices may be implanted adjacent one another or at an extended distance from one another. If not placed in physical contact with one another, a lead may be used to provide power conduction from one device to the other and also be used to conduct communication signals between the devices. Alternatively, each device may include at least one telemetry system that allows direct communication between each or allows indirect communication to occur via the external communication device or other external device. Each device may be supplied with its own power supply. Depending on the communication requirements each device may use two way communication (i.e. both outbound and inbound communication) or allow only one way communication (i.e. outbound communication or possibly inbound communication). [0454]
  • In other alternatives, both the medical device and the communication device may be external devices (e.g. an external pump and an external RF telemetry based communication device). In still further alternatives, a first type of medical device may be implanted (e.g. an infusion pump or a sensor) while a second medical device may be external (e.g. the opposite of a sensor or an infusion pump). Where at least one of the medical devices is external, it may also function as the communication device for the other medical device in which case it may possess a display for providing information to the patient and a keypad for allowing entry of commands for issuance to the implantable device as well as for direct use by itself. Even if at least one of the medical devices is external, it may be inconvenient to access that device when information is needed or commands must be given, as such an external, non-medical communication device may be supplied that has information output (e.g. display) capabilities and input (e.g. keypad) capabilities. If a separate communication device is provided, the external medical device may or may not have display and input capabilities. [0455]
  • The telemetry features presented above may be used with various forms of distant communication (e.g. between the implantable device and other external devices or between the external communication device and other external devices). For example communication may occur via various electromagnetic links like IR, optical links, longer or shorter wavelength RF, audio links, ultrasonic links, acoustic links, inductive links, and the like. Various telemetry systems may be used. Telemetry systems may be of the analog type, digital type, or mixed. [0456]
  • In other embodiments two independent processors may be used that operate from a single timing chain. In these alternatives, it is preferable that at least one of the timing signals (e.g. one of the lower frequency timers) be monitored by an independently timed watchdog circuit to reduce the risk of timing problems going undetected. [0457]
  • In still additional embodiments, an implantable glucose sensor may be used in conjunction with an implantable insulin pump to provide feedback to the patient or physician on the effectiveness of the insulin delivery system. The patient could use the feedback to assist in making insulin delivery decisions in an open loop manner. Alternatively, the operation of the pump could be tied to the sensor output in a more or less closed loop manner to give a more automated character to system operation. Insulin may be infused without any user intervention, without pre-delivery information, and even without direct post delivery feedback. In a less automated closed loop system, drug infusion recommendations could be derived by the system and presented to the user before delivery or the system could require user acknowledgment prior to proceeding with delivery for amounts or rates exceed a predefined limit. The implantable sensor may have its own power supply or may receive power from the control circuitry provided within the pump housing through a physical lead that connects them. Power may be supplied through one or more independent leads or alternatively may be transferred over one or more data lines through the communication signals themselves. Communication may be exchanged in various ways including, for example, via galvanic leads, RF telemetry, fiber optics, and the like, and may be of digital, analog, or combined form. The sensor system may include a plurality of sensor elements which might allow continued glucose data to be supplied even though some portion of the sensors stop operating, lose calibration or produce questionable readings. The most preferred sensors would include electronic processing capability in the form of an integrated circuit mounted in or forming a part of a housing for the sensor. This configuration has the advantage of allowing digital communications between the physical sensor and any separated electronic control module. [0458]
  • Further teachings concerning implantable sensors and implantable sensor systems are found in a number of patents issued to D. A. Gough, including (1) U.S. Pat. No. 4,484,987, entitled “Method And Membrane Applicable To Implantable Sensor”; (2) U.S. Pat. No. 4,627,906, entitled “Electrochemical Sensor Having Improved Stability”; (3) U.S. Pat. No. 4,671,288, entitled “Electrochemical Cell Sensor For Continuous Short-Term Use In Tissues And Blood”; (4) U.S. Pat. No. 4,703,756, entitled “Complete Glucose Monitoring System With An Implantable Telemetered Sensor Module”; and (5) U.S. Pat. No. 4,781,798, entitled “Transparent Multi-Oxygen Sensor Array And Method Of Using Same”. Each of these patents is incorporated herein by reference as if set forth in full. [0459]
  • Still further teachings concerning implantable sensors and sensor systems are found in a number of patents issued to J. H. Schulman, et al., including (1) U.S. Pat. No. 5,497,772, entitled “Glucose Monitoring System”; (2) U.S. Pat. No. 5,651,767, entitled “Replaceable Catheter System for Physiological Sensors, Stimulating Electrodes and/or Implantable Fluid Delivery Systems”; (3) U.S. Pat. No. 5,750,926, entitled “Hermetically Sealed Electrical Feedthrough For Use With Implantable Electronic Devices”; (4) U.S. Pat. No. 6,043,437, entitled “Alumina Insulation for Coating Implantable Components and Other Microminiature Devices”; (5) U.S. Pat. No. 6,088,608, entitled “Implantable Sensor and Integrity Test Therefor”; and (6) U.S. Pat. No. 6,119,028, entitled “Implantable Enzyme-Based Monitoring Systems Having Improved Longevity Due to Improved Exterior Surfaces”. Each of these patents is incorporated herein by reference as if set forth in full. [0460]
  • Additional further teachings concerning implantable sensors and sensor systems are found in (1) U.S. Pat. No. 5,917,346, issued to J. C. Gord, et al., and entitled “Low power current-to-frequency converter”; (2) U.S. Pat. No. 5,999,848, issued to J. C. Gord, and entitled “Daisy Chainable Sensors for Implantation in Living Tissue”; (3) U.S. Pat. No. 5,999,849, issued to L. D. Canfield, et al., and entitled “Low Power Rectifier Circuit for Implantable Medical Devices”; and (4) U.S. Pat. No. 6,081,736, issued to M. S. Colvin, et al., and entitled “Implantable Enzyme-Based Monitoring Systems Adapted for Long Term Use”. Each of these patents is incorporated herein by reference as if set forth in full. [0461]
  • Further teachings concerning implantable infusion pumps are found in a number of patents by R. E. Fischell, including (1) U.S. Pat. No. 4,373,527, entitled “Implantable, Programmable Medication Infusion System”; (2) U.S. Pat. No. 4,494,950, entitled “Infusion Device Intended for Implantation in a Living Body”; (3) U.S. Pat. No. 4,525,165, entitled “Fluid Handling System for Medication Infusion System”; (4) U.S. Pat. No. 4,573,994, entitled “Refillable Medication Infusion Apparatus”; (5) U.S. Pat. No. 4,594,058, entitled “Single Valve Diaphragm Pump with Decreased Sensitivity to Ambient Conditions”; (6) U.S. Pat. No. 4,619,653, entitled “Apparatus For Detecting At Least One Predetermined Condition And Providing An Informational Signal In Response Thereto In A Medication Infusion System”; (7) U.S. Pat. No. 4,661,097, entitled “Method for Clearing a Gas Bubble From a Positive Displacement Pump Contained Within a Fluid Dispensing System”; (8) U.S. Pat. No. 4,731,051, entitled “Programmable Control Means for Providing Safe and Controlled Medication Infusion”; and (9) U.S. Pat. No. 4,784,645, entitled, “Apparatus For Detecting A Condition Of A Medication Infusion System And Providing An Informational Signal In Response Thereto”. Each of these patents is incorporated herein by reference as if set forth in full. [0462]
  • Still further teachings concerning infusion pumps are found in a number of patents by Franetzki, including (1) U.S. Pat. No. 4,191,181, entitled “Apparatus For Infusion of Liquids”, (2) U.S. Pat. No. 4,217,894, entitled “Apparatus for Supplying Medication to the Human or Animal Body”; (3) U.S. Pat. No. 4,270,532, entitled “Device for the Pre-programmable Infusion of Liquids”; (4) U.S. Pat. No. 4,282,872, entitled “Device for the Pre-programmable Infusion of Liquids”, U.S. Pat. No. 4,373,527, entitled “Implantable, Programmable Medication Infusion System”; (5) U.S. Pat. No. 4,511,355, entitled “Plural Module Medication Delivery System”, (6) U.S. Pat. No. 4,559,037, entitled “Device for the Pre-programmable Infusion of Liquids”; (7) U.S. Pat. No. 4,776,842, entitled “Device for the Administration of Medications”. Each of these patents is incorporated herein by reference as if set forth in full. [0463]
  • Teachings concerning tissue stimulators are found in a number of patents by J. H. Schulman, including (1) U.S. Pat. No. 5,193,539, entitled “Implantable microstimulator”; (2) U.S. Pat. No. 5,193,540; entitled “Structure and Method of Manufacture of an Implantable Microstimulator”; and (3) U.S. Pat. No. 5,358,514, entitled “Implantable Microdevices with Self Attaching Electrodes”. Further teachings are also found in (1) U.S. Pat. No. 5,957,958, by Loeb et al., entitled “Implantable nerve or muscle stimulator e.g. a cochlear prosthesis”, in (2) U.S. Pat. No. 5,571,148, by G. E. Loeb, et al., entitled “Implantable Multichannel Stimulator”; and in (3) PCT Publication No. WO 00/74751, by A. E. Mann, and entitled “Method and Apparatus for Infusing Liquids Using a Chemical Reaction in an Implanted Infusion Device”. Each of these publications is incorporated herein by reference as if set forth in full. [0464]
  • The control of an implantable sensor could be provided through the functionality of one or both Processor ICs. One Processor IC could supply power and/or control signals to the sensor(s) and receive data back from the sensor, while the other processor could monitor the activity to ensure that sensor activity meets certain predefined guidelines. [0465]
  • In other embodiments, the External Communication Device of the first embodiment could be functionally linked to an external glucose sensor system such as the continuous glucose monitoring system (CGMS) offered by Minimed Inc. of Northridge, Calif. The link may be established, for example, through a physical lead or by RF telemetry. [0466]
  • In other embodiments other implantable, or external, sensor systems that measure something other than glucose could also be functionally coupled to the implantable device either to receive power and/or to provide data. Other such sensors might include oxygen sensors, peroxide sensors, pulse rate sensors, temperature sensors, accelerometers, and the like. [0467]
  • In still other alternative embodiments, the electronic control system of the first embodiment could be configured to control one or more implantable sensors or electrical stimulators with or without infusion functionality incorporated into the implantable device. [0468]
  • Further embodiments will be apparent to those of skill in the art upon review of the disclosure provided herein. Still further embodiments may be derived from the teachings set forth explicitly herein in combination with the teachings found in the various patent applications. [0469]
  • While the description herein sets forth particular embodiments, it is believed that those of skill in the art will recognize many variations to the presented embodiments based on the teachings herein, as such it is believed that many additional modifications may be made without departing from the spirit of the teachings herein. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention. The disclosed embodiments are therefore to be considered as illustrative and not necessarily restrictive, the scope of the invention being indicated by the appended claims, rather than the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. [0470]

Claims (21)

1.-17. (Cancelled)
18. A medical system, comprising:
a) an ambulatory medical device (MD) comprising MD electronic control circuitry that further comprises at least one MD telemetry system and at least one MD processor that controls, at least in part, operation of the MD telemetry system and operation of the medical device, wherein the medical device is configured to provide a treatment to a body of a patient or to monitor a selected state of the body; and
b) a communication device (CD) comprising CD electronic control circuitry that further comprises at least one CD telemetry system and at least one CD processor that controls, at least in part, operation of the CD telemetry system and operation of the communication device, wherein the CD telemetry system sends messages to or receives messages from the MD telemetry system,
wherein the communication device is configured to receive status information on an MD battery via telemetry from the medical device.
19. The system of claim 18 wherein a first portion of the MD telemetry system is incorporated into the MD processor and a second portion of the MD telemetry system is external to the MD processor, or wherein a first portion of the CD telemetry system is incorporated into the CD processor and a second portion of the CD telemetry system is external to the CD processor.
20. The system of claim 18 wherein (1) the MD electronic control circuitry comprises at least one external MD functional module, other than the second portion of the MD telemetry system, that is external to the MD processor, (2) the CD electronic control circuitry comprises at least one external CD functional module, other than the second portion of the CD telemetry system, that is external to the CD processor, (3) the MD processor comprises an comprises an internal CD CPU and at least one other internal CD functional module.
21. The system of claim 18 wherein the medical device provides a periodic indication of the MD battery voltage when the MD battery is experiencing a current load that is closer to the minimum load during normal operation of the medical device than a maximum load during normal operation.
22. The system of claim 18 wherein the medical device provides a periodic indication of the MD battery voltage when the MD battery is experiencing a current load which is closer to the maximum load during normal operation than a minimum load during normal operation.
23. The system of claim 18 wherein the medical device provides an indication of MD battery status at least once a week.
24. The system of claim 23 wherein the medical device provides an indication of MD battery status at least once every two days.
25. The system of claim 23 wherein MD battery status is provided using both a lower current load and a higher current load at least once a week.
26. The system of claim 25 wherein MD battery status is provided using both a lower current load and a higher current load at least once a every two days.
27. The system of claim 18 wherein the MD battery is rechargeable.
28. The system of claim 18 wherein the MD battery is not rechargeable.
29. The system of claim 18 wherein the communication device provides an auditory, visual, or tactile warning when the MD battery is estimated to be capable of powering the medical device for less than a predetermined additional amount of time.
30. The system of claim 29 wherein the predetermined time is less than about six months.
31. The system of claim 30 wherein the predetermined time is less than about three months.
32. The system of claim 31 wherein the predetermined time is less than about one month.
33. The system of claim 18 wherein the medical device comprises at least one of (1) an implantable infusion pump for selectively dispensing a selected drug, (2) an implantable infusion pump for selectively dispensing insulin, (3) an implantable sensor for sensing a selected state of the body, (4) an implantable sensor for sensing glucose level, or (5) an implantable electrode for selectively stimulating a portion of the body of the patient.
34.-39. (Cancelled)
40. A method of conserving power in a medical system having an ambulatory medical device (MD), for delivering a substance to a body of a patient or for monitoring the body of the patient, with at least one MD processor and at least one MD functional module, the method comprising the steps of:
enabling clock signals used by the at least one MD functional module when the module is needed for operation of the medical device; and
disabling clock signals used by the at least one MD functional module when the module is not needed for operation of the medical device.
41. The method of claim 40 wherein the MD functional module is a synchronous serial interface module, an alarm interface module, a pump interface module, an analog-to-digital converter module, or a timer module.
42. The method of claim 41 wherein the MD functional module is a telemetry module.
US10/824,083 2000-01-21 2004-04-14 Ambulatory medical apparatus with handheld communication device Abandoned US20040193090A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/824,083 US20040193090A1 (en) 2000-01-21 2004-04-14 Ambulatory medical apparatus with handheld communication device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17741400P 2000-01-21 2000-01-21
US09/768,204 US6740075B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US10/824,083 US20040193090A1 (en) 2000-01-21 2004-04-14 Ambulatory medical apparatus with handheld communication device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/768,204 Division US6740075B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device

Publications (1)

Publication Number Publication Date
US20040193090A1 true US20040193090A1 (en) 2004-09-30

Family

ID=26873268

Family Applications (35)

Application Number Title Priority Date Filing Date
US09/768,197 Expired - Lifetime US6974437B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,193 Expired - Lifetime US6958705B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,205 Expired - Lifetime US6811534B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US09/768,035 Expired - Lifetime US6811533B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,044 Expired - Lifetime US6562001B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,204 Expired - Lifetime US6740075B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,221 Expired - Lifetime US6577899B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,199 Expired - Lifetime US6648821B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,045 Expired - Lifetime US6635014B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method having telemetry modifiable control software
US09/768,201 Expired - Lifetime US6694191B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method having telemetry modifiable control software
US09/768,196 Abandoned US20030065308A1 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,209 Expired - Lifetime US6758810B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,206 Expired - Lifetime US6427088B1 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods
US09/768,210 Expired - Lifetime US6668196B1 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,208 Expired - Lifetime US6571128B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,207 Expired - Lifetime US6564105B2 (en) 2000-01-21 2001-01-22 Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
US09/768,194 Expired - Lifetime US6873268B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,198 Expired - Lifetime US6810290B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,202 Expired - Lifetime US6687546B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,203 Expired - Lifetime US6585644B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US09/768,042 Expired - Lifetime US6733446B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US09/768,043 Expired - Lifetime US6813519B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,036 Expired - Lifetime US6659948B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US10/208,721 Expired - Lifetime US6950708B2 (en) 2000-01-21 2002-07-29 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening
US10/411,424 Active 2025-09-21 US7678071B2 (en) 2000-01-21 2003-04-10 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US10/437,366 Expired - Lifetime US7171274B2 (en) 2000-01-21 2003-05-12 Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
US10/824,083 Abandoned US20040193090A1 (en) 2000-01-21 2004-04-14 Ambulatory medical apparatus with handheld communication device
US10/843,196 Expired - Lifetime US7024245B2 (en) 2000-01-21 2004-05-11 Ambulatory medical apparatus and method using a robust communication protocol
US10/867,786 Expired - Fee Related US7347819B2 (en) 2000-01-21 2004-06-15 Ambulatory medical apparatus and method using a robust communication protocol
US10/900,823 Active 2024-05-26 US7831310B2 (en) 2000-01-21 2004-07-28 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US11/347,841 Abandoned US20060173444A1 (en) 2000-01-21 2006-02-03 Ambulatory medical apparatus with hand held communication device
US12/902,038 Abandoned US20110270045A1 (en) 2000-01-21 2010-10-11 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US12/913,234 Expired - Fee Related US8938306B2 (en) 2000-01-21 2010-10-27 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US13/039,259 Expired - Fee Related US8568356B2 (en) 2000-01-21 2011-03-02 Ambulatory medical apparatus with hand held communication device
US14/528,909 Expired - Lifetime US9533096B2 (en) 2000-01-21 2014-10-30 Microprocessor controlled ambulatory medical apparatus with hand held communication device

Family Applications Before (26)

Application Number Title Priority Date Filing Date
US09/768,197 Expired - Lifetime US6974437B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,193 Expired - Lifetime US6958705B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,205 Expired - Lifetime US6811534B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US09/768,035 Expired - Lifetime US6811533B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,044 Expired - Lifetime US6562001B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,204 Expired - Lifetime US6740075B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,221 Expired - Lifetime US6577899B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,199 Expired - Lifetime US6648821B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,045 Expired - Lifetime US6635014B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method having telemetry modifiable control software
US09/768,201 Expired - Lifetime US6694191B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method having telemetry modifiable control software
US09/768,196 Abandoned US20030065308A1 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,209 Expired - Lifetime US6758810B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,206 Expired - Lifetime US6427088B1 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using telemetry system with predefined reception listening periods
US09/768,210 Expired - Lifetime US6668196B1 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,208 Expired - Lifetime US6571128B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,207 Expired - Lifetime US6564105B2 (en) 2000-01-21 2001-01-22 Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data
US09/768,194 Expired - Lifetime US6873268B2 (en) 2000-01-21 2001-01-22 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US09/768,198 Expired - Lifetime US6810290B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus with hand held communication device
US09/768,202 Expired - Lifetime US6687546B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,203 Expired - Lifetime US6585644B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US09/768,042 Expired - Lifetime US6733446B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US09/768,043 Expired - Lifetime US6813519B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a robust communication protocol
US09/768,036 Expired - Lifetime US6659948B2 (en) 2000-01-21 2001-01-22 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods
US10/208,721 Expired - Lifetime US6950708B2 (en) 2000-01-21 2002-07-29 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening
US10/411,424 Active 2025-09-21 US7678071B2 (en) 2000-01-21 2003-04-10 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US10/437,366 Expired - Lifetime US7171274B2 (en) 2000-01-21 2003-05-12 Method and apparatus for communicating between an ambulatory medical device and a control device via telemetry using randomized data

Family Applications After (8)

Application Number Title Priority Date Filing Date
US10/843,196 Expired - Lifetime US7024245B2 (en) 2000-01-21 2004-05-11 Ambulatory medical apparatus and method using a robust communication protocol
US10/867,786 Expired - Fee Related US7347819B2 (en) 2000-01-21 2004-06-15 Ambulatory medical apparatus and method using a robust communication protocol
US10/900,823 Active 2024-05-26 US7831310B2 (en) 2000-01-21 2004-07-28 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US11/347,841 Abandoned US20060173444A1 (en) 2000-01-21 2006-02-03 Ambulatory medical apparatus with hand held communication device
US12/902,038 Abandoned US20110270045A1 (en) 2000-01-21 2010-10-11 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US12/913,234 Expired - Fee Related US8938306B2 (en) 2000-01-21 2010-10-27 Microprocessor controlled ambulatory medical apparatus with hand held communication device
US13/039,259 Expired - Fee Related US8568356B2 (en) 2000-01-21 2011-03-02 Ambulatory medical apparatus with hand held communication device
US14/528,909 Expired - Lifetime US9533096B2 (en) 2000-01-21 2014-10-30 Microprocessor controlled ambulatory medical apparatus with hand held communication device

Country Status (1)

Country Link
US (35) US6974437B2 (en)

Cited By (266)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040145565A1 (en) * 2003-01-13 2004-07-29 Yao-Chia Yang Separable build-in mouse input device
US20060089539A1 (en) * 2004-10-25 2006-04-27 Saul Miodownik Integrated messages from multiple patient care devices
US20060107148A1 (en) * 2004-10-29 2006-05-18 Codman Neuro Sciences Sarl. Automatic self-testing of an internal device in a closed system
US20060113396A1 (en) * 2004-12-01 2006-06-01 Derocco Paul Implantable device and communication integrated circuit implementable therein
US20060274764A1 (en) * 2005-06-02 2006-12-07 Mah Donald T Power saving methods in gateway
US20070020580A1 (en) * 2005-06-03 2007-01-25 Manfred Harre Dental material processing device, information device, communication method, and system
WO2007142867A2 (en) * 2006-05-31 2007-12-13 Calibra Medical, Inc. Disposable infusion device with linear peristaltic pump
US20070287960A1 (en) * 2006-05-31 2007-12-13 Seattle Medical Technologies Disposable infusion device with medicament level indicator
US20080077184A1 (en) * 2006-09-27 2008-03-27 Stephen Denker Intravascular Stimulation System With Wireless Power Supply
US20080132973A1 (en) * 2006-11-28 2008-06-05 Peter Carl Lord Method, Apparatus and System For Assigning Remote Control Device to Ambulatory Medical Device
US20090043290A1 (en) * 2007-08-09 2009-02-12 Daniel Hernandez Villegas Drug Delivery Safety System
US20090088732A1 (en) * 2007-10-02 2009-04-02 Daniel Hernandez Villegas Rapid Refill Programming for Implantable Drug Pump
US20090164239A1 (en) * 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US20090307520A1 (en) * 2008-06-06 2009-12-10 Bruno Anselmi Apparatus and Method for Processing Wirelessly Communicated Information Within an Electronic Device
US20090321076A1 (en) * 2004-04-12 2009-12-31 Baker Hughes Incorporated Completion Method with Telescoping Perforation & Fracturing Tool
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US7679407B2 (en) 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US7756561B2 (en) 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US7768387B2 (en) 2007-04-14 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7768386B2 (en) 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7822455B2 (en) 2006-02-28 2010-10-26 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US20100280502A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Modular medical pump
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7911817B2 (en) 2008-09-18 2011-03-22 Dell Products L.P. Systems and methods for controlling energy consumption of AC-DC adapters
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US7922458B2 (en) 2002-10-09 2011-04-12 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20110150251A1 (en) * 2009-12-21 2011-06-23 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US7981034B2 (en) 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8016789B2 (en) 2008-10-10 2011-09-13 Deka Products Limited Partnership Pump assembly with a removable cover assembly
US8029443B2 (en) 2003-07-15 2011-10-04 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US8029460B2 (en) 2005-03-21 2011-10-04 Abbott Diabetes Care Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8034026B2 (en) 2001-05-18 2011-10-11 Deka Products Limited Partnership Infusion pump assembly
US8047811B2 (en) 2002-10-09 2011-11-01 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8066672B2 (en) 2008-10-10 2011-11-29 Deka Products Limited Partnership Infusion pump assembly with a backup power supply
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8085151B2 (en) 2007-06-28 2011-12-27 Abbott Diabetes Care Inc. Signal converting cradle for medical condition monitoring and management system
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8112138B2 (en) 2005-06-03 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8113244B2 (en) 2006-02-09 2012-02-14 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US8116840B2 (en) 2003-10-31 2012-02-14 Abbott Diabetes Care Inc. Method of calibrating of an analyte-measurement device, and associated methods, devices and systems
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8127046B2 (en) 2006-12-04 2012-02-28 Deka Products Limited Partnership Medical device including a capacitive slider assembly that provides output signals wirelessly to one or more remote medical systems components
US8132037B2 (en) 2008-06-06 2012-03-06 Roche Diagnostics International Ag Apparatus and method for processing wirelessly communicated data and clock information within an electronic device
US8135548B2 (en) 2006-10-26 2012-03-13 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US8140142B2 (en) 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8160670B2 (en) 2005-12-28 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US20120119900A1 (en) * 2010-11-15 2012-05-17 Lewis Innovative Technologies Wireless emergency vehicle light and siren kit
US8185181B2 (en) 2009-10-30 2012-05-22 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US8206296B2 (en) 2006-08-07 2012-06-26 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US8211016B2 (en) 2006-10-25 2012-07-03 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8223028B2 (en) 2008-10-10 2012-07-17 Deka Products Limited Partnership Occlusion detection system and method
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20120213227A1 (en) * 2011-02-23 2012-08-23 Morten Gravild Bjerregaard Jaeger Method and System for Routing Information in a Network
US8252229B2 (en) 2008-04-10 2012-08-28 Abbott Diabetes Care Inc. Method and system for sterilizing an analyte sensor
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8262616B2 (en) 2008-10-10 2012-09-11 Deka Products Limited Partnership Infusion pump assembly
US8267892B2 (en) 2008-10-10 2012-09-18 Deka Products Limited Partnership Multi-language / multi-processor infusion pump assembly
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287495B2 (en) 2009-07-30 2012-10-16 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8344966B2 (en) 2006-01-31 2013-01-01 Abbott Diabetes Care Inc. Method and system for providing a fault tolerant display unit in an electronic device
US8343093B2 (en) 2002-10-09 2013-01-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US8353881B2 (en) 2005-12-28 2013-01-15 Abbott Diabetes Care Inc. Infusion sets for the delivery of a therapeutic substance to a patient
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US8414563B2 (en) 2007-12-31 2013-04-09 Deka Products Limited Partnership Pump assembly with switch
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8496646B2 (en) 2007-02-09 2013-07-30 Deka Products Limited Partnership Infusion pump assembly
US8512244B2 (en) 2006-06-30 2013-08-20 Abbott Diabetes Care Inc. Integrated analyte sensor and infusion device and methods therefor
US8515518B2 (en) 2005-12-28 2013-08-20 Abbott Diabetes Care Inc. Analyte monitoring
US8515517B2 (en) 2006-10-02 2013-08-20 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8514086B2 (en) 2009-08-31 2013-08-20 Abbott Diabetes Care Inc. Displays for a medical device
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
US8583205B2 (en) 2008-03-28 2013-11-12 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US8638220B2 (en) 2005-10-31 2014-01-28 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US8641618B2 (en) 2007-06-27 2014-02-04 Abbott Diabetes Care Inc. Method and structure for securing a monitoring device element
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8650937B2 (en) 2008-09-19 2014-02-18 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8708376B2 (en) 2008-10-10 2014-04-29 Deka Products Limited Partnership Medium connector
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8798934B2 (en) 2009-07-23 2014-08-05 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US8795252B2 (en) 2008-08-31 2014-08-05 Abbott Diabetes Care Inc. Robust closed loop control and methods
US8804988B2 (en) 2010-04-13 2014-08-12 Starkey Laboratories, Inc. Control of low power or standby modes of a hearing assistance device
US8811639B2 (en) 2010-04-13 2014-08-19 Starkey Laboratories, Inc. Range control for wireless hearing assistance device systems
US8821433B2 (en) 2006-10-17 2014-09-02 Tandem Diabetes Care, Inc. Insulin pump having basal rate testing features
US8827979B2 (en) 2007-03-19 2014-09-09 Insuline Medical Ltd. Drug delivery device
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8961458B2 (en) 2008-11-07 2015-02-24 Insuline Medical Ltd. Device and method for drug delivery
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9173996B2 (en) 2001-05-18 2015-11-03 Deka Products Limited Partnership Infusion set for a fluid pump
US9180245B2 (en) 2008-10-10 2015-11-10 Deka Products Limited Partnership System and method for administering an infusible fluid
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US9335910B2 (en) 2012-04-23 2016-05-10 Tandem Diabetes Care, Inc. System and method for reduction of inadvertent activation of medical device during manipulation
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9420385B2 (en) 2009-12-21 2016-08-16 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US9486571B2 (en) 2013-12-26 2016-11-08 Tandem Diabetes Care, Inc. Safety processor for wireless control of a drug delivery device
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9533096B2 (en) 2000-01-21 2017-01-03 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9615780B2 (en) 2007-04-14 2017-04-11 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9669160B2 (en) 2014-07-30 2017-06-06 Tandem Diabetes Care, Inc. Temporary suspension for closed-loop medicament therapy
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US9715327B2 (en) 2012-06-07 2017-07-25 Tandem Diabetes Care, Inc. Preventing inadvertent changes in ambulatory medical devices
US9737656B2 (en) 2013-12-26 2017-08-22 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9774961B2 (en) 2005-06-05 2017-09-26 Starkey Laboratories, Inc. Hearing assistance device ear-to-ear communication using an intermediate device
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9795326B2 (en) 2009-07-23 2017-10-24 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US9833177B2 (en) 2007-05-30 2017-12-05 Tandem Diabetes Care, Inc. Insulin pump based expert system
US9854369B2 (en) 2007-01-03 2017-12-26 Starkey Laboratories, Inc. Wireless system for hearing communication devices providing wireless stereo reception modes
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US9962486B2 (en) 2013-03-14 2018-05-08 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9980670B2 (en) 2002-11-05 2018-05-29 Abbott Diabetes Care Inc. Sensor inserter assembly
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10003379B2 (en) 2014-05-06 2018-06-19 Starkey Laboratories, Inc. Wireless communication with probing bandwidth
US10016559B2 (en) 2009-12-04 2018-07-10 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
US10022499B2 (en) 2007-02-15 2018-07-17 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10051385B2 (en) 2006-07-10 2018-08-14 Starkey Laboratories, Inc. Method and apparatus for a binaural hearing assistance system using monaural audio signals
US10049768B2 (en) 2002-02-28 2018-08-14 Tandem Diabetes Care, Inc. Programmable insulin pump
US10052049B2 (en) 2008-01-07 2018-08-21 Tandem Diabetes Care, Inc. Infusion pump with blood glucose alert delay
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US10111608B2 (en) 2007-04-14 2018-10-30 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10201656B2 (en) 2013-03-13 2019-02-12 Tandem Diabetes Care, Inc. Simplified insulin pump for type II diabetics
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US10258736B2 (en) 2012-05-17 2019-04-16 Tandem Diabetes Care, Inc. Systems including vial adapter for fluid transfer
US10357606B2 (en) 2013-03-13 2019-07-23 Tandem Diabetes Care, Inc. System and method for integration of insulin pumps and continuous glucose monitoring
US10357607B2 (en) 2007-05-24 2019-07-23 Tandem Diabetes Care, Inc. Correction factor testing using frequent blood glucose input
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US10555695B2 (en) 2011-04-15 2020-02-11 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10653834B2 (en) 2012-06-07 2020-05-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10963417B2 (en) 2004-06-04 2021-03-30 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US11049614B2 (en) 2013-03-15 2021-06-29 Tandem Diabetes Care, Inc. Field update of an ambulatory infusion pump system
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11213226B2 (en) 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
US11291763B2 (en) 2007-03-13 2022-04-05 Tandem Diabetes Care, Inc. Basal rate testing using frequent blood glucose input
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11364335B2 (en) 2006-02-09 2022-06-21 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11395877B2 (en) 2006-02-09 2022-07-26 Deka Products Limited Partnership Systems and methods for fluid delivery
US11404776B2 (en) 2007-12-31 2022-08-02 Deka Products Limited Partnership Split ring resonator antenna adapted for use in wirelessly controlled medical device
US11426512B2 (en) 2006-02-09 2022-08-30 Deka Products Limited Partnership Apparatus, systems and methods for an infusion pump assembly
US11464908B2 (en) 2019-02-18 2022-10-11 Tandem Diabetes Care, Inc. Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps
US11478623B2 (en) 2006-02-09 2022-10-25 Deka Products Limited Partnership Infusion pump assembly
US11497846B2 (en) 2006-02-09 2022-11-15 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US11497686B2 (en) 2007-12-31 2022-11-15 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11524151B2 (en) 2012-03-07 2022-12-13 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11523972B2 (en) 2018-04-24 2022-12-13 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11534542B2 (en) 2007-12-31 2022-12-27 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US11597541B2 (en) 2013-07-03 2023-03-07 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter
US11642283B2 (en) 2007-12-31 2023-05-09 Deka Products Limited Partnership Method for fluid delivery
US11717225B2 (en) 2014-03-30 2023-08-08 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
US11723841B2 (en) 2007-12-31 2023-08-15 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11890448B2 (en) 2006-02-09 2024-02-06 Deka Products Limited Partnership Method and system for shape-memory alloy wire control

Families Citing this family (1564)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
JPH04278450A (en) 1991-03-04 1992-10-05 Adam Heller Biosensor and method for analyzing subject
US7192450B2 (en) * 2003-05-21 2007-03-20 Dexcom, Inc. Porous membranes for use with implantable devices
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US20050033132A1 (en) 1997-03-04 2005-02-10 Shults Mark C. Analyte measuring device
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
DE69808965T2 (en) * 1997-12-04 2003-08-14 Roche Diagnostics Corp Method for configuring a handheld device
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
JPH11265544A (en) * 1998-03-16 1999-09-28 Fujitsu Ltd Storage device and password control method for the same
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6558320B1 (en) * 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US8636648B2 (en) 1999-03-01 2014-01-28 West View Research, Llc Endoscopic smart probe
US10973397B2 (en) 1999-03-01 2021-04-13 West View Research, Llc Computerized information collection and processing apparatus
EP1175176B1 (en) * 1999-04-07 2010-09-22 Endonetics, Inc. Implantable monitoring probe
US6796956B2 (en) 1999-04-30 2004-09-28 Medtronic, Inc. Method and apparatus to control drug therapy dosages in an implantable pump
US6635048B1 (en) * 1999-04-30 2003-10-21 Medtronic, Inc. Implantable medical pump with multi-layer back-up memory
US6516227B1 (en) * 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US7177690B2 (en) * 1999-07-27 2007-02-13 Advanced Bionics Corporation Implantable system having rechargeable battery indicator
ES2574232T3 (en) 1999-08-05 2016-06-16 Resmed R&D Germany Gmbh Device for supplying respiratory air, humidification device, respiratory gas tube and connection device for it
US6482145B1 (en) 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US6461292B1 (en) 1999-08-12 2002-10-08 Obtech Medical Ag Anal incontinence treatment with wireless energy supply
US6471635B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US6464628B1 (en) 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
US20030095648A1 (en) * 1999-10-05 2003-05-22 Lifecor, Inc. Fault-tolerant remote reprogramming for a patient-worn medical device
US7933780B2 (en) 1999-10-22 2011-04-26 Telaric, Llc Method and apparatus for controlling an infusion pump or the like
TW559699B (en) * 2000-01-12 2003-11-01 Sony Corp Image display device and method
ATE295136T1 (en) 2000-02-10 2005-05-15 Potencia Medical Ag MECHANICAL DEVICE FOR TREATING IMPOTENCY
DE60113965T2 (en) 2000-02-10 2006-07-06 Potencia Medical Ag TREATMENT OF HARNINE CONTINENCE WITH WIRELESS ENERGY SUPPLY
ATE304336T1 (en) 2000-02-10 2005-09-15 Potencia Medical Ag CONTROLLED URINARY INCONTINENCE TREATMENT
EP1253886B1 (en) 2000-02-11 2008-12-10 Potentica AG Impotence treatment apparatus with energy transforming means
ATE380006T1 (en) * 2000-02-11 2007-12-15 Potencia Medical Ag CONTROLLED IMPOTENCY TREATMENT
CN1196451C (en) 2000-02-14 2005-04-13 波滕西亚医疗公司 Male impotence prosthesis apparatus with wireless energy supply
US20030100929A1 (en) 2000-02-14 2003-05-29 Peter Forsell Controlled penile prosthesis
US7442165B2 (en) 2000-02-14 2008-10-28 Obtech Medical Ag Penile prosthesis
US20030060765A1 (en) * 2000-02-16 2003-03-27 Arthur Campbell Infusion device menu structure and method of using the same
US7905832B1 (en) 2002-04-24 2011-03-15 Ipventure, Inc. Method and system for personalized medical monitoring and notifications therefor
US7321774B1 (en) 2002-04-24 2008-01-22 Ipventure, Inc. Inexpensive position sensing device
US6975941B1 (en) 2002-04-24 2005-12-13 Chung Lau Method and apparatus for intelligent acquisition of position information
US7218938B1 (en) 2002-04-24 2007-05-15 Chung Lau Methods and apparatus to analyze and present location information
US7212829B1 (en) 2000-02-28 2007-05-01 Chung Lau Method and system for providing shipment tracking and notifications
US7366522B2 (en) 2000-02-28 2008-04-29 Thomas C Douglass Method and system for location tracking
US6622050B2 (en) * 2000-03-31 2003-09-16 Medtronic, Inc. Variable encryption scheme for data transfer between medical devices and related data management systems
US6592519B1 (en) * 2000-04-28 2003-07-15 Medtronic, Inc. Smart microfluidic device with universal coating
US9427520B2 (en) 2005-02-11 2016-08-30 Carefusion 303, Inc. Management of pending medication orders
US7860583B2 (en) 2004-08-25 2010-12-28 Carefusion 303, Inc. System and method for dynamically adjusting patient therapy
US11087873B2 (en) 2000-05-18 2021-08-10 Carefusion 303, Inc. Context-aware healthcare notification system
US10062457B2 (en) 2012-07-26 2018-08-28 Carefusion 303, Inc. Predictive notifications for adverse patient events
US20040172283A1 (en) * 2003-02-09 2004-09-02 Vanderveen Timothy W. Medication management and event logger and analysis system
US9069887B2 (en) 2000-05-18 2015-06-30 Carefusion 303, Inc. Patient-specific medication management system
US10353856B2 (en) 2011-03-17 2019-07-16 Carefusion 303, Inc. Scalable communication system
US20130197927A1 (en) * 2000-05-18 2013-08-01 Carefusion 303, Inc. Healthcare validation system
US20050171815A1 (en) * 2003-12-31 2005-08-04 Vanderveen Timothy W. Centralized medication management system
US9741001B2 (en) 2000-05-18 2017-08-22 Carefusion 303, Inc. Predictive medication safety
CZ20023818A3 (en) * 2000-05-18 2003-06-18 Alaris Meidical Systems, Inc. System and method for management of information concerning provision of medical care
SE516707C2 (en) * 2000-05-30 2002-02-19 Volvo Lastvagnar Ab Power units for motor vehicles
US6735479B2 (en) * 2000-06-14 2004-05-11 Medtronic, Inc. Lifestyle management system
US6650951B1 (en) * 2000-06-19 2003-11-18 International Business Machines Corporation Method and insulin pump for providing a forgotten bolus warning
US6738670B1 (en) 2000-06-19 2004-05-18 Medtronic, Inc. Implantable medical device telemetry processor
DE60111223T2 (en) * 2000-06-23 2006-04-27 Medtronic, Inc., Minneapolis PORTABLE EXPANSION DEVICE FOR DATA TRANSMISSION IN A COMMUNICATION SYSTEM OF A MEDICAL DEVICE
US6540675B2 (en) * 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
US20040260233A1 (en) * 2000-09-08 2004-12-23 Garibotto John T. Data collection assembly for patient infusion system
ES2287156T3 (en) * 2000-09-08 2007-12-16 Insulet Corporation DEVICES AND SYSTEMS FOR THE INFUSION OF A PATIENT.
DE10047552B4 (en) * 2000-09-22 2007-01-04 Siemens Ag Medical device
US20020040208A1 (en) * 2000-10-04 2002-04-04 Flaherty J. Christopher Data collection assembly for patient infusion system
US7283874B2 (en) 2000-10-16 2007-10-16 Remon Medical Technologies Ltd. Acoustically powered implantable stimulating device
US6764446B2 (en) 2000-10-16 2004-07-20 Remon Medical Technologies Ltd Implantable pressure sensors and methods for making and using them
US7198603B2 (en) * 2003-04-14 2007-04-03 Remon Medical Technologies, Inc. Apparatus and methods using acoustic telemetry for intrabody communications
US7024248B2 (en) * 2000-10-16 2006-04-04 Remon Medical Technologies Ltd Systems and methods for communicating with implantable devices
JP2002149831A (en) * 2000-11-15 2002-05-24 Sanyo Electric Co Ltd Health management system and information processor
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7085744B2 (en) * 2000-12-08 2006-08-01 International Business Machines Corporation Method and system for conducting a transaction over a network
US7213075B2 (en) * 2000-12-15 2007-05-01 International Business Machines Corporation Application server and streaming server streaming multimedia file in a client specific format
CA2431420C (en) * 2000-12-21 2011-10-11 Insulet Corporation Medical apparatus remote control and method
IL156245A0 (en) * 2000-12-22 2004-01-04 Dca Design Int Ltd Drive mechanism for an injection device
US20020087113A1 (en) * 2000-12-29 2002-07-04 Medtronic, Inc. Drug management techniques for an implantable medical device
US20020087116A1 (en) * 2000-12-29 2002-07-04 Medtronic, Inc. Patient scheduling techniques for an implantable medical device
US7379475B2 (en) * 2002-01-25 2008-05-27 Nvidia Corporation Communications processor
US6975968B2 (en) * 2001-02-08 2005-12-13 Olympus Corporation Medical system control apparatus, and method for dealing with trouble with the medical system control apparatus
DE10107100A1 (en) * 2001-02-13 2002-12-05 Profichip Gmbh Plug device with integrated diagnosis and evaluation circuit and switchable terminating resistor
US6620151B2 (en) * 2001-03-01 2003-09-16 Advanced Neuromodulation Systems, Inc. Non-constant pressure infusion pump
US6708065B2 (en) * 2001-03-02 2004-03-16 Cardiac Pacemakers, Inc. Antenna for an implantable medical device
US20030060695A1 (en) * 2001-03-07 2003-03-27 Connelly Patrick R. Implantable artificial organ devices
EP1368618A1 (en) * 2001-03-09 2003-12-10 Ascot Management Solutions Ltd. Remote monitoring system
GB2373677B (en) * 2001-03-19 2005-08-10 Nokia Mobile Phones Ltd Client server system
US6810380B1 (en) * 2001-03-28 2004-10-26 Bellsouth Intellectual Property Corporation Personal safety enhancement for communication devices
US7117019B2 (en) * 2001-03-30 2006-10-03 Motorola, Inc. Display and keypad backlight management for portable electronic devices
US6662048B2 (en) * 2001-03-30 2003-12-09 Cardiac Pacemakers, Inc. Implantable medical device with temperature measuring and storing capability
US20020154154A1 (en) * 2001-04-20 2002-10-24 Cornelius William L. Methods and apparatus for providing localization of control panels
US6723086B2 (en) * 2001-05-07 2004-04-20 Logiq Wireless Solutions, Inc. Remote controlled transdermal medication delivery device
US6850159B1 (en) * 2001-05-15 2005-02-01 Brian P. Platner Self-powered long-life occupancy sensors and sensor circuits
WO2002097543A1 (en) * 2001-05-31 2002-12-05 Omron Corporation Safety unit, controller system, controller concatenation method, controller system control method, and controller system monitor method
US6687543B1 (en) * 2001-06-06 2004-02-03 Pacesetter, Inc. Implantable cardiac stimulation device having reduced shelf current consumption and method
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CA2448902C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
EP1395185B1 (en) 2001-06-12 2010-10-27 Pelikan Technologies Inc. Electric lancet actuator
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
EP1404061B1 (en) * 2001-06-22 2011-08-10 Omron Corporation Safety network system and safety slave
US10576275B2 (en) 2001-07-06 2020-03-03 Cochlear Limited System and method for configuring an external device using operating parameters from an implanted device
US7502653B2 (en) * 2001-07-06 2009-03-10 Cochlear Limited Cochlear implant having patient-specific parameter storage
US6675049B2 (en) * 2001-07-17 2004-01-06 Medtronic, Inc. Method and apparatus for automatic implantable medical lead recognition and configuration
DE10136355A1 (en) * 2001-07-26 2003-02-13 Niels Rahe-Meyer Device for monitoring vital parameters of an animal or human body consists of a portable bag with sensors, analysis electronics and visual and audible output means as well as interfaces for connection to other devices
US6702857B2 (en) 2001-07-27 2004-03-09 Dexcom, Inc. Membrane for use with implantable devices
US20030032874A1 (en) 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US6678626B2 (en) * 2001-07-31 2004-01-13 Koninklijke Philips Electronics N.V. Power on self test (POST) and extended self test (EST) for ultrasonic imaging system
US7229430B2 (en) * 2001-07-31 2007-06-12 Scott Laboratories Inc. Apparatuses and methods for titrating drug delivery
US7047076B1 (en) 2001-08-03 2006-05-16 Cardiac Pacemakers, Inc. Inverted-F antenna configuration for an implantable medical device
US7903043B2 (en) * 2003-12-22 2011-03-08 Cardiac Pacemakers, Inc. Radio frequency antenna in a header of an implantable medical device
US6456256B1 (en) * 2001-08-03 2002-09-24 Cardiac Pacemakers, Inc. Circumferential antenna for an implantable medical device
US6928338B1 (en) * 2001-08-10 2005-08-09 Medtronic, Inc. Decision information system for drug delivery devices
US20080177154A1 (en) * 2001-08-13 2008-07-24 Novo Nordisk A/S Portable Device and Method Of Communicating Medical Data Information
US6678557B1 (en) * 2001-08-20 2004-01-13 Tvx Internet Services, Inc. System and method for body fat management
JP4170218B2 (en) * 2001-08-29 2008-10-22 メディアテック インコーポレーテッド Method and apparatus for improving the throughput of a cache-based embedded processor by switching tasks in response to a cache miss
US6701188B2 (en) * 2001-09-06 2004-03-02 Medtronic, Inc. Controlling noise sources during telemetry
US6832200B2 (en) * 2001-09-07 2004-12-14 Hewlett-Packard Development Company, L.P. Apparatus for closed-loop pharmaceutical delivery
US6974460B2 (en) * 2001-09-14 2005-12-13 Stryker Spine Biased angulation bone fixation assembly
US6780307B2 (en) * 2001-10-12 2004-08-24 The United States Of America As Represented By The Secretary Of The Navy Ion selective electrodes for direct organic drug analysis in saliva, sweat, and surface wipes
US7254444B2 (en) * 2001-10-17 2007-08-07 Encore Medical Asset Corporation Electrical nerve stimulation device
US7383088B2 (en) 2001-11-07 2008-06-03 Cardiac Pacemakers, Inc. Centralized management system for programmable medical devices
US6989891B2 (en) 2001-11-08 2006-01-24 Optiscan Biomedical Corporation Device and method for in vitro determination of analyte concentrations within body fluids
US20040078028A1 (en) * 2001-11-09 2004-04-22 Flaherty J. Christopher Plunger assembly for patient infusion device
US6941504B2 (en) * 2001-11-15 2005-09-06 International Business Machines Corporation Method and apparatus for test case evaluation using a cyclic redundancy checker
US20030103583A1 (en) * 2001-12-04 2003-06-05 National University Of Singapore Method and apparatus for multi-level phase shift keying communications
US6957102B2 (en) * 2001-12-10 2005-10-18 Medtronic Emergency Response Systems, Inc. Enhanced interface for a medical device and a terminal
US6993393B2 (en) 2001-12-19 2006-01-31 Cardiac Pacemakers, Inc. Telemetry duty cycle management system for an implantable medical device
US7729776B2 (en) 2001-12-19 2010-06-01 Cardiac Pacemakers, Inc. Implantable medical device with two or more telemetry systems
US7204823B2 (en) * 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
US6641544B2 (en) * 2001-12-19 2003-11-04 Hsiang-Ling Liu Body temperature monitoring device
US20030125662A1 (en) * 2002-01-03 2003-07-03 Tuan Bui Method and apparatus for providing medical treatment therapy based on calculated demand
US6985771B2 (en) * 2002-01-22 2006-01-10 Angel Medical Systems, Inc. Rapid response system for the detection and treatment of cardiac events
US7918993B2 (en) * 2002-01-24 2011-04-05 James Harraway Portable dialysis machine
US10173008B2 (en) 2002-01-29 2019-01-08 Baxter International Inc. System and method for communicating with a dialysis machine through a network
US8775196B2 (en) 2002-01-29 2014-07-08 Baxter International Inc. System and method for notification and escalation of medical data
US7315821B2 (en) * 2002-01-31 2008-01-01 Sanyo Electric Co., Ltd. System and method for health care information processing based on acoustic features
US6985773B2 (en) * 2002-02-07 2006-01-10 Cardiac Pacemakers, Inc. Methods and apparatuses for implantable medical device telemetry power management
US7004928B2 (en) * 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US8504179B2 (en) 2002-02-28 2013-08-06 Smiths Medical Asd, Inc. Programmable medical infusion pump
US8043287B2 (en) * 2002-03-05 2011-10-25 Kimberly-Clark Inc. Method of treating biological tissue
US8391989B2 (en) * 2002-12-18 2013-03-05 Cardiac Pacemakers, Inc. Advanced patient management for defining, identifying and using predetermined health-related events
US20040122487A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with composite parameter indices
US7983759B2 (en) 2002-12-18 2011-07-19 Cardiac Pacemakers, Inc. Advanced patient management for reporting multiple health-related parameters
US8043213B2 (en) 2002-12-18 2011-10-25 Cardiac Pacemakers, Inc. Advanced patient management for triaging health-related data using color codes
US20040122296A1 (en) * 2002-12-18 2004-06-24 John Hatlestad Advanced patient management for triaging health-related data
US20040122486A1 (en) * 2002-12-18 2004-06-24 Stahmann Jeffrey E. Advanced patient management for acquiring, trending and displaying health-related parameters
US7043305B2 (en) 2002-03-06 2006-05-09 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US20040122294A1 (en) 2002-12-18 2004-06-24 John Hatlestad Advanced patient management with environmental data
US7468032B2 (en) * 2002-12-18 2008-12-23 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
US7010355B2 (en) * 2002-03-15 2006-03-07 Medtronic, Inc. Method and apparatus for connecting various implantable medical treatment system component devices
US7023359B2 (en) * 2002-03-15 2006-04-04 Medtronic, Inc. Telemetry module with configurable physical layer for use with an implantable medical device
US20030182158A1 (en) * 2002-03-21 2003-09-25 Son William Y. Health care monitoring system and method
US8128616B2 (en) * 2002-03-27 2012-03-06 Medtronic, Inc. System, method and implantable device for delivery of therapeutic substance
AU2003236285A1 (en) * 2002-04-09 2003-10-20 Matsushita Electric Industrial Co., Ltd. Health management system and health management method
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7563232B2 (en) * 2002-04-19 2009-07-21 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7122026B2 (en) * 2002-04-22 2006-10-17 Medtronic, Inc. Implantable infusion device with optimized peristaltic pump motor drive
US20040153032A1 (en) 2002-04-23 2004-08-05 Garribotto John T. Dispenser for patient infusion device
US9182238B2 (en) 2002-04-24 2015-11-10 Ipventure, Inc. Method and apparatus for intelligent acquisition of position information
US9049571B2 (en) 2002-04-24 2015-06-02 Ipventure, Inc. Method and system for enhanced messaging
US6749582B2 (en) * 2002-04-30 2004-06-15 The First Years Inc. Pumping breast milk
US20050055242A1 (en) * 2002-04-30 2005-03-10 Bryan Bello System and method for medical data tracking, analysis and reporting for healthcare system
US8234128B2 (en) 2002-04-30 2012-07-31 Baxter International, Inc. System and method for verifying medical device operational parameters
US20030217187A1 (en) * 2002-05-16 2003-11-20 International Business Machines Corporation System and method for locating a network adapter
JP5075322B2 (en) * 2002-05-16 2012-11-21 スコット・ラボラトリーズ・インコーポレイテッド User authentication system and method for sedation and analgesia system
TW528593B (en) * 2002-05-17 2003-04-21 Jang-Min Yang Device for monitoring physiological status and method for using the device
US20030220673A1 (en) * 2002-05-24 2003-11-27 Snell Jeffrey D. Multi-device telemetry architecture
JP2004023556A (en) * 2002-06-18 2004-01-22 Seiko Epson Corp Electronic apparatus
EP2468358B1 (en) * 2002-06-28 2013-08-07 Boston Scientific Neuromodulation Corporation Microstimulator having self-contained power source and bi-directional telemetry system
DE60334459D1 (en) * 2002-07-10 2010-11-18 Orthodata Inc LOAD MEASURING SYSTEM
US7018360B2 (en) * 2002-07-16 2006-03-28 Insulet Corporation Flow restriction system and method for patient infusion device
JP2005533545A (en) * 2002-07-24 2005-11-10 エム2・メディカル・アクティーゼルスカブ Infusion pump system, infusion pump unit, infusion pump
US20050160858A1 (en) * 2002-07-24 2005-07-28 M 2 Medical A/S Shape memory alloy actuator
US7278983B2 (en) * 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US7069086B2 (en) * 2002-08-08 2006-06-27 Cardiac Pacemakers, Inc. Method and system for improved spectral efficiency of far field telemetry in a medical device
EP1389476A1 (en) * 2002-08-14 2004-02-18 Precimedix S.A. Programming device for a pump for injecting medicaments
US7096383B2 (en) 2002-08-29 2006-08-22 Cosine Communications, Inc. System and method for virtual router failover in a network routing system
US6963340B1 (en) * 2002-09-03 2005-11-08 Nvidia Corporation Graphics processor and system with microcontroller for programmable sequencing of power up or power down operations
US7259906B1 (en) 2002-09-03 2007-08-21 Cheetah Omni, Llc System and method for voice control of medical devices
US20040049245A1 (en) * 2002-09-09 2004-03-11 Volker Gass Autonomous patch for communication with an implantable device, and medical kit for using said patch
US20040049233A1 (en) * 2002-09-11 2004-03-11 Edwards D. Craig Medical device status information system
US6609023B1 (en) * 2002-09-20 2003-08-19 Angel Medical Systems, Inc. System for the detection of cardiac events
AU2003285872A1 (en) * 2002-10-15 2004-05-04 Medtronic Inc. Treatment termination in a medical device
US20040077996A1 (en) * 2002-10-22 2004-04-22 Jasperson Keith E. Drug infusion system with multiple medications
US7967812B2 (en) * 2002-10-22 2011-06-28 Medtronic, Inc. Drug infusion system programmable in flex mode
US7933655B2 (en) * 2002-10-31 2011-04-26 Medtronic, Inc. Neurostimulation therapy manipulation
AU2003288961A1 (en) * 2002-10-31 2004-06-07 Medtronic, Inc. Failsafe programming of implantable medical devices
CN1726059A (en) 2002-11-05 2006-01-25 M2医药有限公司 Disposable wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
DE10253057A1 (en) * 2002-11-14 2004-05-27 Philips Intellectual Property & Standards Gmbh Diagnostic system used with mobile X-ray apparatus incorporates data processing module and mobile data terminal with user interface, microcontroller and bar-code reader
US20040098065A1 (en) * 2002-11-19 2004-05-20 Alliance Health Products, Llc Transcutaneous nerve and muscle stimulator and method of using the same
JP2004234622A (en) * 2002-11-19 2004-08-19 Seiko Instruments Inc Living body information measuring system
ATE385814T1 (en) * 2002-12-23 2008-03-15 M2 Medical As MEDICAL DEVICE FOR DELIVERING INSULIN
WO2004056411A2 (en) * 2002-12-23 2004-07-08 M 2 Medical A/S Flexible piston rod
KR20050083824A (en) * 2002-12-26 2005-08-26 마쯔시다덴기산교 가부시키가이샤 Data transmission device, data transmission system, and method
US6978182B2 (en) 2002-12-27 2005-12-20 Cardiac Pacemakers, Inc. Advanced patient management system including interrogator/transceiver unit
US20040128161A1 (en) * 2002-12-27 2004-07-01 Mazar Scott T. System and method for ad hoc communications with an implantable medical device
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
DE10300735A1 (en) * 2003-01-11 2004-07-22 Corscience Gmbh & Co.Kg Method for detecting a fibrillation state and device for defibrillation
DE60315122D1 (en) * 2003-01-14 2007-09-06 St Microelectronics Srl Method and device for transmitting data over a single line, in particular for transmitting bus data with minimization of the bus switching activity
US7484095B2 (en) * 2003-01-16 2009-01-27 Sun Microsystems, Inc. System for communicating program data between a first device and a second device
US8121955B2 (en) 2003-01-16 2012-02-21 Oracle America, Inc. Signing program data payload sequence in program loading
US7165246B2 (en) * 2003-01-16 2007-01-16 Sun Microsystems, Inc. Optimized representation of data type information in program verification
US7272830B2 (en) * 2003-01-16 2007-09-18 Sun Microsystems, Inc. Ordering program data for loading on a device
US20040143739A1 (en) * 2003-01-16 2004-07-22 Sun Mircosystems, Inc., A Delaware Corporation Run time code integrity checks
US7281244B2 (en) * 2003-01-16 2007-10-09 Sun Microsystems, Inc. Using a digital fingerprint to commit loaded data in a device
US7222331B2 (en) * 2003-01-16 2007-05-22 Sun Microsystems, Inc. Linking of virtual methods
US7742821B1 (en) 2003-06-11 2010-06-22 Boston Scientific Neutomodulation Corporation Remote control for implantable medical device
US20040162586A1 (en) * 2003-02-18 2004-08-19 Covey Kevin K. Defibrillator electrodes with identification tags
US8144810B2 (en) * 2003-02-19 2012-03-27 Csr Technology Inc. Serial radio frequency to baseband interface with programmable clock
WO2004075782A2 (en) * 2003-02-26 2004-09-10 Alfred, E. Mann Institute For Biomedical Engineering At The University Of Southern California An implantable device with sensors for differential monitoring of internal condition
US20040172069A1 (en) * 2003-02-28 2004-09-02 Hakala Douglas T. Recording information for emergency call by defibrillator apparatus
US7052652B2 (en) * 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US7489970B2 (en) * 2003-04-02 2009-02-10 Medtronic, Inc. Management of neurostimulation therapy using parameter sets
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20050182366A1 (en) * 2003-04-18 2005-08-18 Insulet Corporation Method For Visual Output Verification
CA2520880A1 (en) * 2003-04-18 2004-11-04 Insulet Corporation User interface for infusion pump remote controller and method of using the same
ES2737835T3 (en) 2003-04-23 2020-01-16 Valeritas Inc Hydraulically driven pump for long-term medication administration
US7182738B2 (en) 2003-04-23 2007-02-27 Marctec, Llc Patient monitoring apparatus and method for orthosis and other devices
US7187979B2 (en) * 2003-04-25 2007-03-06 Medtronic, Inc. Medical device synchronization
US7330763B1 (en) * 2003-04-30 2008-02-12 Advanced Neuromodulation Systems, Inc. Method for securing the operating system in a handheld medical device and apparatus
AU2004235793A1 (en) * 2003-04-30 2004-11-18 Insulet Corporation RF medical device
WO2004098683A1 (en) * 2003-05-08 2004-11-18 Novo Nordisk A/S Internal needle inserter
ATE474611T1 (en) * 2003-05-08 2010-08-15 Novo Nordisk As AN INJECTION DEVICE THAT CAN BE APPLIED TO THE SKIN WITH A SEPARABLE ACTUATING PART FOR INSERTING THE NEEDLE
EP1475113A1 (en) * 2003-05-08 2004-11-10 Novo Nordisk A/S External needle inserter
JP2004343275A (en) * 2003-05-14 2004-12-02 Murata Mach Ltd Image processing system and scanner
US7875293B2 (en) * 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US6796213B1 (en) * 2003-05-23 2004-09-28 Raytheon Company Method for providing integrity bounding of weapons
US6896220B2 (en) * 2003-05-23 2005-05-24 Raytheon Company Munition with integrity gated go/no-go decision
EP1628567B1 (en) 2003-05-30 2010-08-04 Pelikan Technologies Inc. Method and apparatus for fluid injection
US7516135B2 (en) * 2003-05-30 2009-04-07 Sap Aktiengesellschaft Dynamically managing data conveyance between computing devices
DE10325106A1 (en) * 2003-06-03 2004-12-30 Disetronic Licensing Ag Device and method for recognizing a user of a medical device
ES2490740T3 (en) 2003-06-06 2014-09-04 Sanofi-Aventis Deutschland Gmbh Apparatus for blood fluid sampling and analyte detection
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8071028B2 (en) * 2003-06-12 2011-12-06 Abbott Diabetes Care Inc. Method and apparatus for providing power management in data communication systems
IL156556A (en) * 2003-06-19 2010-02-17 Eran Schenker Life signs detector
AU2003903139A0 (en) * 2003-06-20 2003-07-03 Resmed Limited Breathable gas apparatus with humidifier
DE202004021794U1 (en) 2003-06-20 2011-02-10 ResMed Ltd., Bella Vista Breathing apparatus with humidifier
US7155290B2 (en) * 2003-06-23 2006-12-26 Cardiac Pacemakers, Inc. Secure long-range telemetry for implantable medical device
WO2004112592A1 (en) * 2003-06-24 2004-12-29 Olympus Corporation Capsule type medical device communication system, capsule type medical device, and biological information reception device
US20050010138A1 (en) * 2003-07-11 2005-01-13 Mangiardi Eric K. Lumen-measuring devices and method
US7695239B2 (en) * 2003-07-14 2010-04-13 Fortrend Engineering Corporation End effector gripper arms having corner grippers which reorient reticle during transfer
DE10333133A1 (en) * 2003-07-21 2005-03-03 Siemens Ag Implant according to the "thin client" principle
US20050020889A1 (en) * 2003-07-24 2005-01-27 Garboski Dennis P. Medical monitoring system
WO2007120442A2 (en) 2003-07-25 2007-10-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20050056552A1 (en) * 2003-07-25 2005-03-17 Simpson Peter C. Increasing bias for oxygen production in an electrode system
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US7440805B2 (en) * 2003-07-30 2008-10-21 Cardiac Pacemakers, Inc. Implantable pulse generator system and method for utilizing communication protocols
US8626257B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. Analyte sensor
US7519408B2 (en) 2003-11-19 2009-04-14 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US8275437B2 (en) * 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US6931327B2 (en) 2003-08-01 2005-08-16 Dexcom, Inc. System and methods for processing analyte sensor data
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US8845536B2 (en) * 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
EP1502613A1 (en) * 2003-08-01 2005-02-02 Novo Nordisk A/S Needle device with retraction means
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US8285354B2 (en) 2003-08-01 2012-10-09 Dexcom, Inc. System and methods for processing analyte sensor data
US6899695B2 (en) * 2003-08-08 2005-05-31 Hector J. Herrera Medication security apparatus and method
DE10337679A1 (en) * 2003-08-16 2005-03-17 Roche Diagnostics Gmbh Method and apparatus for remaining service life display
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US20070066873A1 (en) 2003-08-22 2007-03-22 Apurv Kamath Systems and methods for processing analyte sensor data
US8068917B2 (en) * 2003-08-29 2011-11-29 Medtronic, Inc. Fail-safe programming for implantable medical device
US8396565B2 (en) 2003-09-15 2013-03-12 Medtronic, Inc. Automatic therapy adjustments
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
US8442643B2 (en) * 2003-10-02 2013-05-14 Medtronic, Inc. Medical device programmer with reduced-noise power supply
US9033920B2 (en) 2003-10-02 2015-05-19 Medtronic, Inc. Determining catheter status
US9259584B2 (en) 2003-10-02 2016-02-16 Medtronic, Inc. External unit for implantable medical device coupled by cord
US9138537B2 (en) 2003-10-02 2015-09-22 Medtronic, Inc. Determining catheter status
US7356369B2 (en) * 2003-10-02 2008-04-08 Medtronic, Inc. Z-axis assembly of medical device programmer
US7320676B2 (en) * 2003-10-02 2008-01-22 Medtronic, Inc. Pressure sensing in implantable medical devices
US7203549B2 (en) * 2003-10-02 2007-04-10 Medtronic, Inc. Medical device programmer with internal antenna and display
US7272445B2 (en) * 2003-10-02 2007-09-18 Medtronic, Inc. Medical device programmer with faceplate
US8346361B2 (en) * 2003-10-02 2013-01-01 Medtronic, Inc. User interface for external charger for implantable medical device
US7263406B2 (en) 2003-10-02 2007-08-28 Medtronic, Inc. Medical device programmer with selective disablement of display during telemetry
US7729766B2 (en) 2003-10-02 2010-06-01 Medtronic, Inc. Circuit board construction for handheld programmer
US8323244B2 (en) 2007-03-30 2012-12-04 Medtronic, Inc. Catheter malfunction determinations using physiologic pressure
US7561921B2 (en) * 2003-10-02 2009-07-14 Medtronic, Inc. Neurostimulator programmer with internal antenna
US7991479B2 (en) 2003-10-02 2011-08-02 Medtronic, Inc. Neurostimulator programmer with clothing attachable antenna
US20050075685A1 (en) * 2003-10-02 2005-04-07 Forsberg John W. Medical device programmer with infrared communication
US7286872B2 (en) 2003-10-07 2007-10-23 Cardiac Pacemakers, Inc. Method and apparatus for managing data from multiple sensing channels
US9123077B2 (en) 2003-10-07 2015-09-01 Hospira, Inc. Medication management system
US8065161B2 (en) 2003-11-13 2011-11-22 Hospira, Inc. System for maintaining drug information and communicating with medication delivery devices
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US20050102669A1 (en) * 2003-10-15 2005-05-12 Siemens Medical Solutions Usa, Inc. Software installation file verification media and methods for medical equipment
KR20060099520A (en) * 2003-10-21 2006-09-19 노보 노르디스크 에이/에스 Medical skin mountable device
US20050090607A1 (en) * 2003-10-28 2005-04-28 Dexcom, Inc. Silicone composition for biocompatible membrane
US7437194B2 (en) * 2003-10-31 2008-10-14 Medtronic, Inc. Stimulating the prostate gland
US7389144B1 (en) 2003-11-07 2008-06-17 Flint Hills Scientific Llc Medical device failure detection and warning system
US20050102167A1 (en) * 2003-11-12 2005-05-12 Kapoor Ashok K. Provisioning and controlling medical instruments using wireless data communication
US7684861B2 (en) * 2003-11-13 2010-03-23 Cardiac Pacemakers, Inc. Implantable cardiac monitor upgradeable to pacemaker or cardiac resynchronization device
US20050107846A1 (en) * 2003-11-14 2005-05-19 Cardiac Pacemakers, Inc. Implantable medical drive with text messaging capability
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
DE10355511A1 (en) * 2003-11-24 2005-06-09 Biotronik Gmbh & Co. Kg Endovascular implant with an active coating
WO2005057199A1 (en) * 2003-12-03 2005-06-23 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Multiparameter system for environmental monitoring
US8532730B2 (en) * 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8364230B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
ATE480761T1 (en) 2003-12-05 2010-09-15 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTICAL SENSOR
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8425416B2 (en) * 2006-10-04 2013-04-23 Dexcom, Inc. Analyte sensor
US8425417B2 (en) * 2003-12-05 2013-04-23 Dexcom, Inc. Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device
WO2005057175A2 (en) 2003-12-09 2005-06-23 Dexcom, Inc. Signal processing for continuous analyte sensor
WO2005058385A2 (en) * 2003-12-12 2005-06-30 Philometron, Inc. Multiple section parenteral drug delivery apparatus
WO2005061048A1 (en) * 2003-12-12 2005-07-07 Medical Research Products-A, Inc. Telemetry method and apparatus for ambulatory medical device
US7957798B2 (en) 2003-12-17 2011-06-07 Physio-Control, Inc. Defibrillator/monitor system having a pod with leads capable of wirelessly communicating
US10413742B2 (en) 2008-03-05 2019-09-17 Physio-Control, Inc. Defibrillator patient monitoring pod
US20050137573A1 (en) * 2003-12-19 2005-06-23 Animas Corporation System, method, and communication hub for controlling external infusion device
US7471980B2 (en) * 2003-12-22 2008-12-30 Cardiac Pacemakers, Inc. Synchronizing continuous signals and discrete events for an implantable medical device
FR2864388B1 (en) * 2003-12-22 2006-03-17 Estaris Monitoring SYSTEM FOR MODULAR ACQUISITION AND REAL TIME OF SIGNALS, IN PARTICULAR BIOMEDICAL SIGNALS
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
US7571380B2 (en) * 2004-01-13 2009-08-04 International Business Machines Corporation Differential dynamic content delivery with a presenter-alterable session copy of a user profile
US8799324B2 (en) * 2004-01-16 2014-08-05 Verizon Patent And Licensing Inc. Method and system for mobile telemetry device prioritized messaging
US7107096B2 (en) * 2004-01-28 2006-09-12 Angel Medical Systems, Inc. System for patient alerting associated with a cardiac event
US7753879B2 (en) 2004-01-29 2010-07-13 M2 Group Holdings, Inc. Disposable medicine dispensing device
US7471986B2 (en) * 2004-02-20 2008-12-30 Cardiac Pacemakers, Inc. System and method for transmitting energy to and establishing a communications network with one or more implanted devices
WO2009048462A1 (en) 2007-10-09 2009-04-16 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20050192843A1 (en) * 2004-02-27 2005-09-01 Cardiac Pacemakers, Inc. Systems and methods for validating patient and medical devices information
US7347854B2 (en) * 2004-03-02 2008-03-25 Infusion Systems, Llc Method and apparatus for automatically modifying delivery profile of drug delivery system
US7751894B1 (en) 2004-03-04 2010-07-06 Cardiac Pacemakers, Inc. Systems and methods for indicating aberrant behavior detected by an implanted medical device
DE102004012042B4 (en) * 2004-03-10 2008-04-10 Smiths Medical Deutschland Gmbh Patient monitoring device
US7228182B2 (en) * 2004-03-15 2007-06-05 Cardiac Pacemakers, Inc. Cryptographic authentication for telemetry with an implantable medical device
US8725244B2 (en) 2004-03-16 2014-05-13 Medtronic, Inc. Determination of sleep quality for neurological disorders
US7717848B2 (en) 2004-03-16 2010-05-18 Medtronic, Inc. Collecting sleep quality information via a medical device
US7542803B2 (en) * 2004-03-16 2009-06-02 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
WO2005091540A1 (en) * 2004-03-19 2005-09-29 Novo Nordisk A/S A reduced size transmission data packet header format for a medical device
US7293198B2 (en) * 2004-03-25 2007-11-06 Emc Corporation Techniques for maintaining operation of data storage system during a failure
US7281150B1 (en) 2004-03-26 2007-10-09 Emc Corporation Methods and apparatus for controlling operation of a data storage system
CN100586495C (en) * 2004-03-30 2010-02-03 诺和诺德公司 Actuator system comprising lever mechanism
JP4705952B2 (en) * 2004-04-07 2011-06-22 カーディアック ペースメイカーズ, インコーポレイテッド System and method for RF transceiver duty cycle in implantable medical devices
EP1732645B1 (en) 2004-04-07 2012-06-13 Cardiac Pacemakers, Inc. Rf wake-up of implantable medical device
AU2005233945B2 (en) * 2004-04-12 2011-01-27 Baxter International Inc. System and method for medical data tracking, analysis and reporting for a healthcare system
JP2005301859A (en) * 2004-04-15 2005-10-27 Fujitsu Ltd Code search program and device
US8000784B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling device
US8361013B2 (en) 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US7998060B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling delivery device
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8019413B2 (en) 2007-03-19 2011-09-13 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US8337482B2 (en) 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US7850676B2 (en) * 2004-04-19 2010-12-14 The Invention Science Fund I, Llc System with a reservoir for perfusion management
US8092549B2 (en) 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
WO2005106017A2 (en) * 2004-04-21 2005-11-10 University Of Virginia Patent Foundation Method, system and computer program product for evaluating the accuracy of blood glucose monitoring sensors/devices
US7324850B2 (en) * 2004-04-29 2008-01-29 Cardiac Pacemakers, Inc. Method and apparatus for communication between a handheld programmer and an implantable medical device
AU2005243199A1 (en) * 2004-04-30 2005-11-24 Becton, Dickinson And Company System and apparatus for medical error monitoring
EP1593403A1 (en) 2004-05-06 2005-11-09 Bionica International NV Medical device for quantitatively and chronologically sequenced infusion delivery
US20050273080A1 (en) * 2004-05-20 2005-12-08 Paul Patrick J Methods and systems for providing an interface between an ambulatory medical device and a display device
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US7241266B2 (en) * 2004-05-20 2007-07-10 Digital Angel Corporation Transducer for embedded bio-sensor using body energy as a power source
US20050261561A1 (en) * 2004-05-24 2005-11-24 Christopher W. Jones Blood testing and therapeutic compound delivery system
US7860559B2 (en) 2004-05-26 2010-12-28 Angel Medical Systems, Inc. Means and method for the detection of cardiac events
US20050277873A1 (en) * 2004-05-27 2005-12-15 Janice Stewart Identification information recognition system for a medical device
US7927313B2 (en) 2004-05-27 2011-04-19 Baxter International Inc. Medical device configuration based on recognition of identification information
US8961461B2 (en) * 2004-05-27 2015-02-24 Baxter International Inc. Multi-state alarm system for a medical pump
US7450991B2 (en) * 2004-05-28 2008-11-11 Advanced Neuromodulation Systems, Inc. Systems and methods used to reserve a constant battery capacity
US6999854B2 (en) * 2004-05-28 2006-02-14 International Business Machines Corporation Medical infusion pump capable of learning bolus time patterns and providing bolus alerts
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
WO2005120365A1 (en) * 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
US7794499B2 (en) * 2004-06-08 2010-09-14 Theken Disc, L.L.C. Prosthetic intervertebral spinal disc with integral microprocessor
US7457669B2 (en) * 2004-06-17 2008-11-25 Cardiac Pacemakers, Inc. On-demand retransmission of data with an implantable medical device
US7519430B2 (en) * 2004-06-17 2009-04-14 Cardiac Pacemakers, Inc. Dynamic telemetry encoding for an implantable medical device
US7840268B2 (en) * 2004-06-21 2010-11-23 Advanced Neuromodulation Systems, Inc. System and method of managing medical device historical data
US9192772B1 (en) * 2004-06-29 2015-11-24 Quallion Llc Portable medical power system
WO2006014425A1 (en) 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Methods and devices for delivering glp-1 and uses thereof
US7758567B2 (en) * 2004-07-09 2010-07-20 The Alfred E. Mann Foundation For Scientific Research Medical device including processor running independent processes to cooperatively control therapy
EP1781162A1 (en) * 2004-07-09 2007-05-09 Tadiran Spectralink Ltd. Wearable device, system and method for measuring vital parameters
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
WO2006127694A2 (en) 2004-07-13 2006-11-30 Dexcom, Inc. Analyte sensor
US20060016700A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
KR20060005830A (en) * 2004-07-14 2006-01-18 삼성전자주식회사 Printed circuit board including integrated slot
US7819909B2 (en) * 2004-07-20 2010-10-26 Medtronic, Inc. Therapy programming guidance based on stored programming history
US20060020298A1 (en) * 2004-07-20 2006-01-26 Camilleri Michael L Systems and methods for curbing appetite
US20060020302A1 (en) 2004-07-20 2006-01-26 Medtronic, Inc. Medical device telemetry arbitration system based upon user selection
US20060074464A1 (en) * 2004-07-20 2006-04-06 Subera Steven J System and method for creating a customizable report of data from an implantable medical device
ATE465776T1 (en) * 2004-07-20 2010-05-15 Medtronic Inc SWITCHED POWER WITH TELEMETRY IN AN IMPLANTABLE MEDICAL DEVICE
US20060020303A1 (en) * 2004-07-20 2006-01-26 Medtronic, Inc. Medical device telemetry arbitration system using signal strength
WO2006012423A1 (en) * 2004-07-20 2006-02-02 Medtronic, Inc. Therapy programming guidance based on stored programming history
US20060020297A1 (en) * 2004-07-20 2006-01-26 Gerber Martin T Neurostimulation system with distributed stimulators
US20060020304A1 (en) 2004-07-20 2006-01-26 Medtronic, Inc. Medical device telemetry arbitration system using time of response
US8317074B2 (en) 2004-07-28 2012-11-27 Ethicon Endo-Surgery, Inc. Electroactive polymer-based articulation mechanism for circular stapler
US8905977B2 (en) 2004-07-28 2014-12-09 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having an electroactive polymer actuated medical substance dispenser
US7506790B2 (en) * 2004-07-28 2009-03-24 Ethicon Endo-Surgery, Inc. Surgical instrument incorporating an electrically actuated articulation mechanism
US7914551B2 (en) 2004-07-28 2011-03-29 Ethicon Endo-Surgery, Inc. Electroactive polymer-based articulation mechanism for multi-fire surgical fastening instrument
US7513408B2 (en) * 2004-07-28 2009-04-07 Ethicon Endo-Surgery, Inc. Multiple firing stroke surgical instrument incorporating electroactive polymer anti-backup mechanism
US8057508B2 (en) * 2004-07-28 2011-11-15 Ethicon Endo-Surgery, Inc. Surgical instrument incorporating an electrically actuated articulation locking mechanism
US7487899B2 (en) * 2004-07-28 2009-02-10 Ethicon Endo-Surgery, Inc. Surgical instrument incorporating EAP complete firing system lockout mechanism
US7857183B2 (en) * 2004-07-28 2010-12-28 Ethicon Endo-Surgery, Inc. Surgical instrument incorporating an electrically actuated articulation mechanism
US7879070B2 (en) 2004-07-28 2011-02-01 Ethicon Endo-Surgery, Inc. Electroactive polymer-based actuation mechanism for grasper
US8313433B2 (en) * 2004-08-06 2012-11-20 Medtronic Minimed, Inc. Medical data management system and process
US7539541B2 (en) * 2004-08-09 2009-05-26 Cardiac Pacemakers, Inc. Automatic power control for a radio frequency transceiver of an implantable device
US7881802B2 (en) * 2004-08-09 2011-02-01 Cardiac Pacemakers, Inc. Telemetry switchover state machine with firmware priority control
US7406349B2 (en) * 2004-08-09 2008-07-29 Cardiac Pacemakers, Inc. Dynamic telemetry link selection for an implantable device
US7890180B2 (en) * 2004-08-09 2011-02-15 Cardiac Pacemakers, Inc. Secure remote access for an implantable medical device
US20060079831A1 (en) * 2004-08-18 2006-04-13 Gilbert Gregory F Quantitative chronological medical infusion device
EP1804915A1 (en) * 2004-08-18 2007-07-11 Medtronic, Inc. All-in-one interface for programmable implantable medical device
US20060041013A1 (en) * 2004-08-18 2006-02-23 Brittain Jason E Alanosine formulations and methods of use
US7291107B2 (en) * 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
CN1586643A (en) * 2004-08-27 2005-03-02 古群 Central control transfusion method and transfusion monitoring and managing system
US20060047270A1 (en) 2004-08-27 2006-03-02 Shelton Brian M Drug delivery apparatus and method for automatically reducing drug dosage
US7837651B2 (en) * 2004-08-31 2010-11-23 Ethicon Endo-Surgery, Inc. Infusion pump
DE102004043212A1 (en) * 2004-09-03 2006-03-09 Biotronik Vi Patent Ag Communication module and method for its operation
US9569588B2 (en) * 2004-09-13 2017-02-14 John C. Lowe Attached personal information device
WO2006031878A2 (en) * 2004-09-14 2006-03-23 Novartis Vaccines And Diagnostics Inc. Imidazoquinoline compounds
WO2006032692A1 (en) * 2004-09-22 2006-03-30 Novo Nordisk A/S Medical device with cannula inserter
EP1804856A1 (en) * 2004-09-22 2007-07-11 Novo Nordisk A/S Medical device with transcutaneous cannula device
CN101027674A (en) * 2004-09-23 2007-08-29 诺和诺德公司 Device for self-care support
CN101027675A (en) * 2004-09-23 2007-08-29 诺和诺德公司 Remote commander to be used with a drug delivery device
US7720546B2 (en) * 2004-09-30 2010-05-18 Codman Neuro Sciences Sárl Dual power supply switching circuitry for use in a closed system
US7167755B2 (en) 2004-10-05 2007-01-23 Cardiac Pacemakers, Inc. Adaptive software configuration for a medical device
US20060080654A1 (en) * 2004-10-09 2006-04-13 Shelton Brian M Method and apparatus for upgrading implantable medical device operating software
US8150509B2 (en) 2004-10-21 2012-04-03 Cardiac Pacemakers, Inc. Systems and methods for drug therapy enhancement using expected pharmacodynamic models
US7637897B2 (en) * 2004-10-25 2009-12-29 Codman Neuro Sciences Sarl Implantable pump with integrated refill detection
US7191013B1 (en) * 2004-11-08 2007-03-13 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Hand held device for wireless powering and interrogation of biomems sensors and actuators
US7414534B1 (en) * 2004-11-09 2008-08-19 Pacesetter, Inc. Method and apparatus for monitoring ingestion of medications using an implantable medical device
US10709330B2 (en) * 2004-11-15 2020-07-14 Koninklijke Philips N.V. Ambulatory medical telemetry device having an audio indicator
US7019687B1 (en) * 2004-11-22 2006-03-28 Raytheon Company Methods and apparatus for satellite integrity messaging
US20060116639A1 (en) * 2004-11-29 2006-06-01 Russell Claudia J Total patient input monitoring
US20080193139A1 (en) * 2004-12-01 2008-08-14 Ido Bettesh Two-Way Communication in an Autonomous in Vivo Device
EP1824536B1 (en) * 2004-12-06 2009-08-26 Novo Nordisk A/S Ventilated skin mountable device
US8301739B1 (en) 2004-12-23 2012-10-30 Emc Corporation Storage system initialization utility
US7869851B2 (en) * 2004-12-23 2011-01-11 Roche Diagnostics Operations, Inc. System and method for determining insulin bolus quantities
US20090105569A1 (en) 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US20070027381A1 (en) * 2005-07-29 2007-02-01 Therasense, Inc. Inserter and methods of use
US20090082693A1 (en) * 2004-12-29 2009-03-26 Therasense, Inc. Method and apparatus for providing temperature sensor module in a data communication system
US20090054811A1 (en) * 2004-12-30 2009-02-26 Dirk Boecker Method and apparatus for analyte measurement test time
US8652831B2 (en) * 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US7218969B2 (en) * 2005-01-19 2007-05-15 Cardiac Pacemakers, Inc. Dynamic channel selection for RF telemetry with implantable device
WO2006077262A1 (en) * 2005-01-24 2006-07-27 Novo Nordisk A/S Medical device with protected transcutaneous device
US20060166629A1 (en) * 2005-01-24 2006-07-27 Therasense, Inc. Method and apparatus for providing EMC Class-B compliant RF transmitter for data monitoring an detection systems
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US9314633B2 (en) 2008-01-25 2016-04-19 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
US8140165B2 (en) 2005-01-28 2012-03-20 Encore Medical Asset Corporation Independent protection system for an electrical muscle stimulation apparatus and method of using same
EP1688085A1 (en) * 2005-02-02 2006-08-09 Disetronic Licensing AG Ambulatory medical device and method of communication between medical devices
US20080281298A1 (en) * 2005-02-07 2008-11-13 Andersen David R Electronic support system for biological data sensor
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US8147451B2 (en) * 2005-02-11 2012-04-03 Stryker Corporation Reprogrammable fluid delivery system and method of use
WO2006089958A1 (en) 2005-02-25 2006-08-31 Novo Nordisk A/S Pump assembly with safety valve
CN101128229B (en) * 2005-02-28 2011-05-25 诺和诺德公司 Device for providing a change in a drug delivery rate
US7610065B2 (en) * 2005-02-28 2009-10-27 Cardiac Pacemakers, Inc. Method and apparatus for antenna selection in a diversity antenna system for communicating with implantable medical device
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
US7784663B2 (en) * 2005-03-17 2010-08-31 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having load sensing control circuitry
WO2006097453A1 (en) * 2005-03-17 2006-09-21 Novo Nordisk A/S Securing pairing of electronic devices
US7421297B2 (en) * 2005-03-31 2008-09-02 Medtronic, Inc. Monopolar stimulation assembly including at least one remote electrode
US7889069B2 (en) * 2005-04-01 2011-02-15 Codman & Shurtleff, Inc. Wireless patient monitoring system
US8204565B2 (en) * 2005-04-04 2012-06-19 University Of Iowa Research Foundation Reagentless optical analyte detection system
GB0506925D0 (en) * 2005-04-06 2005-05-11 Zarlink Semiconductor Ab Ultra low power wake-up solution for implantable RF telemetry devices
WO2006105793A1 (en) 2005-04-06 2006-10-12 M 2 Medical A/S Method and device for dispensing liquid medicine by means of a twistable element
WO2006108809A1 (en) 2005-04-13 2006-10-19 Novo Nordisk A/S Medical skin mountable device and system
EP2392381B1 (en) 2005-04-19 2016-07-20 Compex Technologies, Inc. Electrical stimulation device
GB2425601B (en) 2005-04-26 2008-01-30 Bio Nano Sensium Technologies Sensor configuration
US7664553B2 (en) 2005-04-27 2010-02-16 Cardiac Pacemakers, Inc. System and method for enabling communications with implantable medical devices
US7827011B2 (en) * 2005-05-03 2010-11-02 Aware, Inc. Method and system for real-time signal classification
US7637892B2 (en) 2005-05-10 2009-12-29 Palyon Medical (Bvi) Limited Variable flow infusion pump system
US8211060B2 (en) * 2005-05-10 2012-07-03 Palyon Medical (Bvi) Limited Reduced size implantable pump
US8915893B2 (en) 2005-05-10 2014-12-23 Palyon Medical (Bvi) Limited Variable flow infusion pump system
US8114055B2 (en) 2005-05-10 2012-02-14 Palyon Medical (Bvi) Limited Implantable pump with infinitely variable resistor
US20080167641A1 (en) * 2005-05-13 2008-07-10 Novo Nordisk A/S Medical Device Adapted To Detect Disengagement Of A Transcutaneous Device
US8391990B2 (en) 2005-05-18 2013-03-05 Cardiac Pacemakers, Inc. Modular antitachyarrhythmia therapy system
US7472301B2 (en) * 2005-05-27 2008-12-30 Codman Neuro Sciences Sárl Circuitry for optimization of power consumption in a system employing multiple electronic components, one of which is always powered on
US20060276771A1 (en) * 2005-06-06 2006-12-07 Galley Paul J System and method providing for user intervention in a diabetes control arrangement
US8677994B2 (en) * 2005-06-08 2014-03-25 Dräger Medical GmbH Multipart medical engineering system
US7670288B2 (en) * 2005-06-08 2010-03-02 Sher Philip M Fluctuating blood glucose notification threshold profiles and methods of use
US8309057B2 (en) * 2005-06-10 2012-11-13 The Invention Science Fund I, Llc Methods for elevating neurotrophic agents
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US20080287922A1 (en) * 2005-06-27 2008-11-20 Novo Nordisk A/S User Interface for Delivery System Providing Graphical Programming of Profile
JP2008543518A (en) 2005-06-27 2008-12-04 ノボ・ノルデイスク・エー/エス Delivery system user interface with dual parameter setting
US20090018495A1 (en) * 2005-06-27 2009-01-15 Novo Nordisk A/S User Interface For Delivery System Providing Shortcut Navigation
US20070016170A1 (en) * 2005-06-29 2007-01-18 Medtronic Minimed, Inc. Infusion device with bolus alarm deactivation and method of using the same
US7752059B2 (en) 2005-07-05 2010-07-06 Cardiac Pacemakers, Inc. Optimization of timing for data collection and analysis in advanced patient management system
US7711419B2 (en) * 2005-07-13 2010-05-04 Cyberonics, Inc. Neurostimulator with reduced size
US20070066956A1 (en) * 2005-07-27 2007-03-22 Medtronic Minimed, Inc. Systems and methods for entering temporary basal rate pattern in an infusion device
US7680540B2 (en) * 2005-07-29 2010-03-16 Medtronic, Inc. Multi-application trial stimulator
JP2007042797A (en) * 2005-08-02 2007-02-15 Matsushita Electric Ind Co Ltd Semiconductor integrated circuit
US20070060869A1 (en) * 2005-08-16 2007-03-15 Tolle Mike C V Controller device for an infusion pump
US20070060870A1 (en) * 2005-08-16 2007-03-15 Tolle Mike Charles V Controller device for an infusion pump
US20070093786A1 (en) * 2005-08-16 2007-04-26 Medtronic Minimed, Inc. Watch controller for a medical device
US20090227855A1 (en) * 2005-08-16 2009-09-10 Medtronic Minimed, Inc. Controller device for an infusion pump
US7737581B2 (en) * 2005-08-16 2010-06-15 Medtronic Minimed, Inc. Method and apparatus for predicting end of battery life
WO2007024147A1 (en) * 2005-08-26 2007-03-01 Fisher & Paykel Healthcare Limited Adjustment mechanism for electrical medical appliances, and methods of use
EP1758039A1 (en) * 2005-08-27 2007-02-28 Roche Diagnostics GmbH Communication adaptor for portable medical or therapeutical devices
US8265768B2 (en) * 2005-08-30 2012-09-11 Boston Scientific Neuromodulation Corporation Telemetry protocol for ultra low error rates useable in implantable medical devices
US8831735B2 (en) * 2005-08-31 2014-09-09 Michael Sasha John Methods and systems for semi-automatic adjustment of medical monitoring and treatment
CA2620586A1 (en) 2005-08-31 2007-03-08 Boris P. Kovatchev Improving the accuracy of continuous glucose sensors
US9089713B2 (en) 2005-08-31 2015-07-28 Michael Sasha John Methods and systems for semi-automatic adjustment of medical monitoring and treatment
US8065018B2 (en) 2005-09-12 2011-11-22 Medtronic, Inc. System and method for unscheduled wireless communication with a medical device
US7890181B2 (en) * 2005-09-12 2011-02-15 Medtronic, Inc. System and method for unscheduled wireless communication with a medical device
US8380320B2 (en) * 2005-09-12 2013-02-19 Medtronic, Inc. Implantable medical device communication system with macro and micro sampling intervals
US8185210B2 (en) 2005-09-12 2012-05-22 Medtronic, Inc. Communication system and method with preamble encoding for an implantable medical device
US7713240B2 (en) * 2005-09-13 2010-05-11 Medtronic Minimed, Inc. Modular external infusion device
US7561912B2 (en) * 2005-09-19 2009-07-14 Cardiac Pacemakers, Inc. Use of periodicity in medical data analysis
US7638897B2 (en) * 2005-09-22 2009-12-29 The General Electric Company Method and system for powering a patient monitoring system
US8409142B2 (en) * 2005-09-26 2013-04-02 Asante Solutions, Inc. Operating an infusion pump system
US8551046B2 (en) 2006-09-18 2013-10-08 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
EP2162168B1 (en) 2005-09-26 2018-11-07 Bigfoot Biomedical, Inc. Modular infusion pump having two different energy sources
US8105279B2 (en) 2005-09-26 2012-01-31 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US8057436B2 (en) 2005-09-26 2011-11-15 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US7534226B2 (en) 2005-09-26 2009-05-19 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US8951190B2 (en) 2005-09-28 2015-02-10 Zin Technologies, Inc. Transfer function control for biometric monitoring system
US8764654B2 (en) 2008-03-19 2014-07-01 Zin Technologies, Inc. Data acquisition for modular biometric monitoring system
US8801631B2 (en) * 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
EP2989981B8 (en) 2005-09-30 2018-09-05 Intuity Medical, Inc. Multi-site body fluid sampling and analysis cartridge
US20070167086A1 (en) * 2005-10-05 2007-07-19 Tolli William D Electronic Communication Devices and Methods
US20070080223A1 (en) * 2005-10-07 2007-04-12 Sherwood Services Ag Remote monitoring of medical device
US7798973B2 (en) * 2005-10-13 2010-09-21 Cardiac Pacemakers, Inc. Detection of hypovolemia using implantable medical device
EP2471450A1 (en) 2005-10-14 2012-07-04 Nanostim, Inc. Leadless cardiac pacemaker and system
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US7733224B2 (en) 2006-06-30 2010-06-08 Bao Tran Mesh network personal emergency response appliance
US7420472B2 (en) * 2005-10-16 2008-09-02 Bao Tran Patient monitoring apparatus
US7489561B2 (en) * 2005-10-24 2009-02-10 Cyberonics, Inc. Implantable medical device with reconfigurable non-volatile program
US20090054747A1 (en) * 2005-10-31 2009-02-26 Abbott Diabetes Care, Inc. Method and system for providing analyte sensor tester isolation
US8852148B2 (en) * 2005-11-01 2014-10-07 Curlin Medical Inc. Infusion pump having function keys
CN101351240B (en) * 2005-11-02 2011-12-07 英杰克蒂卡股份公司 Implantable infusion device with advanceable and retractable needle
JP4626490B2 (en) * 2005-11-07 2011-02-09 ソニー株式会社 Circuit equipment
EP3064236B1 (en) 2005-11-08 2020-02-05 Bigfoot Biomedical, Inc. Method and system for manual and autonomous control of an infusion pump
WO2007056504A1 (en) 2005-11-08 2007-05-18 M2 Medical A/S Infusion pump system
US8936590B2 (en) 2005-11-09 2015-01-20 The Invention Science Fund I, Llc Acoustically controlled reaction device
US7699834B2 (en) * 2005-11-09 2010-04-20 Searete Llc Method and system for control of osmotic pump device
US8992511B2 (en) 2005-11-09 2015-03-31 The Invention Science Fund I, Llc Acoustically controlled substance delivery device
US20070106275A1 (en) 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Reaction device controlled by RF control signal
US9067047B2 (en) * 2005-11-09 2015-06-30 The Invention Science Fund I, Llc Injectable controlled release fluid delivery system
US8083710B2 (en) 2006-03-09 2011-12-27 The Invention Science Fund I, Llc Acoustically controlled substance delivery device
US8882747B2 (en) * 2005-11-09 2014-11-11 The Invention Science Fund I, Llc Substance delivery system
US8273071B2 (en) 2006-01-18 2012-09-25 The Invention Science Fund I, Llc Remote controller for substance delivery system
US7450902B2 (en) * 2005-11-16 2008-11-11 Codman Neuro Sciences Sárl Continuous phase frequency shift keying modulation during wireless transmissions in a closed system while minimizing power consumption
US7704226B2 (en) * 2005-11-17 2010-04-27 Medtronic Minimed, Inc. External infusion device with programmable capabilities to time-shift basal insulin and method of using the same
US7686768B2 (en) 2005-11-23 2010-03-30 Vital Sensors Holding Company, Inc. Implantable pressure monitor
US7682313B2 (en) 2005-11-23 2010-03-23 Vital Sensors Holding Company, Inc. Implantable pressure monitor
CN101313307A (en) * 2005-11-23 2008-11-26 皇家飞利浦电子股份有限公司 Method and apparatus for remote patient monitoring
US8634925B2 (en) * 2005-11-30 2014-01-21 Medtronic, Inc. Portable programmer for providing patient status information
WO2007064924A1 (en) * 2005-12-02 2007-06-07 Medtronic, Inc. Closed-loop therapy adjustment
US7853322B2 (en) * 2005-12-02 2010-12-14 Medtronic, Inc. Closed-loop therapy adjustment
US7957809B2 (en) * 2005-12-02 2011-06-07 Medtronic, Inc. Closed-loop therapy adjustment
WO2007065944A1 (en) * 2005-12-08 2007-06-14 Novo Nordisk A/S Medical system comprising a sensor device
US7941200B2 (en) * 2005-12-08 2011-05-10 Roche Diagnostics Operations, Inc. System and method for determining drug administration information
EP1795117A1 (en) * 2005-12-12 2007-06-13 F. Hoffmann-La Roche AG Patient device with remote user interface
US20070203547A1 (en) * 2005-12-15 2007-08-30 Costello Benedict J Medical device identification
US8102789B2 (en) * 2005-12-29 2012-01-24 Medtronic, Inc. System and method for synchronous wireless communication with a medical device
US8660659B2 (en) 2006-01-09 2014-02-25 Greatbatch Ltd. Cross-band communications in an implantable device
US20070162089A1 (en) * 2006-01-09 2007-07-12 Transoma Medical, Inc. Cross-band communications in an implantable device
US8301254B2 (en) 2006-01-09 2012-10-30 Greatbatch Ltd. Cross-band communications in an implantable device
US8078278B2 (en) 2006-01-10 2011-12-13 Remon Medical Technologies Ltd. Body attachable unit in wireless communication with implantable devices
US20090138061A1 (en) * 2006-01-16 2009-05-28 Continence Control Systems International Pty Limit Stimulator For The Control of a Bodily Function
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
JP4754361B2 (en) * 2006-01-18 2011-08-24 セイコーインスツル株式会社 Biological information transmitter
US7668600B2 (en) * 2006-01-19 2010-02-23 Medtronic, Inc. System and method for telemetry with an implantable medical device
US7720543B2 (en) * 2006-01-19 2010-05-18 Medtronic, Inc. System and method for telemetry with an implantable medical device
US7574266B2 (en) * 2006-01-19 2009-08-11 Medtronic, Inc. System and method for telemetry with an implantable medical device
US7996079B2 (en) * 2006-01-24 2011-08-09 Cyberonics, Inc. Input response override for an implantable medical device
US7657310B2 (en) 2006-01-26 2010-02-02 Cyberonics, Inc. Treatment of reproductive endocrine disorders by vagus nerve stimulation
US8204760B2 (en) * 2006-02-07 2012-06-19 Eflag Professional Solutions, Llc Systems, methods, and computer program products for facilitating communications, workflow, and task assignments in medical practices and clinics
US8784312B2 (en) * 2006-02-10 2014-07-22 Cochlear Limited Recognition of implantable medical device
EP3649925A1 (en) 2006-02-22 2020-05-13 DexCom, Inc. Analyte sensor
EP4218548A1 (en) 2006-03-09 2023-08-02 Dexcom, Inc. Systems and methods for processing analyte sensor data
US20080140057A1 (en) 2006-03-09 2008-06-12 Searete Llc, A Limited Liability Corporation Of State Of The Delaware Injectable controlled release fluid delivery system
US7747330B2 (en) * 2006-03-09 2010-06-29 Medtronic, Inc. Global parameter adjustment for multiple stimulation programs
JP2009529930A (en) 2006-03-13 2009-08-27 ノボ・ノルデイスク・エー/エス Medical system with bi-purpose communication means
JP2009530880A (en) * 2006-03-13 2009-08-27 ノボ・ノルデイスク・エー/エス Secure pairing of electronic devices using complex communication means
WO2007107984A2 (en) * 2006-03-22 2007-09-27 Ianiv Seror System and method for real time monitoring of a subject and verification of an emergency situation
EP2007765B1 (en) * 2006-03-23 2012-06-27 Novartis AG Immunopotentiating compounds
US8744587B2 (en) 2006-03-24 2014-06-03 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
WO2007115103A1 (en) 2006-03-29 2007-10-11 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
EP1839566A1 (en) * 2006-03-29 2007-10-03 F. Hoffmann-La Roche AG Method and assembly for the observation of a medical instrument.
JP2009532117A (en) 2006-03-30 2009-09-10 ヴァレリタス,エルエルシー Multi-cartridge fluid dispensing device
DE502006000203D1 (en) * 2006-03-30 2008-01-10 Roche Diagnostics Gmbh Infusion system with an infusion unit and a remote control unit
US7725272B2 (en) * 2006-03-30 2010-05-25 Codman Neuro Sciences, Sarl Methods and devices for monitoring fluid of an implantable infusion pump
US7502992B2 (en) 2006-03-31 2009-03-10 Emc Corporation Method and apparatus for detecting presence of errors in data transmitted between components in a data storage system using an I2C protocol
US8089903B2 (en) * 2006-03-31 2012-01-03 Emc Corporation Method and apparatus for providing a logical separation of a customer device and a service device connected to a data storage system
US20090171178A1 (en) * 2006-03-31 2009-07-02 Abbott Diabetes Care, Inc. Method and System for Powering an Electronic Device
US20070233051A1 (en) 2006-03-31 2007-10-04 David Hohl Drug delivery systems and methods
US7742816B2 (en) * 2006-03-31 2010-06-22 Medtronic, Inc. Multichannel communication for implantable medical device applications
WO2007123764A2 (en) 2006-04-06 2007-11-01 Medtronic, Inc. Systems and methods of identifying catheter malfunctions using pressure sensing
US7559899B2 (en) * 2006-04-12 2009-07-14 Salutron, Inc. Power saving techniques for continuous heart rate monitoring
US20120035540A1 (en) 2006-04-12 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Event-based control of a lumen traveling device
US20070245258A1 (en) * 2006-04-13 2007-10-18 Codman Neuro Sciences Sàrl Graphical user interface of an external control device for controlling an implantable medical device while minimizing human error
ES2336360T3 (en) 2006-04-20 2010-04-12 Lifescan Scotland Ltd METHOD FOR TRANSMITTING DATA IN A GLUCOSE SYSTEM IN BLOOD AND GLUCOSE SYSTEM IN BLOOD CORRESPONDING.
US7650185B2 (en) * 2006-04-25 2010-01-19 Cardiac Pacemakers, Inc. System and method for walking an implantable medical device from a sleep state
US20090163874A1 (en) * 2006-04-26 2009-06-25 Novo Nordisk A/S Skin-Mountable Device in Packaging Comprising Coated Seal Member
US7869885B2 (en) 2006-04-28 2011-01-11 Cyberonics, Inc Threshold optimization for tissue stimulation therapy
US8805526B2 (en) 2006-05-03 2014-08-12 Cardiac Pacemakers, Inc. Configurable medical telemetry radio system
KR101191195B1 (en) * 2006-05-04 2012-10-15 엘지전자 주식회사 apparatus for transmitting contents, apparatus for outputting contents, method for transmitting contents and method for outputting contents
US9020597B2 (en) 2008-11-12 2015-04-28 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US20070269322A1 (en) * 2006-05-19 2007-11-22 Falk Theodore J Low power electromagnetic pump
US20070270677A1 (en) * 2006-05-22 2007-11-22 Steve Thuss Interactive device for monitoring and reporting glucose levels
US20100249566A1 (en) * 2006-05-22 2010-09-30 Suess Frank P Interactive device for monitoring and reporting glucose levels with integrated atomic clock module
WO2007134622A1 (en) * 2006-05-22 2007-11-29 Lifescan Scotland Limited Blood glucose level measurement and wireless transmission unit
US7727143B2 (en) * 2006-05-31 2010-06-01 Allergan, Inc. Locator system for implanted access port with RFID tag
US20090054749A1 (en) * 2006-05-31 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Data Transmission in a Data Management System
WO2007141210A1 (en) * 2006-06-06 2007-12-13 Novo Nordisk A/S Assembly comprising skin-mountable device and packaging therefore
WO2007142562A1 (en) 2006-06-09 2007-12-13 St Jude Medical Ab Methods in a medical telemetry system
US7720544B2 (en) * 2006-06-09 2010-05-18 Cardiac Pacemakers, Inc. Systems for enabling telemetry in an implantable medical device
US7613522B2 (en) * 2006-06-09 2009-11-03 Cardiac Pacemakers, Inc. Multi-antenna for an implantable medical device
US20070299317A1 (en) * 2006-06-13 2007-12-27 Hoyme Kenneth P System and method for programming customized data collection for an autonomous medical device
US20080004601A1 (en) * 2006-06-28 2008-01-03 Abbott Diabetes Care, Inc. Analyte Monitoring and Therapy Management System and Methods Therefor
US20090171269A1 (en) * 2006-06-29 2009-07-02 Abbott Diabetes Care, Inc. Infusion Device and Methods Therefor
US8279059B2 (en) 2006-06-29 2012-10-02 Given Imaging Ltd. Data recorder, system and method for transmitting data received from an in-vivo sensing device
EP2037983A1 (en) * 2006-06-30 2009-03-25 Novo Nordisk A/S Perfusion device with compensation of medical infusion during wear-time
US20090105571A1 (en) * 2006-06-30 2009-04-23 Abbott Diabetes Care, Inc. Method and System for Providing Data Communication in Data Management Systems
JP5241714B2 (en) 2006-07-07 2013-07-17 プロテウス デジタル ヘルス, インコーポレイテッド Smart parenteral delivery system
WO2008053368A2 (en) * 2006-07-07 2008-05-08 Medingo Ltd. Fluid delivery device and methods of its operation
US7623922B2 (en) * 2006-07-12 2009-11-24 Cardiac Pacemakers, Inc. Implantable medical device telemetry with periodic frequency hopping
US8185204B2 (en) 2006-07-12 2012-05-22 Cardiac Pacemakers, Inc. Implantable medical device telemetry with adaptive frequency hopping
WO2008010133A2 (en) * 2006-07-14 2008-01-24 Philips Intellectual Property & Standards Gmbh Heartbeat monitoring device, system and method
US7908334B2 (en) * 2006-07-21 2011-03-15 Cardiac Pacemakers, Inc. System and method for addressing implantable devices
US9962112B2 (en) * 2006-07-21 2018-05-08 The Regents Of The University Of Colorado, A Body Corporate Medical systems and methods of use
US8326390B2 (en) * 2006-07-25 2012-12-04 Edward Belotserkovsky Optical non-invasive blood monitoring system and method
US7486976B1 (en) 2006-07-25 2009-02-03 Edward Belotserkovsky Optical non-invasive blood monitoring system and method
US20080146989A1 (en) * 2006-07-30 2008-06-19 Jaime Zacharias Anti-repulsion anti-clogging system and method for driving a dual-axis lensectomy probe
US20080039820A1 (en) * 2006-08-10 2008-02-14 Jeff Sommers Medical Device With Septum
US20080076969A1 (en) * 2006-08-29 2008-03-27 Ulrich Kraft Methods for modifying control software of electronic medical devices
EP1895437A1 (en) * 2006-09-01 2008-03-05 F.Hoffmann-La Roche Ag Medical infusion devices and method for administrating such devices
JP4153003B2 (en) * 2006-09-04 2008-09-17 シャープ株式会社 Biological information measuring device, power consumption control method, biological information measuring program, and computer-readable recording medium
US20080071328A1 (en) * 2006-09-06 2008-03-20 Medtronic, Inc. Initiating medical system communications
US8025634B1 (en) * 2006-09-18 2011-09-27 Baxter International Inc. Method and system for controlled infusion of therapeutic substances
US7917812B2 (en) * 2006-09-30 2011-03-29 Codman Neuro Sciences Sárl Resetting of multiple processors in an electronic device
US8447376B2 (en) * 2006-10-04 2013-05-21 Dexcom, Inc. Analyte sensor
US8275438B2 (en) 2006-10-04 2012-09-25 Dexcom, Inc. Analyte sensor
US8562528B2 (en) 2006-10-04 2013-10-22 Dexcom, Inc. Analyte sensor
US8478377B2 (en) 2006-10-04 2013-07-02 Dexcom, Inc. Analyte sensor
US8641660B2 (en) * 2006-10-04 2014-02-04 P Tech, Llc Methods and devices for controlling biologic microenvironments
US8506524B2 (en) * 2006-10-04 2013-08-13 Novo Nordisk A/S User interface for delivery system comprising diary function
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8449464B2 (en) 2006-10-04 2013-05-28 Dexcom, Inc. Analyte sensor
US8298142B2 (en) 2006-10-04 2012-10-30 Dexcom, Inc. Analyte sensor
US9724510B2 (en) 2006-10-09 2017-08-08 Endostim, Inc. System and methods for electrical stimulation of biological systems
US20150224310A1 (en) 2006-10-09 2015-08-13 Endostim, Inc. Device and Implantation System for Electrical Stimulation of Biological Systems
US9345879B2 (en) 2006-10-09 2016-05-24 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US11577077B2 (en) 2006-10-09 2023-02-14 Endostim, Inc. Systems and methods for electrical stimulation of biological systems
US8202267B2 (en) 2006-10-10 2012-06-19 Medsolve Technologies, Inc. Method and apparatus for infusing liquid to a body
US20080089519A1 (en) * 2006-10-12 2008-04-17 Nokia Corporation Secure key exchange algorithm for wireless protocols
US9675285B2 (en) * 2006-10-16 2017-06-13 Given Imaging Ltd. Delivery device for implantable monitor
CA2666509C (en) 2006-10-16 2017-05-09 Hospira, Inc. System and method for comparing and utilizing activity information and configuration information from multiple medical device management systems
KR101108960B1 (en) * 2006-10-17 2012-01-31 쇼와 덴코 가부시키가이샤 Method for forming solder layer on printed-wiring board and slurry discharge device
US7881803B2 (en) * 2006-10-18 2011-02-01 Boston Scientific Neuromodulation Corporation Multi-electrode implantable stimulator device with a single current path decoupling capacitor
US7720545B2 (en) * 2006-10-20 2010-05-18 Pacesetter, Inc. Method and apparatus for preventing excessive power drain from an implantable device
US8229562B2 (en) 2006-10-25 2012-07-24 Codman NeuroSciences Sárl Universal external control device for use by multiple conditional access users with varying access to functionality of an implantable medical device
US7869867B2 (en) 2006-10-27 2011-01-11 Cyberonics, Inc. Implantable neurostimulator with refractory stimulation
US7667606B2 (en) * 2006-10-30 2010-02-23 Visible Assets, Inc RF enabled surgical cart and use of same in operating room environment
US20080119710A1 (en) * 2006-10-31 2008-05-22 Abbott Diabetes Care, Inc. Medical devices and methods of using the same
US20080119705A1 (en) * 2006-11-17 2008-05-22 Medtronic Minimed, Inc. Systems and Methods for Diabetes Management Using Consumer Electronic Devices
JP5137385B2 (en) * 2006-11-17 2013-02-06 オリンパス株式会社 Capsule medical device
WO2008061552A1 (en) * 2006-11-23 2008-05-29 Lifescan Scotland Limited Blood glucose meter capable of wireless communication
US20080129517A1 (en) * 2006-11-24 2008-06-05 Ventrassist Pty Ltd Control System With Alarm
US8079955B2 (en) * 2006-11-28 2011-12-20 Isense Corporation Method and apparatus for managing glucose control
US8352041B2 (en) * 2006-11-28 2013-01-08 The Alfred E. Mann Foundation For Scientific Research Remote controls and ambulatory medical systems including the same
US8352042B2 (en) * 2006-11-28 2013-01-08 The Alfred E. Mann Foundation For Scientific Research Remote controls and ambulatory medical systems including the same
US20080140163A1 (en) * 2006-12-06 2008-06-12 Keacher Jeffrey T Telemetry device for a medical device programmer
WO2008070069A1 (en) * 2006-12-06 2008-06-12 Medtronic, Inc. Programming a medical device with a general purpose instrument
JP4398971B2 (en) * 2006-12-07 2010-01-13 シャープ株式会社 Image processing device
DE102006059019A1 (en) * 2006-12-14 2008-06-19 Endocrine Technologies (Et) Gmbh Device for the computer-controlled infusion of drugs with discrete-time measurement value acquisition in a control loop
US8395581B2 (en) * 2006-12-14 2013-03-12 Novo Nordisk A/S User interface for medical system comprising diary function with time change feature
US8036330B2 (en) * 2006-12-29 2011-10-11 Samsung Electronics Co., Ltd. System and method for frequency synchronization in a wireless non-hierarchical network
US20080167531A1 (en) * 2007-01-05 2008-07-10 Cardiac Pacemakers, Inc. System and method to monitor battery status in an implantable medical device
US20080171941A1 (en) * 2007-01-12 2008-07-17 Huelskamp Paul J Low power methods for pressure waveform signal sampling using implantable medical devices
US7616021B2 (en) * 2007-01-18 2009-11-10 Advanced Micro Devices, Inc. Method and device for determining an operational lifetime of an integrated circuit device
US7734323B2 (en) * 2007-01-24 2010-06-08 Smiths Medical Asd, Inc. Correction factor testing using frequent blood glucose input
US20080183133A1 (en) * 2007-01-30 2008-07-31 Animas Corporation Infusion pump keypad assembly and method for making the same
US20080189163A1 (en) * 2007-02-05 2008-08-07 Inquira, Inc. Information management system
US8620438B1 (en) 2007-02-13 2013-12-31 Encore Medical Asset Corporation Method and apparatus for applying neuromuscular electrical stimulation
US8339262B2 (en) * 2007-02-22 2012-12-25 Autonamic Technologies, Inc. Patient identification system
WO2008107467A1 (en) * 2007-03-06 2008-09-12 Novo Nordisk A/S Pump assembly comprising actuator system
EP1967132B8 (en) 2007-03-09 2015-06-03 Roche Diagnostics GmbH Medical data transmission system
US8046079B2 (en) 2007-03-13 2011-10-25 Cardiac Pacemakers, Inc. Implantable medical device telemetry with hop-on-error frequency hopping
MX2009009999A (en) * 2007-03-19 2010-03-17 Insuline Medical Ltd Method and device for drug delivery.
EP2136863A2 (en) * 2007-03-19 2009-12-30 Insuline Medical Ltd. Device for drug delivery and associated connections thereto
JP5231525B2 (en) 2007-03-26 2013-07-10 レモン メディカル テクノロジーズ, リミテッド Biased acoustic switch for implantable medical devices
CN101646471A (en) * 2007-03-27 2010-02-10 皇家飞利浦电子股份有限公司 Reduce the automatic drug administration of power consumption
EP2142077B1 (en) 2007-03-30 2014-10-01 Novo Nordisk A/S Electronic device assembly with safety electric connector
US9044537B2 (en) 2007-03-30 2015-06-02 Medtronic, Inc. Devices and methods for detecting catheter complications
US8390244B2 (en) * 2007-03-30 2013-03-05 Nipro Healthcare Systems, Llc Rechargeable battery backup apparatus and method for insulin pump
US8034019B2 (en) * 2007-04-10 2011-10-11 Amrita Vishwa Vidyapeetham Dual microcontroller-based liquid infusion system
US8863106B2 (en) * 2007-04-18 2014-10-14 Weinmann Gerate Fur Medizin Gmbh & Co. Kg Method and device for updating medical apparatus
US8425469B2 (en) * 2007-04-23 2013-04-23 Jacobson Technologies, Llc Systems and methods for controlled substance delivery network
US20080269714A1 (en) * 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US7974701B2 (en) 2007-04-27 2011-07-05 Cyberonics, Inc. Dosing limitation for an implantable medical device
US20080269724A1 (en) * 2007-04-27 2008-10-30 Medtronic, Inc. Implantable drug delivery device with programmable rate capacitor charge control
US20080278332A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281179A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080281171A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US20080312845A1 (en) * 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US20200037874A1 (en) 2007-05-18 2020-02-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7892199B2 (en) 2007-05-21 2011-02-22 Asante Solutions, Inc. Occlusion sensing for an infusion pump
US7981102B2 (en) 2007-05-21 2011-07-19 Asante Solutions, Inc. Removable controller for an infusion pump
US7833196B2 (en) 2007-05-21 2010-11-16 Asante Solutions, Inc. Illumination instrument for an infusion pump
US7794426B2 (en) 2007-05-21 2010-09-14 Asante Solutions, Inc. Infusion pump system with contamination-resistant features
US8258921B2 (en) * 2007-06-01 2012-09-04 Ishida Co., Ltd. Electronic shelf label system
US20080300572A1 (en) * 2007-06-01 2008-12-04 Medtronic Minimed, Inc. Wireless monitor for a personal medical device system
US8369944B2 (en) 2007-06-06 2013-02-05 Zoll Medical Corporation Wearable defibrillator with audio input/output
US8603050B2 (en) * 2007-06-07 2013-12-10 The Alfred E. Mann Foundation For Scientific Research Implantable infusion devices including apparatus for confirming side port access
US8365726B2 (en) 2007-06-07 2013-02-05 Resmed Limited Tub for humidifier
EP2001188A1 (en) * 2007-06-08 2008-12-10 F.Hoffmann-La Roche Ag Method for authenticating a medical device and a remote device
WO2008154312A1 (en) 2007-06-08 2008-12-18 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
TWI500609B (en) * 2007-06-12 2015-09-21 Solvay Product containing epichlorohydrin, its preparation and its use in various applications
EP2167186B1 (en) 2007-06-14 2016-10-19 Second Sight Medical Products, Inc. Video processing unit for a visual prosthetic apparatus
US8798756B2 (en) * 2007-11-07 2014-08-05 Second Sight Medical Products, Inc. Video processing unit for a visual prosthetic apparatus
US8449523B2 (en) * 2007-06-15 2013-05-28 Animas Corporation Method of operating a medical device and at least a remote controller for such medical device
US9391670B2 (en) 2007-06-15 2016-07-12 Animas Corporation Methods for secure communication and pairing of a medical infusion device and a remote controller for such medical device
US8444595B2 (en) * 2007-06-15 2013-05-21 Animas Corporation Methods to pair a medical device and at least a remote controller for such medical device
US8932250B2 (en) * 2007-06-15 2015-01-13 Animas Corporation Systems and methods to pair a medical device and a remote controller for such medical device
US20080319294A1 (en) * 2007-06-21 2008-12-25 Abbott Diabetes Care, Inc. Health management devices and methods
US20100274218A1 (en) * 2007-06-22 2010-10-28 Medingo Ltd Communications for medicinal fluid delivery system
US8649858B2 (en) * 2007-06-25 2014-02-11 Boston Scientific Neuromodulation Corporation Architectures for an implantable medical device system
EP2167168B1 (en) * 2007-06-25 2017-05-10 Roche Diabetes Care GmbH Tailored basal insulin delivery system
US20090005729A1 (en) * 2007-06-27 2009-01-01 Animas Corporation Medical infusion pumps
EP2008577A1 (en) * 2007-06-28 2008-12-31 F.Hoffmann-La Roche Ag Assembly with infusion pump and measuring device
MX2009014275A (en) * 2007-06-29 2010-04-27 Hoffmann La Roche Device and methods for optimizing communications between a medical device and a remote electronic device.
EP2170159B8 (en) * 2007-06-29 2016-09-21 Roche Diabetes Care GmbH Combination communication device and medical device for communicating wirelessly with a remote medical device
US8213652B2 (en) * 2007-07-02 2012-07-03 Siemens Medical Instruments Pte. Ltd. Multi-component hearing aid system and a method for its operation
US20090036760A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
DK2185219T3 (en) * 2007-08-01 2019-09-09 Hoffmann La Roche Portable infusion device provided with means for monitoring and controlling fluid delivery
CN102831293B (en) * 2007-08-10 2016-05-18 施曼信医疗Asd公司 The formulating method of Medical Equipment Maintenance timetable and management system
US7981082B2 (en) * 2007-08-21 2011-07-19 Hospira, Inc. System and method for reducing air bubbles in a fluid delivery line
US9968742B2 (en) * 2007-08-29 2018-05-15 Medtronic Minimed, Inc. Combined sensor and infusion set using separated sites
EP2197521B1 (en) * 2007-08-31 2016-04-13 Leon Dejournett Computerized blood glucose level adjustment system
US8515547B2 (en) 2007-08-31 2013-08-20 Cardiac Pacemakers, Inc. Wireless patient communicator for use in a life critical network
US9848058B2 (en) 2007-08-31 2017-12-19 Cardiac Pacemakers, Inc. Medical data transport over wireless life critical network employing dynamic communication link mapping
WO2009029899A1 (en) * 2007-09-01 2009-03-05 Sang Hoon Woo Controlling body fluid condition using diuretics
US7717903B2 (en) 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
US7828528B2 (en) * 2007-09-06 2010-11-09 Asante Solutions, Inc. Occlusion sensing system for infusion pumps
US7935105B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Data storage for an infusion pump system
US8287514B2 (en) 2007-09-07 2012-10-16 Asante Solutions, Inc. Power management techniques for an infusion pump system
US7879026B2 (en) 2007-09-07 2011-02-01 Asante Solutions, Inc. Controlled adjustment of medicine dispensation from an infusion pump device
US7935076B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Activity sensing techniques for an infusion pump system
DE102007043090A1 (en) * 2007-09-10 2009-03-12 Biotronik Crm Patent Ag Remote programmable personal device and arrangement and method for remote programming of a personal device
US20090069862A1 (en) * 2007-09-11 2009-03-12 Brian Michael Shelton Adaptive Telemetry Wakeup for an Implantable Medical Device
US20100261980A1 (en) * 2007-09-19 2010-10-14 Koninklijke Philips Electronics N.V. Method and apparatus for detecting an abnormal situation
EP2203216A1 (en) * 2007-09-20 2010-07-07 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
EP2039286A1 (en) * 2007-09-21 2009-03-25 Roche Diagnostics GmbH Interface device between data management unit and medical device
US8535280B2 (en) * 2007-09-26 2013-09-17 Medtronic, In Pressure based refill status monitor for implantable pumps
US8467873B2 (en) * 2007-09-27 2013-06-18 St. Jude Medical, AB Synchronization methods and devices in telemetry system
US8352038B2 (en) * 2007-10-01 2013-01-08 Medtronic, Inc. Medical device function configuration post-manufacturing
US9129047B2 (en) * 2007-10-03 2015-09-08 Medallion Therapeutics, Inc. Programming and bolus monitoring device for an implantable drug pump
CA2702116C (en) 2007-10-10 2021-01-05 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
WO2010042045A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. A system, an apparatus, and a method for treating a sexual dysfunctional female patient
EP2204786A4 (en) * 2007-10-17 2013-08-21 Hochiki Co Communication system
US8000918B2 (en) * 2007-10-23 2011-08-16 Edwards Lifesciences Corporation Monitoring and compensating for temperature-related error in an electrochemical sensor
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
EP2211974A4 (en) 2007-10-25 2013-02-27 Proteus Digital Health Inc Fluid transfer port information system
US8557179B2 (en) * 2007-10-31 2013-10-15 Novo Nordisk A/S Non-porous material as sterilization barrier
WO2009059203A1 (en) * 2007-11-02 2009-05-07 Edwards Lifesciences Corporation Analyte monitoring system having back-up power source for use in either transport of the system or primary power loss
US20090118779A1 (en) * 2007-11-07 2009-05-07 Nader Najafi Modular System For A Wireless Implantable Device
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
DK2060296T3 (en) * 2007-11-19 2016-12-05 Hollister Inc Damphydratiseret catheter assembly and method for production thereof
US9089707B2 (en) 2008-07-02 2015-07-28 The Board Of Regents, The University Of Texas System Systems, methods and devices for paired plasticity
WO2009070738A1 (en) * 2007-11-26 2009-06-04 Micro Transponder Inc. Implantable transponder pulse stimulation systems and methods
DE112008003192T5 (en) * 2007-11-26 2010-10-07 Micro-Transponder, Inc., Dallas Transmission coils Architecture
US8457757B2 (en) * 2007-11-26 2013-06-04 Micro Transponder, Inc. Implantable transponder systems and methods
US20090188811A1 (en) 2007-11-28 2009-07-30 Edwards Lifesciences Corporation Preparation and maintenance of sensors
US20090150174A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Healthcare management system having improved printing of display screen information
US20090150877A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Data driven communication protocol grammar
US20090150439A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Common extensible data exchange format
US8112390B2 (en) * 2007-12-07 2012-02-07 Roche Diagnostics Operations, Inc. Method and system for merging extensible data into a database using globally unique identifiers
US9003538B2 (en) * 2007-12-07 2015-04-07 Roche Diagnostics Operations, Inc. Method and system for associating database content for security enhancement
US20090147011A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method and system for graphically indicating multiple data values
US20090147026A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Graphic zoom functionality for a custom report
US8132101B2 (en) * 2007-12-07 2012-03-06 Roche Diagnostics Operations, Inc. Method and system for data selection and display
US8019721B2 (en) * 2007-12-07 2011-09-13 Roche Diagnostics Operations, Inc. Method and system for enhanced data transfer
US8078592B2 (en) 2007-12-07 2011-12-13 Roche Diagnostics Operations, Inc. System and method for database integrity checking
US8566818B2 (en) 2007-12-07 2013-10-22 Roche Diagnostics Operations, Inc. Method and system for configuring a consolidated software application
US20090150482A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method of cloning a server installation to a network client
US8365065B2 (en) * 2007-12-07 2013-01-29 Roche Diagnostics Operations, Inc. Method and system for creating user-defined outputs
US20090150865A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method and system for activating features and functions of a consolidated software application
US9886549B2 (en) * 2007-12-07 2018-02-06 Roche Diabetes Care, Inc. Method and system for setting time blocks
US8103241B2 (en) * 2007-12-07 2012-01-24 Roche Diagnostics Operations, Inc. Method and system for wireless device communication
US8402151B2 (en) * 2007-12-07 2013-03-19 Roche Diagnostics Operations, Inc. Dynamic communication stack
US8819040B2 (en) * 2007-12-07 2014-08-26 Roche Diagnostics Operations, Inc. Method and system for querying a database
US20090150780A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Help utility functionality and architecture
US20090147006A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method and system for event based data comparison
US20090150812A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method and system for data source and modification tracking
US20090150451A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method and system for selective merging of patient data
US7996245B2 (en) * 2007-12-07 2011-08-09 Roche Diagnostics Operations, Inc. Patient-centric healthcare information maintenance
US20090150331A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method and system for creating reports
US20090150438A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Export file format with manifest for enhanced data transfer
US20090150771A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. System and method for reporting medical information
US7979136B2 (en) * 2007-12-07 2011-07-12 Roche Diagnostics Operation, Inc Method and system for multi-device communication
US20090150181A1 (en) * 2007-12-07 2009-06-11 Roche Diagnostics Operations, Inc. Method and system for personal medical data database merging
CN103961792B (en) * 2007-12-17 2016-09-21 新世界药品有限公司 Intra-dermal delivery, diagnosis and the communication system integrated
US9839395B2 (en) 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
US8517990B2 (en) * 2007-12-18 2013-08-27 Hospira, Inc. User interface improvements for medical devices
US20090164190A1 (en) * 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Physiological condition simulation device and method
ES2425769T5 (en) * 2007-12-20 2017-07-28 University Of Southern California Apparatus for the administration of therapeutic agents
JP4718595B2 (en) * 2007-12-27 2011-07-06 パナソニック株式会社 Wireless communication system and portable terminal device
US8823500B2 (en) 2009-05-22 2014-09-02 The Quantum Group, Inc. System and method for automating and verifying product value, usage, and suitability for use or sale
US8041431B2 (en) * 2008-01-07 2011-10-18 Cardiac Pacemakers, Inc. System and method for in situ trimming of oscillators in a pair of implantable medical devices
US20090177142A1 (en) * 2008-01-09 2009-07-09 Smiths Medical Md, Inc Insulin pump with add-on modules
US7970042B2 (en) * 2008-01-11 2011-06-28 Lexmark International, Inc. Spread spectrum clock interoperability control and inspection circuit
USD612279S1 (en) 2008-01-18 2010-03-23 Lifescan Scotland Limited User interface in an analyte meter
WO2009094609A1 (en) 2008-01-25 2009-07-30 Sharma Virender K Device and implantation system for electrical stimulation of biological systems
EP3964243A1 (en) * 2008-01-28 2022-03-09 Implantica Patent Ltd Blood clot removal device, system, and method
US8708961B2 (en) 2008-01-28 2014-04-29 Medsolve Technologies, Inc. Apparatus for infusing liquid to a body
HUE054386T2 (en) 2008-01-29 2021-09-28 Implantica Patent Ltd Apparatus for treating obesity
US20090192813A1 (en) * 2008-01-29 2009-07-30 Roche Diagnostics Operations, Inc. Information transfer through optical character recognition
US8301262B2 (en) 2008-02-06 2012-10-30 Cardiac Pacemakers, Inc. Direct inductive/acoustic converter for implantable medical device
US8285386B2 (en) * 2008-02-19 2012-10-09 Codman Neuro Sciences Sárl Implant revision recognition by exchanging the revision data during transmission
WO2009105170A1 (en) * 2008-02-19 2009-08-27 Cardiac Pacemakers, Inc. Multimedia presentation for use with implantable medical device
CA2715624A1 (en) * 2008-02-20 2009-08-27 Dexcom, Inc. Continuous medicament sensor system for in vivo use
EP2252196A4 (en) 2008-02-21 2013-05-15 Dexcom Inc Systems and methods for processing, transmitting and displaying sensor data
GB2458139A (en) 2008-03-06 2009-09-09 Toumaz Technology Ltd Monitoring and tracking of wireless sensor devices in a healthcare monitoring system
US20090231890A1 (en) * 2008-03-11 2009-09-17 General Electric Boost converter input ripple current reduction circuit
CN102037528A (en) * 2008-03-20 2011-04-27 格瑞巴奇有限公司 Shielded three-terminal flat-through EMI/energy dissipating filter
USD612275S1 (en) 2008-03-21 2010-03-23 Lifescan Scotland, Ltd. Analyte test meter
USD611853S1 (en) 2008-03-21 2010-03-16 Lifescan Scotland Limited Analyte test meter
IL197532A0 (en) 2008-03-21 2009-12-24 Lifescan Scotland Ltd Analyte testing method and system
USD615431S1 (en) 2008-03-21 2010-05-11 Lifescan Scotland Limited Analyte test meter
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US8031722B1 (en) 2008-03-31 2011-10-04 Emc Corporation Techniques for controlling a network switch of a data storage system
WO2009124095A1 (en) * 2008-03-31 2009-10-08 Abbott Diabetes Care Inc. Shallow implantable analyte sensor with rapid physiological response
US7914483B2 (en) 2008-04-02 2011-03-29 Baxter International Inc. Pain controlled analgesic (“PCA”) apparatus
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
CN101569540B (en) * 2008-04-29 2011-05-11 香港理工大学 Wireless ultrasonic scanning system
US20100256047A1 (en) * 2009-04-03 2010-10-07 Lifescan, Inc. Analyte Measurement and Management Device and Associated Methods
JP2009271831A (en) * 2008-05-09 2009-11-19 Sharp Corp Image data processing apparatus
WO2009139846A1 (en) * 2008-05-12 2009-11-19 Department Of Veterans Affairs Automated system and method for diabetes control
US9503526B2 (en) 2008-05-19 2016-11-22 Tandem Diabetes Care, Inc. Therapy management system
US20090300616A1 (en) * 2008-05-30 2009-12-03 Abbott Diabetes Care, Inc. Automated task execution for an analyte monitoring system
EP2293719B1 (en) 2008-05-30 2015-09-09 Intuity Medical, Inc. Body fluid sampling device -- sampling site interface
US8781147B1 (en) * 2008-06-04 2014-07-15 National Acquisition Sub, Inc. Acoustic headphone having a single interface to receive audio signals and configuration data
WO2009148624A1 (en) 2008-06-06 2009-12-10 Intuity Medical, Inc. Detection meter and mode of operation
EP2299904B1 (en) 2008-06-06 2019-09-11 Intuity Medical, Inc. Medical measurement method
USD611151S1 (en) 2008-06-10 2010-03-02 Lifescan Scotland, Ltd. Test meter
US20090312650A1 (en) * 2008-06-12 2009-12-17 Cardiac Pacemakers, Inc. Implantable pressure sensor with automatic measurement and storage capabilities
US7799016B2 (en) * 2008-06-20 2010-09-21 Pharmaco-Kinesis Corporation Magnetic breather pump and a method for treating a brain tumor using the same
WO2009158062A1 (en) * 2008-06-27 2009-12-30 Cardiac Pacemakers, Inc. Systems and methods of monitoring the acoustic coupling of medical devices
US20090326443A1 (en) * 2008-06-30 2009-12-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Preparatory dispensation systems and methods
EP2140893B1 (en) * 2008-06-30 2012-08-01 Animas Corporation System for using status indicators in wireless communications with medical devices
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US9662045B2 (en) 2008-07-11 2017-05-30 Medtronic, Inc. Generation of sleep quality information based on posture state data
US9440084B2 (en) 2008-07-11 2016-09-13 Medtronic, Inc. Programming posture responsive therapy
US9050471B2 (en) 2008-07-11 2015-06-09 Medtronic, Inc. Posture state display on medical device user interface
US8504150B2 (en) 2008-07-11 2013-08-06 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US8644945B2 (en) 2008-07-11 2014-02-04 Medtronic, Inc. Patient interaction with posture-responsive therapy
US9545518B2 (en) 2008-07-11 2017-01-17 Medtronic, Inc. Posture state classification for a medical device
US8755901B2 (en) * 2008-07-11 2014-06-17 Medtronic, Inc. Patient assignment of therapy parameter to posture state
US8708934B2 (en) 2008-07-11 2014-04-29 Medtronic, Inc. Reorientation of patient posture states for posture-responsive therapy
US8315710B2 (en) 2008-07-11 2012-11-20 Medtronic, Inc. Associating therapy adjustments with patient posture states
US8041720B2 (en) * 2008-07-23 2011-10-18 Honeywell International Inc. Ordering telemetry messages
US20100023091A1 (en) * 2008-07-24 2010-01-28 Stahmann Jeffrey E Acoustic communication of implantable device status
USD611489S1 (en) 2008-07-25 2010-03-09 Lifescan, Inc. User interface display for a glucose meter
EP2149957B1 (en) * 2008-07-30 2017-06-14 Harman Becker Automotive Systems GmbH Priority based power distribution arrangement
US8378831B2 (en) * 2008-08-06 2013-02-19 The Quantum Group, Inc. System and method for coordinated health monitoring, emergency response, and medical record delivery
US8970381B2 (en) 2008-08-06 2015-03-03 The Quantum Group, Inc. System and method for coordinated health monitoring, emergency response, and medical record delivery
US20100036459A1 (en) * 2008-08-06 2010-02-11 Texas Instruments Incorporated Signaling in a medical implant based system
US20100036508A1 (en) * 2008-08-06 2010-02-11 Texas Instruments Incorporation Enabling non-interoperability among transceivers of devices
JP2010057898A (en) * 2008-08-08 2010-03-18 Ricoh Co Ltd Liquid medicine injection amount adjusting device, liquid medicine injection amount adjusting method, and liquid medicine injection system
US8126566B2 (en) 2008-08-14 2012-02-28 Cardiac Pacemakers, Inc. Performance assessment and adaptation of an acoustic communication link
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US8900431B2 (en) 2008-08-27 2014-12-02 Edwards Lifesciences Corporation Analyte sensor
WO2010025289A2 (en) * 2008-08-28 2010-03-04 Isense Corporation Method and system for communication between wireless devices
EP2164013B1 (en) 2008-09-02 2017-03-01 F. Hoffmann-La Roche AG Method and apparatus for setting a basal rate profile for an insulin pump
EP2355865A2 (en) * 2008-09-02 2011-08-17 Medingo Ltd. Remote control for fluid dispensing device with a rechargeable power source
US8280517B2 (en) 2008-09-19 2012-10-02 Medtronic, Inc. Automatic validation techniques for validating operation of medical devices
USD611372S1 (en) 2008-09-19 2010-03-09 Lifescan Scotland Limited Analyte test meter
US8335551B2 (en) * 2008-09-29 2012-12-18 Chong Il Lee Method and means for connecting a large number of electrodes to a measuring device
US20100082364A1 (en) * 2008-09-30 2010-04-01 Abbott Diabetes Care, Inc. Medical Information Management
US10603489B2 (en) 2008-10-09 2020-03-31 Virender K. Sharma Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
WO2010042686A1 (en) 2008-10-09 2010-04-15 Sharma Virender K Method and apparatus for stimulating the vascular system
WO2010042058A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. An improved artificial valve
EP2349078A4 (en) 2008-10-10 2018-02-07 Kirk Promotion LTD. Fastening means for implantable medcial control assembly
EP3708136A1 (en) 2008-10-10 2020-09-16 MedicalTree Patent Ltd. Heart help device, system, and method
EP2349170B1 (en) 2008-10-10 2023-09-27 Implantica Patent Ltd. Apparatus for the treatment of female sexual dysfunction
CA3004075C (en) 2008-10-10 2020-06-02 Medicaltree Patent Ltd. Heart help device, system, and method
US8554579B2 (en) 2008-10-13 2013-10-08 Fht, Inc. Management, reporting and benchmarking of medication preparation
US11375929B2 (en) 2008-10-15 2022-07-05 The University Of Tennessee Research Foundation Method and device for detection of bioavailable drug concentration in a fluid sample
US9700246B2 (en) 2008-10-15 2017-07-11 The University Of Tennessee Research Foundation Method and device for detection of bioavailable drug concentration in a fluid sample
US20100100038A1 (en) * 2008-10-15 2010-04-22 Symbios Medical Products, Llc Electronic flow control
US8572459B2 (en) * 2008-10-16 2013-10-29 Codman Neuro Sciences Sárl Insuring proper communication with chosen implant among multiple implants in proximity to one another
US20120123241A1 (en) * 2008-10-27 2012-05-17 Physio-Control, Inc. External medical device warning other medical device of impending administration of treatment
JP5492903B2 (en) 2008-10-27 2014-05-14 カーディアック ペースメイカーズ, インコーポレイテッド Method and system for charging an implantable device
US20120123242A1 (en) * 2008-10-27 2012-05-17 Physio-Control, Inc. External medical device reacting to warning from other medical device about impending independent administration of treatment
US9968788B2 (en) * 2008-10-29 2018-05-15 Medtronic, Inc. Timing coordination of implantable medical sensor modules
US8527208B2 (en) * 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
US9084551B2 (en) 2008-12-08 2015-07-21 Medtronic Xomed, Inc. Method and system for monitoring a nerve
EP2377115A1 (en) * 2008-12-11 2011-10-19 Sanofi-Aventis Deutschland GmbH Medical delivery device
FI2198902T3 (en) * 2008-12-19 2023-02-28 Hoffmann La Roche Portable drug administration device switchable between two different administration modes
US9330237B2 (en) 2008-12-24 2016-05-03 Medtronic Minimed, Inc. Pattern recognition and filtering in a therapy management system
US20100161346A1 (en) * 2008-12-24 2010-06-24 Kristen Getschmann Systems and Methods for Providing Bolus Dosage Recommendations
WO2010083485A2 (en) 2009-01-16 2010-07-22 Learning Curve Brands, Inc. Breast pump and method of use
US8126736B2 (en) 2009-01-23 2012-02-28 Warsaw Orthopedic, Inc. Methods and systems for diagnosing, treating, or tracking spinal disorders
US8685093B2 (en) 2009-01-23 2014-04-01 Warsaw Orthopedic, Inc. Methods and systems for diagnosing, treating, or tracking spinal disorders
US20100198279A1 (en) * 2009-01-30 2010-08-05 Corndorf Eric D Transceiver duty cycled operational mode
US20100198196A1 (en) * 2009-01-30 2010-08-05 Abbott Diabetes Care, Inc. Therapy Delivery Device Programming Tool
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9345892B2 (en) 2009-01-30 2016-05-24 Medtronic, Inc. Transceiver duty cycled operational mode
WO2010088687A1 (en) * 2009-02-02 2010-08-05 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US8571678B2 (en) * 2009-02-03 2013-10-29 Medtronic, Inc. Adaptation of modulation parameters for communications between an implantable medical device and an external instrument
US8335569B2 (en) 2009-02-10 2012-12-18 Boston Scientific Neuromodulation Corporation External device for communicating with an implantable medical device having data telemetry and charging integrated in a single housing
DK3912551T3 (en) * 2009-02-26 2023-10-30 Abbott Diabetes Care Inc Procedure for calibrating an analyte sensor
US8812841B2 (en) 2009-03-04 2014-08-19 Cardiac Pacemakers, Inc. Communications hub for use in life critical network
US8319631B2 (en) 2009-03-04 2012-11-27 Cardiac Pacemakers, Inc. Modular patient portable communicator for use in life critical network
US20100227585A1 (en) * 2009-03-05 2010-09-09 Lockheed Martin Corporation Method and apparatus for transmission of emergency information from emergency personnel
US9596989B2 (en) 2009-03-12 2017-03-21 Raytheon Company Networked symbiotic edge user infrastructure
JP4936479B2 (en) * 2009-03-26 2012-05-23 任天堂株式会社 Information processing program, information processing apparatus, information processing system, and information processing method
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
JP5478101B2 (en) * 2009-03-31 2014-04-23 シスメックス株式会社 Reagent preparation apparatus and specimen processing system
WO2010114942A1 (en) * 2009-03-31 2010-10-07 Abbott Diabetes Care Inc. Precise fluid dispensing method and device
US8271106B2 (en) 2009-04-17 2012-09-18 Hospira, Inc. System and method for configuring a rule set for medical event management and responses
US20100268303A1 (en) * 2009-04-19 2010-10-21 Mitchell William J Establishing a communication session between an implantable medical device and an external device using a burst period and a sniff interval
US20100274323A1 (en) * 2009-04-28 2010-10-28 Pacesetter, Inc. Method and system for power management
US20100274515A1 (en) * 2009-04-28 2010-10-28 Abbott Diabetes Care Inc. Dynamic Analyte Sensor Calibration Based On Sensor Stability Profile
KR20100118960A (en) * 2009-04-29 2010-11-08 삼성전자주식회사 Device, coordinator and method for managing emergency event
US8231555B2 (en) 2009-04-30 2012-07-31 Medtronic, Inc. Therapy system including multiple posture sensors
US8175720B2 (en) 2009-04-30 2012-05-08 Medtronic, Inc. Posture-responsive therapy control based on patient input
US8162874B2 (en) 2009-04-30 2012-04-24 Medtronic, Inc. Medical pump with fixed stroke length
US9327070B2 (en) 2009-04-30 2016-05-03 Medtronic, Inc. Medical device therapy based on posture and timing
AU2010245880B2 (en) 2009-05-05 2016-02-04 Carefusion 303, Inc. Model-based infusion site monitor
US9283339B2 (en) * 2009-05-18 2016-03-15 Zoll Medical Corporation Life support and monitoring apparatus with malfunction correction guidance
WO2010135646A1 (en) * 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
EP2438527B1 (en) * 2009-06-04 2018-05-02 Abbott Diabetes Care, Inc. Method and system for updating a medical device
AU2010255324A1 (en) * 2009-06-04 2012-01-19 F.Hoffmann-La Roche Ag Device and method for adjusting basal delivery profile
US8394077B2 (en) * 2009-06-09 2013-03-12 Jacobson Technologies, Llc Controlled delivery of substances system and method
US20100331918A1 (en) * 2009-06-30 2010-12-30 Boston Scientific Neuromodulation Corporation Moldable charger with curable material for charging an implantable pulse generator
US20100331919A1 (en) * 2009-06-30 2010-12-30 Boston Scientific Neuromodulation Corporation Moldable charger having hinged sections for charging an implantable pulse generator
US20100332902A1 (en) * 2009-06-30 2010-12-30 Rajesh Banginwar Power efficient watchdog service
US9468767B2 (en) * 2009-06-30 2016-10-18 Medtronic, Inc. Acoustic activation of components of an implantable medical device
US8260432B2 (en) 2009-06-30 2012-09-04 Boston Scientific Neuromodulation Corporation Moldable charger with shape-sensing means for an implantable pulse generator
US20100331915A1 (en) * 2009-06-30 2010-12-30 Hill Gerard J Acoustic activation of components of an implantable medical device
US9399131B2 (en) * 2009-06-30 2016-07-26 Boston Scientific Neuromodulation Corporation Moldable charger with support members for charging an implantable pulse generator
EP3970610A3 (en) 2009-07-02 2022-05-18 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US9351677B2 (en) 2009-07-02 2016-05-31 Dexcom, Inc. Analyte sensor with increased reference capacity
US10952836B2 (en) 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US8320600B2 (en) * 2009-07-21 2012-11-27 Boston Scientific Neuromodulation Corporation Method and apparatus to enhance communication in the operating room
US20110022981A1 (en) * 2009-07-23 2011-01-27 Deepa Mahajan Presentation of device utilization and outcome from a patient management system
US11169010B2 (en) 2009-07-27 2021-11-09 Integra Lifesciences Switzerland Sàrl Method for the calibration of an implantable sensor
US8313811B2 (en) * 2009-08-12 2012-11-20 Medos International S.A.R.L. Plasma enhanced polymer ultra-thin multi-layer packaging
US8313819B2 (en) 2009-08-12 2012-11-20 Medos International S.A.R.L. Ultra-thin multi-layer packaging
US8361591B2 (en) * 2009-08-12 2013-01-29 Medos International Sarl Packaging with active protection layer
EP2467811A4 (en) * 2009-08-17 2014-04-30 Zin Technologies Inc Method and system for monitoring and managing patient care
US20110046698A1 (en) * 2009-08-24 2011-02-24 Medtronic, Inc. Recovery of a wireless communication session with an implantable medical device
WO2011025999A1 (en) * 2009-08-29 2011-03-03 Abbott Diabetes Care Inc. Analyte sensor
WO2011026130A1 (en) * 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Inserter device including rotor subassembly
LT2476223T (en) 2009-09-08 2021-07-12 Abbott Diabetes Care, Inc. Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device
EP2295098B1 (en) * 2009-09-10 2011-10-26 F. Hoffmann-La Roche AG Medical infusion pump and method for determining the cause of a power supply interruption in the pump
WO2011034468A1 (en) * 2009-09-16 2011-03-24 St.Jude Medical Ab Implantable medical device power saving communication
US8207651B2 (en) 2009-09-16 2012-06-26 Tyco Healthcare Group Lp Low energy or minimum disturbance method for measuring frequency response functions of ultrasonic surgical devices in determining optimum operating point
US8628460B2 (en) * 2009-09-21 2014-01-14 Heartware, Inc. Hard-wired implanted controller system
US8299920B2 (en) 2009-09-25 2012-10-30 Fedex Corporate Services, Inc. Sensor based logistics system
EP2306352B1 (en) * 2009-09-25 2013-01-09 Roche Diagnostics GmbH Diabetes therapy device enabling shifting of parameter profiles
US8239169B2 (en) 2009-09-25 2012-08-07 Gregory Timothy L Portable computing device and method for asset management in a logistics system
US9633327B2 (en) 2009-09-25 2017-04-25 Fedex Corporate Services, Inc. Sensor zone management
US20110077708A1 (en) * 2009-09-28 2011-03-31 Alan Ostroff MRI Compatible Leadless Cardiac Pacemaker
WO2011041449A1 (en) * 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Sensor inserter having introducer
US20110077718A1 (en) * 2009-09-30 2011-03-31 Broadcom Corporation Electromagnetic power booster for bio-medical units
WO2011044386A1 (en) * 2009-10-07 2011-04-14 Abbott Diabetes Care Inc. Sensor inserter assembly having rotatable trigger
WO2011069535A1 (en) 2009-12-08 2011-06-16 St. Jude Medical Ab Cardiac stimulating device with backup pulse
WO2011053196A1 (en) * 2009-10-27 2011-05-05 St. Jude Medical Ab Implantable medical device power saving communication
US20110118578A1 (en) * 2009-11-17 2011-05-19 Roche Diagnostics Operations, Inc. Hypoglycemic treatment methods and systems
US20110124996A1 (en) * 2009-11-20 2011-05-26 Roche Diagnostics Operations, Inc. Diabetes health management systems and methods
US8919605B2 (en) 2009-11-30 2014-12-30 Intuity Medical, Inc. Calibration material delivery devices and methods
US8552880B2 (en) * 2009-12-04 2013-10-08 Smiths Medical Asd, Inc. Guided user help system for an ambulatory infusion system
US8998841B2 (en) 2009-12-11 2015-04-07 Medtronic, Inc. Monitoring conditions of implantable medical fluid delivery device
JP5497914B2 (en) * 2009-12-16 2014-05-21 カーディアック ペースメイカーズ, インコーポレイテッド System and method for qualifying limited functionality
US8771251B2 (en) 2009-12-17 2014-07-08 Hospira, Inc. Systems and methods for managing and delivering patient therapy through electronic drug delivery systems
US8495515B2 (en) * 2009-12-18 2013-07-23 Roche Diagnostics Operations, Inc. Methods, systems and computer readable media for modifying parameters of a configuration file
US8535265B2 (en) * 2009-12-22 2013-09-17 Kimberly-Clark Worldwide, Inc. Tracheal catheter with suction lumen port in close proximity to the cuff
US8092428B2 (en) * 2009-12-23 2012-01-10 Roche Diagnostics Operations, Inc. Methods and systems for adjusting an insulin delivery profile of an insulin pump
US8758274B2 (en) 2010-01-08 2014-06-24 Medtronic, Inc. Automated adjustment of posture state definitions for a medical device
US8579834B2 (en) 2010-01-08 2013-11-12 Medtronic, Inc. Display of detected patient posture state
US9357949B2 (en) 2010-01-08 2016-06-07 Medtronic, Inc. User interface that displays medical therapy and posture data
US9956418B2 (en) 2010-01-08 2018-05-01 Medtronic, Inc. Graphical manipulation of posture zones for posture-responsive therapy
US10108785B2 (en) 2010-01-22 2018-10-23 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US20110313789A1 (en) 2010-01-22 2011-12-22 Deka Products Limited Partnership Electronic patient monitoring system
US9295778B2 (en) 2011-12-21 2016-03-29 Deka Products Limited Partnership Syringe pump
US11881307B2 (en) 2012-05-24 2024-01-23 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US10911515B2 (en) 2012-05-24 2021-02-02 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US9789247B2 (en) 2011-12-21 2017-10-17 Deka Products Limited Partnership Syringe pump, and related method and system
US11164672B2 (en) 2010-01-22 2021-11-02 Deka Products Limited Partnership System and apparatus for electronic patient care
US9744300B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Syringe pump and related method
US20110184268A1 (en) * 2010-01-22 2011-07-28 Abbott Diabetes Care Inc. Method, Device and System for Providing Analyte Sensor Calibration
US9677555B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US10242159B2 (en) 2010-01-22 2019-03-26 Deka Products Limited Partnership System and apparatus for electronic patient care
US9151646B2 (en) 2011-12-21 2015-10-06 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US10453157B2 (en) 2010-01-22 2019-10-22 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
US11244745B2 (en) 2010-01-22 2022-02-08 Deka Products Limited Partnership Computer-implemented method, system, and apparatus for electronic patient care
US11210611B2 (en) 2011-12-21 2021-12-28 Deka Products Limited Partnership System, method, and apparatus for electronic patient care
ES2864077T3 (en) * 2010-01-28 2021-10-13 Hoffmann La Roche Modular infusion set with an integrated, electrically powered functional component
US20110184258A1 (en) * 2010-01-28 2011-07-28 Abbott Diabetes Care Inc. Balloon Catheter Analyte Measurement Sensors and Methods for Using the Same
AU2011210648B2 (en) 2010-02-01 2014-10-16 Otsuka Pharmaceutical Co., Ltd. Data gathering system
EP2531096A4 (en) 2010-02-01 2013-09-11 Proteus Digital Health Inc Two-wrist data gathering system
US9041730B2 (en) 2010-02-12 2015-05-26 Dexcom, Inc. Receivers for analyzing and displaying sensor data
JP5432767B2 (en) * 2010-02-25 2014-03-05 日本光電工業株式会社 Remote maintenance system and relay unit
US11717681B2 (en) 2010-03-05 2023-08-08 Endostim, Inc. Systems and methods for treating gastroesophageal reflux disease
US8447404B2 (en) 2010-03-05 2013-05-21 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US8219171B2 (en) * 2010-03-16 2012-07-10 Given Imaging Ltd. Delivery device for implantable monitor
JP5056880B2 (en) * 2010-03-24 2012-10-24 横河電機株式会社 Field equipment maintenance system
US8612055B2 (en) 2010-04-16 2013-12-17 Medtronic, Inc. System and method for delivering a therapeutic agent according to default infusion schedule
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8810394B2 (en) 2010-04-16 2014-08-19 Medtronic, Inc. Reservoir monitoring for implantable fluid delivery devices
US9687603B2 (en) 2010-04-16 2017-06-27 Medtronic, Inc. Volume monitoring for implantable fluid delivery devices
US8246573B2 (en) * 2010-04-27 2012-08-21 Medtronic, Inc. Detecting empty medical pump reservoir
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US9566441B2 (en) 2010-04-30 2017-02-14 Medtronic, Inc. Detecting posture sensor signal shift or drift in medical devices
USD669165S1 (en) 2010-05-27 2012-10-16 Asante Solutions, Inc. Infusion pump
US9336353B2 (en) 2010-06-25 2016-05-10 Dexcom, Inc. Systems and methods for communicating sensor data between communication devices of a glucose monitoring system
CA2803797A1 (en) 2010-06-25 2011-12-29 Intuity Medical, Inc. Analyte monitoring methods and systems
WO2012004298A1 (en) 2010-07-06 2012-01-12 Novo Nordisk A/S System for indicating lifetime status for medical component
US11901069B2 (en) 2010-08-12 2024-02-13 Fenwal, Inc. Processing blood donation data for presentation on operator interface
US8676600B2 (en) 2010-08-12 2014-03-18 Fenwal, Inc Mobile applications for blood centers
AU2011292039B2 (en) * 2010-08-17 2013-11-28 Boston Scientific Neuromodulation Corporation Telemetry-based wake up of an implantable medical device in a therapeutic network
US9669226B2 (en) 2010-09-07 2017-06-06 Empi, Inc. Methods and systems for reducing interference in stimulation treatment
CN102397623B (en) * 2010-09-17 2015-04-15 苏州景昱医疗器械有限公司 Implanted electrical nerve stimulation system with automatic alarm function and method
EP2621339B1 (en) 2010-09-29 2020-01-15 Dexcom, Inc. Advanced continuous analyte monitoring system
CA2814657A1 (en) 2010-10-12 2012-04-19 Kevin J. Tanis Medical device
US8543205B2 (en) 2010-10-12 2013-09-24 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
JP2013540022A (en) 2010-10-13 2013-10-31 ナノスティム・インコーポレイテッド Leadless cardiac pacemaker with screw anti-rotation element
US20120095313A1 (en) * 2010-10-15 2012-04-19 Roche Diagnostics Operations, Inc. Medical devices that support enhanced system extensibility for diabetes care
US9241631B2 (en) 2010-10-27 2016-01-26 Dexcom, Inc. Continuous analyte monitor data recording device operable in a blinded mode
US9192719B2 (en) 2010-11-01 2015-11-24 Medtronic, Inc. Implantable medical pump diagnostics
WO2012082735A1 (en) 2010-12-13 2012-06-21 Nanostim, Inc. Delivery catheter systems and methods
WO2012082755A1 (en) 2010-12-13 2012-06-21 Nanostim, Inc. Pacemaker retrieval systems and methods
US9242102B2 (en) 2010-12-20 2016-01-26 Pacesetter, Inc. Leadless pacemaker with radial fixation mechanism
EP2654878B1 (en) 2010-12-20 2019-05-15 Abiomed, Inc. Transcutaneous energy transfer system with multiple secondary coils
US8766788B2 (en) 2010-12-20 2014-07-01 Abiomed, Inc. Transcutaneous energy transfer system with vibration inducing warning circuitry
US9220826B2 (en) 2010-12-20 2015-12-29 Abiomed, Inc. Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system
CN103458951B (en) 2011-01-06 2016-06-01 亿诺医疗公司 Gas transportation facilities and system
EP2663224A4 (en) 2011-01-12 2017-01-11 The Regents of The University of California System and method for closed-loop patient-adaptive hemodynamic management
US9020419B2 (en) 2011-01-14 2015-04-28 Covidien, LP Wireless relay module for remote monitoring systems having power and medical device proximity monitoring functionality
US8694600B2 (en) 2011-03-01 2014-04-08 Covidien Lp Remote monitoring systems for monitoring medical devices via wireless communication networks
US8818260B2 (en) 2011-01-14 2014-08-26 Covidien, LP Wireless relay module for remote monitoring systems
US8855550B2 (en) 2011-01-14 2014-10-07 Covidien Lp Wireless relay module having emergency call functionality
US8811888B2 (en) 2011-01-14 2014-08-19 Covidien Lp Wireless relay module for monitoring network status
US20130162426A1 (en) * 2011-12-22 2013-06-27 Tyco Healthcare Group Lp Wireless Relay Module For Remote Monitoring Systems Having Alarm And Display Functionality
US8798527B2 (en) 2011-01-14 2014-08-05 Covidien Lp Wireless relay module for remote monitoring systems
US8903308B2 (en) 2011-01-14 2014-12-02 Covidien Lp System and method for patient identification in a remote monitoring system
US8897198B2 (en) 2011-01-14 2014-11-25 Covidien Lp Medical device wireless network architectures
US8639335B2 (en) 2011-01-28 2014-01-28 Medtronic, Inc. Disabling an implanted medical device with another medical device
US8852152B2 (en) 2011-02-09 2014-10-07 Asante Solutions, Inc. Infusion pump systems and methods
WO2012112179A1 (en) 2011-02-18 2012-08-23 Medtronic, Inc. Medical device programmer with adjustable kickstand
US8532775B2 (en) 2011-02-18 2013-09-10 Medtronic, Inc. Modular medical device programmer
US8454581B2 (en) 2011-03-16 2013-06-04 Asante Solutions, Inc. Infusion pump systems and methods
JP6178243B2 (en) * 2011-03-18 2017-08-09 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Calculating drug dose
US8348814B1 (en) 2011-03-18 2013-01-08 Robert S. Hinds Exercise bars and handles with interchangeable attachment of elastic and inelastic members
EP2503481A1 (en) * 2011-03-24 2012-09-26 F. Hoffmann-La Roche AG Blood sugar measuring device and method for reading blood sugar readings
WO2012135062A1 (en) 2011-03-25 2012-10-04 Zoll Medical Corporation Selection of optimal channel for rate determination
US8600486B2 (en) 2011-03-25 2013-12-03 Zoll Medical Corporation Method of detecting signal clipping in a wearable ambulatory medical device
EP2689363B1 (en) 2011-03-25 2022-07-27 Zoll Medical Corporation System and method for adapting alarms in a wearable medical device
US9002390B2 (en) 2011-04-08 2015-04-07 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
RS60728B1 (en) 2011-04-12 2020-09-30 Applied Science Inc Method for managing blood donations
US8206378B1 (en) 2011-04-13 2012-06-26 Medtronic, Inc. Estimating the volume of fluid in therapeutic fluid delivery device reservoir
AU2012242533B2 (en) 2011-04-14 2016-10-20 Endostim, Inc. Systems and methods for treating gastroesophageal reflux disease
EP4119184A1 (en) 2011-04-14 2023-01-18 Abiomed, Inc. Transcutaneous energy transfer coil with integrated radio frequency antenna
US8979825B2 (en) * 2011-04-15 2015-03-17 Medtronic, Inc. Implantable fluid delivery device including gas chamber pressure sensor
US8615684B2 (en) * 2011-04-18 2013-12-24 Astronautics Corporation Of America High reliability processor system
US9940440B2 (en) 2011-04-28 2018-04-10 Medtronic, Inc. Detecting and responding to software and hardware anomalies in a fluid delivery system
CN102813977B (en) * 2011-06-06 2016-04-06 西诺医药有限责任公司 The medical pump of customizable programming license is provided
US20130194066A1 (en) * 2011-06-10 2013-08-01 Aliphcom Motion profile templates and movement languages for wearable devices
US8585657B2 (en) 2011-06-21 2013-11-19 Asante Solutions, Inc. Dispensing fluid from an infusion pump system
US20130027186A1 (en) 2011-07-26 2013-01-31 Can Cinbis Ultralow-power implantable hub-based wireless implantable sensor communication
CA3154143A1 (en) 2011-08-03 2013-02-07 Intuity Medical, Inc. Devices and methods for body fluid sampling and analysis
AU2012299169B2 (en) 2011-08-19 2017-08-24 Icu Medical, Inc. Systems and methods for a graphical interface including a graphical representation of medical data
US8805512B1 (en) 2011-08-30 2014-08-12 Valencia Technologies Corporation Implantable electroacupuncture device and method for reducing hypertension
WO2013033673A1 (en) 2011-09-02 2013-03-07 Endostim, Inc. Endoscopic lead implantation method
US9925367B2 (en) 2011-09-02 2018-03-27 Endostim, Inc. Laparoscopic lead implantation method
US8808230B2 (en) 2011-09-07 2014-08-19 Asante Solutions, Inc. Occlusion detection for an infusion pump system
US9248300B2 (en) 2011-09-09 2016-02-02 Medtronic, Inc. Controlling wireless communication in an implanted cardiac device
US8996125B2 (en) 2011-09-23 2015-03-31 Valencia Technologies Corporation Implantable electroacupuncture system and method for treating cardiovascular disease
WO2013044153A1 (en) 2011-09-23 2013-03-28 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
MX346827B (en) * 2011-10-17 2017-04-03 Koninklijke Philips Nv A medical monitoring system based on sound analysis in a medical environment.
EP2769357B1 (en) 2011-10-21 2023-08-30 ICU Medical, Inc. Medical device update system
TWI459228B (en) * 2011-11-04 2014-11-01 Inventec Corp Reminding method for daily life menagement
WO2013067496A2 (en) 2011-11-04 2013-05-10 Nanostim, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
KR20130055156A (en) * 2011-11-18 2013-05-28 삼성에스디아이 주식회사 Apparatus for reporting fault of battery management system and energy storage system using the same
US9002468B2 (en) 2011-12-16 2015-04-07 Abiomed, Inc. Automatic power regulation for transcutaneous energy transfer charging system
US10022498B2 (en) 2011-12-16 2018-07-17 Icu Medical, Inc. System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
US9675756B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership Apparatus for infusing fluid
US9724466B2 (en) 2011-12-21 2017-08-08 Deka Products Limited Partnership Flow meter
US9746093B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Flow meter and related system and apparatus
US10228683B2 (en) 2011-12-21 2019-03-12 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US9746094B2 (en) 2011-12-21 2017-08-29 Deka Products Limited Partnership Flow meter having a background pattern with first and second portions
US11217340B2 (en) 2011-12-21 2022-01-04 Deka Products Limited Partnership Syringe pump having a pressure sensor assembly
US10722645B2 (en) 2011-12-21 2020-07-28 Deka Products Limited Partnership Syringe pump, and related method and system
US9435455B2 (en) 2011-12-21 2016-09-06 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US10488848B2 (en) 2011-12-21 2019-11-26 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US11295846B2 (en) 2011-12-21 2022-04-05 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US9372486B2 (en) 2011-12-21 2016-06-21 Deka Products Limited Partnership System, method, and apparatus for monitoring, regulating, or controlling fluid flow
US9098610B2 (en) * 2011-12-22 2015-08-04 Greatbatch Ltd. Communication for implantable medical devices
US8568360B2 (en) 2011-12-28 2013-10-29 Palyon Medical (Bvi) Limited Programmable implantable pump design
US8634914B2 (en) * 2012-01-27 2014-01-21 Medtronic, Inc. Pacemaker event queue to control device processor operating power
CN102609617A (en) * 2012-01-31 2012-07-25 成都成电医星数字健康软件有限公司 Method for intelligently calculating dispensing amount of clinical drugs
US10576278B2 (en) 2012-02-21 2020-03-03 Virender K. Sharma System and method for electrical stimulation of anorectal structures to treat urinary dysfunction
US8706234B2 (en) 2012-02-21 2014-04-22 Virender K. Sharma System and method for electrical stimulation of anorectal structures to treat anal dysfunction
US9782583B2 (en) 2012-02-21 2017-10-10 Virender K. Sharma System and method for electrical stimulation of anorectal structures to treat urinary dysfunction
US9433786B2 (en) * 2012-03-06 2016-09-06 Valencia Technologies Corporation Implantable electroacupuncture system and method for treating Parkinson's disease and essential tremor
US9314399B2 (en) 2012-03-06 2016-04-19 Valencia Technologies Corporation Implantable electroacupuncture system and method for treating dyslipidemia and obesity
US8981938B2 (en) 2012-03-08 2015-03-17 Linquet Technologies, Inc. Comprehensive system and method of universal real-time linking of real objects to a machine, network, internet, or software service
US10769924B2 (en) 2012-03-08 2020-09-08 Linquet Technologies Inc. Comprehensive system and method of universal real-time linking of real objects to a machine, network, internet, or software service
US9827421B2 (en) 2012-03-12 2017-11-28 Valencia Technologies Corporation Methods and systems for treating a chronic low back pain condition using an implantable electroacupuncture device
US9327134B2 (en) 2012-03-12 2016-05-03 Valencia Technologies Corporation Implantable electroacupuncture device and method
WO2013138369A1 (en) 2012-03-16 2013-09-19 Dexcom, Inc. Systems and methods for processing analyte sensor data
USD767507S1 (en) 2012-03-17 2016-09-27 Abbott Medical Optics Inc. Remote control
WO2013148798A1 (en) 2012-03-30 2013-10-03 Hospira, Inc. Air detection system and method for detecting air in a pump of an infusion system
CN104203097B (en) * 2012-03-30 2017-10-24 生命扫描苏格兰有限公司 Battery status detection and storage method and system in medical monitoring
WO2013149186A1 (en) 2012-03-30 2013-10-03 Insulet Corporation Fluid delivery device with transcutaneous access tool, insertion mechansim and blood glucose monitoring for use therewith
US9907959B2 (en) 2012-04-12 2018-03-06 Medtronic, Inc. Velocity detection for posture-responsive therapy
US9737719B2 (en) 2012-04-26 2017-08-22 Medtronic, Inc. Adjustment of therapy based on acceleration
US9556860B2 (en) * 2012-04-27 2017-01-31 Medtronic, Inc. Implantable infusion device having selective voltage boost circuit with charge pump circuit for generating control signals using first and second profiles
US8929980B2 (en) 2012-05-03 2015-01-06 Physio-Control, Inc. External defibrillator electrode, method and system for reducing ECG artifact
US9289621B2 (en) * 2012-05-08 2016-03-22 Physio-Control, Inc. Defibrillator network system
US9465910B2 (en) 2012-05-15 2016-10-11 James Minor Diagnostic methods and devices for monitoring chronic glycemia
US8827890B2 (en) 2012-05-17 2014-09-09 Thoratec Corporation Touch screen interface and infrared communication system integrated into a battery
EP2856133B1 (en) 2012-06-01 2018-05-09 The University of Tennessee Research Foundation Improved method and device for detection of bioavailable drug concentration
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US20130338576A1 (en) * 2012-06-15 2013-12-19 Wayne C. Jaeschke, Jr. Portable infusion pump with pressure and temperature compensation
US10099063B2 (en) * 2012-07-02 2018-10-16 Physio-Control, Inc. Medical monitor-defibrillator with defibrillator and data operations processors
US10303852B2 (en) 2012-07-02 2019-05-28 Physio-Control, Inc. Decision support tool for use with a medical monitor-defibrillator
CN102764465B (en) * 2012-07-06 2013-12-25 南昌航空大学 Medical automatic transfusion monitoring and warning system
US8454557B1 (en) 2012-07-19 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US8454562B1 (en) 2012-07-20 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US8706691B2 (en) 2012-07-24 2014-04-22 Roche Diagnostics Operations, Inc. System for managing insulin dosage data
CA3089257C (en) 2012-07-31 2023-07-25 Icu Medical, Inc. Patient care system for critical medications
US9802054B2 (en) 2012-08-01 2017-10-31 Pacesetter, Inc. Biostimulator circuit with flying cell
AU2013305543A1 (en) 2012-08-23 2015-03-19 Endostim, Inc. Device and implantation system for electrical stimulation of biological systems
US9031652B2 (en) 2012-08-27 2015-05-12 Cardiac Pacemakers, Inc. Use case-based services
US11027138B2 (en) 2012-08-27 2021-06-08 Cardiac Pacemakers, Inc. Location-based services
US8868199B2 (en) 2012-08-31 2014-10-21 Greatbatch Ltd. System and method of compressing medical maps for pulse generator or database storage
US9375582B2 (en) 2012-08-31 2016-06-28 Nuvectra Corporation Touch screen safety controls for clinician programmer
US8983616B2 (en) * 2012-09-05 2015-03-17 Greatbatch Ltd. Method and system for associating patient records with pulse generators
ES2743154T3 (en) 2012-09-13 2020-02-18 Kpr Us Llc Docking station for enteral feeding pump
US9026147B2 (en) 2012-09-24 2015-05-05 Physio-Control, Inc. Defibrillator location tracking device
US9072885B2 (en) * 2012-09-27 2015-07-07 Covidien Lp Systems for hydrating defibrillation electrodes
US9724512B2 (en) 2012-09-28 2017-08-08 Valencia Technologies Corporation Implantable electroacupuncture system and method for treating parkinson's disease and essential tremor through application of stimului at or near an acupoint on the chorea line
CA2889210C (en) 2012-10-26 2020-12-15 Baxter Corporation Englewood Improved image acquisition for medical dose preparation system
NZ707430A (en) 2012-10-26 2016-04-29 Baxter Corp Englewood Improved work station for medical dose preparation system
US9119528B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for providing sensitive and specific alarms
US9282911B2 (en) 2012-11-27 2016-03-15 Physio-Control, Inc. Linear display of ECG signals
US9427523B2 (en) 2012-12-10 2016-08-30 Bigfoot Biomedical, Inc. Infusion pump system and method
US20140276536A1 (en) 2013-03-14 2014-09-18 Asante Solutions, Inc. Infusion Pump System and Methods
US9759343B2 (en) 2012-12-21 2017-09-12 Deka Products Limited Partnership Flow meter using a dynamic background image
US9730620B2 (en) 2012-12-31 2017-08-15 Dexcom, Inc. Remote monitoring of analyte measurements
US9801541B2 (en) 2012-12-31 2017-10-31 Dexcom, Inc. Remote monitoring of analyte measurements
USD723957S1 (en) * 2013-10-22 2015-03-10 Tile, Inc. Electronic tracking device
US9357348B2 (en) 2013-01-29 2016-05-31 Tile, Inc. Systems and methods for locating a tracking device
US10430554B2 (en) 2013-05-23 2019-10-01 Carefusion 303, Inc. Medication preparation queue
US11182728B2 (en) 2013-01-30 2021-11-23 Carefusion 303, Inc. Medication workflow management
US9227014B2 (en) 2013-02-07 2016-01-05 The Board Of Trustees Of The Laland Stanford Junior University Kalman filter based on-off switch for insulin pump
KR101398141B1 (en) 2013-02-08 2014-05-20 엘지전자 주식회사 Mobile terminal
US9687193B2 (en) * 2013-02-09 2017-06-27 Ali Mireshghi Sleep apnea avoidance and data collection device
US9498619B2 (en) 2013-02-26 2016-11-22 Endostim, Inc. Implantable electrical stimulation leads
US9446186B2 (en) 2013-03-01 2016-09-20 Bigfoot Biomedical, Inc. Operating an infusion pump system
US20140249838A1 (en) * 2013-03-04 2014-09-04 David A. Gelb Medical implant management
EP2964079B1 (en) 2013-03-06 2022-02-16 ICU Medical, Inc. Medical device communication method
US9940441B2 (en) 2013-03-13 2018-04-10 Tandem Diabetes Care, Inc. System and method for maximum insulin pump bolus override
CN105074765B (en) 2013-03-13 2022-05-24 康尔福盛303公司 Patient-specific medication management system
WO2014159286A1 (en) * 2013-03-13 2014-10-02 Carefusion 303, Inc. Healthcare communication system
WO2014159284A1 (en) * 2013-03-13 2014-10-02 Carefusion 303, Inc. Healthcare validation system
EP4195119A1 (en) 2013-03-13 2023-06-14 Carefusion 303 Inc. Predictive medication safety
US9445445B2 (en) 2013-03-14 2016-09-13 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP3401818B1 (en) 2013-03-14 2023-12-06 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9737649B2 (en) 2013-03-14 2017-08-22 Smith & Nephew, Inc. Systems and methods for applying reduced pressure therapy
US9931036B2 (en) 2013-03-14 2018-04-03 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
MX2015011812A (en) 2013-03-14 2016-07-05 Smith & Nephew Inc Systems and methods for applying reduced pressure therapy.
US9180243B2 (en) 2013-03-15 2015-11-10 Tandem Diabetes Care, Inc. Detection of infusion pump conditions
US9603995B2 (en) 2013-03-15 2017-03-28 Tandem Diabetes Care. Inc. Device and method for setting therapeutic parameters for an infusion device
US10046112B2 (en) 2013-05-24 2018-08-14 Icu Medical, Inc. Multi-sensor infusion system for detecting air or an occlusion in the infusion system
AU2014274122A1 (en) 2013-05-29 2016-01-21 Icu Medical, Inc. Infusion system and method of use which prevents over-saturation of an analog-to-digital converter
EP3003441B1 (en) 2013-05-29 2020-12-02 ICU Medical, Inc. Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system
US9457141B2 (en) 2013-06-03 2016-10-04 Bigfoot Biomedical, Inc. Infusion pump system and method
US20140358945A1 (en) 2013-06-03 2014-12-04 Tencent Technology (Shenzhen) Company Limited Systems and Methods for Matching Users
US9446187B2 (en) 2013-06-03 2016-09-20 Bigfoot Biomedical, Inc. Infusion pump system and method
WO2014205412A1 (en) 2013-06-21 2014-12-24 Intuity Medical, Inc. Analyte monitoring system with audible feedback
US9075906B2 (en) * 2013-06-28 2015-07-07 Elwha Llc Medical support system including medical equipment case
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
WO2015009385A1 (en) 2013-07-19 2015-01-22 Dexcom, Inc. Time averaged basal rate optimizer
US10155070B2 (en) 2013-08-13 2018-12-18 Smith & Nephew, Inc. Systems and methods for applying reduced pressure therapy
JP6621748B2 (en) 2013-08-30 2019-12-18 アイシーユー・メディカル・インコーポレーテッド System and method for monitoring and managing a remote infusion regimen
WO2015034867A2 (en) 2013-09-03 2015-03-12 Endostim, Inc. Methods and systems of electrode polarity switching in electrical stimulation therapy
USD746441S1 (en) 2013-09-13 2015-12-29 Covidien Lp Pump
US9662436B2 (en) * 2013-09-20 2017-05-30 Icu Medical, Inc. Fail-safe drug infusion therapy system
CN106061528B (en) 2013-10-24 2020-10-16 波士顿大学信托人 Infusion system for preventing misdirection of multiple medicaments
US9566450B2 (en) * 2013-10-25 2017-02-14 Medtronic, Inc. Medical device communication with wireless telemetry head
USD752209S1 (en) 2013-11-06 2016-03-22 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD745661S1 (en) 2013-11-06 2015-12-15 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD751690S1 (en) * 2013-11-06 2016-03-15 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD749206S1 (en) 2013-11-06 2016-02-09 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
USD751689S1 (en) 2013-11-06 2016-03-15 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
CA3205443A1 (en) 2013-11-07 2015-05-14 Dexcom, Inc. Systems and methods for transmitting and continuous monitoring of analyte values
US10311972B2 (en) 2013-11-11 2019-06-04 Icu Medical, Inc. Medical device system performance index
EP3071253B1 (en) 2013-11-19 2019-05-22 ICU Medical, Inc. Infusion pump automation system and method
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
US9477865B2 (en) * 2013-12-13 2016-10-25 Symbol Technologies, Llc System for and method of accurately determining true bearings of radio frequency identification (RFID) tags associated with items in a controlled area
US20150182697A1 (en) * 2013-12-31 2015-07-02 Abbvie Inc. Pump, motor and assembly for beneficial agent delivery
CA2935565A1 (en) 2013-12-31 2015-07-09 Senseonics, Incorporated Continuous analyte monitoring system
AU2015204701B2 (en) 2014-01-10 2018-03-15 Cardiac Pacemakers, Inc. Systems and methods for detecting cardiac arrhythmias
EP3092038B1 (en) 2014-01-10 2017-12-27 Cardiac Pacemakers, Inc. Methods and systems for improved communication between medical devices
WO2015109172A1 (en) * 2014-01-17 2015-07-23 Pitroda Satyan G System and method for electronic vault to manage digital contents
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
US9724520B2 (en) * 2014-01-30 2017-08-08 Medtronic, Inc. Methods, implantable medical devices, and systems to continue implementing a special mode of operation after experiencing a device reset
US9486580B2 (en) * 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
AU2015218864B2 (en) 2014-02-21 2019-10-03 Deka Products Limited Partnership Syringe pump having a pressure sensor assembly
EP3110474B1 (en) 2014-02-28 2019-12-18 ICU Medical, Inc. Infusion system and method which utilizes dual wavelength optical air-in-line detection
US10004913B2 (en) 2014-03-03 2018-06-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for power conversion and data transmission in implantable sensors, stimulators, and actuators
AU2015253001A1 (en) 2014-04-30 2016-10-20 Icu Medical, Inc. Patient care system with conditional alarm forwarding
US10279106B1 (en) 2014-05-08 2019-05-07 Tandem Diabetes Care, Inc. Insulin patch pump
WO2015171213A1 (en) 2014-05-09 2015-11-12 The Board Of Trustees Of The Leland Stanford Junior University Autofocus wireless power transfer to implantable devices in freely moving animals
CA2947045C (en) 2014-05-29 2022-10-18 Hospira, Inc. Infusion system and pump with configurable closed loop delivery rate catch-up
WO2015184462A1 (en) 2014-05-30 2015-12-03 Applied Science Inc Systems and methods for managing blood donations
WO2015187819A1 (en) 2014-06-03 2015-12-10 Covidien Lp Enteral feeding pump certification
JP6817074B2 (en) 2014-06-03 2021-01-20 アムジエン・インコーポレーテツド Controllable drug delivery system and usage
US10979862B2 (en) 2014-06-10 2021-04-13 Pb Inc. Tracking device system
US11792605B2 (en) 2014-06-10 2023-10-17 PB, Inc. Tracking device systems
US11145183B2 (en) 2014-06-10 2021-10-12 PB, Inc Tracking device programs, systems and methods
US10937286B2 (en) 2014-06-10 2021-03-02 Pb Inc. Radiobeacon data sharing by forwarding low energy transmissions to a cloud host
US10580281B2 (en) 2014-06-10 2020-03-03 PB, Inc. Tracking device system
US9774410B2 (en) 2014-06-10 2017-09-26 PB, Inc. Radiobeacon data sharing by forwarding low energy transmissions to a cloud host
US9892626B2 (en) 2014-06-10 2018-02-13 Pb Inc. Tracking device program
US9724470B2 (en) 2014-06-16 2017-08-08 Icu Medical, Inc. System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
CA2953392A1 (en) 2014-06-30 2016-01-07 Baxter Corporation Englewood Managed medical information exchange
US9629901B2 (en) 2014-07-01 2017-04-25 Bigfoot Biomedical, Inc. Glucagon administration system and methods
US9755294B2 (en) 2014-07-07 2017-09-05 Symbol Technologies, Llc Accurately estimating true bearings of radio frequency identification (RFID) tags associated with items located in a controlled area
US9757570B2 (en) 2014-08-06 2017-09-12 Cardiac Pacemakers, Inc. Communications in a medical device system
US10137246B2 (en) 2014-08-06 2018-11-27 Bigfoot Biomedical, Inc. Infusion pump assembly and method
US9808631B2 (en) 2014-08-06 2017-11-07 Cardiac Pacemakers, Inc. Communication between a plurality of medical devices using time delays between communication pulses to distinguish between symbols
US9694189B2 (en) 2014-08-06 2017-07-04 Cardiac Pacemakers, Inc. Method and apparatus for communicating between medical devices
US9919096B2 (en) 2014-08-26 2018-03-20 Bigfoot Biomedical, Inc. Infusion pump system and method
CN107073275B (en) 2014-08-28 2020-09-01 心脏起搏器股份公司 Medical device with triggered blanking period
JP2016051240A (en) * 2014-08-29 2016-04-11 日本光電工業株式会社 Medical instrument system and medical instrument
US9539383B2 (en) 2014-09-15 2017-01-10 Hospira, Inc. System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein
WO2016044146A2 (en) 2014-09-18 2016-03-24 Deka Products Limited Partnership Apparatus and method for infusing fluid through a tube by appropriately heating the tube
US11575673B2 (en) 2014-09-30 2023-02-07 Baxter Corporation Englewood Central user management in a distributed healthcare information management system
US11107574B2 (en) 2014-09-30 2021-08-31 Baxter Corporation Englewood Management of medication preparation with formulary management
US9841014B2 (en) * 2014-10-20 2017-12-12 Medtronic Minimed, Inc. Insulin pump data acquisition device and system
KR101619293B1 (en) * 2014-11-12 2016-05-11 현대오트론 주식회사 Method and apparatus for controlling power source semiconductor
WO2016081468A2 (en) 2014-11-17 2016-05-26 Endostim, Inc. Implantable electro-medical device programmable for improved operational life
US20160136057A1 (en) * 2014-11-19 2016-05-19 Umm Al-Qura University System and apparatus for controlling food intake
JP2018503180A (en) 2014-12-05 2018-02-01 バクスター・コーポレーション・イングルウッドBaxter Corporation Englewood Dose preparation data analysis
US10105539B2 (en) 2014-12-17 2018-10-23 Cochlear Limited Configuring a stimulation unit of a hearing device
US11344668B2 (en) 2014-12-19 2022-05-31 Icu Medical, Inc. Infusion system with concurrent TPN/insulin infusion
US10688233B2 (en) * 2014-12-19 2020-06-23 Fenwal, Inc. Method and system for the automated processing of biological fluid during low level alert condition
EP3233159B1 (en) 2014-12-19 2020-03-04 Amgen Inc. Drug delivery device with live button or user interface field
EP3233163B1 (en) 2014-12-19 2021-10-13 Amgen Inc. Drug delivery device with proximity sensor
US10445092B2 (en) * 2014-12-27 2019-10-15 Intel Corporation Method and apparatus for performing a vector permute with an index and an immediate
US10159844B2 (en) * 2015-01-29 2018-12-25 Hcl Technologies Limited Implantable medical device and a method for optimizing power consumption thereof
WO2016126968A1 (en) 2015-02-06 2016-08-11 Cardiac Pacemakers, Inc. Systems and methods for safe delivery of electrical stimulation therapy
EP3827877A1 (en) 2015-02-06 2021-06-02 Cardiac Pacemakers, Inc. Systems for treating cardiac arrhythmias
US10046167B2 (en) 2015-02-09 2018-08-14 Cardiac Pacemakers, Inc. Implantable medical device with radiopaque ID tag
CN107405446B (en) 2015-02-18 2020-09-29 英赛罗公司 Fluid delivery and infusion device and method of use
US9901293B2 (en) 2015-02-24 2018-02-27 Senseonics, Incorporated Analyte sensor
US10850024B2 (en) 2015-03-02 2020-12-01 Icu Medical, Inc. Infusion system, device, and method having advanced infusion features
CN107530002B (en) 2015-03-04 2021-04-30 心脏起搏器股份公司 System and method for treating cardiac arrhythmias
US10050700B2 (en) 2015-03-18 2018-08-14 Cardiac Pacemakers, Inc. Communications in a medical device system with temporal optimization
EP3270768B1 (en) 2015-03-18 2023-12-13 Cardiac Pacemakers, Inc. Communications in a medical device system with link quality assessment
US10272010B2 (en) 2015-03-20 2019-04-30 Zoll Medical Corporation Systems and methods for testing a medical device
JP2016181055A (en) * 2015-03-23 2016-10-13 株式会社東芝 Information processing apparatus
US10835449B2 (en) 2015-03-30 2020-11-17 Zoll Medical Corporation Modular components for medical devices
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
EP4068297A1 (en) * 2015-05-18 2022-10-05 Dexcom, Inc. Simulation model of type 1 diabetic patient decision-making
EP3304370B1 (en) 2015-05-26 2020-12-30 ICU Medical, Inc. Infusion pump system and method with multiple drug library editor source capability
US10137243B2 (en) 2015-05-26 2018-11-27 Medtronic Minimed, Inc. Infusion devices with distributed motor control and related operating methods
US9999721B2 (en) * 2015-05-26 2018-06-19 Medtronic Minimed, Inc. Error handling in infusion devices with distributed motor control and related operating methods
EP3314488A1 (en) 2015-06-25 2018-05-02 Gambro Lundia AB Medical device system and method having a distributed database
JP7125204B2 (en) 2015-07-08 2022-08-24 トラスティーズ オブ ボストン ユニバーシティ Infusion system and its components
MX2018000913A (en) * 2015-07-21 2018-11-12 Biocorp Production SA Dose control system for injectable-drug delivery devices and associated methods of use.
EP3419700B1 (en) * 2015-07-21 2023-09-06 Biocorp Production S.A. Dose control device for injectable-drug delivery devices
WO2017031221A1 (en) 2015-08-20 2017-02-23 Cardiac Pacemakers, Inc. Systems and methods for communication between medical devices
CN108136187B (en) 2015-08-20 2021-06-29 心脏起搏器股份公司 System and method for communication between medical devices
EP4104878A1 (en) 2015-08-20 2022-12-21 Tandem Diabetes Care, Inc. Drive mechanism for infusion pump
US9956414B2 (en) 2015-08-27 2018-05-01 Cardiac Pacemakers, Inc. Temporal configuration of a motion sensor in an implantable medical device
US9968787B2 (en) 2015-08-27 2018-05-15 Cardiac Pacemakers, Inc. Spatial configuration of a motion sensor in an implantable medical device
WO2017040115A1 (en) 2015-08-28 2017-03-09 Cardiac Pacemakers, Inc. System for detecting tamponade
US10137305B2 (en) 2015-08-28 2018-11-27 Cardiac Pacemakers, Inc. Systems and methods for behaviorally responsive signal detection and therapy delivery
US10226631B2 (en) 2015-08-28 2019-03-12 Cardiac Pacemakers, Inc. Systems and methods for infarct detection
US10252070B2 (en) 2015-09-08 2019-04-09 Zoll Medical Corporation Secure limited components for use with medical devices
WO2017044389A1 (en) 2015-09-11 2017-03-16 Cardiac Pacemakers, Inc. Arrhythmia detection and confirmation
DK178729B1 (en) * 2015-10-06 2016-12-12 Nordic Healthcare Advisory Aps Positioning Device for determining and registering an injection site
US10065041B2 (en) 2015-10-08 2018-09-04 Cardiac Pacemakers, Inc. Devices and methods for adjusting pacing rates in an implantable medical device
US9773136B2 (en) 2015-10-19 2017-09-26 Symbol Technologies, Llc System for, and method of, accurately and rapidly determining, in real-time, true bearings of radio frequency identification (RFID) tags associated with items in a controlled area
US20170124275A1 (en) 2015-10-30 2017-05-04 Dexcom, Inc. Data backfilling for continuous glucose monitoring
US10492141B2 (en) * 2015-11-17 2019-11-26 Tandem Diabetes Care, Inc. Methods for reduction of battery usage in ambulatory infusion pumps
US10361800B2 (en) 2015-11-18 2019-07-23 PB, Inc Radiobeacon data sharing by forwarding low energy transmissions to a cloud host
WO2017091624A1 (en) 2015-11-24 2017-06-01 Insulet Corporation Wearable automated medication delivery system
US9781679B2 (en) * 2015-11-27 2017-10-03 Samsung Electronics Co., Ltd. Electronic systems and method of operating electronic systems
US10183170B2 (en) 2015-12-17 2019-01-22 Cardiac Pacemakers, Inc. Conducted communication in a medical device system
EP3397299B1 (en) * 2015-12-28 2023-02-22 Heartware, Inc. Vad controller tester
CA3002096C (en) 2015-12-28 2023-08-01 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US10905886B2 (en) 2015-12-28 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device for deployment across the atrioventricular septum
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10987468B2 (en) 2016-01-05 2021-04-27 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
EP3400055B1 (en) 2016-01-08 2019-11-06 Cardiac Pacemakers, Inc. Progressive adaptive data transfer
US11083372B2 (en) 2016-01-08 2021-08-10 Cardiac Pacemakers, Inc. Syncing multiple sources of physiological data
WO2017120560A1 (en) * 2016-01-08 2017-07-13 Cardiac Pacemakers, Inc. Obtaining high-resolution information from an implantable medical device
US11709747B2 (en) 2016-01-08 2023-07-25 Zoll Medical Corporation Patient assurance system and method
EP3373810A4 (en) * 2016-01-14 2020-03-25 Bigfoot Biomedical, Inc. Diabetes management system
CN108495665B (en) 2016-01-14 2021-04-09 比格福特生物医药公司 Adjusting insulin delivery rate
WO2017127548A1 (en) 2016-01-19 2017-07-27 Cardiac Pacemakers, Inc. Devices for wirelessly recharging a rechargeable battery of an implantable medical device
USD905848S1 (en) 2016-01-28 2020-12-22 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
CN113855905B (en) 2016-01-28 2024-01-12 德卡产品有限公司 Drip chamber and device for infusing fluid into patient
EP3411113B1 (en) 2016-02-04 2019-11-27 Cardiac Pacemakers, Inc. Delivery system with force sensor for leadless cardiac device
WO2017152152A1 (en) 2016-03-04 2017-09-08 Cardiac Pacemakers, Inc. Reducing false positives in detection of potential cardiac pauses
USD809134S1 (en) 2016-03-10 2018-01-30 Bigfoot Biomedical, Inc. Infusion pump assembly
US11617538B2 (en) 2016-03-14 2023-04-04 Zoll Medical Corporation Proximity based processing systems and methods
KR102522154B1 (en) * 2016-03-15 2023-04-17 에스케이하이닉스 주식회사 Controller of semiconductor memory device and operating method thereof
US10346406B2 (en) * 2016-03-28 2019-07-09 International Business Machines Corporation Decentralized autonomous edge compute coordinated by smart contract on a blockchain
BR112018068937A8 (en) 2016-03-29 2023-03-07 Hoffmann La Roche METHOD FOR OPERATING A RECEIVER TO RECEIVE ANALYTE, RECEIVER AND COMPUTER PROGRAM PRODUCT DATA
US10565396B2 (en) 2016-03-30 2020-02-18 Zoll Medical Corporation Patient data hub
US10674911B2 (en) 2016-03-30 2020-06-09 Zoll Medical Corporation Systems and methods of integrating ambulatory medical devices
WO2017173275A1 (en) 2016-03-31 2017-10-05 Cardiac Pacemakers, Inc. Implantable medical device with rechargeable battery
US10426342B2 (en) 2016-03-31 2019-10-01 Zoll Medical Corporation Remote access for ambulatory medical device
CA3133253A1 (en) 2016-03-31 2017-10-05 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US11244758B2 (en) * 2016-04-12 2022-02-08 White Bear Medical, LLC Self-validating module for software control of medical devices
US10631744B2 (en) 2016-04-13 2020-04-28 Cardiac Pacemakers, Inc. AF monitor and offline processing
US10850093B2 (en) 2016-04-13 2020-12-01 Cardiac Pacemakers, Inc. Lead integrity monitoring
KR102564469B1 (en) * 2016-04-14 2023-08-08 삼성전자주식회사 Method and apparatus for protecting a battery
US10668294B2 (en) 2016-05-10 2020-06-02 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker configured for over the wire delivery
US10328272B2 (en) 2016-05-10 2019-06-25 Cardiac Pacemakers, Inc. Retrievability for implantable medical devices
US11246985B2 (en) 2016-05-13 2022-02-15 Icu Medical, Inc. Infusion pump system and method with common line auto flush
WO2017201696A1 (en) * 2016-05-25 2017-11-30 深圳市汇顶科技股份有限公司 Method and device for unlocking touch device
USD854145S1 (en) 2016-05-25 2019-07-16 Deka Products Limited Partnership Apparatus to control fluid flow through a tube
CA3027176A1 (en) 2016-06-10 2017-12-14 Icu Medical, Inc. Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion
WO2017222937A1 (en) 2016-06-20 2017-12-28 Senseonics, Incorporated Communication between devices using a wireless communication protocol
CN109414582B (en) 2016-06-27 2022-10-28 心脏起搏器股份公司 Cardiac therapy system for resynchronization pacing management using subcutaneous sensing of P-waves
US11903727B2 (en) * 2016-06-29 2024-02-20 Koninklijke Philips N.V. Method and device for health devices and wearable/implantable devices
US11207527B2 (en) 2016-07-06 2021-12-28 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
US10426962B2 (en) 2016-07-07 2019-10-01 Cardiac Pacemakers, Inc. Leadless pacemaker using pressure measurements for pacing capture verification
EP3484541A4 (en) 2016-07-14 2020-03-25 ICU Medical, Inc. Multi-communication path selection and security system for a medical device
US10602284B2 (en) 2016-07-18 2020-03-24 Cochlear Limited Transducer management
EP3484577A4 (en) 2016-07-18 2020-03-25 Nalu Medical, Inc. Methods and systems for treating pelvic disorders and pain conditions
US10688304B2 (en) 2016-07-20 2020-06-23 Cardiac Pacemakers, Inc. Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system
WO2018035051A1 (en) 2016-08-14 2018-02-22 Insulet Corporation Drug delivery device with detection of position of the plunger
EP3500342B1 (en) 2016-08-19 2020-05-13 Cardiac Pacemakers, Inc. Trans-septal implantable medical device
WO2018039335A1 (en) 2016-08-24 2018-03-01 Cardiac Pacemakers, Inc. Integrated multi-device cardiac resynchronization therapy using p-wave to pace timing
CN109641129B (en) 2016-08-24 2023-06-30 心脏起搏器股份公司 Cardiac resynchronization with timing management using fusion facilitation
US20180063784A1 (en) * 2016-08-26 2018-03-01 Qualcomm Incorporated Devices and methods for an efficient wakeup protocol
EP3515553B1 (en) 2016-09-21 2020-08-26 Cardiac Pacemakers, Inc. Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery
US10758737B2 (en) 2016-09-21 2020-09-01 Cardiac Pacemakers, Inc. Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter
WO2018057626A1 (en) 2016-09-21 2018-03-29 Cardiac Pacemakers, Inc. Implantable cardiac monitor
EP3515535A1 (en) * 2016-09-23 2019-07-31 Insulet Corporation Fluid delivery device with sensor
US11229751B2 (en) 2016-09-27 2022-01-25 Bigfoot Biomedical, Inc. Personalizing preset meal sizes in insulin delivery system
EP3522951A1 (en) 2016-10-07 2019-08-14 Insulet Corporation Multi-stage delivery system
US10561330B2 (en) 2016-10-27 2020-02-18 Cardiac Pacemakers, Inc. Implantable medical device having a sense channel with performance adjustment
US10413733B2 (en) 2016-10-27 2019-09-17 Cardiac Pacemakers, Inc. Implantable medical device with gyroscope
WO2018081225A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Implantable medical device delivery system with integrated sensor
WO2018081237A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Use of a separate device in managing the pace pulse energy of a cardiac pacemaker
US10463305B2 (en) 2016-10-27 2019-11-05 Cardiac Pacemakers, Inc. Multi-device cardiac resynchronization therapy with timing enhancements
USD835648S1 (en) 2016-10-27 2018-12-11 Smith & Nephew, Inc. Display screen or portion thereof with a graphical user interface for a therapy device
WO2018081017A1 (en) 2016-10-27 2018-05-03 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
EP3532158B1 (en) 2016-10-31 2022-12-14 Cardiac Pacemakers, Inc. Systems for activity level pacing
EP3532157B1 (en) 2016-10-31 2020-08-26 Cardiac Pacemakers, Inc. Systems for activity level pacing
US10583301B2 (en) 2016-11-08 2020-03-10 Cardiac Pacemakers, Inc. Implantable medical device for atrial deployment
US20180193426A1 (en) * 2016-11-09 2018-07-12 PhysioLogic Devices, Inc. Insulins compatible with new generation implantable pumps
EP3538213B1 (en) 2016-11-09 2023-04-12 Cardiac Pacemakers, Inc. Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device
US10780217B2 (en) 2016-11-10 2020-09-22 Insulet Corporation Ratchet drive for on body delivery system
WO2018094207A1 (en) 2016-11-17 2018-05-24 Endostim, Inc. Modular stimulation system for the treatment of gastrointestinal disorders
JP6781346B2 (en) 2016-11-21 2020-11-04 カーディアック ペースメイカーズ, インコーポレイテッド Leadless cardiac pacemaker with multi-mode communication
US10639486B2 (en) 2016-11-21 2020-05-05 Cardiac Pacemakers, Inc. Implantable medical device with recharge coil
JP6843240B2 (en) 2016-11-21 2021-03-17 カーディアック ペースメイカーズ, インコーポレイテッド Implantable medical device with permeable housing and induction coil placed around the housing
US10881869B2 (en) 2016-11-21 2021-01-05 Cardiac Pacemakers, Inc. Wireless re-charge of an implantable medical device
WO2018093605A1 (en) 2016-11-21 2018-05-24 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker providing cardiac resynchronization therapy
USD836769S1 (en) 2016-12-12 2018-12-25 Bigfoot Biomedical, Inc. Insulin delivery controller
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
CN110100283B (en) 2016-12-21 2023-07-04 甘布罗伦迪亚股份公司 Medical device system including information technology infrastructure with secure cluster domain supporting external domain
DE102016015685A1 (en) * 2016-12-22 2018-06-28 Drägerwerk AG & Co. KGaA Device for controlling an operating state of at least one medical device in a medical data network and medical device for a medical data network
WO2018119258A1 (en) * 2016-12-22 2018-06-28 Bioventures, Llc Medical device alert system and method
CN106730129A (en) * 2016-12-22 2017-05-31 郑州万辉医疗设备有限公司 A kind of insulin pump with Bluetooth connected mode
EP3562543A4 (en) * 2016-12-30 2020-11-11 Nalu Medical, Inc. Stimulation apparatus
US11207532B2 (en) 2017-01-04 2021-12-28 Cardiac Pacemakers, Inc. Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system
WO2018129354A1 (en) 2017-01-06 2018-07-12 Trustees Of Boston University Infusion system and components thereof
WO2018132578A1 (en) 2017-01-11 2018-07-19 Tandem Diabetes Care, Inc. Electromagnetic signal-based infusion pump control
WO2018132765A1 (en) 2017-01-13 2018-07-19 Mazlish Bryan Insulin delivery methods, systems and devices
US10610644B2 (en) 2017-01-13 2020-04-07 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
EP3568862A1 (en) 2017-01-13 2019-11-20 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
WO2018136699A1 (en) 2017-01-19 2018-07-26 Insulet Corporation Cartridge hold-up volume reduction
EP3573709A1 (en) 2017-01-26 2019-12-04 Cardiac Pacemakers, Inc. Leadless device with overmolded components
EP3573708B1 (en) 2017-01-26 2021-03-10 Cardiac Pacemakers, Inc. Leadless implantable device with detachable fixation
JP7000438B2 (en) 2017-01-26 2022-01-19 カーディアック ペースメイカーズ, インコーポレイテッド Human device communication with redundant message transmission
US10173068B2 (en) 2017-02-02 2019-01-08 Pacesetter, Inc. Mitigating false messaging in leadless dual-chamber pacing systems and other IMD systems
US10052491B1 (en) * 2017-02-02 2018-08-21 Pacesetter, Inc. Mitigating false messaging in leadless dual-chamber pacing systems and other IMD systems
US10552580B2 (en) * 2017-02-07 2020-02-04 Medtronic Minimed, Inc. Infusion system consumables and related calibration methods
US11234623B2 (en) * 2017-02-14 2022-02-01 Dexcom, Inc. Needle alignment for wearable biosensors
EP3585475A4 (en) 2017-02-24 2021-01-06 Nalu Medical, Inc. Apparatus with sequentially implanted stimulators
US11086609B2 (en) 2017-02-24 2021-08-10 Masimo Corporation Medical monitoring hub
US11213691B2 (en) 2017-02-27 2022-01-04 Zoll Medical Corporation Ambulatory medical device interaction
US10124182B2 (en) * 2017-02-28 2018-11-13 Medtronic, Inc. Mitigating implantable device power drain associated with stalled telemetry sessions
JP7063912B2 (en) 2017-03-07 2022-05-09 スミス アンド ネフュー インコーポレイテッド Decompression therapy system and method including antenna
US10695485B2 (en) 2017-03-07 2020-06-30 Insulet Corporation Very high volume user filled drug delivery device
USD853583S1 (en) 2017-03-29 2019-07-09 Becton, Dickinson And Company Hand-held device housing
US10905872B2 (en) 2017-04-03 2021-02-02 Cardiac Pacemakers, Inc. Implantable medical device with a movable electrode biased toward an extended position
AU2018248361B2 (en) 2017-04-03 2020-08-27 Cardiac Pacemakers, Inc. Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate
CN107115576B (en) * 2017-04-20 2020-06-16 深圳麦科田生物医疗技术有限公司 Infusion system
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
US10842924B2 (en) 2017-06-29 2020-11-24 Fresenius Medical Care Deutschland Gmbh Therapy control by comprehensive feedback
WO2019014594A1 (en) 2017-07-13 2019-01-17 Desborough Lane Multi-scale display of blood glucose information
US10726218B2 (en) 2017-07-27 2020-07-28 Symbol Technologies, Llc Method and apparatus for radio frequency identification (RFID) tag bearing estimation
US11596795B2 (en) 2017-07-31 2023-03-07 Medtronic, Inc. Therapeutic electrical stimulation therapy for patient gait freeze
WO2019028342A1 (en) 2017-08-03 2019-02-07 Insulet Corporation Micro piston pump
US10973978B2 (en) 2017-08-03 2021-04-13 Insulet Corporation Fluid flow regulation arrangements for drug delivery devices
WO2019036568A1 (en) 2017-08-18 2019-02-21 Cardiac Pacemakers, Inc. Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator
EP3668592B1 (en) 2017-08-18 2021-11-17 Cardiac Pacemakers, Inc. Implantable medical device with pressure sensor
CN111107899A (en) 2017-09-20 2020-05-05 心脏起搏器股份公司 Implantable medical device with multiple modes of operation
US11786668B2 (en) 2017-09-25 2023-10-17 Insulet Corporation Drug delivery devices, systems, and methods with force transfer elements
USD863343S1 (en) 2017-09-27 2019-10-15 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
DE102017010150A1 (en) * 2017-11-02 2019-05-02 Drägerwerk AG & Co. KGaA Method, control unit, computer program product and system for providing a failsafe medical monitoring process
US11185703B2 (en) 2017-11-07 2021-11-30 Cardiac Pacemakers, Inc. Leadless cardiac pacemaker for bundle of his pacing
CN111432874A (en) 2017-12-01 2020-07-17 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference within search window from a ventricular implanted leadless cardiac pacemaker
US11071870B2 (en) 2017-12-01 2021-07-27 Cardiac Pacemakers, Inc. Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker
CN111417432A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Leadless cardiac pacemaker with involution behavior
CN111417433A (en) 2017-12-01 2020-07-14 心脏起搏器股份公司 Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
EP3724889A2 (en) 2017-12-12 2020-10-21 Bigfoot Biomedical, Inc. Therapy assist information and/or tracking device and related methods and systems
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11197964B2 (en) 2017-12-12 2021-12-14 Bigfoot Biomedical, Inc. Pen cap for medication injection pen having temperature sensor
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
WO2019120434A1 (en) * 2017-12-22 2019-06-27 Coloplast A/S Processing schemes for an ostomy system, monitor device for an ostomy appliance and related methods
US10915954B2 (en) * 2017-12-26 2021-02-09 Chicago Mercantile Exchange Inc. Integration application utilizing a communications protocol
US10089055B1 (en) 2017-12-27 2018-10-02 Icu Medical, Inc. Synchronized display of screen content on networked devices
US10874861B2 (en) 2018-01-04 2020-12-29 Cardiac Pacemakers, Inc. Dual chamber pacing without beat-to-beat communication
US11529523B2 (en) 2018-01-04 2022-12-20 Cardiac Pacemakers, Inc. Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone
US11354393B2 (en) 2018-02-01 2022-06-07 Pelstar, Llc Systems and methods for controlling units for a scale
US20190247568A1 (en) * 2018-02-09 2019-08-15 Michael George Thatcher Medical Infusion Pump System
US10602945B2 (en) 2018-03-13 2020-03-31 Zoll Medical Corporation Telemetry of wearable medical device information to secondary medical device or system
JP2021518208A (en) 2018-03-23 2021-08-02 メドトロニック,インコーポレイテッド AV Synchronized VfA Cardiac Treatment
CN111936046A (en) 2018-03-23 2020-11-13 美敦力公司 VFA cardiac therapy for tachycardia
EP3768377B1 (en) 2018-03-23 2023-11-22 Medtronic, Inc. Vfa cardiac resynchronization therapy
JP2019175755A (en) * 2018-03-29 2019-10-10 セイコーエプソン株式会社 Circuit device, control device, power-receiving device, and electronic equipment
EP3776801A4 (en) 2018-04-10 2021-12-22 Tandem Diabetes Care, Inc. System and method for inductively charging a medical device
US11278670B2 (en) * 2018-04-26 2022-03-22 Carefusion 303, Inc. Semi-autonomous hot-swap infusion module
CN112236826A (en) 2018-05-04 2021-01-15 英赛罗公司 Safety constraints for drug delivery systems based on control algorithms
USD897361S1 (en) 2018-05-18 2020-09-29 Carefusion 303, Inc. Display screen of a modular infusion device with transitional graphical user interface
US10874803B2 (en) 2018-05-31 2020-12-29 Insulet Corporation Drug cartridge with drive system
WO2019236818A1 (en) 2018-06-06 2019-12-12 Insulet Corporation Linear shuttle pump for drug delivery
US10970669B2 (en) 2018-06-18 2021-04-06 General Electric Company Blockchain enabled transaction processing for an industrial asset supply chain
WO2020018388A1 (en) 2018-07-17 2020-01-23 Icu Medical, Inc. Updating infusion pump drug libraries and operational software in a networked environment
US10861592B2 (en) 2018-07-17 2020-12-08 Icu Medical, Inc. Reducing infusion pump network congestion by staggering updates
US11152108B2 (en) 2018-07-17 2021-10-19 Icu Medical, Inc. Passing authentication token to authorize access to rest calls via web sockets
EP3824383B1 (en) 2018-07-17 2023-10-11 ICU Medical, Inc. Systems and methods for facilitating clinical messaging in a network environment
US10795422B2 (en) * 2018-07-24 2020-10-06 Motorola Solutions, Inc. Method and apparatus for mission critical standby of a portable communication drive
EP3827337A4 (en) 2018-07-26 2022-04-13 ICU Medical, Inc. Drug library management system
US10692595B2 (en) 2018-07-26 2020-06-23 Icu Medical, Inc. Drug library dynamic version management
USD875765S1 (en) 2018-08-10 2020-02-18 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
USD875766S1 (en) 2018-08-10 2020-02-18 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
BR112021002737A2 (en) 2018-08-16 2021-06-08 Deka Products Limited Partnership medical bomb
USD880496S1 (en) 2018-08-20 2020-04-07 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
USD864218S1 (en) 2018-08-20 2019-10-22 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
USD864217S1 (en) 2018-08-20 2019-10-22 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
USD864219S1 (en) 2018-08-20 2019-10-22 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
USD882622S1 (en) 2018-08-22 2020-04-28 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
USD875767S1 (en) 2018-08-23 2020-02-18 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
US11241532B2 (en) 2018-08-29 2022-02-08 Insulet Corporation Drug delivery system with sensor having optimized communication and infusion site
US11678141B2 (en) 2018-09-18 2023-06-13 Pb Inc. Hybrid cellular Bluetooth tracking devices, methods and systems
US11184858B2 (en) 2018-09-18 2021-11-23 PB, Inc. Bluecell devices and methods
CN112770807A (en) 2018-09-26 2021-05-07 美敦力公司 Capture in atrial-to-ventricular cardiac therapy
US10705984B1 (en) * 2018-09-26 2020-07-07 Cadence Design Systems, Inc. High-speed low VT drift receiver
CN112789070A (en) 2018-09-28 2021-05-11 英赛罗公司 Mode of activity of the artificial pancreas System
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
EP3857555A4 (en) 2018-10-17 2022-12-21 Tempus Labs Data based cancer research and treatment systems and methods
US10395772B1 (en) 2018-10-17 2019-08-27 Tempus Labs Mobile supplementation, extraction, and analysis of health records
US10967190B2 (en) * 2018-11-02 2021-04-06 Advanced Neuromodulation Systems, Inc. Methods of operating a system for management of implantable medical devices (IMDs) using reconciliation operations and revocation data
EP3887680B1 (en) 2018-11-28 2022-10-26 Insulet Corporation Drug delivery shuttle pump system and valve assembly
EP3891755A4 (en) 2018-12-03 2022-09-07 Tempus Labs, Inc. Clinical concept identification, extraction, and prediction system and related methods
US11679265B2 (en) 2019-02-14 2023-06-20 Medtronic, Inc. Lead-in-lead systems and methods for cardiac therapy
EP3927391A4 (en) 2019-02-19 2022-11-16 Tandem Diabetes Care, Inc. System and method of pairing an infusion pump with a remote control device
US11194913B2 (en) * 2019-03-12 2021-12-07 International Business Machines Corporation Unsecure to secure transition of mutable core root of trust
EP3946514A4 (en) 2019-03-26 2022-12-21 Tandem Diabetes Care, Inc. Method of pairing an infusion pump with a remote control device
US11697025B2 (en) 2019-03-29 2023-07-11 Medtronic, Inc. Cardiac conduction system capture
US11213676B2 (en) 2019-04-01 2022-01-04 Medtronic, Inc. Delivery systems for VfA cardiac therapy
US20200353163A1 (en) * 2019-05-07 2020-11-12 University Of South Carolina Syringe pump system and method for operating the same
US11712188B2 (en) 2019-05-07 2023-08-01 Medtronic, Inc. Posterior left bundle branch engagement
US11146918B2 (en) * 2019-06-10 2021-10-12 Ford Global Technologies, Llc Systems and methods for network node communication using dynamically configurable interaction modes
US11239928B2 (en) 2019-06-21 2022-02-01 Pacesetter, Inc. Dynamic sensitivity and strength control of communication signals between implantable medical devices
MX2022000669A (en) 2019-07-16 2022-08-22 Beta Bionics Inc Blood glucose control system.
DE112020003400T5 (en) 2019-07-16 2022-03-31 Beta Bionics, Inc. OUTPATIENT INSTITUTION AND ITS COMPONENTS
US11771880B2 (en) 2019-07-17 2023-10-03 Nxgenport, Llc Implantable venous access port with remote physiological monitoring capabilities
USD964563S1 (en) 2019-07-26 2022-09-20 Deka Products Limited Partnership Medical flow clamp
WO2021021596A1 (en) 2019-07-26 2021-02-04 Deka Products Limited Partnership Apparatus for monitoring, regulating, or controlling fluid flow
US11295841B2 (en) 2019-08-22 2022-04-05 Tempus Labs, Inc. Unsupervised learning and prediction of lines of therapy from high-dimensional longitudinal medications data
US11305127B2 (en) 2019-08-26 2022-04-19 Medtronic Inc. VfA delivery and implant region detection
EP3785759A1 (en) * 2019-09-01 2021-03-03 CereGate GmbH Data integrity for medical devices using blockchain solutions
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11657125B2 (en) * 2019-09-20 2023-05-23 Canon Kabushiki Kaisha Information processing apparatus and reset control method
US11633610B2 (en) 2019-09-27 2023-04-25 Pacesetter, Inc. Mitigating false messages and effects thereof in multi-chamber leadless pacemaker systems and other IMD systems
USD924181S1 (en) * 2019-10-10 2021-07-06 Johnson & Johnson Surgical Vision, Inc. Remote control
USD924180S1 (en) * 2019-10-10 2021-07-06 Johnson & Johnson Surgical Vision, Inc. Remote control
JP2022554242A (en) * 2019-10-28 2022-12-28 サノフイ Electronic labels for drug delivery devices
CA3098223A1 (en) * 2019-11-05 2021-05-05 3D Bridge Solutions Inc. Systems, devices and methods for securing and tracking drug dispensing devices
US11369735B2 (en) 2019-11-05 2022-06-28 Insulet Corporation Component positioning of a linear shuttle pump
DE102019130410A1 (en) * 2019-11-12 2021-05-12 B. Braun Melsungen Aktiengesellschaft Medical device with a data transmission system and method for ensuring the completeness of a data stream
US11278671B2 (en) 2019-12-04 2022-03-22 Icu Medical, Inc. Infusion pump with safety sequence keypad
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
WO2022126080A1 (en) * 2020-12-07 2022-06-16 Beta Bionics, Inc. Medicament pumps and control systems for managing glucose control therapy data of a subject
USD931306S1 (en) 2020-01-20 2021-09-21 Tandem Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
US11813466B2 (en) 2020-01-27 2023-11-14 Medtronic, Inc. Atrioventricular nodal stimulation
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
CN111317889B (en) * 2020-02-14 2022-06-24 微泰医疗器械(杭州)股份有限公司 Insulin pump infusion control method
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US11650965B2 (en) * 2020-03-05 2023-05-16 Zscaler, Inc. Systems and methods for efficiently maintaining records in a cloud-based system
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
US11911168B2 (en) 2020-04-03 2024-02-27 Medtronic, Inc. Cardiac conduction system therapy benefit determination
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11583631B2 (en) * 2020-04-23 2023-02-21 Medtronic Minimed, Inc. Intuitive user interface features and related functionality for a therapy delivery system
US11690955B2 (en) 2020-04-23 2023-07-04 Medtronic Minimed, Inc. Continuous analyte sensor quality measures and related therapy actions for an automated therapy delivery system
CN111510503B (en) * 2020-04-28 2021-03-26 苏州鱼得水电气科技有限公司 Designated range signal control system and method adopting communication networking platform
US11400298B2 (en) 2020-05-04 2022-08-02 Medtronic, Inc. Power source longevity
AU2021300178A1 (en) * 2020-07-01 2022-11-24 Agilent Technologies, Inc. Instrument monitoring system
CA3189781A1 (en) 2020-07-21 2022-01-27 Icu Medical, Inc. Fluid transfer devices and methods of use
US20220036992A1 (en) * 2020-07-30 2022-02-03 Medtronic Minimed, Inc. Automatic device configuration via a network service
US11813464B2 (en) 2020-07-31 2023-11-14 Medtronic, Inc. Cardiac conduction system evaluation
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
CN114123368A (en) * 2020-09-01 2022-03-01 深圳迈瑞生物医疗电子股份有限公司 Medical apparatus, control method thereof, and storage medium
WO2022072734A1 (en) 2020-09-30 2022-04-07 Zoll Medical Corporation Remote monitoring devices and related methods and systems with audible aed signal listening
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US11135360B1 (en) 2020-12-07 2021-10-05 Icu Medical, Inc. Concurrent infusion with common line auto flush
WO2022125471A1 (en) * 2020-12-07 2022-06-16 Icu Medical, Inc. Concurrent infusion with common line auto flush
US20220265143A1 (en) 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US11594314B2 (en) 2020-12-07 2023-02-28 Beta Bionics, Inc. Modular blood glucose control systems
US11497852B2 (en) 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
EP4284467A1 (en) * 2021-01-28 2023-12-06 Tandem Diabetes Care, Inc. Temporary alarm modifications in ambulatory infusion pump system
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US11904139B2 (en) * 2021-04-05 2024-02-20 Medtronic Minimed, Inc. Closed-loop control in steady-state conditions
US11330145B1 (en) 2021-06-10 2022-05-10 Bank Of America Corporation Image processing edge device for document noise removal
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
WO2023088782A1 (en) * 2021-11-19 2023-05-25 Biotronik Se & Co. Kg Computer implemented method and system for protecting a patient critical firmware function of an implantable medical device
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
US11716278B1 (en) 2022-01-25 2023-08-01 Bank Of America Corporation System and method for determining the shortest data transfer path in data communication

Citations (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258711A (en) * 1979-02-05 1981-03-31 Metal Bellows Corporation Infusion apparatus and method
US4373527A (en) * 1979-04-27 1983-02-15 The Johns Hopkins University Implantable, programmable medication infusion system
US4487603A (en) * 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4494950A (en) * 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
US4731051A (en) * 1979-04-27 1988-03-15 The Johns Hopkins University Programmable control means for providing safe and controlled medication infusion
US5127404A (en) * 1990-01-22 1992-07-07 Medtronic, Inc. Telemetry format for implanted medical device
US5191326A (en) * 1991-09-05 1993-03-02 Schlumberger Technology Corporation Communications protocol for digital telemetry system
US5368562A (en) * 1993-07-30 1994-11-29 Pharmacia Deltec, Inc. Systems and methods for operating ambulatory medical devices such as drug delivery devices
US5369364A (en) * 1993-04-26 1994-11-29 Medtronic, Inc. Battery state of charge determination with plural periodic measurements to determine its internal impedance and geometric capacitance
US5416695A (en) * 1993-03-09 1995-05-16 Metriplex, Inc. Method and apparatus for alerting patients and medical personnel of emergency medical situations
US5438621A (en) * 1988-11-02 1995-08-01 Hewlett-Packard Company DC-free line code and bit and frame synchronization for arbitrary data transmission
US5456692A (en) * 1993-09-03 1995-10-10 Pacesetter, Inc. System and method for noninvasively altering the function of an implanted pacemaker
US5620474A (en) * 1995-04-24 1997-04-15 Vitatron Medical, B.V. System and method for determining indicated pacemaker replacement time based upon battery impedance measurement
US5630710A (en) * 1994-03-09 1997-05-20 Baxter International Inc. Ambulatory infusion pump
US5647854A (en) * 1994-04-15 1997-07-15 Sims Deltec, Inc. Base plate for a drug pump
US5659299A (en) * 1992-01-28 1997-08-19 Servio Logic Corporation High speed infrared communications system using pulse sets
US5658133A (en) * 1994-03-09 1997-08-19 Baxter International Inc. Pump chamber back pressure dissipation apparatus and method
US5658250A (en) * 1993-07-13 1997-08-19 Sims Deltec, Inc. Systems and methods for operating ambulatory medical devices such as drug delivery devices
US5669877A (en) * 1994-03-07 1997-09-23 Sims Deltec, Inc. Systems and methods for automated testing of medical equipment
US5695473A (en) * 1994-07-27 1997-12-09 Sims Deltec, Inc. Occlusion detection system for an infusion pump
US5718234A (en) * 1996-09-30 1998-02-17 Northrop Grumman Corporation Physiological data communication system
US5720770A (en) * 1995-10-06 1998-02-24 Pacesetter, Inc. Cardiac stimulation system with enhanced communication and control capability
US5724985A (en) * 1995-08-02 1998-03-10 Pacesetter, Inc. User interface for an implantable medical device using an integrated digitizer display screen
US5730125A (en) * 1995-02-22 1998-03-24 Sulzer Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
US5733313A (en) * 1996-08-01 1998-03-31 Exonix Corporation RF coupled, implantable medical device with rechargeable back-up power source
US5749907A (en) * 1997-02-18 1998-05-12 Pacesetter, Inc. System and method for identifying and displaying medical data which violate programmable alarm conditions
US5788669A (en) * 1995-11-22 1998-08-04 Sims Deltec, Inc. Pump tracking system
US5800472A (en) * 1996-05-14 1998-09-01 Pacesetter, Inc. Recommended replacement time trigger for use within an implantable rate-responsive pacemaker
US5876370A (en) * 1995-10-11 1999-03-02 Sims Deltec, Inc. Intermittent fluid delivery apparatus and method
US5935099A (en) * 1992-09-09 1999-08-10 Sims Deltec, Inc. Drug pump systems and methods
US5974341A (en) * 1997-12-22 1999-10-26 Pacesetter, Inc. Method and apparatus for detecting and displaying diagnostic information in conjunction with intracardiac electrograms and surface electrocardiograms
US6024539A (en) * 1992-09-09 2000-02-15 Sims Deltec, Inc. Systems and methods for communicating with ambulatory medical devices such as drug delivery devices
US6026124A (en) * 1995-10-05 2000-02-15 Silicon Image, Inc. Transition-controlled digital encoding and signal transmission system
US6057758A (en) * 1998-05-20 2000-05-02 Hewlett-Packard Company Handheld clinical terminal
US6070103A (en) * 1996-11-05 2000-05-30 Intermedics Inc. Apparatus for making direct electrical connection with an implantable medical device
US6088618A (en) * 1998-07-07 2000-07-11 Vitatron Medical, B.V. Pacemaker system and method for providing manual display concurrent with pacemaker software modification
US6155267A (en) * 1998-12-31 2000-12-05 Medtronic, Inc. Implantable medical device monitoring method and system regarding same
US6167303A (en) * 1998-04-29 2000-12-26 Medtronic, Inc. Power consumption reduction in medical devices employing just-in-time clock
US6249703B1 (en) * 1994-07-08 2001-06-19 Medtronic, Inc. Handheld patient programmer for implantable human tissue stimulator
US6409674B1 (en) * 1998-09-24 2002-06-25 Data Sciences International, Inc. Implantable sensor with wireless communication
US6418346B1 (en) * 1999-12-14 2002-07-09 Medtronic, Inc. Apparatus and method for remote therapy and diagnosis in medical devices via interface systems

Family Cites Families (305)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US578866A (en) * 1897-03-16 Apparatus for oxidizing stockings
US6241704B1 (en) * 1901-11-22 2001-06-05 Sims Deltec, Inc. Drug pump systems and methods
US2144310A (en) * 1935-07-12 1939-01-17 Bendix Radio Corp Radio apparatus and method of manufacture
US2147148A (en) * 1936-03-17 1939-02-14 Rca Corp Loop antenna
US2203517A (en) * 1938-05-28 1940-06-04 Gen Electric Radio receiver
US2273955A (en) * 1939-06-05 1942-02-24 Philco Radio & Television Corp Loop antenna
US2343306A (en) * 1939-12-14 1944-03-07 Lear Avia Inc Loop antenna system
US2292182A (en) * 1940-07-23 1942-08-04 Gen Electric Loop antenna
US3446974A (en) 1966-11-07 1969-05-27 Zenith Radio Corp Solid state acoustic signal translating device with light activated electrode interconnections
US3495264A (en) * 1966-12-09 1970-02-10 Continental Electronics Mfg Loop antenna comprising plural helical coils on closed magnetic core
US3621482A (en) 1969-12-04 1971-11-16 Zenith Radio Corp Tunable surface-wave signal-translating device
US3614955A (en) 1970-02-09 1971-10-26 Medtronic Inc Standby defibrillator and method of operation
US3683389A (en) * 1971-01-20 1972-08-08 Corning Glass Works Omnidirectional loop antenna array
US3942536A (en) 1971-03-15 1976-03-09 Mieczyslaw Mirowski Cardioverting device having single intravascular catheter electrode system and method for its use
US3796221A (en) * 1971-07-07 1974-03-12 N Hagfors Apparatus for delivering electrical stimulation energy to body-implanted apparatus with signal-receiving means
US3908667A (en) 1973-01-17 1975-09-30 Robert I Bernstein Cardiac pacer
US3910257A (en) * 1973-04-25 1975-10-07 Nasa Medical subject monitoring systems
FR2266394B1 (en) 1974-03-26 1981-02-27 Thomson Csf
US3923060A (en) * 1974-04-23 1975-12-02 Jr Everett H Ellinwood Apparatus and method for implanted self-powered medication dispensing having timing and evaluator means
US4066086A (en) * 1975-06-05 1978-01-03 Medtronic, Inc. Programmable body stimulator
DE2652026C2 (en) 1976-11-15 1983-01-05 Siemens AG, 1000 Berlin und 8000 München Device for infusing liquids
DE2721752C2 (en) 1977-05-13 1983-12-29 Siemens AG, 1000 Berlin und 8000 München Device implantable in a human or animal body for the infusion of a medical liquid
US4102332A (en) 1977-05-17 1978-07-25 Gessman Lawrence J Remote, telephonic cardiac resuscitation device
DE2758467C2 (en) 1977-12-28 1985-04-04 Siemens AG, 1000 Berlin und 8000 München Device for the pre-programmable infusion of liquids
US4559037A (en) 1977-12-28 1985-12-17 Siemens Aktiengesellschaft Device for the pre-programmable infusion of liquids
DE2758368C2 (en) * 1977-12-28 1985-10-17 Siemens AG, 1000 Berlin und 8000 München Device for the pre-programmable infusion of liquids
US4201965A (en) * 1978-06-29 1980-05-06 Rca Corporation Inductance fabricated on a metal base printed circuit board
US4233636A (en) * 1978-07-03 1980-11-11 Eocom Corporation Optical read-write system with electronically variable image size
US4360019A (en) * 1979-02-28 1982-11-23 Andros Incorporated Implantable infusion device
US4573994A (en) * 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4525165A (en) 1979-04-27 1985-06-25 The Johns Hopkins University Fluid handling system for medication infusion system
US4619653A (en) 1979-04-27 1986-10-28 The Johns Hopkins University Apparatus for detecting at least one predetermined condition and providing an informational signal in response thereto in a medication infusion system
US4440173A (en) * 1979-11-08 1984-04-03 Medtronic Programmable body stimulation system
US4374382A (en) * 1981-01-16 1983-02-15 Medtronic, Inc. Marker channel telemetry system for a medical device
US4399821A (en) * 1981-02-19 1983-08-23 Bowers David L Free moving animal physiological monitoring and identification system and method
US4432360A (en) * 1981-07-06 1984-02-21 Cordis Corporation Interactive programmer for biomedical implantable devices
DE3138320A1 (en) 1981-09-25 1983-04-14 Siemens AG, 1000 Berlin und 8000 München INFUSION DEVICE PROVIDED FOR IMPLANTATION IN A LIVING BODY
US4443218A (en) * 1982-09-09 1984-04-17 Infusaid Corporation Programmable implantable infusate pump
EP0107150B2 (en) 1982-10-18 1992-04-15 Siemens Aktiengesellschaft Medicine-delivering apparatus
US4784645A (en) * 1982-11-04 1988-11-15 The Johns Hopkins University Apparatus for detecting a condition of a medication infusion system and providing an informational signal in response thereto
US4561443A (en) * 1983-03-08 1985-12-31 The Johns Hopkins University Coherent inductive communications link for biomedical applications
US4484987A (en) * 1983-05-19 1984-11-27 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4601557A (en) * 1983-07-05 1986-07-22 Bogle Robert W Motion picture camera automatic focusing system
US4627906A (en) 1983-10-03 1986-12-09 The Regents Of The University Of California Electrochemical sensor having improved stability
US4586508A (en) * 1984-03-23 1986-05-06 Cordis Corporation Implant communication system with patient coil
CA1233363A (en) 1984-06-01 1988-03-01 Robert E. Fischell Single valve diaphragm pump with decreased sensitivity to ambient conditions
US4661097A (en) 1984-06-01 1987-04-28 The Johns Hopkins University Method for clearing a gas bubble from a positive displacement pump contained within a fluid dispensing system
US4608993A (en) * 1984-07-31 1986-09-02 Quinton Instrument Company Blood flow measurement device and method
CA1254091A (en) 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
US4781798A (en) 1985-04-19 1988-11-01 The Regents Of The University Of California Transparent multi-oxygen sensor array and method of using same
US4671288A (en) * 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
JPS6272251A (en) * 1985-09-26 1987-04-02 Toshiba Corp Loop network
US4714462A (en) * 1986-02-03 1987-12-22 Intermedics Infusaid, Inc. Positive pressure programmable infusion pump
US4755173A (en) 1986-02-25 1988-07-05 Pacesetter Infusion, Ltd. Soft cannula subcutaneous injection set
JPH069869B2 (en) 1986-04-30 1994-02-09 市光工業株式会社 Joint structure of synthetic resin members
US4703756A (en) 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4854328A (en) * 1987-03-23 1989-08-08 Philip Pollack Animal monitoring telltale and information system
US4925444A (en) * 1987-08-07 1990-05-15 Baxter Travenol Laboratories, Inc. Closed multi-fluid delivery system and method
US4809697A (en) * 1987-10-14 1989-03-07 Siemens-Pacesetter, Inc. Interactive programming and diagnostic system for use with implantable pacemaker
US4838887A (en) * 1987-12-15 1989-06-13 Shiley Infusaid Inc. Programmable valve pump
EP0346783B1 (en) 1988-06-14 1993-12-15 Ascom Ericsson Transmission AG Method and device for transmitting digital telemetry signals in a digital data flow
DE3831809A1 (en) * 1988-09-19 1990-03-22 Funke Hermann DEVICE DETERMINED AT LEAST PARTLY IN THE LIVING BODY
US4980836A (en) * 1988-10-14 1990-12-25 Compaq Computer Corporation Apparatus for reducing computer system power consumption
US4953197A (en) * 1988-12-08 1990-08-28 International Mobile Machines Corporation Combination spatial diversity system
EP0675425B1 (en) * 1989-06-30 1997-12-10 Fujitsu Personal Systems, Inc. A method for reducing power consumed by a computer
US4944299A (en) * 1989-08-08 1990-07-31 Siemens-Pacesetter, Inc. High speed digital telemetry system for implantable device
US5049141A (en) * 1990-04-25 1991-09-17 Infusaid, Inc. Programmable valve pump
US5113869A (en) 1990-08-21 1992-05-19 Telectronics Pacing Systems, Inc. Implantable ambulatory electrocardiogram monitor
US5139028A (en) * 1990-10-26 1992-08-18 Telectronics Pacing Systems, Inc. Heart rejection monitoring apparatus and method
US5311449A (en) * 1991-03-25 1994-05-10 Angeion Corporation Sterilizable hand-held programmer/interrogator
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5138328A (en) * 1991-08-22 1992-08-11 Motorola, Inc. Integral diversity antenna for a laptop computer
US5358514A (en) * 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes
US5193540A (en) * 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US5193539A (en) * 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Implantable microstimulator
US5231987A (en) * 1992-04-10 1993-08-03 Random Technologies, Inc. Time domain reflectometer-integrity testing system and method for implantable electrode
US5302787A (en) * 1992-05-05 1994-04-12 Square D Company Automatic miniature circuit breaker with Z-axis assemblable contact assembly
US5231990A (en) * 1992-07-09 1993-08-03 Spacelabs, Medical, Inc. Application specific integrated circuit for physiological monitoring
US5368582A (en) * 1992-08-10 1994-11-29 The Schepens Eye Research Institute Method and apparatus for introducing fluid material into an eye
US5376070A (en) * 1992-09-29 1994-12-27 Minimed Inc. Data transfer system for an infusion pump
US5832448A (en) 1996-10-16 1998-11-03 Health Hero Network Multiple patient monitoring system for proactive health management
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5307263A (en) 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US5350407A (en) * 1992-12-30 1994-09-27 Telectronics Pacing Systems, Inc. Implantable stimulator having quiescent and active modes of operation
US5342408A (en) * 1993-01-07 1994-08-30 Incontrol, Inc. Telemetry system for an implantable cardiac device
US5545143A (en) 1993-01-21 1996-08-13 T. S. I. Medical Device for subcutaneous medication delivery
DK25793A (en) 1993-03-09 1994-09-10 Pharma Plast Int As Infusion set for intermittent or continuous administration of a therapeutic agent
US5314457A (en) * 1993-04-08 1994-05-24 Jeutter Dean C Regenerative electrical
US5370668A (en) 1993-06-22 1994-12-06 Medtronic, Inc. Fault-tolerant elective replacement indication for implantable medical device
US5350411A (en) * 1993-06-28 1994-09-27 Medtronic, Inc. Pacemaker telemetry system
DE4329898A1 (en) * 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
US5389078A (en) * 1993-10-06 1995-02-14 Sims Deltec, Inc. Programmable infusion pump for administering medication to patients
US5381798A (en) * 1993-11-02 1995-01-17 Quinton Instrument Company Spread spectrum telemetry of physiological signals
JP3192297B2 (en) * 1993-11-05 2001-07-23 シャープ株式会社 Coordinate input device
US5791344A (en) * 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5476488A (en) * 1993-12-15 1995-12-19 Pacesetter, Inc. Telemetry system power control for implantable medical devices
US5544661A (en) * 1994-01-13 1996-08-13 Charles L. Davis Real time ambulatory patient monitor
US5464435A (en) * 1994-02-03 1995-11-07 Medtronic, Inc. Parallel processors in implantable medical device
US5536249A (en) 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US5391250A (en) 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
EP0672427A1 (en) * 1994-03-17 1995-09-20 Siemens-Elema AB System for infusion of medicine into the body of a patient
US5569186A (en) * 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5651767A (en) 1994-05-06 1997-07-29 Alfred F. Mann Foundation For Scientific Research Replaceable catheter system for physiological sensors, stimulating electrodes and/or implantable fluid delivery systems
US5559828A (en) 1994-05-16 1996-09-24 Armstrong; John T. Transmitted reference spread spectrum communication using a single carrier with two mutually orthogonal modulated basis vectors
US5664270A (en) * 1994-07-19 1997-09-09 Kinetic Concepts, Inc. Patient interface system
US5582593A (en) * 1994-07-21 1996-12-10 Hultman; Barry W. Ambulatory medication delivery system
US5571148A (en) 1994-08-10 1996-11-05 Loeb; Gerald E. Implantable multichannel stimulator
US5495258A (en) * 1994-09-01 1996-02-27 Nicholas L. Muhlhauser Multiple beam antenna system for simultaneously receiving multiple satellite signals
US5579001A (en) 1994-10-20 1996-11-26 Hewlett-Packard Co. Paging-based backchannel in a medical telemetry system
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US5581687A (en) * 1994-11-10 1996-12-03 Baxter International Inc. Interactive control systems for medical processing devices
US5620472A (en) * 1995-01-12 1997-04-15 Pacesetter, Inc. Apparatus and method for dynamically interpreting and displaying a real-time telemetry link
US5628619A (en) * 1995-03-06 1997-05-13 Sabratek Corporation Infusion pump having power-saving modes
US5646435A (en) 1995-04-04 1997-07-08 Taiwan Semiconductor Manufacturing Company, Ltd. Method for fabricating CMOS field effect transistors having sub-quarter micrometer channel lengths with improved short channel effect characteristics
US6219580B1 (en) * 1995-04-26 2001-04-17 Advanced Bionics Corporation Multichannel cochlear prosthesis with flexible control of stimulus waveforms
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US6238338B1 (en) * 1999-07-19 2001-05-29 Altec, Inc. Biosignal monitoring system and method
US5752976A (en) * 1995-06-23 1998-05-19 Medtronic, Inc. World wide patient location and data telemetry system for implantable medical devices
US6083248A (en) * 1995-06-23 2000-07-04 Medtronic, Inc. World wide patient location and data telemetry system for implantable medical devices
US5726644A (en) * 1995-06-30 1998-03-10 Philips Electronics North America Corporation Lighting control system with packet hopping communication
US5759199A (en) * 1995-08-02 1998-06-02 Pacesetter, Inc. System and method for ambulatory monitoring and programming of an implantable medical device
US5750926A (en) * 1995-08-16 1998-05-12 Alfred E. Mann Foundation For Scientific Research Hermetically sealed electrical feedthrough for use with implantable electronic devices
US5736973A (en) * 1995-11-01 1998-04-07 Digital Ocean, Inc. Integrated backlight display system for a personal digital assistant
US5704364A (en) * 1995-11-08 1998-01-06 Instromedix, Inc. Concurrent medical patient data and voice communication method and apparatus
US5748103A (en) * 1995-11-13 1998-05-05 Vitalcom, Inc. Two-way TDMA telemetry system with power conservation features
AU1058297A (en) 1995-11-22 1997-06-11 Minimed, Inc. Detection of biological molecules using chemical amplification and optical sensors
US6766183B2 (en) 1995-11-22 2004-07-20 Medtronic Minimed, Inc. Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers
US5740454A (en) * 1995-12-20 1998-04-14 Compaq Computer Corporation Circuit for setting computer system bus signals to predetermined states in low power mode
US5683432A (en) * 1996-01-11 1997-11-04 Medtronic, Inc. Adaptive, performance-optimizing communication system for communicating with an implanted medical device
US5725559A (en) * 1996-05-16 1998-03-10 Intermedics Inc. Programmably upgradable implantable medical device
FR2749462B1 (en) * 1996-06-04 1998-07-24 Ela Medical Sa AUTONOMOUS DEVICE, IN PARTICULAR ACTIVE IMPLANTABLE MEDICAL DEVICE, AND ITS EXTERNAL PROGRAMMER WITH SYNCHRONOUS TRANSMISSION
EP1249479B1 (en) * 1996-07-15 2004-02-18 Sekisui Kagaku Kogyo Kabushiki Kaisha Method for joining members
US5807336A (en) * 1996-08-02 1998-09-15 Sabratek Corporation Apparatus for monitoring and/or controlling a medical device
US5944745A (en) 1996-09-25 1999-08-31 Medtronic, Inc. Implantable medical device capable of prioritizing diagnostic data and allocating memory for same
US6353406B1 (en) * 1996-10-17 2002-03-05 R.F. Technologies, Inc. Dual mode tracking system
US6073033A (en) * 1996-11-01 2000-06-06 Telxon Corporation Portable telephone with integrated heads-up display and data terminal functions
US5855550A (en) * 1996-11-13 1999-01-05 Lai; Joseph Method and system for remotely monitoring multiple medical parameters
US6364834B1 (en) * 1996-11-13 2002-04-02 Criticare Systems, Inc. Method and system for remotely monitoring multiple medical parameters in an integrated medical monitoring system
US5949812A (en) * 1996-12-12 1999-09-07 Trimble Navigation Limited Method and system for conserving battery reserves in a navigation receiver by slowing and/or stopping the system clock during low demand
US6043437A (en) * 1996-12-20 2000-03-28 Alfred E. Mann Foundation Alumina insulation for coating implantable components and other microminiature devices
US6010483A (en) * 1996-12-23 2000-01-04 Spencer; Robert F. Patient controlled analgesia device for use with ultrashort acting opioid medication and method for using the same
US5957958A (en) 1997-01-15 1999-09-28 Advanced Bionics Corporation Implantable electrode arrays
US6607509B2 (en) 1997-12-31 2003-08-19 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6208894B1 (en) * 1997-02-26 2001-03-27 Alfred E. Mann Foundation For Scientific Research And Advanced Bionics System of implantable devices for monitoring and/or affecting body parameters
US6270455B1 (en) * 1997-03-28 2001-08-07 Health Hero Network, Inc. Networked system for interactive communications and remote monitoring of drug delivery
US5752977A (en) * 1997-04-15 1998-05-19 Medtronic, Inc. Efficient high data rate telemetry format for implanted medical device
DE19717107B4 (en) 1997-04-23 2005-06-23 Disetronic Licensing Ag System of container and drive device for a piston, which is held in the container containing a drug fluid
US6186982B1 (en) 1998-05-05 2001-02-13 Elan Corporation, Plc Subcutaneous drug delivery device with improved filling system
US5954643A (en) 1997-06-09 1999-09-21 Minimid Inc. Insertion set for a transcutaneous sensor
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
WO1998059487A1 (en) * 1997-06-23 1998-12-30 Enact Health Management Systems Improved system for downloading and reporting medical information
JPH1119210A (en) 1997-07-09 1999-01-26 Terumo Corp Liquid medicine injection system and its readable memory
IT1293974B1 (en) * 1997-08-13 1999-03-15 Sorin Biomedica Cardio Spa ACTIVE IMPLANTABLE DEVICE.
US6248080B1 (en) * 1997-09-03 2001-06-19 Medtronic, Inc. Intracranial monitoring and therapy delivery control device, system and method
US5917346A (en) 1997-09-12 1999-06-29 Alfred E. Mann Foundation Low power current to frequency converter circuit for use in implantable sensors
US5999848A (en) * 1997-09-12 1999-12-07 Alfred E. Mann Foundation Daisy chainable sensors and stimulators for implantation in living tissue
US5999849A (en) 1997-09-12 1999-12-07 Alfred E. Mann Foundation Low power rectifier circuit for implantable medical device
US6211858B1 (en) * 1997-09-26 2001-04-03 Ericsson Inc. Method and apparatus for displaying a rotating meter icon on a portable intelligent communications device
DE69840754D1 (en) * 1997-10-14 2009-05-28 Cypress Semiconductor Corp DIGITAL RADIO TRANSMITTER
US6088608A (en) * 1997-10-20 2000-07-11 Alfred E. Mann Foundation Electrochemical sensor and integrity tests therefor
US6081736A (en) 1997-10-20 2000-06-27 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems adapted for long term use
US6119028A (en) 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
EP1025530A2 (en) * 1997-10-31 2000-08-09 Amira Medical Analyte concentration information collection and communication s ystem
US5931791A (en) * 1997-11-05 1999-08-03 Instromedix, Inc. Medical patient vital signs-monitoring apparatus
US6129744A (en) 1997-12-04 2000-10-10 Vitatron Medical, B.V. Cardiac treatment system and method for sensing and responding to heart failure
IL122597A0 (en) * 1997-12-14 1998-06-15 Pylon Inc System and method for monitoring activity
CA2320238C (en) 1998-02-05 2011-08-23 James R. Mault Metabolic calorimeter employing respiratory gas analysis
US5904708A (en) 1998-03-19 1999-05-18 Medtronic, Inc. System and method for deriving relative physiologic signals
JPH11305289A (en) 1998-04-24 1999-11-05 Olympus Optical Co Ltd Camera
US6185454B1 (en) * 1998-04-29 2001-02-06 Medtronic, Inc. Power consumption reduction in medical devices employing just-in-time voltage control
US7647237B2 (en) 1998-04-29 2010-01-12 Minimed, Inc. Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6255962B1 (en) * 1998-05-15 2001-07-03 System Excelerator, Inc. Method and apparatus for low power, micro-electronic mechanical sensing and processing
US6283923B1 (en) * 1998-05-28 2001-09-04 The Trustees Of Columbia University In The City Of New York System and method for remotely monitoring asthma severity
US6736797B1 (en) 1998-06-19 2004-05-18 Unomedical A/S Subcutaneous infusion set
US6477424B1 (en) * 1998-06-19 2002-11-05 Medtronic, Inc. Medical management system integrated programming apparatus for communication with an implantable medical device
US6185461B1 (en) * 1998-07-01 2001-02-06 Pacesetter, Inc. System and method for verification of recommended replacement time indication in an implantable cardiac stimulation device
US6735474B1 (en) * 1998-07-06 2004-05-11 Advanced Bionics Corporation Implantable stimulator system and method for treatment of incontinence and pain
US6941171B2 (en) * 1998-07-06 2005-09-06 Advanced Bionics Corporation Implantable stimulator methods for treatment of incontinence and pain
US6355021B1 (en) 1998-07-14 2002-03-12 Maersk Medical A/S Medical puncturing device
US6558320B1 (en) * 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6248067B1 (en) 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6219255B1 (en) * 1998-08-20 2001-04-17 Dell Usa, L.P. Method and apparatus for reducing EMI in a computer system
JP2000075802A (en) * 1998-08-26 2000-03-14 Matsushita Electric Ind Co Ltd Back light device and back light element
US6402689B1 (en) * 1998-09-30 2002-06-11 Sicel Technologies, Inc. Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors
ATE514372T1 (en) 1998-10-08 2011-07-15 Medtronic Minimed Inc LICENSE PLATE MONITORING SYSTEM WITH REMOTE MEASUREMENT
US6212645B1 (en) * 1998-10-09 2001-04-03 Mediaq Inc. Programmable and flexible power management unit
US7193521B2 (en) 1998-10-29 2007-03-20 Medtronic Minimed, Inc. Method and apparatus for detecting errors, fluid pressure, and occlusions in an ambulatory infusion pump
DK1124608T3 (en) 1998-10-29 2006-04-03 Medtronic Minimed Inc reservoir connector
US6248093B1 (en) 1998-10-29 2001-06-19 Minimed Inc. Compact pump drive system
US6426680B1 (en) * 1999-05-26 2002-07-30 Broadcom Corporation System and method for narrow band PLL tuning
US6108571A (en) * 1998-12-14 2000-08-22 Medtronic, Inc. Ambulatory recorder having a communication watchdog between two processors
US6115636A (en) * 1998-12-22 2000-09-05 Medtronic, Inc. Telemetry for implantable devices using the body as an antenna
AU3363000A (en) * 1999-02-12 2000-08-29 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system
US6336900B1 (en) * 1999-04-12 2002-01-08 Agilent Technologies, Inc. Home hub for reporting patient health parameters
US6450953B1 (en) * 1999-04-15 2002-09-17 Nexan Limited Portable signal transfer unit
US6190324B1 (en) * 1999-04-28 2001-02-20 Medtronic, Inc. Implantable medical device for tracking patient cardiac status
US6169925B1 (en) * 1999-04-30 2001-01-02 Medtronic, Inc. Telemetry system for implantable medical devices
US6471675B1 (en) * 1999-04-30 2002-10-29 Medtronic, Inc. Passive flow control devices for implantable pumps
US6796956B2 (en) * 1999-04-30 2004-09-28 Medtronic, Inc. Method and apparatus to control drug therapy dosages in an implantable pump
US7806886B2 (en) 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
CA2370623C (en) 1999-06-08 2004-07-20 Medical Research Group, Inc. Method and apparatus for infusing liquids using a chemical reaction in an implanted infusion device
US20020052539A1 (en) * 1999-07-07 2002-05-02 Markus Haller System and method for emergency communication between an implantable medical device and a remote computer system or health care provider
US6238337B1 (en) * 1999-07-09 2001-05-29 International Business Machines Corporation Medical non-intrusive prevention based on network of embedded systems
US7177690B2 (en) * 1999-07-27 2007-02-13 Advanced Bionics Corporation Implantable system having rechargeable battery indicator
US6516227B1 (en) * 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6584590B1 (en) * 1999-08-13 2003-06-24 Lucent Technologies Inc. JTAG port-sharing device
US6415175B1 (en) * 1999-08-20 2002-07-02 Cardiac Pacemakers, Inc. Interface for a medical device system
US6263246B1 (en) * 1999-09-14 2001-07-17 Medtronic, Inc. Method and apparatus for communications with an implantable device
US6654642B2 (en) * 1999-09-29 2003-11-25 Medtronic, Inc. Patient interactive neurostimulation system and method
US6442433B1 (en) * 1999-10-26 2002-08-27 Medtronic, Inc. Apparatus and method for remote troubleshooting, maintenance and upgrade of implantable device systems
US6644321B1 (en) * 1999-10-29 2003-11-11 Medtronic, Inc. Tactile feedback for indicating validity of communication link with an implantable medical device
US6406426B1 (en) * 1999-11-03 2002-06-18 Criticare Systems Medical monitoring and alert system for use with therapeutic devices
US6453956B2 (en) 1999-11-05 2002-09-24 Medtronic Minimed, Inc. Needle safe transfer guard
WO2001043818A1 (en) * 1999-12-17 2001-06-21 Advanced Bionics Corporation Magnitude programming for implantable electrical stimulator
US6497655B1 (en) * 1999-12-17 2002-12-24 Medtronic, Inc. Virtual remote monitor, alert, diagnostics and programming for implantable medical device systems
DK1248660T3 (en) 2000-01-21 2012-07-23 Medtronic Minimed Inc Microprocessor controlled outpatient medical device with handheld communication device
WO2001052935A1 (en) 2000-01-21 2001-07-26 Medical Research Group, Inc. Ambulatory medical apparatus and method having telemetry modifiable control software
US6974437B2 (en) * 2000-01-21 2005-12-13 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US7003336B2 (en) 2000-02-10 2006-02-21 Medtronic Minimed, Inc. Analyte sensor method of making the same
US6895263B2 (en) 2000-02-23 2005-05-17 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US7890295B2 (en) 2000-02-23 2011-02-15 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US6572542B1 (en) * 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
US20010041869A1 (en) 2000-03-23 2001-11-15 Causey James D. Control tabs for infusion devices and methods of using the same
US6561975B1 (en) * 2000-04-19 2003-05-13 Medtronic, Inc. Method and apparatus for communicating with medical device systems
US7066910B2 (en) * 2000-04-27 2006-06-27 Medtronic, Inc. Patient directed therapy management
AU2001264654B2 (en) * 2000-05-19 2005-06-16 Welch Allyn Protocol Inc. Patient monitoring system
US6687538B1 (en) * 2000-06-19 2004-02-03 Medtronic, Inc. Trial neuro stimulator with lead diagnostics
AU2001280076B2 (en) * 2000-08-28 2007-04-05 In4Tel Ltd. Apparatus and method for enhancing low-frequency operation of mobile communication antennas
ES2287156T3 (en) 2000-09-08 2007-12-16 Insulet Corporation DEVICES AND SYSTEMS FOR THE INFUSION OF A PATIENT.
US6567703B1 (en) * 2000-11-08 2003-05-20 Medtronic, Inc. Implantable medical device incorporating miniaturized circuit module
US6396252B1 (en) * 2000-12-14 2002-05-28 National Semiconductor Corporation Switching DC-to-DC converter with discontinuous pulse skipping and continuous operating modes without external sense resistor
US6556871B2 (en) * 2001-01-04 2003-04-29 Cardiac Pacemakers, Inc. System and method for receiving telemetry data from an implantable medical device
US6749587B2 (en) 2001-02-22 2004-06-15 Insulet Corporation Modular infusion device and method
US6526310B1 (en) * 2001-03-02 2003-02-25 Ge Medical Systems Information Technologies, Inc. Patient transceiver system which uses conductors within leads of leadset to provide phased antenna array
US6678563B2 (en) * 2001-03-30 2004-01-13 Neurocontrol Corporation Systems and methods for performing prosthetic or therapeutic neuromuscular stimulation using a universal external controller having a graphical user interface
JP4450556B2 (en) 2001-04-06 2010-04-14 ディセトロニック・ライセンシング・アクチェンゲゼルシャフト Injection device
USD459814S1 (en) * 2001-04-09 2002-07-02 Medtronic, Inc. Programmer for a therapeutic medical device
US20020071225A1 (en) 2001-04-19 2002-06-13 Minimed Inc. Direct current motor safety circuits for fluid delivery systems
EP1267111A1 (en) 2001-06-15 2002-12-18 Dsm N.V. Pressurized fluid conduit
US6704600B2 (en) * 2001-07-13 2004-03-09 Cardiac Pacemakers, Inc. Device programmer with enclosed imaging capability
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US6754527B2 (en) * 2001-09-06 2004-06-22 Medtronic, Inc. System and method for reducing noise in an implantable medical device
US6740072B2 (en) * 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US20030050676A1 (en) * 2001-09-11 2003-03-13 Mark Hubelbank Suspension of implantable device
US7399277B2 (en) 2001-12-27 2008-07-15 Medtronic Minimed, Inc. System for monitoring physiological characteristics
FI20020076A (en) * 2002-01-15 2003-07-16 Microcell S A Luxembourg Zweig EMC arrangement for wireless communication device
US7231252B2 (en) * 2002-01-21 2007-06-12 Neopraxis Pty Ltd. FES stimulator having multiple bundled leads
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7041082B2 (en) 2002-02-28 2006-05-09 Smiths Medical Md, Inc. Syringe pump control systems and methods
US6960192B1 (en) 2002-04-23 2005-11-01 Insulet Corporation Transcutaneous fluid delivery system
US6983441B2 (en) * 2002-06-28 2006-01-03 Texas Instruments Incorporated Embedding a JTAG host controller into an FPGA design
EP2468358B1 (en) * 2002-06-28 2013-08-07 Boston Scientific Neuromodulation Corporation Microstimulator having self-contained power source and bi-directional telemetry system
US7278983B2 (en) 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US20040064166A1 (en) * 2002-09-30 2004-04-01 Thompson David L. Multi-mode programmer for medical device communication
KR100449745B1 (en) * 2002-11-21 2004-09-22 삼성전자주식회사 Apparatus and Method for avoiding noise of touch screen
US7072718B2 (en) * 2002-12-03 2006-07-04 Cardiac Pacemakers, Inc. Antenna systems for implantable medical device telemetry
US20040125016A1 (en) * 2002-12-27 2004-07-01 Atwood Michael Brian Compressed cube antenna in a volume
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
EP2273615A1 (en) * 2003-07-22 2011-01-12 Psion Teklogix Inc. Internal antenna with slots
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US6917833B2 (en) * 2003-09-16 2005-07-12 Kenergy, Inc. Omnidirectional antenna for wireless communication with implanted medical devices
US8442643B2 (en) * 2003-10-02 2013-05-14 Medtronic, Inc. Medical device programmer with reduced-noise power supply
US7991479B2 (en) * 2003-10-02 2011-08-02 Medtronic, Inc. Neurostimulator programmer with clothing attachable antenna
US7561921B2 (en) * 2003-10-02 2009-07-14 Medtronic, Inc. Neurostimulator programmer with internal antenna
US7272445B2 (en) * 2003-10-02 2007-09-18 Medtronic, Inc. Medical device programmer with faceplate
US7263406B2 (en) * 2003-10-02 2007-08-28 Medtronic, Inc. Medical device programmer with selective disablement of display during telemetry
US20050075685A1 (en) * 2003-10-02 2005-04-07 Forsberg John W. Medical device programmer with infrared communication
US7356369B2 (en) * 2003-10-02 2008-04-08 Medtronic, Inc. Z-axis assembly of medical device programmer
US7729766B2 (en) * 2003-10-02 2010-06-01 Medtronic, Inc. Circuit board construction for handheld programmer
US7203549B2 (en) * 2003-10-02 2007-04-10 Medtronic, Inc. Medical device programmer with internal antenna and display
US7699807B2 (en) 2003-11-10 2010-04-20 Smiths Medical Asd, Inc. Device and method for insertion of a cannula of an infusion device
WO2005057175A2 (en) 2003-12-09 2005-06-23 Dexcom, Inc. Signal processing for continuous analyte sensor
GB0329161D0 (en) 2003-12-16 2004-01-21 Precisense As Reagant for detecting an analyte
GB0329849D0 (en) 2003-12-23 2004-01-28 Precisense As Fluorometers
US7344500B2 (en) 2004-07-27 2008-03-18 Medtronic Minimed, Inc. Sensing system with auxiliary display
US8313433B2 (en) 2004-08-06 2012-11-20 Medtronic Minimed, Inc. Medical data management system and process
US7468033B2 (en) 2004-09-08 2008-12-23 Medtronic Minimed, Inc. Blood contacting sensor
EP1863559A4 (en) 2005-03-21 2008-07-30 Abbott Diabetes Care Inc Method and system for providing integrated medication infusion and analyte monitoring system
WO2006108809A1 (en) 2005-04-13 2006-10-19 Novo Nordisk A/S Medical skin mountable device and system
US8137314B2 (en) 2006-08-23 2012-03-20 Medtronic Minimed, Inc. Infusion medium delivery device and method with compressible or curved reservoir or conduit
US9233203B2 (en) 2005-05-06 2016-01-12 Medtronic Minimed, Inc. Medical needles for damping motion
US8277415B2 (en) 2006-08-23 2012-10-02 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US20080097291A1 (en) 2006-08-23 2008-04-24 Hanson Ian B Infusion pumps and methods and delivery devices and methods with same
US7713240B2 (en) 2005-09-13 2010-05-11 Medtronic Minimed, Inc. Modular external infusion device
WO2007056504A1 (en) 2005-11-08 2007-05-18 M2 Medical A/S Infusion pump system
US8114269B2 (en) 2005-12-30 2012-02-14 Medtronic Minimed, Inc. System and method for determining the point of hydration and proper time to apply potential to a glucose sensor
US7985330B2 (en) 2005-12-30 2011-07-26 Medtronic Minimed, Inc. Method and system for detecting age, hydration, and functional states of sensors using electrochemical impedance spectroscopy
US8114268B2 (en) 2005-12-30 2012-02-14 Medtronic Minimed, Inc. Method and system for remedying sensor malfunctions detected by electrochemical impedance spectroscopy
US20070255125A1 (en) 2006-04-28 2007-11-01 Moberg Sheldon B Monitor devices for networked fluid infusion systems
ITRM20060336A1 (en) 2006-06-27 2007-12-28 Emsar Spa CLOSING CAP FOR CONTAINERS
US7828764B2 (en) 2006-08-23 2010-11-09 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7682338B2 (en) 2006-08-23 2010-03-23 Medtronic Minimed, Inc. Infusion medium delivery system, device and method with needle inserter and needle inserter device and method
US20080125700A1 (en) 2006-11-29 2008-05-29 Moberg Sheldon B Methods and apparatuses for detecting medical device acceleration, temperature, and humidity conditions
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US20080269714A1 (en) 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US7963954B2 (en) 2007-04-30 2011-06-21 Medtronic Minimed, Inc. Automated filling systems and methods
US8323250B2 (en) 2007-04-30 2012-12-04 Medtronic Minimed, Inc. Adhesive patch systems and methods
ES2715604T3 (en) 2007-07-20 2019-06-05 Hoffmann La Roche Manual portable infusion device
US8207860B2 (en) 2008-04-28 2012-06-26 Medtronic Minimed, Inc. Automobile physiological monitoring system and method for using the same
US8181849B2 (en) 2008-12-30 2012-05-22 Medtronic Minimed, Inc. Color detection system for detecting reservoir presence and content in device
US8308679B2 (en) 2009-12-30 2012-11-13 Medtronic Minimed, Inc. Alignment systems and methods

Patent Citations (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258711A (en) * 1979-02-05 1981-03-31 Metal Bellows Corporation Infusion apparatus and method
US4373527B1 (en) * 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4373527A (en) * 1979-04-27 1983-02-15 The Johns Hopkins University Implantable, programmable medication infusion system
US4731051A (en) * 1979-04-27 1988-03-15 The Johns Hopkins University Programmable control means for providing safe and controlled medication infusion
US4494950A (en) * 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
US4487603A (en) * 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US5438621A (en) * 1988-11-02 1995-08-01 Hewlett-Packard Company DC-free line code and bit and frame synchronization for arbitrary data transmission
US5127404A (en) * 1990-01-22 1992-07-07 Medtronic, Inc. Telemetry format for implanted medical device
US5191326A (en) * 1991-09-05 1993-03-02 Schlumberger Technology Corporation Communications protocol for digital telemetry system
US5659299A (en) * 1992-01-28 1997-08-19 Servio Logic Corporation High speed infrared communications system using pulse sets
US5935099A (en) * 1992-09-09 1999-08-10 Sims Deltec, Inc. Drug pump systems and methods
US6024539A (en) * 1992-09-09 2000-02-15 Sims Deltec, Inc. Systems and methods for communicating with ambulatory medical devices such as drug delivery devices
US5416695A (en) * 1993-03-09 1995-05-16 Metriplex, Inc. Method and apparatus for alerting patients and medical personnel of emergency medical situations
US5369364A (en) * 1993-04-26 1994-11-29 Medtronic, Inc. Battery state of charge determination with plural periodic measurements to determine its internal impedance and geometric capacitance
US5658250A (en) * 1993-07-13 1997-08-19 Sims Deltec, Inc. Systems and methods for operating ambulatory medical devices such as drug delivery devices
US5368562A (en) * 1993-07-30 1994-11-29 Pharmacia Deltec, Inc. Systems and methods for operating ambulatory medical devices such as drug delivery devices
US5456692A (en) * 1993-09-03 1995-10-10 Pacesetter, Inc. System and method for noninvasively altering the function of an implanted pacemaker
US5810771A (en) * 1994-03-07 1998-09-22 Sims Deltec, Inc. Systems and methods for automated testing of medical equipment
US5669877A (en) * 1994-03-07 1997-09-23 Sims Deltec, Inc. Systems and methods for automated testing of medical equipment
US5630710A (en) * 1994-03-09 1997-05-20 Baxter International Inc. Ambulatory infusion pump
US5658133A (en) * 1994-03-09 1997-08-19 Baxter International Inc. Pump chamber back pressure dissipation apparatus and method
US6123686A (en) * 1994-04-15 2000-09-26 Sims Deltec, Inc. Systems and methods for cassette identification for drug pumps
US5647854A (en) * 1994-04-15 1997-07-15 Sims Deltec, Inc. Base plate for a drug pump
US6249703B1 (en) * 1994-07-08 2001-06-19 Medtronic, Inc. Handheld patient programmer for implantable human tissue stimulator
US5695473A (en) * 1994-07-27 1997-12-09 Sims Deltec, Inc. Occlusion detection system for an infusion pump
US5935106A (en) * 1994-07-27 1999-08-10 Sims Deltec, Inc. Occlusion detection system for an infusion pump
US5730125A (en) * 1995-02-22 1998-03-24 Sulzer Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
US5620474A (en) * 1995-04-24 1997-04-15 Vitatron Medical, B.V. System and method for determining indicated pacemaker replacement time based upon battery impedance measurement
US5724985A (en) * 1995-08-02 1998-03-10 Pacesetter, Inc. User interface for an implantable medical device using an integrated digitizer display screen
US6026124A (en) * 1995-10-05 2000-02-15 Silicon Image, Inc. Transition-controlled digital encoding and signal transmission system
US5720770A (en) * 1995-10-06 1998-02-24 Pacesetter, Inc. Cardiac stimulation system with enhanced communication and control capability
US5876370A (en) * 1995-10-11 1999-03-02 Sims Deltec, Inc. Intermittent fluid delivery apparatus and method
US5788669A (en) * 1995-11-22 1998-08-04 Sims Deltec, Inc. Pump tracking system
US5800472A (en) * 1996-05-14 1998-09-01 Pacesetter, Inc. Recommended replacement time trigger for use within an implantable rate-responsive pacemaker
US5733313A (en) * 1996-08-01 1998-03-31 Exonix Corporation RF coupled, implantable medical device with rechargeable back-up power source
US5718234A (en) * 1996-09-30 1998-02-17 Northrop Grumman Corporation Physiological data communication system
US6070103A (en) * 1996-11-05 2000-05-30 Intermedics Inc. Apparatus for making direct electrical connection with an implantable medical device
US5749907A (en) * 1997-02-18 1998-05-12 Pacesetter, Inc. System and method for identifying and displaying medical data which violate programmable alarm conditions
US5974341A (en) * 1997-12-22 1999-10-26 Pacesetter, Inc. Method and apparatus for detecting and displaying diagnostic information in conjunction with intracardiac electrograms and surface electrocardiograms
US6167303A (en) * 1998-04-29 2000-12-26 Medtronic, Inc. Power consumption reduction in medical devices employing just-in-time clock
US6057758A (en) * 1998-05-20 2000-05-02 Hewlett-Packard Company Handheld clinical terminal
US6088618A (en) * 1998-07-07 2000-07-11 Vitatron Medical, B.V. Pacemaker system and method for providing manual display concurrent with pacemaker software modification
US6409674B1 (en) * 1998-09-24 2002-06-25 Data Sciences International, Inc. Implantable sensor with wireless communication
US6155267A (en) * 1998-12-31 2000-12-05 Medtronic, Inc. Implantable medical device monitoring method and system regarding same
US6418346B1 (en) * 1999-12-14 2002-07-09 Medtronic, Inc. Apparatus and method for remote therapy and diagnosis in medical devices via interface systems

Cited By (786)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9533096B2 (en) 2000-01-21 2017-01-03 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8236242B2 (en) 2001-04-02 2012-08-07 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8268243B2 (en) 2001-04-02 2012-09-18 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US8765059B2 (en) 2001-04-02 2014-07-01 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8034026B2 (en) 2001-05-18 2011-10-11 Deka Products Limited Partnership Infusion pump assembly
US9173996B2 (en) 2001-05-18 2015-11-03 Deka Products Limited Partnership Infusion set for a fluid pump
US10049768B2 (en) 2002-02-28 2018-08-14 Tandem Diabetes Care, Inc. Programmable insulin pump
US8047812B2 (en) 2002-10-09 2011-11-01 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8029245B2 (en) 2002-10-09 2011-10-04 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8343093B2 (en) 2002-10-09 2013-01-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US7993109B2 (en) 2002-10-09 2011-08-09 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8029250B2 (en) 2002-10-09 2011-10-04 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US7993108B2 (en) 2002-10-09 2011-08-09 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8047811B2 (en) 2002-10-09 2011-11-01 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US7922458B2 (en) 2002-10-09 2011-04-12 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US10973443B2 (en) 2002-11-05 2021-04-13 Abbott Diabetes Care Inc. Sensor inserter assembly
US9980670B2 (en) 2002-11-05 2018-05-29 Abbott Diabetes Care Inc. Sensor inserter assembly
US11141084B2 (en) 2002-11-05 2021-10-12 Abbott Diabetes Care Inc. Sensor inserter assembly
US11116430B2 (en) 2002-11-05 2021-09-14 Abbott Diabetes Care Inc. Sensor inserter assembly
US8622903B2 (en) 2002-12-31 2014-01-07 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8187183B2 (en) 2002-12-31 2012-05-29 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10039881B2 (en) 2002-12-31 2018-08-07 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US20040145565A1 (en) * 2003-01-13 2004-07-29 Yao-Chia Yang Separable build-in mouse input device
US7679407B2 (en) 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US8512246B2 (en) 2003-04-28 2013-08-20 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US8512239B2 (en) 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US8647269B2 (en) 2003-06-10 2014-02-11 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8029443B2 (en) 2003-07-15 2011-10-04 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US8219175B2 (en) 2003-10-31 2012-07-10 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8116840B2 (en) 2003-10-31 2012-02-14 Abbott Diabetes Care Inc. Method of calibrating of an analyte-measurement device, and associated methods, devices and systems
US8684930B2 (en) 2003-10-31 2014-04-01 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8219174B2 (en) 2003-10-31 2012-07-10 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US11627900B2 (en) 2003-12-05 2023-04-18 Dexcom, Inc. Analyte sensor
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US11020031B1 (en) 2003-12-05 2021-06-01 Dexcom, Inc. Analyte sensor
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20090321076A1 (en) * 2004-04-12 2009-12-31 Baker Hughes Incorporated Completion Method with Telescoping Perforation & Fracturing Tool
US11507530B2 (en) 2004-06-04 2022-11-22 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US10963417B2 (en) 2004-06-04 2021-03-30 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US11182332B2 (en) 2004-06-04 2021-11-23 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20060089539A1 (en) * 2004-10-25 2006-04-27 Saul Miodownik Integrated messages from multiple patient care devices
WO2006047275A3 (en) * 2004-10-25 2007-08-16 Sloan Kettering Inst Cancer Integrated messages from multiple patient care devices
WO2006047275A2 (en) * 2004-10-25 2006-05-04 Sloan Kettering Institute For Cancer Research Integrated messages from multiple patient care devices
US20060107148A1 (en) * 2004-10-29 2006-05-18 Codman Neuro Sciences Sarl. Automatic self-testing of an internal device in a closed system
EP1666091A3 (en) * 2004-12-01 2006-08-02 The Alfred E Mann Foundation for Scientific Research An implantable device and communication integrated circuit implementable therein
US20060113396A1 (en) * 2004-12-01 2006-06-01 Derocco Paul Implantable device and communication integrated circuit implementable therein
US7237712B2 (en) 2004-12-01 2007-07-03 Alfred E. Mann Foundation For Scientific Research Implantable device and communication integrated circuit implementable therein
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US11160475B2 (en) 2004-12-29 2021-11-02 Abbott Diabetes Care Inc. Sensor inserter having introducer
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US10743801B2 (en) 2005-03-10 2020-08-18 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10856787B2 (en) 2005-03-10 2020-12-08 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10716498B2 (en) 2005-03-10 2020-07-21 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11051726B2 (en) 2005-03-10 2021-07-06 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918316B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610135B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10925524B2 (en) 2005-03-10 2021-02-23 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918318B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11000213B2 (en) 2005-03-10 2021-05-11 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10898114B2 (en) 2005-03-10 2021-01-26 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10617336B2 (en) 2005-03-10 2020-04-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918317B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10709364B2 (en) 2005-03-10 2020-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8029460B2 (en) 2005-03-21 2011-10-04 Abbott Diabetes Care Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US8029459B2 (en) 2005-03-21 2011-10-04 Abbott Diabetes Care Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US8343092B2 (en) 2005-03-21 2013-01-01 Abbott Diabetes Care Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US7884729B2 (en) 2005-05-17 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8471714B2 (en) 2005-05-17 2013-06-25 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8653977B2 (en) 2005-05-17 2014-02-18 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8089363B2 (en) 2005-05-17 2012-01-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US9750440B2 (en) 2005-05-17 2017-09-05 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US9332944B2 (en) 2005-05-17 2016-05-10 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US10206611B2 (en) 2005-05-17 2019-02-19 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US20060274764A1 (en) * 2005-06-02 2006-12-07 Mah Donald T Power saving methods in gateway
US8112138B2 (en) 2005-06-03 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US20070020580A1 (en) * 2005-06-03 2007-01-25 Manfred Harre Dental material processing device, information device, communication method, and system
US20100222921A1 (en) * 2005-06-03 2010-09-02 3M Innovative Properties Company Dental material processing device, information device, communication mthod, and system
US9774961B2 (en) 2005-06-05 2017-09-26 Starkey Laboratories, Inc. Hearing assistance device ear-to-ear communication using an intermediate device
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US9775563B2 (en) 2005-09-30 2017-10-03 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10342489B2 (en) 2005-09-30 2019-07-09 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
USD979766S1 (en) 2005-09-30 2023-02-28 Abbott Diabetes Care Inc. Analyte sensor device
US11457869B2 (en) 2005-09-30 2022-10-04 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US9480421B2 (en) 2005-09-30 2016-11-01 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US10194863B2 (en) 2005-09-30 2019-02-05 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US7756561B2 (en) 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US8638220B2 (en) 2005-10-31 2014-01-28 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11538580B2 (en) 2005-11-04 2022-12-27 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8515518B2 (en) 2005-12-28 2013-08-20 Abbott Diabetes Care Inc. Analyte monitoring
US9332933B2 (en) 2005-12-28 2016-05-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9795331B2 (en) 2005-12-28 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US10219728B2 (en) 2005-12-28 2019-03-05 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US8160670B2 (en) 2005-12-28 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US8852101B2 (en) 2005-12-28 2014-10-07 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11439326B2 (en) 2005-12-28 2022-09-13 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US10307091B2 (en) 2005-12-28 2019-06-04 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9669156B2 (en) 2005-12-28 2017-06-06 Abbott Diabetes Care Inc. Infusion sets for the delivery of a therapeutic substance to a patient
US8353881B2 (en) 2005-12-28 2013-01-15 Abbott Diabetes Care Inc. Infusion sets for the delivery of a therapeutic substance to a patient
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8792956B2 (en) 2005-12-28 2014-07-29 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US7951080B2 (en) 2006-01-30 2011-05-31 Abbott Diabetes Care Inc. On-body medical device securement
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US8734344B2 (en) 2006-01-30 2014-05-27 Abbott Diabetes Care Inc. On-body medical device securement
US9326727B2 (en) 2006-01-30 2016-05-03 Abbott Diabetes Care Inc. On-body medical device securement
US8344966B2 (en) 2006-01-31 2013-01-01 Abbott Diabetes Care Inc. Method and system for providing a fault tolerant display unit in an electronic device
US8585377B2 (en) 2006-02-09 2013-11-19 Deka Products Limited Partnership Pumping fluid delivery systems and methods using force application assembly
US8545445B2 (en) 2006-02-09 2013-10-01 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US8414522B2 (en) 2006-02-09 2013-04-09 Deka Products Limited Partnership Fluid delivery systems and methods
US11904134B2 (en) 2006-02-09 2024-02-20 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US11890448B2 (en) 2006-02-09 2024-02-06 Deka Products Limited Partnership Method and system for shape-memory alloy wire control
US11426512B2 (en) 2006-02-09 2022-08-30 Deka Products Limited Partnership Apparatus, systems and methods for an infusion pump assembly
US11413391B2 (en) 2006-02-09 2022-08-16 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US11478623B2 (en) 2006-02-09 2022-10-25 Deka Products Limited Partnership Infusion pump assembly
US11491273B2 (en) 2006-02-09 2022-11-08 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11844926B2 (en) 2006-02-09 2023-12-19 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11406753B2 (en) 2006-02-09 2022-08-09 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11408414B2 (en) 2006-02-09 2022-08-09 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US8113244B2 (en) 2006-02-09 2012-02-14 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11497846B2 (en) 2006-02-09 2022-11-15 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US11786651B2 (en) 2006-02-09 2023-10-17 Deka Products Limited Partnership Patch-sized fluid delivery system
US11395877B2 (en) 2006-02-09 2022-07-26 Deka Products Limited Partnership Systems and methods for fluid delivery
US11738139B2 (en) 2006-02-09 2023-08-29 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US11391273B2 (en) 2006-02-09 2022-07-19 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11534543B2 (en) 2006-02-09 2022-12-27 Deka Products Limited Partnership Method for making patch-sized fluid delivery systems
US11364335B2 (en) 2006-02-09 2022-06-21 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11717609B2 (en) 2006-02-09 2023-08-08 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11712513B2 (en) 2006-02-09 2023-08-01 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11690952B2 (en) 2006-02-09 2023-07-04 Deka Products Limited Partnership Pumping fluid delivery systems and methods using force application assembly
US11339774B2 (en) 2006-02-09 2022-05-24 Deka Products Limited Partnership Adhesive and peripheral systems and methods for medical devices
US11559625B2 (en) 2006-02-09 2023-01-24 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US11617826B2 (en) 2006-02-09 2023-04-04 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US7822455B2 (en) 2006-02-28 2010-10-26 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US11064916B2 (en) 2006-02-28 2021-07-20 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US11179071B2 (en) 2006-02-28 2021-11-23 Abbott Diabetes Care Inc Analyte sensor transmitter unit configuration for a data monitoring and management system
US11179072B2 (en) 2006-02-28 2021-11-23 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US8506482B2 (en) 2006-02-28 2013-08-13 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US9844329B2 (en) 2006-02-28 2017-12-19 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US10945647B2 (en) 2006-02-28 2021-03-16 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9782076B2 (en) 2006-02-28 2017-10-10 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US7981034B2 (en) 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US10117614B2 (en) 2006-02-28 2018-11-06 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US9031630B2 (en) 2006-02-28 2015-05-12 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US9364149B2 (en) 2006-02-28 2016-06-14 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US10159433B2 (en) 2006-02-28 2018-12-25 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US11872039B2 (en) 2006-02-28 2024-01-16 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
USD961778S1 (en) 2006-02-28 2022-08-23 Abbott Diabetes Care Inc. Analyte sensor device
US10448834B2 (en) 2006-02-28 2019-10-22 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US8543183B2 (en) 2006-03-31 2013-09-24 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9743863B2 (en) 2006-03-31 2017-08-29 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8086292B2 (en) 2006-03-31 2011-12-27 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US20080097324A1 (en) * 2006-05-31 2008-04-24 Seattle Medical Technologies Disposable infusion device with linear peristaltic pump
US7713262B2 (en) * 2006-05-31 2010-05-11 Calibra Medical, Inc. Disposable infusion device with linear peristaltic pump
WO2007142867A3 (en) * 2006-05-31 2008-08-28 Seattle Medical Technologies I Disposable infusion device with linear peristaltic pump
US20070287960A1 (en) * 2006-05-31 2007-12-13 Seattle Medical Technologies Disposable infusion device with medicament level indicator
WO2007142867A2 (en) * 2006-05-31 2007-12-13 Calibra Medical, Inc. Disposable infusion device with linear peristaltic pump
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US8512244B2 (en) 2006-06-30 2013-08-20 Abbott Diabetes Care Inc. Integrated analyte sensor and infusion device and methods therefor
US9119582B2 (en) 2006-06-30 2015-09-01 Abbott Diabetes Care, Inc. Integrated analyte sensor and infusion device and methods therefor
US10728678B2 (en) 2006-07-10 2020-07-28 Starkey Laboratories, Inc. Method and apparatus for a binaural hearing assistance system using monaural audio signals
US10051385B2 (en) 2006-07-10 2018-08-14 Starkey Laboratories, Inc. Method and apparatus for a binaural hearing assistance system using monaural audio signals
US10469960B2 (en) 2006-07-10 2019-11-05 Starkey Laboratories, Inc. Method and apparatus for a binaural hearing assistance system using monaural audio signals
US11064302B2 (en) 2006-07-10 2021-07-13 Starkey Laboratories, Inc. Method and apparatus for a binaural hearing assistance system using monaural audio signals
US11678128B2 (en) 2006-07-10 2023-06-13 Starkey Laboratories, Inc. Method and apparatus for a binaural hearing assistance system using monaural audio signals
US11806110B2 (en) 2006-08-07 2023-11-07 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US11445910B2 (en) 2006-08-07 2022-09-20 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US10206629B2 (en) 2006-08-07 2019-02-19 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US8727982B2 (en) 2006-08-07 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US9697332B2 (en) 2006-08-07 2017-07-04 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8206296B2 (en) 2006-08-07 2012-06-26 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US8376945B2 (en) 2006-08-09 2013-02-19 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9408566B2 (en) 2006-08-09 2016-08-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9833181B2 (en) 2006-08-09 2017-12-05 Abbot Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US10278630B2 (en) 2006-08-09 2019-05-07 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US11864894B2 (en) 2006-08-09 2024-01-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US8862198B2 (en) 2006-09-10 2014-10-14 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
USD974564S1 (en) 2006-09-10 2023-01-03 Abbott Diabetes Care Inc. Analyte sensor device
US9808186B2 (en) 2006-09-10 2017-11-07 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US10362972B2 (en) 2006-09-10 2019-07-30 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US20080077184A1 (en) * 2006-09-27 2008-03-27 Stephen Denker Intravascular Stimulation System With Wireless Power Supply
US10342469B2 (en) 2006-10-02 2019-07-09 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9629578B2 (en) 2006-10-02 2017-04-25 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9839383B2 (en) 2006-10-02 2017-12-12 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9357959B2 (en) 2006-10-02 2016-06-07 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8515517B2 (en) 2006-10-02 2013-08-20 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8821433B2 (en) 2006-10-17 2014-09-02 Tandem Diabetes Care, Inc. Insulin pump having basal rate testing features
US11217339B2 (en) 2006-10-17 2022-01-04 Tandem Diabetes Care, Inc. Food database for insulin pump
US10070810B2 (en) 2006-10-23 2018-09-11 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US11234621B2 (en) 2006-10-23 2022-02-01 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US10363363B2 (en) 2006-10-23 2019-07-30 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US11724029B2 (en) 2006-10-23 2023-08-15 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9113828B2 (en) 2006-10-25 2015-08-25 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8216137B2 (en) 2006-10-25 2012-07-10 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US11282603B2 (en) 2006-10-25 2022-03-22 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US9814428B2 (en) 2006-10-25 2017-11-14 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US10194868B2 (en) 2006-10-25 2019-02-05 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8211016B2 (en) 2006-10-25 2012-07-03 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US10903914B2 (en) 2006-10-26 2021-01-26 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US11722229B2 (en) 2006-10-26 2023-08-08 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8718958B2 (en) 2006-10-26 2014-05-06 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8135548B2 (en) 2006-10-26 2012-03-13 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US9882660B2 (en) 2006-10-26 2018-01-30 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US11043300B2 (en) 2006-10-31 2021-06-22 Abbott Diabetes Care Inc. Infusion devices and methods
US11508476B2 (en) 2006-10-31 2022-11-22 Abbott Diabetes Care, Inc. Infusion devices and methods
US11837358B2 (en) 2006-10-31 2023-12-05 Abbott Diabetes Care Inc. Infusion devices and methods
US9064107B2 (en) 2006-10-31 2015-06-23 Abbott Diabetes Care Inc. Infusion devices and methods
US10007759B2 (en) 2006-10-31 2018-06-26 Abbott Diabetes Care Inc. Infusion devices and methods
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
US9135810B2 (en) 2006-11-28 2015-09-15 Medallion Therapeutics, Inc. Method, apparatus and system for assigning remote control device to ambulatory medical device
US20080132973A1 (en) * 2006-11-28 2008-06-05 Peter Carl Lord Method, Apparatus and System For Assigning Remote Control Device to Ambulatory Medical Device
US8127046B2 (en) 2006-12-04 2012-02-28 Deka Products Limited Partnership Medical device including a capacitive slider assembly that provides output signals wirelessly to one or more remote medical systems components
US11218815B2 (en) 2007-01-03 2022-01-04 Starkey Laboratories, Inc. Wireless system for hearing communication devices providing wireless stereo reception modes
US11765526B2 (en) 2007-01-03 2023-09-19 Starkey Laboratories, Inc. Wireless system for hearing communication devices providing wireless stereo reception modes
US9854369B2 (en) 2007-01-03 2017-12-26 Starkey Laboratories, Inc. Wireless system for hearing communication devices providing wireless stereo reception modes
US10511918B2 (en) 2007-01-03 2019-12-17 Starkey Laboratories, Inc. Wireless system for hearing communication devices providing wireless stereo reception modes
US8496646B2 (en) 2007-02-09 2013-07-30 Deka Products Limited Partnership Infusion pump assembly
US8417545B2 (en) 2007-02-15 2013-04-09 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10617823B2 (en) 2007-02-15 2020-04-14 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8676601B2 (en) 2007-02-15 2014-03-18 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10022499B2 (en) 2007-02-15 2018-07-17 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US11291763B2 (en) 2007-03-13 2022-04-05 Tandem Diabetes Care, Inc. Basal rate testing using frequent blood glucose input
US9056167B2 (en) 2007-03-19 2015-06-16 Insuline Medical Ltd. Method and device for drug delivery
US8827979B2 (en) 2007-03-19 2014-09-09 Insuline Medical Ltd. Drug delivery device
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US10194846B2 (en) 2007-04-14 2019-02-05 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US11039767B2 (en) 2007-04-14 2021-06-22 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9615780B2 (en) 2007-04-14 2017-04-11 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US10349877B2 (en) 2007-04-14 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US7768387B2 (en) 2007-04-14 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7948369B2 (en) 2007-04-14 2011-05-24 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8427298B2 (en) 2007-04-14 2013-04-23 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage amplification in a medical device
US8937540B2 (en) 2007-04-14 2015-01-20 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8698615B2 (en) 2007-04-14 2014-04-15 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US9402584B2 (en) 2007-04-14 2016-08-02 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8149103B2 (en) 2007-04-14 2012-04-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage amplification in a medical device
US9743866B2 (en) 2007-04-14 2017-08-29 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8140142B2 (en) 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US10111608B2 (en) 2007-04-14 2018-10-30 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10653317B2 (en) 2007-05-08 2020-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US11696684B2 (en) 2007-05-08 2023-07-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10178954B2 (en) 2007-05-08 2019-01-15 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10952611B2 (en) 2007-05-08 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10976304B2 (en) 2007-05-14 2021-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9558325B2 (en) 2007-05-14 2017-01-31 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11300561B2 (en) 2007-05-14 2022-04-12 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US8571808B2 (en) 2007-05-14 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10653344B2 (en) 2007-05-14 2020-05-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10634662B2 (en) 2007-05-14 2020-04-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10143409B2 (en) 2007-05-14 2018-12-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10991456B2 (en) 2007-05-14 2021-04-27 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US9060719B2 (en) 2007-05-14 2015-06-23 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11076785B2 (en) 2007-05-14 2021-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US9483608B2 (en) 2007-05-14 2016-11-01 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11119090B2 (en) 2007-05-14 2021-09-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11125592B2 (en) 2007-05-14 2021-09-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10261069B2 (en) 2007-05-14 2019-04-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8682615B2 (en) 2007-05-14 2014-03-25 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10119956B2 (en) 2007-05-14 2018-11-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10463310B2 (en) 2007-05-14 2019-11-05 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9804150B2 (en) 2007-05-14 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10820841B2 (en) 2007-05-14 2020-11-03 Abbot Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9737249B2 (en) 2007-05-14 2017-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11828748B2 (en) 2007-05-14 2023-11-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9801571B2 (en) 2007-05-14 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9797880B2 (en) 2007-05-14 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10031002B2 (en) 2007-05-14 2018-07-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8612163B2 (en) 2007-05-14 2013-12-17 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10045720B2 (en) 2007-05-14 2018-08-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8484005B2 (en) 2007-05-14 2013-07-09 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11257580B2 (en) 2007-05-24 2022-02-22 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US10357607B2 (en) 2007-05-24 2019-07-23 Tandem Diabetes Care, Inc. Correction factor testing using frequent blood glucose input
US11848089B2 (en) 2007-05-24 2023-12-19 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US10943687B2 (en) 2007-05-24 2021-03-09 Tandem Diabetes Care, Inc. Expert system for insulin pump therapy
US11576594B2 (en) 2007-05-30 2023-02-14 Tandem Diabetes Care, Inc. Insulin pump based expert system
US9833177B2 (en) 2007-05-30 2017-12-05 Tandem Diabetes Care, Inc. Insulin pump based expert system
US11298053B2 (en) 2007-05-30 2022-04-12 Tandem Diabetes Care, Inc. Insulin pump based expert system
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US11264133B2 (en) 2007-06-21 2022-03-01 Abbott Diabetes Care Inc. Health management devices and methods
US11276492B2 (en) 2007-06-21 2022-03-15 Abbott Diabetes Care Inc. Health management devices and methods
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US8641618B2 (en) 2007-06-27 2014-02-04 Abbott Diabetes Care Inc. Method and structure for securing a monitoring device element
US8085151B2 (en) 2007-06-28 2011-12-27 Abbott Diabetes Care Inc. Signal converting cradle for medical condition monitoring and management system
US8502682B2 (en) 2007-06-28 2013-08-06 Abbott Diabetes Care Inc. Signal converting cradle for medical condition monitoring and management system
US9913600B2 (en) 2007-06-29 2018-03-13 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US11678821B2 (en) 2007-06-29 2023-06-20 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US10856785B2 (en) 2007-06-29 2020-12-08 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US7768386B2 (en) 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9398872B2 (en) 2007-07-31 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US20140207122A1 (en) * 2007-08-09 2014-07-24 Alfred E. Mann Foundation For Scientific Research Drug Delivery Safety System
US20090043290A1 (en) * 2007-08-09 2009-02-12 Daniel Hernandez Villegas Drug Delivery Safety System
US9440023B2 (en) * 2007-08-09 2016-09-13 Medallion Therapeutics, Inc. Drug delivery safety system
US8683381B2 (en) * 2007-08-09 2014-03-25 Alfred E. Mann Foundation For Scientific Research Drug delivery safety system
US20090088732A1 (en) * 2007-10-02 2009-04-02 Daniel Hernandez Villegas Rapid Refill Programming for Implantable Drug Pump
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US11083843B2 (en) 2007-10-23 2021-08-10 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US9743865B2 (en) 2007-10-23 2017-08-29 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US9804148B2 (en) 2007-10-23 2017-10-31 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US9439586B2 (en) 2007-10-23 2016-09-13 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US9332934B2 (en) 2007-10-23 2016-05-10 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US10173007B2 (en) 2007-10-23 2019-01-08 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US20090164239A1 (en) * 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US10685749B2 (en) 2007-12-19 2020-06-16 Abbott Diabetes Care Inc. Insulin delivery apparatuses capable of bluetooth data transmission
US11701300B2 (en) 2007-12-31 2023-07-18 Deka Products Limited Partnership Method for fluid delivery
US11497686B2 (en) 2007-12-31 2022-11-15 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11534542B2 (en) 2007-12-31 2022-12-27 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US9526830B2 (en) 2007-12-31 2016-12-27 Deka Products Limited Partnership Wearable pump assembly
US8491570B2 (en) 2007-12-31 2013-07-23 Deka Products Limited Partnership Infusion pump assembly
US11404776B2 (en) 2007-12-31 2022-08-02 Deka Products Limited Partnership Split ring resonator antenna adapted for use in wirelessly controlled medical device
US11894609B2 (en) 2007-12-31 2024-02-06 Deka Products Limited Partnership Split ring resonator antenna adapted for use in wirelessly controlled medical device
US11642283B2 (en) 2007-12-31 2023-05-09 Deka Products Limited Partnership Method for fluid delivery
US8414563B2 (en) 2007-12-31 2013-04-09 Deka Products Limited Partnership Pump assembly with switch
US11723841B2 (en) 2007-12-31 2023-08-15 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11302433B2 (en) 2008-01-07 2022-04-12 Tandem Diabetes Care, Inc. Diabetes therapy coaching
US10052049B2 (en) 2008-01-07 2018-08-21 Tandem Diabetes Care, Inc. Infusion pump with blood glucose alert delay
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US9320468B2 (en) 2008-01-31 2016-04-26 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US9770211B2 (en) 2008-01-31 2017-09-26 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US9320462B2 (en) 2008-03-28 2016-04-26 Abbott Diabetes Care Inc. Analyte sensor calibration management
US10463288B2 (en) 2008-03-28 2019-11-05 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9730623B2 (en) 2008-03-28 2017-08-15 Abbott Diabetes Care Inc. Analyte sensor calibration management
US11779248B2 (en) 2008-03-28 2023-10-10 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8583205B2 (en) 2008-03-28 2013-11-12 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8718739B2 (en) 2008-03-28 2014-05-06 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8252229B2 (en) 2008-04-10 2012-08-28 Abbott Diabetes Care Inc. Method and system for sterilizing an analyte sensor
US8802006B2 (en) 2008-04-10 2014-08-12 Abbott Diabetes Care Inc. Method and system for sterilizing an analyte sensor
US10327682B2 (en) 2008-05-30 2019-06-25 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9184875B2 (en) 2008-05-30 2015-11-10 Abbott Diabetes Care, Inc. Close proximity communication device and methods
US9795328B2 (en) 2008-05-30 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9831985B2 (en) 2008-05-30 2017-11-28 Abbott Diabetes Care Inc. Close proximity communication device and methods
US11770210B2 (en) 2008-05-30 2023-09-26 Abbott Diabetes Care Inc. Close proximity communication device and methods
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8737259B2 (en) 2008-05-30 2014-05-27 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8509107B2 (en) 2008-05-30 2013-08-13 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US11735295B2 (en) 2008-05-30 2023-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9931075B2 (en) 2008-05-30 2018-04-03 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9541556B2 (en) 2008-05-30 2017-01-10 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8117481B2 (en) 2008-06-06 2012-02-14 Roche Diagnostics International Ag Apparatus and method for processing wirelessly communicated information within an electronic device
US8738957B2 (en) 2008-06-06 2014-05-27 Roche Diagnostics Operations, Inc. Apparatus and method for processing a wirelessly received information encoded in form of embedded data and clock
US20090307520A1 (en) * 2008-06-06 2009-12-10 Bruno Anselmi Apparatus and Method for Processing Wirelessly Communicated Information Within an Electronic Device
US8132037B2 (en) 2008-06-06 2012-03-06 Roche Diagnostics International Ag Apparatus and method for processing wirelessly communicated data and clock information within an electronic device
US11621073B2 (en) 2008-07-14 2023-04-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US10328201B2 (en) 2008-07-14 2019-06-25 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US9610046B2 (en) 2008-08-31 2017-04-04 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US9572934B2 (en) 2008-08-31 2017-02-21 Abbott DiabetesCare Inc. Robust closed loop control and methods
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US8795252B2 (en) 2008-08-31 2014-08-05 Abbott Diabetes Care Inc. Robust closed loop control and methods
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US8448824B2 (en) 2008-09-16 2013-05-28 Tandem Diabetes Care, Inc. Slideable flow metering devices and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
US7911817B2 (en) 2008-09-18 2011-03-22 Dell Products L.P. Systems and methods for controlling energy consumption of AC-DC adapters
US8650937B2 (en) 2008-09-19 2014-02-18 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
US9662056B2 (en) 2008-09-30 2017-05-30 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US11484234B2 (en) 2008-09-30 2022-11-01 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US11013439B2 (en) 2008-09-30 2021-05-25 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US11464434B2 (en) 2008-09-30 2022-10-11 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8744547B2 (en) 2008-09-30 2014-06-03 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US10045739B2 (en) 2008-09-30 2018-08-14 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US11202592B2 (en) 2008-09-30 2021-12-21 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US9180245B2 (en) 2008-10-10 2015-11-10 Deka Products Limited Partnership System and method for administering an infusible fluid
US8016789B2 (en) 2008-10-10 2011-09-13 Deka Products Limited Partnership Pump assembly with a removable cover assembly
US8066672B2 (en) 2008-10-10 2011-11-29 Deka Products Limited Partnership Infusion pump assembly with a backup power supply
US8708376B2 (en) 2008-10-10 2014-04-29 Deka Products Limited Partnership Medium connector
US8262616B2 (en) 2008-10-10 2012-09-11 Deka Products Limited Partnership Infusion pump assembly
US8267892B2 (en) 2008-10-10 2012-09-18 Deka Products Limited Partnership Multi-language / multi-processor infusion pump assembly
US8223028B2 (en) 2008-10-10 2012-07-17 Deka Products Limited Partnership Occlusion detection system and method
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US8961458B2 (en) 2008-11-07 2015-02-24 Insuline Medical Ltd. Device and method for drug delivery
US9731084B2 (en) 2008-11-07 2017-08-15 Insuline Medical Ltd. Device and method for drug delivery
US9730650B2 (en) 2008-11-10 2017-08-15 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US11678848B2 (en) 2008-11-10 2023-06-20 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US11272890B2 (en) 2008-11-10 2022-03-15 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8532935B2 (en) 2009-01-29 2013-09-10 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US11464430B2 (en) 2009-01-29 2022-10-11 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8676513B2 (en) 2009-01-29 2014-03-18 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9066709B2 (en) 2009-01-29 2015-06-30 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US10089446B2 (en) 2009-01-29 2018-10-02 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8473220B2 (en) 2009-01-29 2013-06-25 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US9993188B2 (en) 2009-02-03 2018-06-12 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11202591B2 (en) 2009-02-03 2021-12-21 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD957642S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor inserter
USD957643S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor device
USD882432S1 (en) 2009-02-03 2020-04-28 Abbott Diabetes Care Inc. Analyte sensor on body unit
US9636068B2 (en) 2009-02-03 2017-05-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11213229B2 (en) 2009-02-03 2022-01-04 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006871B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US10786190B2 (en) 2009-02-03 2020-09-29 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11166656B2 (en) 2009-02-03 2021-11-09 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD955599S1 (en) 2009-02-03 2022-06-21 Abbott Diabetes Care Inc. Analyte sensor inserter
US9178752B2 (en) 2009-04-15 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8730058B2 (en) 2009-04-15 2014-05-20 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US10009244B2 (en) 2009-04-15 2018-06-26 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
US9693688B2 (en) 2009-04-29 2017-07-04 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9310230B2 (en) 2009-04-29 2016-04-12 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9949639B2 (en) 2009-04-29 2018-04-24 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10172518B2 (en) 2009-04-29 2019-01-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9088452B2 (en) 2009-04-29 2015-07-21 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10617296B2 (en) 2009-04-29 2020-04-14 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US20100280502A1 (en) * 2009-04-30 2010-11-04 Medtronic, Inc. Modular medical pump
US11872370B2 (en) 2009-05-29 2024-01-16 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
US9795326B2 (en) 2009-07-23 2017-10-24 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US10872102B2 (en) 2009-07-23 2020-12-22 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US8798934B2 (en) 2009-07-23 2014-08-05 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US10827954B2 (en) 2009-07-23 2020-11-10 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US9211377B2 (en) 2009-07-30 2015-12-15 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8926561B2 (en) 2009-07-30 2015-01-06 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8287495B2 (en) 2009-07-30 2012-10-16 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US10434253B2 (en) 2009-07-30 2019-10-08 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US11285263B2 (en) 2009-07-30 2022-03-29 Tandem Diabetes Care, Inc. Infusion pump systems and methods
US8298184B2 (en) 2009-07-30 2012-10-30 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8758323B2 (en) 2009-07-30 2014-06-24 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US11135362B2 (en) 2009-07-30 2021-10-05 Tandem Diabetes Care, Inc. Infusion pump systems and methods
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US8718965B2 (en) 2009-07-31 2014-05-06 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US9936910B2 (en) 2009-07-31 2018-04-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US10660554B2 (en) 2009-07-31 2020-05-26 Abbott Diabetes Care Inc. Methods and devices for analyte monitoring calibration
US11234625B2 (en) 2009-07-31 2022-02-01 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US9186113B2 (en) 2009-08-31 2015-11-17 Abbott Diabetes Care Inc. Displays for a medical device
US10918342B1 (en) 2009-08-31 2021-02-16 Abbott Diabetes Care Inc. Displays for a medical device
US11150145B2 (en) 2009-08-31 2021-10-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
USRE47315E1 (en) 2009-08-31 2019-03-26 Abbott Diabetes Care Inc. Displays for a medical device
US11202586B2 (en) 2009-08-31 2021-12-21 Abbott Diabetes Care Inc. Displays for a medical device
US11241175B2 (en) 2009-08-31 2022-02-08 Abbott Diabetes Care Inc. Displays for a medical device
US10772572B2 (en) 2009-08-31 2020-09-15 Abbott Diabetes Care Inc. Displays for a medical device
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US10123752B2 (en) 2009-08-31 2018-11-13 Abbott Diabetes Care Inc. Displays for a medical device
US10492685B2 (en) 2009-08-31 2019-12-03 Abbott Diabetes Care Inc. Medical devices and methods
US8514086B2 (en) 2009-08-31 2013-08-20 Abbott Diabetes Care Inc. Displays for a medical device
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9226714B2 (en) 2009-08-31 2016-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US9814416B2 (en) 2009-08-31 2017-11-14 Abbott Diabetes Care Inc. Displays for a medical device
US11045147B2 (en) 2009-08-31 2021-06-29 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US11635332B2 (en) 2009-08-31 2023-04-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US10429250B2 (en) 2009-08-31 2019-10-01 Abbott Diabetes Care, Inc. Analyte monitoring system and methods for managing power and noise
US9549694B2 (en) 2009-08-31 2017-01-24 Abbott Diabetes Care Inc. Displays for a medical device
US10881355B2 (en) 2009-08-31 2021-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US8816862B2 (en) 2009-08-31 2014-08-26 Abbott Diabetes Care Inc. Displays for a medical device
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
USD962446S1 (en) 2009-08-31 2022-08-30 Abbott Diabetes Care, Inc. Analyte sensor device
US10456091B2 (en) 2009-08-31 2019-10-29 Abbott Diabetes Care Inc. Displays for a medical device
USD1010133S1 (en) 2009-08-31 2024-01-02 Abbott Diabetes Care Inc. Analyte sensor assembly
US11730429B2 (en) 2009-08-31 2023-08-22 Abbott Diabetes Care Inc. Displays for a medical device
US9750439B2 (en) 2009-09-29 2017-09-05 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US10349874B2 (en) 2009-09-29 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US10765351B2 (en) 2009-09-30 2020-09-08 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9750444B2 (en) 2009-09-30 2017-09-05 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US11259725B2 (en) 2009-09-30 2022-03-01 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US11207005B2 (en) 2009-10-30 2021-12-28 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US8185181B2 (en) 2009-10-30 2012-05-22 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US9050041B2 (en) 2009-10-30 2015-06-09 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US10117606B2 (en) 2009-10-30 2018-11-06 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US10016559B2 (en) 2009-12-04 2018-07-10 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US11090432B2 (en) 2009-12-04 2021-08-17 Smiths Medical Asd, Inc. Advanced step therapy delivery for an ambulatory infusion pump and system
US11019589B2 (en) 2009-12-21 2021-05-25 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US10212682B2 (en) 2009-12-21 2019-02-19 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US20110150254A1 (en) * 2009-12-21 2011-06-23 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
EP2348756A3 (en) * 2009-12-21 2012-10-17 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US9426586B2 (en) 2009-12-21 2016-08-23 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US20110150251A1 (en) * 2009-12-21 2011-06-23 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US9420387B2 (en) 2009-12-21 2016-08-16 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
US9420385B2 (en) 2009-12-21 2016-08-16 Starkey Laboratories, Inc. Low power intermittent messaging for hearing assistance devices
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US11000216B2 (en) 2010-03-24 2021-05-11 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11064922B1 (en) 2010-03-24 2021-07-20 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9687183B2 (en) 2010-03-24 2017-06-27 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD948722S1 (en) 2010-03-24 2022-04-12 Abbott Diabetes Care Inc. Analyte sensor inserter
USD997362S1 (en) 2010-03-24 2023-08-29 Abbott Diabetes Care Inc. Analyte sensor inserter
US10772547B1 (en) 2010-03-24 2020-09-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11058334B1 (en) 2010-03-24 2021-07-13 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881341B1 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9186098B2 (en) 2010-03-24 2015-11-17 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9265453B2 (en) 2010-03-24 2016-02-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881340B2 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11013440B2 (en) 2010-03-24 2021-05-25 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10945649B2 (en) 2010-03-24 2021-03-16 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9215992B2 (en) 2010-03-24 2015-12-22 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD987830S1 (en) 2010-03-24 2023-05-30 Abbott Diabetes Care Inc. Analyte sensor inserter
US10010280B2 (en) 2010-03-24 2018-07-03 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10959654B2 (en) 2010-03-24 2021-03-30 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11246519B2 (en) 2010-03-24 2022-02-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11266335B2 (en) 2010-03-24 2022-03-08 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10952657B2 (en) 2010-03-24 2021-03-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10292632B2 (en) 2010-03-24 2019-05-21 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9402142B2 (en) 2010-04-13 2016-07-26 Starkey Laboratories, Inc. Range control for wireless hearing assistance device systems
US8811639B2 (en) 2010-04-13 2014-08-19 Starkey Laboratories, Inc. Range control for wireless hearing assistance device systems
US8804988B2 (en) 2010-04-13 2014-08-12 Starkey Laboratories, Inc. Control of low power or standby modes of a hearing assistance device
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10973449B2 (en) 2010-06-29 2021-04-13 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11478173B2 (en) 2010-06-29 2022-10-25 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US10959653B2 (en) 2010-06-29 2021-03-30 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10966644B2 (en) 2010-06-29 2021-04-06 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11213226B2 (en) 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US20120119900A1 (en) * 2010-11-15 2012-05-17 Lewis Innovative Technologies Wireless emergency vehicle light and siren kit
US20140092911A1 (en) * 2011-02-23 2014-04-03 Hp Ventures A/S Method and System for Routing Information in a Network
US8625424B2 (en) * 2011-02-23 2014-01-07 Hp Ventures A/S Method and system for routing information in a network
US20120213227A1 (en) * 2011-02-23 2012-08-23 Morten Gravild Bjerregaard Jaeger Method and System for Routing Information in a Network
US9641426B2 (en) * 2011-02-23 2017-05-02 Hp Ventures A/S Method and system for routing information in a network
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US11627898B2 (en) 2011-02-28 2023-04-18 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US11534089B2 (en) 2011-02-28 2022-12-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US10722162B2 (en) 2011-04-15 2020-07-28 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10610141B2 (en) 2011-04-15 2020-04-07 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10624568B2 (en) 2011-04-15 2020-04-21 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10835162B2 (en) 2011-04-15 2020-11-17 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10555695B2 (en) 2011-04-15 2020-02-11 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10682084B2 (en) 2011-04-15 2020-06-16 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10561354B2 (en) 2011-04-15 2020-02-18 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9913619B2 (en) 2011-10-31 2018-03-13 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US11406331B2 (en) 2011-10-31 2022-08-09 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9465420B2 (en) 2011-10-31 2016-10-11 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9743872B2 (en) 2011-11-23 2017-08-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9289179B2 (en) 2011-11-23 2016-03-22 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10939859B2 (en) 2011-11-23 2021-03-09 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10136847B2 (en) 2011-11-23 2018-11-27 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US11391723B2 (en) 2011-11-25 2022-07-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US10082493B2 (en) 2011-11-25 2018-09-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US11051725B2 (en) 2011-12-11 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US11179068B2 (en) 2011-12-11 2021-11-23 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
USD903877S1 (en) 2011-12-11 2020-12-01 Abbott Diabetes Care Inc. Analyte sensor device
USD915601S1 (en) 2011-12-11 2021-04-06 Abbott Diabetes Care Inc. Analyte sensor device
US11051724B2 (en) 2011-12-11 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9693713B2 (en) 2011-12-11 2017-07-04 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
USD915602S1 (en) 2011-12-11 2021-04-06 Abbott Diabetes Care Inc. Analyte sensor device
US9931066B2 (en) 2011-12-11 2018-04-03 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US11524151B2 (en) 2012-03-07 2022-12-13 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US9335910B2 (en) 2012-04-23 2016-05-10 Tandem Diabetes Care, Inc. System and method for reduction of inadvertent activation of medical device during manipulation
US11694794B2 (en) 2012-04-23 2023-07-04 Tandem Diabetes Care, Inc. System and method for reduction of inadvertent activation of medical device during manipulation
US10258736B2 (en) 2012-05-17 2019-04-16 Tandem Diabetes Care, Inc. Systems including vial adapter for fluid transfer
US11676694B2 (en) 2012-06-07 2023-06-13 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US9715327B2 (en) 2012-06-07 2017-07-25 Tandem Diabetes Care, Inc. Preventing inadvertent changes in ambulatory medical devices
US10430043B2 (en) 2012-06-07 2019-10-01 Tandem Diabetes Care, Inc. Preventing inadvertent changes in ambulatory medical devices
US10653834B2 (en) 2012-06-07 2020-05-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
US10656139B2 (en) 2012-08-30 2020-05-19 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10345291B2 (en) 2012-08-30 2019-07-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10942164B2 (en) 2012-08-30 2021-03-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US11612363B2 (en) 2012-09-17 2023-03-28 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US10842420B2 (en) 2012-09-26 2020-11-24 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US11896371B2 (en) 2012-09-26 2024-02-13 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US10188334B2 (en) 2012-10-30 2019-01-29 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US9801577B2 (en) 2012-10-30 2017-10-31 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US11607492B2 (en) 2013-03-13 2023-03-21 Tandem Diabetes Care, Inc. System and method for integration and display of data of insulin pumps and continuous glucose monitoring
US10357606B2 (en) 2013-03-13 2019-07-23 Tandem Diabetes Care, Inc. System and method for integration of insulin pumps and continuous glucose monitoring
US10201656B2 (en) 2013-03-13 2019-02-12 Tandem Diabetes Care, Inc. Simplified insulin pump for type II diabetics
US11364340B2 (en) 2013-03-13 2022-06-21 Tandem Diabetes Care, Inc. Simplified insulin pump for type II diabetics
US9962486B2 (en) 2013-03-14 2018-05-08 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10874336B2 (en) 2013-03-15 2020-12-29 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US11049614B2 (en) 2013-03-15 2021-06-29 Tandem Diabetes Care, Inc. Field update of an ambulatory infusion pump system
US11776689B2 (en) 2013-03-15 2023-10-03 Tandem Diabetes Care, Inc. Field update of an ambulatory infusion pump system
US10016561B2 (en) 2013-03-15 2018-07-10 Tandem Diabetes Care, Inc. Clinical variable determination
US11152115B2 (en) 2013-03-15 2021-10-19 Tandem Diabetes Care, Inc. Field update of an ambulatory infusion pump system
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US11597541B2 (en) 2013-07-03 2023-03-07 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US10478551B2 (en) 2013-12-26 2019-11-19 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US10213547B2 (en) 2013-12-26 2019-02-26 Tandem Diabetes Care, Inc. Safety processor for a drug delivery device
US11383027B2 (en) 2013-12-26 2022-07-12 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US9486571B2 (en) 2013-12-26 2016-11-08 Tandem Diabetes Care, Inc. Safety processor for wireless control of a drug delivery device
US11911590B2 (en) 2013-12-26 2024-02-27 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US10806851B2 (en) 2013-12-26 2020-10-20 Tandem Diabetes Care, Inc. Wireless control of a drug delivery device
US10918785B2 (en) 2013-12-26 2021-02-16 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US9737656B2 (en) 2013-12-26 2017-08-22 Tandem Diabetes Care, Inc. Integration of infusion pump with remote electronic device
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
US11717225B2 (en) 2014-03-30 2023-08-08 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
US10003379B2 (en) 2014-05-06 2018-06-19 Starkey Laboratories, Inc. Wireless communication with probing bandwidth
US9669160B2 (en) 2014-07-30 2017-06-06 Tandem Diabetes Care, Inc. Temporary suspension for closed-loop medicament therapy
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
USD980986S1 (en) 2015-05-14 2023-03-14 Abbott Diabetes Care Inc. Analyte sensor inserter
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US11638781B2 (en) 2015-12-29 2023-05-02 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US10569016B2 (en) 2015-12-29 2020-02-25 Tandem Diabetes Care, Inc. System and method for switching between closed loop and open loop control of an ambulatory infusion pump
US11071478B2 (en) 2017-01-23 2021-07-27 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11382540B2 (en) 2017-10-24 2022-07-12 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11706876B2 (en) 2017-10-24 2023-07-18 Dexcom, Inc. Pre-connected analyte sensors
US11523972B2 (en) 2018-04-24 2022-12-13 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US11464908B2 (en) 2019-02-18 2022-10-11 Tandem Diabetes Care, Inc. Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
USD1006235S1 (en) 2020-12-21 2023-11-28 Abbott Diabetes Care Inc. Analyte sensor inserter
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter

Also Published As

Publication number Publication date
US20010041831A1 (en) 2001-11-15
US20020173702A1 (en) 2002-11-21
US20150057518A1 (en) 2015-02-26
US6694191B2 (en) 2004-02-17
US6585644B2 (en) 2003-07-01
US6648821B2 (en) 2003-11-18
US20030028079A1 (en) 2003-02-06
US20050010269A1 (en) 2005-01-13
US20030028080A1 (en) 2003-02-06
US20020173830A1 (en) 2002-11-21
US7831310B2 (en) 2010-11-09
US6427088B1 (en) 2002-07-30
US20010041920A1 (en) 2001-11-15
US20110275904A1 (en) 2011-11-10
US20020058906A1 (en) 2002-05-16
US6659948B2 (en) 2003-12-09
US20030050535A1 (en) 2003-03-13
US6562001B2 (en) 2003-05-13
US20020198513A1 (en) 2002-12-26
US6668196B1 (en) 2003-12-23
US6687546B2 (en) 2004-02-03
US20030065308A1 (en) 2003-04-03
US20030028184A1 (en) 2003-02-06
US20030069614A1 (en) 2003-04-10
US20030055406A1 (en) 2003-03-20
US6740075B2 (en) 2004-05-25
US20020019606A1 (en) 2002-02-14
US6950708B2 (en) 2005-09-27
US6564105B2 (en) 2003-05-13
US6974437B2 (en) 2005-12-13
US7171274B2 (en) 2007-01-30
US20040210267A1 (en) 2004-10-21
US6811534B2 (en) 2004-11-02
US9533096B2 (en) 2017-01-03
US20020173703A1 (en) 2002-11-21
US6811533B2 (en) 2004-11-02
US20020065454A1 (en) 2002-05-30
US20030176933A1 (en) 2003-09-18
US7347819B2 (en) 2008-03-25
US8568356B2 (en) 2013-10-29
US20020049480A1 (en) 2002-04-25
US6733446B2 (en) 2004-05-11
US6571128B2 (en) 2003-05-27
US20060173444A1 (en) 2006-08-03
US20110270045A1 (en) 2011-11-03
US7678071B2 (en) 2010-03-16
US20030212441A1 (en) 2003-11-13
US6813519B2 (en) 2004-11-02
US20030065370A1 (en) 2003-04-03
US6958705B2 (en) 2005-10-25
US7024245B2 (en) 2006-04-04
US6635014B2 (en) 2003-10-21
US20020065509A1 (en) 2002-05-30
US6577899B2 (en) 2003-06-10
US6873268B2 (en) 2005-03-29
US20020065540A1 (en) 2002-05-30
US20110125095A1 (en) 2011-05-26
US20040225338A1 (en) 2004-11-11
US20030009203A1 (en) 2003-01-09
US20020016568A1 (en) 2002-02-07
US6758810B2 (en) 2004-07-06
US8938306B2 (en) 2015-01-20
US6810290B2 (en) 2004-10-26

Similar Documents

Publication Publication Date Title
US6668196B1 (en) Ambulatory medical apparatus with hand held communication device
EP1248660B1 (en) Microprocessor controlled ambulatory medical apparatus with hand held communication device
WO2003008014A2 (en) Ambulatory medical apparatus with hand held communication device

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION